{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "Abstract = '''The ongoing pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a serious threat to global public health and there is currently no effective antiviral therapy It has been suggested that Chloroquine (CQ) and hydroxychloroquine (HCQ), which were primarily employed as prophylaxis and treatment for malaria, could be used to treat COVID-19 CQ and HCQ may be potential inhibitors of SARS-CoV-2 entry into host cells, which is mediated via the angiotensin-converting enzyme 2 (ACE2), and may also inhibit subsequent intracellular processes which lead to COVID-19, including damage to the cardiovascular system However, paradoxically, CQ and HCQ have also been reported to cause damage to the cardiovascular system In this review, we provide a critical examination of the published evidence CQ and HCQ could potentially be useful drugs in the treatment of COVID-19 and other ACE2 involved virus infections, but the antiviral effects of CQ and HCQ need to be tested in more well-designed clinical randomized studies and their actions on the cardiovascular system need to be further elucidated However, even if it were to turn out that CQ and HCQ are not useful drugs in practice, further studies of their mechanism of action could be helpful in improving our understanding of COVID-19 pathology\n",
    "Background and aims As the Coronavirus disease 2019 (COVID-19) pandemic unravels rapidly, there is a glut of confusing and divergent scientific information emanating from differing sources, including the Indian National Task Force for COVID-19 Thus, a web-based survey was conducted to decipher the approach of Indian doctors to the various options for treatment of COVID-19 Methods A web-based questionnaire among one lakh doctors across India through email and social media was circulated After data quality and internal validation, 826 responses were included for analysis Basic demographic and comparative analysis were performed using the Python3 8 2 software (Windows 10 64 bit, USA) Results Amongst all the states of India most respondents hailed from the top ten affected states Overall 76 15% of doctors would either prescribe or consider prescribing hydroxychloroquine (HCQ) as prophylaxis for health-care providers (HCP) Doctors with experience of managing COVID-19 were more likely to advocate use of HCQ as prophylaxis for HCP (χ2 = 4 357, P = 0 037) Intensivists were more likely to advocate HCQ as prophylaxis (χ2 = 14 588, P < 0 001) as well as for management of mild to moderate COVID-19 (χ2 = 3 91, P = 0 048) In COVID-19, 65 8% doctors overwhelmingly preferred using anti-viral agents in severe cases, continuing ACEi/ARB (60 9%), and routinely screening for COVID-19 as a pre-operative strategy (73 85%) Conclusions Indian doctors are largely following the scientific guidance provided by Indian National Task Force for COVID-19 and would consider prescribing HCQ as prophylaxis for COVID-19 They would also consider using it in mild to moderate COVID-19\n",
    "Hydroxychloroquine sulfate is one of a large series of 4-aminoquinolines with antimalarial activity Moreover, it is used for the treatment of rheumatoid arthritis Sometimes Hydroxychloroquine sulfate is very effective for the treatment of autoimmune diseases Based on the recent clinical experiments it is exploiting for the treatment of COVID-19, corona virus across the globe A Reverse phase RP-HPLC method have been developed and validated as per the current ICH guidelines for estimation of Hydroxychloroquine sulfate tablets As part of method validation specificity, linearity, precision and recovery parameters were verified The concentration and area relationships were linear (R (2) > 0 999), over the concentration range of 25 to 300 µg mL (-1) for HCQ The relative standard deviations for precision and intermediate precision were less than 1 5% The proposed RP-HPLC generic method was applied successfully for evaluation of invitro dissolution profile with different pH conditions like 0 1N HCl, pH 4 5 Acetate buffer and pH 6 8 Phosphate buffers of US marketed reference product\n",
    "The use of hydroxychloroquine (HCQ) has been considered a therapeutic option by international guidelines and expert opinions during the first phase of COVID-19 pandemics, 1-10 although scientific evidence remained too scarce to make a definitive recommendation 11 . While HCQ use has now been questioned by recent data 7 , some previous works draw attention to contrasting results on enhanced viral clearance after HCQ treatment 1-6,10 .\n",
    "In recent months, the new coronavirus SARS-CoV-2 has emerged as a worldwide threat with about 4.2 million confirmed cases and almost 300 000 deaths. Its major clinical presentation is characterized by respiratory symptoms ranging from mild cough to serve pneumonia with fever and potentially even death. Until today, there is no known medication to improve clinical symptoms or even prevent or fight the infection. The search for a useful vaccination is ongoing and it will probably not be available before the end of 2020. In this review, we highlight hydroxychloroquine (HCQ) as a potential agent to prevent coronavirus disease 2019 (COVID-19) and reduce as well as shorten clinical symptoms. Moreover, it might serve as a potential post-exposition prophylaxis. Although it has been used in the treatment of rheumatoid arthritis, discoid or systemic lupus erythematosus, and malaria prophylaxis and therapy for decades, knowledge on HCQ as a potential treatment for COVID-19 is limited and multiple clinical trials have just emerged. Especially, rare HCQ side effects which were of minor importance for use in selected indications might gain major relevance with population-wide application. These rare side effects include retinopathy and-even more important-QT prolongation leading to sudden cardiac death by malignant arrhythmias.\n",
    "Severe acute respiratory coronavirus 2 (SARS-CoV-2) has caused a devastating worldwide pandemic. Hydroxychloroquine (HCQ) has in vitro activity against SARS-CoV-2, but clinical data supporting HCQ for coronavirus disease 2019 (COVID-19) are limited.\n",
    "METHODS:\n",
    "This was a retrospective cohort study of hospitalized patients with COVID-19 who received ≥1 dose of HCQ at two New York City hospitals. We measured incident Grade 3 or 4 blood count and liver test abnormalities, ventricular arrhythmias, and vomiting and diarrhea within 10 days after HCQ initiation, and the proportion of patients who completed HCQ therapy. We also describe changes in Sequential Organ Failure Assessment hypoxia scores between baseline and day 10 after HCQ initiation and in-hospital mortality.\n",
    "RESULTS:\n",
    "None of the 153 hospitalized patients with COVID-19 who received HCQ developed a sustained ventricular tachyarrhythmia. Incident blood count and liver test abnormalities occurred in <15% of patients and incident vomiting or diarrhea was rare. Eighty-nine percent of patients completed their HCQ course and three patients discontinued therapy because of QT prolongation. Fifty-two percent of patients had improved hypoxia scores 10 days after starting HCQ. Thirty-one percent of patients who were receiving mechanical ventilation at the time of HCQ initiation died during their hospitalization, compared to 18% of patients who were receiving supplemental oxygen but not requiring mechanical ventilation, and 8% of patients who were not requiring supplemental oxygen. Co-administration of azithromycin was not associated with improved outcomes.\n",
    "CONCLUSIONS:\n",
    "HCQ appears to be reasonably safe and tolerable in most hospitalized patients with COVID-19. However, nearly one-half of patients did not improve with this treatment, highlighting the need to evaluate HCQ and alternate therapies in randomized trials.\n",
    "The aim of this work is to trace how rheumatologists all over Egypt are approaching the COVID-19 pandemic and what changes it has brought about in the patients' care with special attention to its effect on vulnerable rheumatic disease (RD) patients. This survey further aims to help inform the rheumatology community about the changes in practice during the COVID-19 pandemic. The survey included 26 questions distributed to University staff members across Egypt members of the Egyptian College of Rheumatology (ECR). It takes 5-10 min to fill out. The practice setting of participating rheumatologists included University Teaching Hospitals that are the main rheumatology and clinical immunology service providers for adults and children RD patients. There was an overall agreement across the country in the responses to the survey that took a median time of 7 min to fill in. Potential changes in rheumatology outpatient practice by staff members evolved since the COVID-19 pandemic. None of the university rheumatology staff members has prescribed chloroquine or HCQ to prevent or treat COVID-19 in a non-hospitalized patient who was not previously on it. Twenty-three recommended decrease/avoid NSAIDs if the RD patient had confirmed COVID-19 or symptoms. There is an agreement to the key emerging frontline role of rheumatologists in treating COVID-19. During the pandemic, RD cases requiring admission were dealt with by several modified strategies. The overall agreement among the different university rheumatology departments during such critical situation has provoked the ECR to consider providing provisional guidelines for dealing with RD patients during this global catastrophe.\n",
    "COVID-19 has rapidly become a pandemic for which no antiviral drug or vaccine is yet available2-4. Several clinical studies are ongoing to evaluate the efficacy of repurposed drugs that have demonstrated antiviral efficacy in vitro. Among these candidates, hydroxychloroquine (HCQ) has been given to thousands of individuals worldwide but definitive evidence for HCQ efficacy in treatment of COVID-19 is still missing6,7,17,18. We evaluated the antiviral activity of HCQ both in vitro and in SARS-CoV-2-infected macaques. HCQ showed antiviral activity in African green monkey kidney cells (VeroE6) but not in a model of reconstituted human airway epithelium. In macaques, we tested different treatment strategies in comparison to placebo, before and after peak viral load, alone or in combination with azithromycin (AZTH). Neither HCQ nor HCQ+AZTH showed a significant effect on the viral load levels in any of the tested compartments. When the drug was used as a pre-exposure prophylaxis (PrEP), HCQ did not confer protection against acquisition of infection. Our findings do not support the use of HCQ, either alone or in combination with AZTH, as an antiviral treatment for COVID-19 in humans.\n",
    "Over the last few months, coronavirus disease 2019 (COVID-19) pandemic caused by the novel coronavirus SARS-CoV-2 has posed a serious threat to public health on a global scale. Given the current lack of an effective vaccine, several drugs have been repurposed for treatment and prophylaxis of COVID-19 in an attempt to find an effective cure. AREAS COVERED The antimalarial drug hydroxychloroquine (HCQ) initially garnered widespread attention following the publication of preliminary results showing that this drug exerts an anti-SARS-CoV-2 activity in vitro. EXPERT OPINION To date, clinical evidence suggests lack of benefit from HCQ use for the treatment of hospitalized patients with COVID-19. In such patients, HCQ also appears to be associated with an increased risk of QT interval prolongation and potentially lethal ventricular arrhythmias. Therefore, FDA has recently revoked the Emergency Use Authorization (EUA) for emergency use of HCQ and chloroquine to treat COVID-19. Conversely, whether HCQ use may represent an effective prophylactic strategy against COVID-19 is a separate question that still remains to be answered. In addition, relevant aspects regarding the potential risks and benefits of HCQ need to be clarified, in pursuit of a rational use of this drug in the COVID-19 pandemic era.\n",
    "Three months have passed since the World Health Organization (WHO) declared coronavirus disease 19 (COVID-19) as a pandemic on March 11, 2020. Due to the high infection rates and occurrence of severe and fatal cases, the search for effective drugs to treat and control the COVID-19 pandemic has been prioritized by health and political authorities. Antimalarials, well-known for their use in dermatology and rheumatology, are one of the medications with the largest - albeit limited - scientific background warranting their use in the COVID-19 treatment protocols. Hydroxychloroquine (HCQ) has been used for the treatment of COVID-19 in 50 patients in our and other centres in several countries with encouraging results. However, recent studies disprove the real effectiveness of this drug, either alone or when combined with macrolides. As a result, the World Health Organization has discouraged the use of HCQ in the treatment and prevention of COVID-19. Herein we report our experience in the use of hydroxychloroquine for COVID-19 treatment.\n",
    "Novel coronavirus disease (COVID-19) is a highly contagious disease caused by severe acute respiratory distress syndrome coronavirus-2 that has resulted in the current global pandemic. Currently, there is no available treatment proven to be effective against COVID-19, but multiple medications, including hydroxychloroquine (HCQ), are used off label. We report the case of a 60-year-old woman without any cardiac history who developed right bundle brunch block and critically prolonged corrected electrocardiographic QT interval (QTc 631 ms) after treatment for 3 days with HCQ, which resolved on discontinuation of the medication. This case highlights a significant and potentially life-threatening complication of HCQ use\n",
    "Malaria is a threat to human mankind and kills about half a million people every year. On the other hand, COVID-19 resulted in several hundred thousand deaths since December 2019 and remains without an efficient and safe treatment. The antimalarials chloroquine (CQ) and its analogue, hydroxychloroquine (HCQ), have been tested for COVID-19 treatment, and several conflicting evidence has been obtained. Therefore, the aim of this review was to summarize the evidence regarding action mechanisms of these compounds against Plasmodium and SARS-CoV-2 infection, together with cytometry applications. CQ and HCQ act on the renin angiotensin system, with possible implications on the cardiorespiratory system. In this context, flow and image cytometry emerge as powerful technologies to investigate the mechanism of therapeutic candidates, as well as for the identification of the immune response and prognostics of disease severity. Data from the large randomized trials support the conclusion that CQ and HCQ do not provide any clinical beneficial in disease severity and progression in SARS-CoV-2 patients, as well as, do not present any solid evidence of increased serious side effects. These drugs are safe and effective antimalarials agents, but in SARS-CoV-2 patients, they need further studies in the context of a clinical trials.\n",
    "Amid controversial reports that COVID-19 can be treated with a combination of the antimalarial drug hydroxychloroquine (HCQ) and the antibiotic azithromycin (AZI), a clinical trial (ONCOCOVID, NCT04341207) was launched at Gustave Roussy Cancer Campus to investigate the utility of this combination therapy in cancer patients. In this preclinical study, we investigated whether the combination of HCQ+AZI would be compatible with the therapeutic induction of anticancer immune responses. For this, we used doses of HCQ and AZI that affect whole-body physiology (as indicated by a partial blockade in cardiac and hepatic autophagic flux for HCQ and a reduction in body weight for AZI), showing that their combined administration did not interfere with tumor growth control induced by the immunogenic cell death inducer oxaliplatin. Moreover, the HCQ+AZI combination did not affect the capacity of a curative regimen (cisplatin + crizotinib + PD-1 blockade) to eradicate established orthotopic lung cancers in mice. In conclusion, it appears that HCQ+AZI does not interfere with the therapeutic induction of therapeutic anticancer immune responses.\n",
    "On 3 March 2020, the document 'Drug treatment options for patients with COVID-19 (infections with SARS-CoV-2)' was published on the website of the Dutch Working Party on Antibiotic Policy (Stichting Werkgroep Antibioticabeleid, SWAB) Based on a 7-step analysis of the literature, hydroxychloroquine (HCQ) and chloroquine (CQ) were initially included in the SWAB document as possible drug treatments for hospitalized adult COVID-19 patients However, recent weeks have seen the publication of the results of various studies into the effectiveness of treatment with HCQ and CQ in patients with COVID-19 On the basis of these results, we conclude that there is insufficient evidence to consider HCQ and CQ as meaningful treatment options in patients with COVID-19 Clinically relevant QTc prolongation occurs in at least 1 in 10 COVID-19 patients treated with HCQ or HQ\n",
    "'''"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "import re\n",
    "rawtext=Abstract\n",
    "cleantext=re.sub('\\n',' ',rawtext)\n",
    "cleantext=re.sub(r'[^a-z A-Z]',' ',rawtext)     \n",
    "cleantext=re.sub(' +',' ',rawtext)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Bi-gram"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "def generate_ngrams(text, WordsToCombine):\n",
    "    words = text.split()\n",
    "    output = []  \n",
    "    for i in range(len(words)- WordsToCombine+1):\n",
    "        output.append(words[i:i+WordsToCombine])\n",
    "    return output"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "l2=generate_ngrams(cleantext,2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[['The', 'ongoing'],\n",
       " ['ongoing', 'pandemic'],\n",
       " ['pandemic', 'of'],\n",
       " ['of', 'coronavirus'],\n",
       " ['coronavirus', 'disease'],\n",
       " ['disease', '2019'],\n",
       " ['2019', '(COVID-19)'],\n",
       " ['(COVID-19)', 'caused'],\n",
       " ['caused', 'by'],\n",
       " ['by', 'the'],\n",
       " ['the', 'severe'],\n",
       " ['severe', 'acute'],\n",
       " ['acute', 'respiratory'],\n",
       " ['respiratory', 'syndrome'],\n",
       " ['syndrome', 'coronavirus'],\n",
       " ['coronavirus', '2'],\n",
       " ['2', '(SARS-CoV-2)'],\n",
       " ['(SARS-CoV-2)', 'poses'],\n",
       " ['poses', 'a'],\n",
       " ['a', 'serious'],\n",
       " ['serious', 'threat'],\n",
       " ['threat', 'to'],\n",
       " ['to', 'global'],\n",
       " ['global', 'public'],\n",
       " ['public', 'health'],\n",
       " ['health', 'and'],\n",
       " ['and', 'there'],\n",
       " ['there', 'is'],\n",
       " ['is', 'currently'],\n",
       " ['currently', 'no'],\n",
       " ['no', 'effective'],\n",
       " ['effective', 'antiviral'],\n",
       " ['antiviral', 'therapy'],\n",
       " ['therapy', 'It'],\n",
       " ['It', 'has'],\n",
       " ['has', 'been'],\n",
       " ['been', 'suggested'],\n",
       " ['suggested', 'that'],\n",
       " ['that', 'Chloroquine'],\n",
       " ['Chloroquine', '(CQ)'],\n",
       " ['(CQ)', 'and'],\n",
       " ['and', 'hydroxychloroquine'],\n",
       " ['hydroxychloroquine', '(HCQ),'],\n",
       " ['(HCQ),', 'which'],\n",
       " ['which', 'were'],\n",
       " ['were', 'primarily'],\n",
       " ['primarily', 'employed'],\n",
       " ['employed', 'as'],\n",
       " ['as', 'prophylaxis'],\n",
       " ['prophylaxis', 'and'],\n",
       " ['and', 'treatment'],\n",
       " ['treatment', 'for'],\n",
       " ['for', 'malaria,'],\n",
       " ['malaria,', 'could'],\n",
       " ['could', 'be'],\n",
       " ['be', 'used'],\n",
       " ['used', 'to'],\n",
       " ['to', 'treat'],\n",
       " ['treat', 'COVID-19'],\n",
       " ['COVID-19', 'CQ'],\n",
       " ['CQ', 'and'],\n",
       " ['and', 'HCQ'],\n",
       " ['HCQ', 'may'],\n",
       " ['may', 'be'],\n",
       " ['be', 'potential'],\n",
       " ['potential', 'inhibitors'],\n",
       " ['inhibitors', 'of'],\n",
       " ['of', 'SARS-CoV-2'],\n",
       " ['SARS-CoV-2', 'entry'],\n",
       " ['entry', 'into'],\n",
       " ['into', 'host'],\n",
       " ['host', 'cells,'],\n",
       " ['cells,', 'which'],\n",
       " ['which', 'is'],\n",
       " ['is', 'mediated'],\n",
       " ['mediated', 'via'],\n",
       " ['via', 'the'],\n",
       " ['the', 'angiotensin-converting'],\n",
       " ['angiotensin-converting', 'enzyme'],\n",
       " ['enzyme', '2'],\n",
       " ['2', '(ACE2),'],\n",
       " ['(ACE2),', 'and'],\n",
       " ['and', 'may'],\n",
       " ['may', 'also'],\n",
       " ['also', 'inhibit'],\n",
       " ['inhibit', 'subsequent'],\n",
       " ['subsequent', 'intracellular'],\n",
       " ['intracellular', 'processes'],\n",
       " ['processes', 'which'],\n",
       " ['which', 'lead'],\n",
       " ['lead', 'to'],\n",
       " ['to', 'COVID-19,'],\n",
       " ['COVID-19,', 'including'],\n",
       " ['including', 'damage'],\n",
       " ['damage', 'to'],\n",
       " ['to', 'the'],\n",
       " ['the', 'cardiovascular'],\n",
       " ['cardiovascular', 'system'],\n",
       " ['system', 'However,'],\n",
       " ['However,', 'paradoxically,'],\n",
       " ['paradoxically,', 'CQ'],\n",
       " ['CQ', 'and'],\n",
       " ['and', 'HCQ'],\n",
       " ['HCQ', 'have'],\n",
       " ['have', 'also'],\n",
       " ['also', 'been'],\n",
       " ['been', 'reported'],\n",
       " ['reported', 'to'],\n",
       " ['to', 'cause'],\n",
       " ['cause', 'damage'],\n",
       " ['damage', 'to'],\n",
       " ['to', 'the'],\n",
       " ['the', 'cardiovascular'],\n",
       " ['cardiovascular', 'system'],\n",
       " ['system', 'In'],\n",
       " ['In', 'this'],\n",
       " ['this', 'review,'],\n",
       " ['review,', 'we'],\n",
       " ['we', 'provide'],\n",
       " ['provide', 'a'],\n",
       " ['a', 'critical'],\n",
       " ['critical', 'examination'],\n",
       " ['examination', 'of'],\n",
       " ['of', 'the'],\n",
       " ['the', 'published'],\n",
       " ['published', 'evidence'],\n",
       " ['evidence', 'CQ'],\n",
       " ['CQ', 'and'],\n",
       " ['and', 'HCQ'],\n",
       " ['HCQ', 'could'],\n",
       " ['could', 'potentially'],\n",
       " ['potentially', 'be'],\n",
       " ['be', 'useful'],\n",
       " ['useful', 'drugs'],\n",
       " ['drugs', 'in'],\n",
       " ['in', 'the'],\n",
       " ['the', 'treatment'],\n",
       " ['treatment', 'of'],\n",
       " ['of', 'COVID-19'],\n",
       " ['COVID-19', 'and'],\n",
       " ['and', 'other'],\n",
       " ['other', 'ACE2'],\n",
       " ['ACE2', 'involved'],\n",
       " ['involved', 'virus'],\n",
       " ['virus', 'infections,'],\n",
       " ['infections,', 'but'],\n",
       " ['but', 'the'],\n",
       " ['the', 'antiviral'],\n",
       " ['antiviral', 'effects'],\n",
       " ['effects', 'of'],\n",
       " ['of', 'CQ'],\n",
       " ['CQ', 'and'],\n",
       " ['and', 'HCQ'],\n",
       " ['HCQ', 'need'],\n",
       " ['need', 'to'],\n",
       " ['to', 'be'],\n",
       " ['be', 'tested'],\n",
       " ['tested', 'in'],\n",
       " ['in', 'more'],\n",
       " ['more', 'well-designed'],\n",
       " ['well-designed', 'clinical'],\n",
       " ['clinical', 'randomized'],\n",
       " ['randomized', 'studies'],\n",
       " ['studies', 'and'],\n",
       " ['and', 'their'],\n",
       " ['their', 'actions'],\n",
       " ['actions', 'on'],\n",
       " ['on', 'the'],\n",
       " ['the', 'cardiovascular'],\n",
       " ['cardiovascular', 'system'],\n",
       " ['system', 'need'],\n",
       " ['need', 'to'],\n",
       " ['to', 'be'],\n",
       " ['be', 'further'],\n",
       " ['further', 'elucidated'],\n",
       " ['elucidated', 'However,'],\n",
       " ['However,', 'even'],\n",
       " ['even', 'if'],\n",
       " ['if', 'it'],\n",
       " ['it', 'were'],\n",
       " ['were', 'to'],\n",
       " ['to', 'turn'],\n",
       " ['turn', 'out'],\n",
       " ['out', 'that'],\n",
       " ['that', 'CQ'],\n",
       " ['CQ', 'and'],\n",
       " ['and', 'HCQ'],\n",
       " ['HCQ', 'are'],\n",
       " ['are', 'not'],\n",
       " ['not', 'useful'],\n",
       " ['useful', 'drugs'],\n",
       " ['drugs', 'in'],\n",
       " ['in', 'practice,'],\n",
       " ['practice,', 'further'],\n",
       " ['further', 'studies'],\n",
       " ['studies', 'of'],\n",
       " ['of', 'their'],\n",
       " ['their', 'mechanism'],\n",
       " ['mechanism', 'of'],\n",
       " ['of', 'action'],\n",
       " ['action', 'could'],\n",
       " ['could', 'be'],\n",
       " ['be', 'helpful'],\n",
       " ['helpful', 'in'],\n",
       " ['in', 'improving'],\n",
       " ['improving', 'our'],\n",
       " ['our', 'understanding'],\n",
       " ['understanding', 'of'],\n",
       " ['of', 'COVID-19'],\n",
       " ['COVID-19', 'pathology'],\n",
       " ['pathology', 'Background'],\n",
       " ['Background', 'and'],\n",
       " ['and', 'aims'],\n",
       " ['aims', 'As'],\n",
       " ['As', 'the'],\n",
       " ['the', 'Coronavirus'],\n",
       " ['Coronavirus', 'disease'],\n",
       " ['disease', '2019'],\n",
       " ['2019', '(COVID-19)'],\n",
       " ['(COVID-19)', 'pandemic'],\n",
       " ['pandemic', 'unravels'],\n",
       " ['unravels', 'rapidly,'],\n",
       " ['rapidly,', 'there'],\n",
       " ['there', 'is'],\n",
       " ['is', 'a'],\n",
       " ['a', 'glut'],\n",
       " ['glut', 'of'],\n",
       " ['of', 'confusing'],\n",
       " ['confusing', 'and'],\n",
       " ['and', 'divergent'],\n",
       " ['divergent', 'scientific'],\n",
       " ['scientific', 'information'],\n",
       " ['information', 'emanating'],\n",
       " ['emanating', 'from'],\n",
       " ['from', 'differing'],\n",
       " ['differing', 'sources,'],\n",
       " ['sources,', 'including'],\n",
       " ['including', 'the'],\n",
       " ['the', 'Indian'],\n",
       " ['Indian', 'National'],\n",
       " ['National', 'Task'],\n",
       " ['Task', 'Force'],\n",
       " ['Force', 'for'],\n",
       " ['for', 'COVID-19'],\n",
       " ['COVID-19', 'Thus,'],\n",
       " ['Thus,', 'a'],\n",
       " ['a', 'web-based'],\n",
       " ['web-based', 'survey'],\n",
       " ['survey', 'was'],\n",
       " ['was', 'conducted'],\n",
       " ['conducted', 'to'],\n",
       " ['to', 'decipher'],\n",
       " ['decipher', 'the'],\n",
       " ['the', 'approach'],\n",
       " ['approach', 'of'],\n",
       " ['of', 'Indian'],\n",
       " ['Indian', 'doctors'],\n",
       " ['doctors', 'to'],\n",
       " ['to', 'the'],\n",
       " ['the', 'various'],\n",
       " ['various', 'options'],\n",
       " ['options', 'for'],\n",
       " ['for', 'treatment'],\n",
       " ['treatment', 'of'],\n",
       " ['of', 'COVID-19'],\n",
       " ['COVID-19', 'Methods'],\n",
       " ['Methods', 'A'],\n",
       " ['A', 'web-based'],\n",
       " ['web-based', 'questionnaire'],\n",
       " ['questionnaire', 'among'],\n",
       " ['among', 'one'],\n",
       " ['one', 'lakh'],\n",
       " ['lakh', 'doctors'],\n",
       " ['doctors', 'across'],\n",
       " ['across', 'India'],\n",
       " ['India', 'through'],\n",
       " ['through', 'email'],\n",
       " ['email', 'and'],\n",
       " ['and', 'social'],\n",
       " ['social', 'media'],\n",
       " ['media', 'was'],\n",
       " ['was', 'circulated'],\n",
       " ['circulated', 'After'],\n",
       " ['After', 'data'],\n",
       " ['data', 'quality'],\n",
       " ['quality', 'and'],\n",
       " ['and', 'internal'],\n",
       " ['internal', 'validation,'],\n",
       " ['validation,', '826'],\n",
       " ['826', 'responses'],\n",
       " ['responses', 'were'],\n",
       " ['were', 'included'],\n",
       " ['included', 'for'],\n",
       " ['for', 'analysis'],\n",
       " ['analysis', 'Basic'],\n",
       " ['Basic', 'demographic'],\n",
       " ['demographic', 'and'],\n",
       " ['and', 'comparative'],\n",
       " ['comparative', 'analysis'],\n",
       " ['analysis', 'were'],\n",
       " ['were', 'performed'],\n",
       " ['performed', 'using'],\n",
       " ['using', 'the'],\n",
       " ['the', 'Python3'],\n",
       " ['Python3', '8'],\n",
       " ['8', '2'],\n",
       " ['2', 'software'],\n",
       " ['software', '(Windows'],\n",
       " ['(Windows', '10'],\n",
       " ['10', '64'],\n",
       " ['64', 'bit,'],\n",
       " ['bit,', 'USA)'],\n",
       " ['USA)', 'Results'],\n",
       " ['Results', 'Amongst'],\n",
       " ['Amongst', 'all'],\n",
       " ['all', 'the'],\n",
       " ['the', 'states'],\n",
       " ['states', 'of'],\n",
       " ['of', 'India'],\n",
       " ['India', 'most'],\n",
       " ['most', 'respondents'],\n",
       " ['respondents', 'hailed'],\n",
       " ['hailed', 'from'],\n",
       " ['from', 'the'],\n",
       " ['the', 'top'],\n",
       " ['top', 'ten'],\n",
       " ['ten', 'affected'],\n",
       " ['affected', 'states'],\n",
       " ['states', 'Overall'],\n",
       " ['Overall', '76'],\n",
       " ['76', '15%'],\n",
       " ['15%', 'of'],\n",
       " ['of', 'doctors'],\n",
       " ['doctors', 'would'],\n",
       " ['would', 'either'],\n",
       " ['either', 'prescribe'],\n",
       " ['prescribe', 'or'],\n",
       " ['or', 'consider'],\n",
       " ['consider', 'prescribing'],\n",
       " ['prescribing', 'hydroxychloroquine'],\n",
       " ['hydroxychloroquine', '(HCQ)'],\n",
       " ['(HCQ)', 'as'],\n",
       " ['as', 'prophylaxis'],\n",
       " ['prophylaxis', 'for'],\n",
       " ['for', 'health-care'],\n",
       " ['health-care', 'providers'],\n",
       " ['providers', '(HCP)'],\n",
       " ['(HCP)', 'Doctors'],\n",
       " ['Doctors', 'with'],\n",
       " ['with', 'experience'],\n",
       " ['experience', 'of'],\n",
       " ['of', 'managing'],\n",
       " ['managing', 'COVID-19'],\n",
       " ['COVID-19', 'were'],\n",
       " ['were', 'more'],\n",
       " ['more', 'likely'],\n",
       " ['likely', 'to'],\n",
       " ['to', 'advocate'],\n",
       " ['advocate', 'use'],\n",
       " ['use', 'of'],\n",
       " ['of', 'HCQ'],\n",
       " ['HCQ', 'as'],\n",
       " ['as', 'prophylaxis'],\n",
       " ['prophylaxis', 'for'],\n",
       " ['for', 'HCP'],\n",
       " ['HCP', '(χ2'],\n",
       " ['(χ2', '='],\n",
       " ['=', '4'],\n",
       " ['4', '357,'],\n",
       " ['357,', 'P'],\n",
       " ['P', '='],\n",
       " ['=', '0'],\n",
       " ['0', '037)'],\n",
       " ['037)', 'Intensivists'],\n",
       " ['Intensivists', 'were'],\n",
       " ['were', 'more'],\n",
       " ['more', 'likely'],\n",
       " ['likely', 'to'],\n",
       " ['to', 'advocate'],\n",
       " ['advocate', 'HCQ'],\n",
       " ['HCQ', 'as'],\n",
       " ['as', 'prophylaxis'],\n",
       " ['prophylaxis', '(χ2'],\n",
       " ['(χ2', '='],\n",
       " ['=', '14'],\n",
       " ['14', '588,'],\n",
       " ['588,', 'P'],\n",
       " ['P', '<'],\n",
       " ['<', '0'],\n",
       " ['0', '001)'],\n",
       " ['001)', 'as'],\n",
       " ['as', 'well'],\n",
       " ['well', 'as'],\n",
       " ['as', 'for'],\n",
       " ['for', 'management'],\n",
       " ['management', 'of'],\n",
       " ['of', 'mild'],\n",
       " ['mild', 'to'],\n",
       " ['to', 'moderate'],\n",
       " ['moderate', 'COVID-19'],\n",
       " ['COVID-19', '(χ2'],\n",
       " ['(χ2', '='],\n",
       " ['=', '3'],\n",
       " ['3', '91,'],\n",
       " ['91,', 'P'],\n",
       " ['P', '='],\n",
       " ['=', '0'],\n",
       " ['0', '048)'],\n",
       " ['048)', 'In'],\n",
       " ['In', 'COVID-19,'],\n",
       " ['COVID-19,', '65'],\n",
       " ['65', '8%'],\n",
       " ['8%', 'doctors'],\n",
       " ['doctors', 'overwhelmingly'],\n",
       " ['overwhelmingly', 'preferred'],\n",
       " ['preferred', 'using'],\n",
       " ['using', 'anti-viral'],\n",
       " ['anti-viral', 'agents'],\n",
       " ['agents', 'in'],\n",
       " ['in', 'severe'],\n",
       " ['severe', 'cases,'],\n",
       " ['cases,', 'continuing'],\n",
       " ['continuing', 'ACEi/ARB'],\n",
       " ['ACEi/ARB', '(60'],\n",
       " ['(60', '9%),'],\n",
       " ['9%),', 'and'],\n",
       " ['and', 'routinely'],\n",
       " ['routinely', 'screening'],\n",
       " ['screening', 'for'],\n",
       " ['for', 'COVID-19'],\n",
       " ['COVID-19', 'as'],\n",
       " ['as', 'a'],\n",
       " ['a', 'pre-operative'],\n",
       " ['pre-operative', 'strategy'],\n",
       " ['strategy', '(73'],\n",
       " ['(73', '85%)'],\n",
       " ['85%)', 'Conclusions'],\n",
       " ['Conclusions', 'Indian'],\n",
       " ['Indian', 'doctors'],\n",
       " ['doctors', 'are'],\n",
       " ['are', 'largely'],\n",
       " ['largely', 'following'],\n",
       " ['following', 'the'],\n",
       " ['the', 'scientific'],\n",
       " ['scientific', 'guidance'],\n",
       " ['guidance', 'provided'],\n",
       " ['provided', 'by'],\n",
       " ['by', 'Indian'],\n",
       " ['Indian', 'National'],\n",
       " ['National', 'Task'],\n",
       " ['Task', 'Force'],\n",
       " ['Force', 'for'],\n",
       " ['for', 'COVID-19'],\n",
       " ['COVID-19', 'and'],\n",
       " ['and', 'would'],\n",
       " ['would', 'consider'],\n",
       " ['consider', 'prescribing'],\n",
       " ['prescribing', 'HCQ'],\n",
       " ['HCQ', 'as'],\n",
       " ['as', 'prophylaxis'],\n",
       " ['prophylaxis', 'for'],\n",
       " ['for', 'COVID-19'],\n",
       " ['COVID-19', 'They'],\n",
       " ['They', 'would'],\n",
       " ['would', 'also'],\n",
       " ['also', 'consider'],\n",
       " ['consider', 'using'],\n",
       " ['using', 'it'],\n",
       " ['it', 'in'],\n",
       " ['in', 'mild'],\n",
       " ['mild', 'to'],\n",
       " ['to', 'moderate'],\n",
       " ['moderate', 'COVID-19'],\n",
       " ['COVID-19', 'Hydroxychloroquine'],\n",
       " ['Hydroxychloroquine', 'sulfate'],\n",
       " ['sulfate', 'is'],\n",
       " ['is', 'one'],\n",
       " ['one', 'of'],\n",
       " ['of', 'a'],\n",
       " ['a', 'large'],\n",
       " ['large', 'series'],\n",
       " ['series', 'of'],\n",
       " ['of', '4-aminoquinolines'],\n",
       " ['4-aminoquinolines', 'with'],\n",
       " ['with', 'antimalarial'],\n",
       " ['antimalarial', 'activity'],\n",
       " ['activity', 'Moreover,'],\n",
       " ['Moreover,', 'it'],\n",
       " ['it', 'is'],\n",
       " ['is', 'used'],\n",
       " ['used', 'for'],\n",
       " ['for', 'the'],\n",
       " ['the', 'treatment'],\n",
       " ['treatment', 'of'],\n",
       " ['of', 'rheumatoid'],\n",
       " ['rheumatoid', 'arthritis'],\n",
       " ['arthritis', 'Sometimes'],\n",
       " ['Sometimes', 'Hydroxychloroquine'],\n",
       " ['Hydroxychloroquine', 'sulfate'],\n",
       " ['sulfate', 'is'],\n",
       " ['is', 'very'],\n",
       " ['very', 'effective'],\n",
       " ['effective', 'for'],\n",
       " ['for', 'the'],\n",
       " ['the', 'treatment'],\n",
       " ['treatment', 'of'],\n",
       " ['of', 'autoimmune'],\n",
       " ['autoimmune', 'diseases'],\n",
       " ['diseases', 'Based'],\n",
       " ['Based', 'on'],\n",
       " ['on', 'the'],\n",
       " ['the', 'recent'],\n",
       " ['recent', 'clinical'],\n",
       " ['clinical', 'experiments'],\n",
       " ['experiments', 'it'],\n",
       " ['it', 'is'],\n",
       " ['is', 'exploiting'],\n",
       " ['exploiting', 'for'],\n",
       " ['for', 'the'],\n",
       " ['the', 'treatment'],\n",
       " ['treatment', 'of'],\n",
       " ['of', 'COVID-19,'],\n",
       " ['COVID-19,', 'corona'],\n",
       " ['corona', 'virus'],\n",
       " ['virus', 'across'],\n",
       " ['across', 'the'],\n",
       " ['the', 'globe'],\n",
       " ['globe', 'A'],\n",
       " ['A', 'Reverse'],\n",
       " ['Reverse', 'phase'],\n",
       " ['phase', 'RP-HPLC'],\n",
       " ['RP-HPLC', 'method'],\n",
       " ['method', 'have'],\n",
       " ['have', 'been'],\n",
       " ['been', 'developed'],\n",
       " ['developed', 'and'],\n",
       " ['and', 'validated'],\n",
       " ['validated', 'as'],\n",
       " ['as', 'per'],\n",
       " ['per', 'the'],\n",
       " ['the', 'current'],\n",
       " ['current', 'ICH'],\n",
       " ['ICH', 'guidelines'],\n",
       " ['guidelines', 'for'],\n",
       " ['for', 'estimation'],\n",
       " ['estimation', 'of'],\n",
       " ['of', 'Hydroxychloroquine'],\n",
       " ['Hydroxychloroquine', 'sulfate'],\n",
       " ['sulfate', 'tablets'],\n",
       " ['tablets', 'As'],\n",
       " ['As', 'part'],\n",
       " ['part', 'of'],\n",
       " ['of', 'method'],\n",
       " ['method', 'validation'],\n",
       " ['validation', 'specificity,'],\n",
       " ['specificity,', 'linearity,'],\n",
       " ['linearity,', 'precision'],\n",
       " ['precision', 'and'],\n",
       " ['and', 'recovery'],\n",
       " ['recovery', 'parameters'],\n",
       " ['parameters', 'were'],\n",
       " ['were', 'verified'],\n",
       " ['verified', 'The'],\n",
       " ['The', 'concentration'],\n",
       " ['concentration', 'and'],\n",
       " ['and', 'area'],\n",
       " ['area', 'relationships'],\n",
       " ['relationships', 'were'],\n",
       " ['were', 'linear'],\n",
       " ['linear', '(R'],\n",
       " ['(R', '(2)'],\n",
       " ['(2)', '>'],\n",
       " ['>', '0'],\n",
       " ['0', '999),'],\n",
       " ['999),', 'over'],\n",
       " ['over', 'the'],\n",
       " ['the', 'concentration'],\n",
       " ['concentration', 'range'],\n",
       " ['range', 'of'],\n",
       " ['of', '25'],\n",
       " ['25', 'to'],\n",
       " ['to', '300'],\n",
       " ['300', 'µg'],\n",
       " ['µg', 'mL'],\n",
       " ['mL', '(-1)'],\n",
       " ['(-1)', 'for'],\n",
       " ['for', 'HCQ'],\n",
       " ['HCQ', 'The'],\n",
       " ['The', 'relative'],\n",
       " ['relative', 'standard'],\n",
       " ['standard', 'deviations'],\n",
       " ['deviations', 'for'],\n",
       " ['for', 'precision'],\n",
       " ['precision', 'and'],\n",
       " ['and', 'intermediate'],\n",
       " ['intermediate', 'precision'],\n",
       " ['precision', 'were'],\n",
       " ['were', 'less'],\n",
       " ['less', 'than'],\n",
       " ['than', '1'],\n",
       " ['1', '5%'],\n",
       " ['5%', 'The'],\n",
       " ['The', 'proposed'],\n",
       " ['proposed', 'RP-HPLC'],\n",
       " ['RP-HPLC', 'generic'],\n",
       " ['generic', 'method'],\n",
       " ['method', 'was'],\n",
       " ['was', 'applied'],\n",
       " ['applied', 'successfully'],\n",
       " ['successfully', 'for'],\n",
       " ['for', 'evaluation'],\n",
       " ['evaluation', 'of'],\n",
       " ['of', 'invitro'],\n",
       " ['invitro', 'dissolution'],\n",
       " ['dissolution', 'profile'],\n",
       " ['profile', 'with'],\n",
       " ['with', 'different'],\n",
       " ['different', 'pH'],\n",
       " ['pH', 'conditions'],\n",
       " ['conditions', 'like'],\n",
       " ['like', '0'],\n",
       " ['0', '1N'],\n",
       " ['1N', 'HCl,'],\n",
       " ['HCl,', 'pH'],\n",
       " ['pH', '4'],\n",
       " ['4', '5'],\n",
       " ['5', 'Acetate'],\n",
       " ['Acetate', 'buffer'],\n",
       " ['buffer', 'and'],\n",
       " ['and', 'pH'],\n",
       " ['pH', '6'],\n",
       " ['6', '8'],\n",
       " ['8', 'Phosphate'],\n",
       " ['Phosphate', 'buffers'],\n",
       " ['buffers', 'of'],\n",
       " ['of', 'US'],\n",
       " ['US', 'marketed'],\n",
       " ['marketed', 'reference'],\n",
       " ['reference', 'product'],\n",
       " ['product', 'The'],\n",
       " ['The', 'use'],\n",
       " ['use', 'of'],\n",
       " ['of', 'hydroxychloroquine'],\n",
       " ['hydroxychloroquine', '(HCQ)'],\n",
       " ['(HCQ)', 'has'],\n",
       " ['has', 'been'],\n",
       " ['been', 'considered'],\n",
       " ['considered', 'a'],\n",
       " ['a', 'therapeutic'],\n",
       " ['therapeutic', 'option'],\n",
       " ['option', 'by'],\n",
       " ['by', 'international'],\n",
       " ['international', 'guidelines'],\n",
       " ['guidelines', 'and'],\n",
       " ['and', 'expert'],\n",
       " ['expert', 'opinions'],\n",
       " ['opinions', 'during'],\n",
       " ['during', 'the'],\n",
       " ['the', 'first'],\n",
       " ['first', 'phase'],\n",
       " ['phase', 'of'],\n",
       " ['of', 'COVID-19'],\n",
       " ['COVID-19', 'pandemics,'],\n",
       " ['pandemics,', '1-10'],\n",
       " ['1-10', 'although'],\n",
       " ['although', 'scientific'],\n",
       " ['scientific', 'evidence'],\n",
       " ['evidence', 'remained'],\n",
       " ['remained', 'too'],\n",
       " ['too', 'scarce'],\n",
       " ['scarce', 'to'],\n",
       " ['to', 'make'],\n",
       " ['make', 'a'],\n",
       " ['a', 'definitive'],\n",
       " ['definitive', 'recommendation'],\n",
       " ['recommendation', '11'],\n",
       " ['11', '.'],\n",
       " ['.', 'While'],\n",
       " ['While', 'HCQ'],\n",
       " ['HCQ', 'use'],\n",
       " ['use', 'has'],\n",
       " ['has', 'now'],\n",
       " ['now', 'been'],\n",
       " ['been', 'questioned'],\n",
       " ['questioned', 'by'],\n",
       " ['by', 'recent'],\n",
       " ['recent', 'data'],\n",
       " ['data', '7'],\n",
       " ['7', ','],\n",
       " [',', 'some'],\n",
       " ['some', 'previous'],\n",
       " ['previous', 'works'],\n",
       " ['works', 'draw'],\n",
       " ['draw', 'attention'],\n",
       " ['attention', 'to'],\n",
       " ['to', 'contrasting'],\n",
       " ['contrasting', 'results'],\n",
       " ['results', 'on'],\n",
       " ['on', 'enhanced'],\n",
       " ['enhanced', 'viral'],\n",
       " ['viral', 'clearance'],\n",
       " ['clearance', 'after'],\n",
       " ['after', 'HCQ'],\n",
       " ['HCQ', 'treatment'],\n",
       " ['treatment', '1-6,10'],\n",
       " ['1-6,10', '.'],\n",
       " ['.', 'In'],\n",
       " ['In', 'recent'],\n",
       " ['recent', 'months,'],\n",
       " ['months,', 'the'],\n",
       " ['the', 'new'],\n",
       " ['new', 'coronavirus'],\n",
       " ['coronavirus', 'SARS-CoV-2'],\n",
       " ['SARS-CoV-2', 'has'],\n",
       " ['has', 'emerged'],\n",
       " ['emerged', 'as'],\n",
       " ['as', 'a'],\n",
       " ['a', 'worldwide'],\n",
       " ['worldwide', 'threat'],\n",
       " ['threat', 'with'],\n",
       " ['with', 'about'],\n",
       " ['about', '4.2'],\n",
       " ['4.2', 'million'],\n",
       " ['million', 'confirmed'],\n",
       " ['confirmed', 'cases'],\n",
       " ['cases', 'and'],\n",
       " ['and', 'almost'],\n",
       " ['almost', '300'],\n",
       " ['300', '000'],\n",
       " ['000', 'deaths.'],\n",
       " ['deaths.', 'Its'],\n",
       " ['Its', 'major'],\n",
       " ['major', 'clinical'],\n",
       " ['clinical', 'presentation'],\n",
       " ['presentation', 'is'],\n",
       " ['is', 'characterized'],\n",
       " ['characterized', 'by'],\n",
       " ['by', 'respiratory'],\n",
       " ['respiratory', 'symptoms'],\n",
       " ['symptoms', 'ranging'],\n",
       " ['ranging', 'from'],\n",
       " ['from', 'mild'],\n",
       " ['mild', 'cough'],\n",
       " ['cough', 'to'],\n",
       " ['to', 'serve'],\n",
       " ['serve', 'pneumonia'],\n",
       " ['pneumonia', 'with'],\n",
       " ['with', 'fever'],\n",
       " ['fever', 'and'],\n",
       " ['and', 'potentially'],\n",
       " ['potentially', 'even'],\n",
       " ['even', 'death.'],\n",
       " ['death.', 'Until'],\n",
       " ['Until', 'today,'],\n",
       " ['today,', 'there'],\n",
       " ['there', 'is'],\n",
       " ['is', 'no'],\n",
       " ['no', 'known'],\n",
       " ['known', 'medication'],\n",
       " ['medication', 'to'],\n",
       " ['to', 'improve'],\n",
       " ['improve', 'clinical'],\n",
       " ['clinical', 'symptoms'],\n",
       " ['symptoms', 'or'],\n",
       " ['or', 'even'],\n",
       " ['even', 'prevent'],\n",
       " ['prevent', 'or'],\n",
       " ['or', 'fight'],\n",
       " ['fight', 'the'],\n",
       " ['the', 'infection.'],\n",
       " ['infection.', 'The'],\n",
       " ['The', 'search'],\n",
       " ['search', 'for'],\n",
       " ['for', 'a'],\n",
       " ['a', 'useful'],\n",
       " ['useful', 'vaccination'],\n",
       " ['vaccination', 'is'],\n",
       " ['is', 'ongoing'],\n",
       " ['ongoing', 'and'],\n",
       " ['and', 'it'],\n",
       " ['it', 'will'],\n",
       " ['will', 'probably'],\n",
       " ['probably', 'not'],\n",
       " ['not', 'be'],\n",
       " ['be', 'available'],\n",
       " ['available', 'before'],\n",
       " ['before', 'the'],\n",
       " ['the', 'end'],\n",
       " ['end', 'of'],\n",
       " ['of', '2020.'],\n",
       " ['2020.', 'In'],\n",
       " ['In', 'this'],\n",
       " ['this', 'review,'],\n",
       " ['review,', 'we'],\n",
       " ['we', 'highlight'],\n",
       " ['highlight', 'hydroxychloroquine'],\n",
       " ['hydroxychloroquine', '(HCQ)'],\n",
       " ['(HCQ)', 'as'],\n",
       " ['as', 'a'],\n",
       " ['a', 'potential'],\n",
       " ['potential', 'agent'],\n",
       " ['agent', 'to'],\n",
       " ['to', 'prevent'],\n",
       " ['prevent', 'coronavirus'],\n",
       " ['coronavirus', 'disease'],\n",
       " ['disease', '2019'],\n",
       " ['2019', '(COVID-19)'],\n",
       " ['(COVID-19)', 'and'],\n",
       " ['and', 'reduce'],\n",
       " ['reduce', 'as'],\n",
       " ['as', 'well'],\n",
       " ['well', 'as'],\n",
       " ['as', 'shorten'],\n",
       " ['shorten', 'clinical'],\n",
       " ['clinical', 'symptoms.'],\n",
       " ['symptoms.', 'Moreover,'],\n",
       " ['Moreover,', 'it'],\n",
       " ['it', 'might'],\n",
       " ['might', 'serve'],\n",
       " ['serve', 'as'],\n",
       " ['as', 'a'],\n",
       " ['a', 'potential'],\n",
       " ['potential', 'post-exposition'],\n",
       " ['post-exposition', 'prophylaxis.'],\n",
       " ['prophylaxis.', 'Although'],\n",
       " ['Although', 'it'],\n",
       " ['it', 'has'],\n",
       " ['has', 'been'],\n",
       " ['been', 'used'],\n",
       " ['used', 'in'],\n",
       " ['in', 'the'],\n",
       " ['the', 'treatment'],\n",
       " ['treatment', 'of'],\n",
       " ['of', 'rheumatoid'],\n",
       " ['rheumatoid', 'arthritis,'],\n",
       " ['arthritis,', 'discoid'],\n",
       " ['discoid', 'or'],\n",
       " ['or', 'systemic'],\n",
       " ['systemic', 'lupus'],\n",
       " ['lupus', 'erythematosus,'],\n",
       " ['erythematosus,', 'and'],\n",
       " ['and', 'malaria'],\n",
       " ['malaria', 'prophylaxis'],\n",
       " ['prophylaxis', 'and'],\n",
       " ['and', 'therapy'],\n",
       " ['therapy', 'for'],\n",
       " ['for', 'decades,'],\n",
       " ['decades,', 'knowledge'],\n",
       " ['knowledge', 'on'],\n",
       " ['on', 'HCQ'],\n",
       " ['HCQ', 'as'],\n",
       " ['as', 'a'],\n",
       " ['a', 'potential'],\n",
       " ['potential', 'treatment'],\n",
       " ['treatment', 'for'],\n",
       " ['for', 'COVID-19'],\n",
       " ['COVID-19', 'is'],\n",
       " ['is', 'limited'],\n",
       " ['limited', 'and'],\n",
       " ['and', 'multiple'],\n",
       " ['multiple', 'clinical'],\n",
       " ['clinical', 'trials'],\n",
       " ['trials', 'have'],\n",
       " ['have', 'just'],\n",
       " ['just', 'emerged.'],\n",
       " ['emerged.', 'Especially,'],\n",
       " ['Especially,', 'rare'],\n",
       " ['rare', 'HCQ'],\n",
       " ['HCQ', 'side'],\n",
       " ['side', 'effects'],\n",
       " ['effects', 'which'],\n",
       " ['which', 'were'],\n",
       " ['were', 'of'],\n",
       " ['of', 'minor'],\n",
       " ['minor', 'importance'],\n",
       " ['importance', 'for'],\n",
       " ['for', 'use'],\n",
       " ['use', 'in'],\n",
       " ['in', 'selected'],\n",
       " ['selected', 'indications'],\n",
       " ['indications', 'might'],\n",
       " ['might', 'gain'],\n",
       " ['gain', 'major'],\n",
       " ['major', 'relevance'],\n",
       " ['relevance', 'with'],\n",
       " ['with', 'population-wide'],\n",
       " ['population-wide', 'application.'],\n",
       " ['application.', 'These'],\n",
       " ['These', 'rare'],\n",
       " ['rare', 'side'],\n",
       " ['side', 'effects'],\n",
       " ['effects', 'include'],\n",
       " ['include', 'retinopathy'],\n",
       " ['retinopathy', 'and-even'],\n",
       " ['and-even', 'more'],\n",
       " ['more', 'important-QT'],\n",
       " ['important-QT', 'prolongation'],\n",
       " ['prolongation', 'leading'],\n",
       " ['leading', 'to'],\n",
       " ['to', 'sudden'],\n",
       " ['sudden', 'cardiac'],\n",
       " ['cardiac', 'death'],\n",
       " ['death', 'by'],\n",
       " ['by', 'malignant'],\n",
       " ['malignant', 'arrhythmias.'],\n",
       " ['arrhythmias.', 'Severe'],\n",
       " ['Severe', 'acute'],\n",
       " ['acute', 'respiratory'],\n",
       " ['respiratory', 'coronavirus'],\n",
       " ['coronavirus', '2'],\n",
       " ['2', '(SARS-CoV-2)'],\n",
       " ['(SARS-CoV-2)', 'has'],\n",
       " ['has', 'caused'],\n",
       " ['caused', 'a'],\n",
       " ['a', 'devastating'],\n",
       " ['devastating', 'worldwide'],\n",
       " ['worldwide', 'pandemic.'],\n",
       " ['pandemic.', 'Hydroxychloroquine'],\n",
       " ['Hydroxychloroquine', '(HCQ)'],\n",
       " ['(HCQ)', 'has'],\n",
       " ['has', 'in'],\n",
       " ['in', 'vitro'],\n",
       " ['vitro', 'activity'],\n",
       " ['activity', 'against'],\n",
       " ['against', 'SARS-CoV-2,'],\n",
       " ['SARS-CoV-2,', 'but'],\n",
       " ['but', 'clinical'],\n",
       " ['clinical', 'data'],\n",
       " ['data', 'supporting'],\n",
       " ['supporting', 'HCQ'],\n",
       " ['HCQ', 'for'],\n",
       " ['for', 'coronavirus'],\n",
       " ['coronavirus', 'disease'],\n",
       " ['disease', '2019'],\n",
       " ['2019', '(COVID-19)'],\n",
       " ['(COVID-19)', 'are'],\n",
       " ['are', 'limited.'],\n",
       " ['limited.', 'METHODS:'],\n",
       " ['METHODS:', 'This'],\n",
       " ['This', 'was'],\n",
       " ['was', 'a'],\n",
       " ['a', 'retrospective'],\n",
       " ['retrospective', 'cohort'],\n",
       " ['cohort', 'study'],\n",
       " ['study', 'of'],\n",
       " ['of', 'hospitalized'],\n",
       " ['hospitalized', 'patients'],\n",
       " ['patients', 'with'],\n",
       " ['with', 'COVID-19'],\n",
       " ['COVID-19', 'who'],\n",
       " ['who', 'received'],\n",
       " ['received', '≥1'],\n",
       " ['≥1', 'dose'],\n",
       " ['dose', 'of'],\n",
       " ['of', 'HCQ'],\n",
       " ['HCQ', 'at'],\n",
       " ['at', 'two'],\n",
       " ['two', 'New'],\n",
       " ['New', 'York'],\n",
       " ['York', 'City'],\n",
       " ['City', 'hospitals.'],\n",
       " ['hospitals.', 'We'],\n",
       " ['We', 'measured'],\n",
       " ['measured', 'incident'],\n",
       " ['incident', 'Grade'],\n",
       " ['Grade', '3'],\n",
       " ['3', 'or'],\n",
       " ['or', '4'],\n",
       " ['4', 'blood'],\n",
       " ['blood', 'count'],\n",
       " ['count', 'and'],\n",
       " ['and', 'liver'],\n",
       " ['liver', 'test'],\n",
       " ['test', 'abnormalities,'],\n",
       " ['abnormalities,', 'ventricular'],\n",
       " ['ventricular', 'arrhythmias,'],\n",
       " ['arrhythmias,', 'and'],\n",
       " ['and', 'vomiting'],\n",
       " ['vomiting', 'and'],\n",
       " ['and', 'diarrhea'],\n",
       " ['diarrhea', 'within'],\n",
       " ['within', '10'],\n",
       " ['10', 'days'],\n",
       " ['days', 'after'],\n",
       " ['after', 'HCQ'],\n",
       " ['HCQ', 'initiation,'],\n",
       " ['initiation,', 'and'],\n",
       " ['and', 'the'],\n",
       " ['the', 'proportion'],\n",
       " ['proportion', 'of'],\n",
       " ['of', 'patients'],\n",
       " ['patients', 'who'],\n",
       " ['who', 'completed'],\n",
       " ['completed', 'HCQ'],\n",
       " ['HCQ', 'therapy.'],\n",
       " ['therapy.', 'We'],\n",
       " ['We', 'also'],\n",
       " ['also', 'describe'],\n",
       " ['describe', 'changes'],\n",
       " ['changes', 'in'],\n",
       " ...]"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "l2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "new_list=[]\n",
    "for x in l2:\n",
    "    new_list.append('_'.join(x))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['The_ongoing',\n",
       " 'ongoing_pandemic',\n",
       " 'pandemic_of',\n",
       " 'of_coronavirus',\n",
       " 'coronavirus_disease',\n",
       " 'disease_2019',\n",
       " '2019_(COVID-19)',\n",
       " '(COVID-19)_caused',\n",
       " 'caused_by',\n",
       " 'by_the',\n",
       " 'the_severe',\n",
       " 'severe_acute',\n",
       " 'acute_respiratory',\n",
       " 'respiratory_syndrome',\n",
       " 'syndrome_coronavirus',\n",
       " 'coronavirus_2',\n",
       " '2_(SARS-CoV-2)',\n",
       " '(SARS-CoV-2)_poses',\n",
       " 'poses_a',\n",
       " 'a_serious',\n",
       " 'serious_threat',\n",
       " 'threat_to',\n",
       " 'to_global',\n",
       " 'global_public',\n",
       " 'public_health',\n",
       " 'health_and',\n",
       " 'and_there',\n",
       " 'there_is',\n",
       " 'is_currently',\n",
       " 'currently_no',\n",
       " 'no_effective',\n",
       " 'effective_antiviral',\n",
       " 'antiviral_therapy',\n",
       " 'therapy_It',\n",
       " 'It_has',\n",
       " 'has_been',\n",
       " 'been_suggested',\n",
       " 'suggested_that',\n",
       " 'that_Chloroquine',\n",
       " 'Chloroquine_(CQ)',\n",
       " '(CQ)_and',\n",
       " 'and_hydroxychloroquine',\n",
       " 'hydroxychloroquine_(HCQ),',\n",
       " '(HCQ),_which',\n",
       " 'which_were',\n",
       " 'were_primarily',\n",
       " 'primarily_employed',\n",
       " 'employed_as',\n",
       " 'as_prophylaxis',\n",
       " 'prophylaxis_and',\n",
       " 'and_treatment',\n",
       " 'treatment_for',\n",
       " 'for_malaria,',\n",
       " 'malaria,_could',\n",
       " 'could_be',\n",
       " 'be_used',\n",
       " 'used_to',\n",
       " 'to_treat',\n",
       " 'treat_COVID-19',\n",
       " 'COVID-19_CQ',\n",
       " 'CQ_and',\n",
       " 'and_HCQ',\n",
       " 'HCQ_may',\n",
       " 'may_be',\n",
       " 'be_potential',\n",
       " 'potential_inhibitors',\n",
       " 'inhibitors_of',\n",
       " 'of_SARS-CoV-2',\n",
       " 'SARS-CoV-2_entry',\n",
       " 'entry_into',\n",
       " 'into_host',\n",
       " 'host_cells,',\n",
       " 'cells,_which',\n",
       " 'which_is',\n",
       " 'is_mediated',\n",
       " 'mediated_via',\n",
       " 'via_the',\n",
       " 'the_angiotensin-converting',\n",
       " 'angiotensin-converting_enzyme',\n",
       " 'enzyme_2',\n",
       " '2_(ACE2),',\n",
       " '(ACE2),_and',\n",
       " 'and_may',\n",
       " 'may_also',\n",
       " 'also_inhibit',\n",
       " 'inhibit_subsequent',\n",
       " 'subsequent_intracellular',\n",
       " 'intracellular_processes',\n",
       " 'processes_which',\n",
       " 'which_lead',\n",
       " 'lead_to',\n",
       " 'to_COVID-19,',\n",
       " 'COVID-19,_including',\n",
       " 'including_damage',\n",
       " 'damage_to',\n",
       " 'to_the',\n",
       " 'the_cardiovascular',\n",
       " 'cardiovascular_system',\n",
       " 'system_However,',\n",
       " 'However,_paradoxically,',\n",
       " 'paradoxically,_CQ',\n",
       " 'CQ_and',\n",
       " 'and_HCQ',\n",
       " 'HCQ_have',\n",
       " 'have_also',\n",
       " 'also_been',\n",
       " 'been_reported',\n",
       " 'reported_to',\n",
       " 'to_cause',\n",
       " 'cause_damage',\n",
       " 'damage_to',\n",
       " 'to_the',\n",
       " 'the_cardiovascular',\n",
       " 'cardiovascular_system',\n",
       " 'system_In',\n",
       " 'In_this',\n",
       " 'this_review,',\n",
       " 'review,_we',\n",
       " 'we_provide',\n",
       " 'provide_a',\n",
       " 'a_critical',\n",
       " 'critical_examination',\n",
       " 'examination_of',\n",
       " 'of_the',\n",
       " 'the_published',\n",
       " 'published_evidence',\n",
       " 'evidence_CQ',\n",
       " 'CQ_and',\n",
       " 'and_HCQ',\n",
       " 'HCQ_could',\n",
       " 'could_potentially',\n",
       " 'potentially_be',\n",
       " 'be_useful',\n",
       " 'useful_drugs',\n",
       " 'drugs_in',\n",
       " 'in_the',\n",
       " 'the_treatment',\n",
       " 'treatment_of',\n",
       " 'of_COVID-19',\n",
       " 'COVID-19_and',\n",
       " 'and_other',\n",
       " 'other_ACE2',\n",
       " 'ACE2_involved',\n",
       " 'involved_virus',\n",
       " 'virus_infections,',\n",
       " 'infections,_but',\n",
       " 'but_the',\n",
       " 'the_antiviral',\n",
       " 'antiviral_effects',\n",
       " 'effects_of',\n",
       " 'of_CQ',\n",
       " 'CQ_and',\n",
       " 'and_HCQ',\n",
       " 'HCQ_need',\n",
       " 'need_to',\n",
       " 'to_be',\n",
       " 'be_tested',\n",
       " 'tested_in',\n",
       " 'in_more',\n",
       " 'more_well-designed',\n",
       " 'well-designed_clinical',\n",
       " 'clinical_randomized',\n",
       " 'randomized_studies',\n",
       " 'studies_and',\n",
       " 'and_their',\n",
       " 'their_actions',\n",
       " 'actions_on',\n",
       " 'on_the',\n",
       " 'the_cardiovascular',\n",
       " 'cardiovascular_system',\n",
       " 'system_need',\n",
       " 'need_to',\n",
       " 'to_be',\n",
       " 'be_further',\n",
       " 'further_elucidated',\n",
       " 'elucidated_However,',\n",
       " 'However,_even',\n",
       " 'even_if',\n",
       " 'if_it',\n",
       " 'it_were',\n",
       " 'were_to',\n",
       " 'to_turn',\n",
       " 'turn_out',\n",
       " 'out_that',\n",
       " 'that_CQ',\n",
       " 'CQ_and',\n",
       " 'and_HCQ',\n",
       " 'HCQ_are',\n",
       " 'are_not',\n",
       " 'not_useful',\n",
       " 'useful_drugs',\n",
       " 'drugs_in',\n",
       " 'in_practice,',\n",
       " 'practice,_further',\n",
       " 'further_studies',\n",
       " 'studies_of',\n",
       " 'of_their',\n",
       " 'their_mechanism',\n",
       " 'mechanism_of',\n",
       " 'of_action',\n",
       " 'action_could',\n",
       " 'could_be',\n",
       " 'be_helpful',\n",
       " 'helpful_in',\n",
       " 'in_improving',\n",
       " 'improving_our',\n",
       " 'our_understanding',\n",
       " 'understanding_of',\n",
       " 'of_COVID-19',\n",
       " 'COVID-19_pathology',\n",
       " 'pathology_Background',\n",
       " 'Background_and',\n",
       " 'and_aims',\n",
       " 'aims_As',\n",
       " 'As_the',\n",
       " 'the_Coronavirus',\n",
       " 'Coronavirus_disease',\n",
       " 'disease_2019',\n",
       " '2019_(COVID-19)',\n",
       " '(COVID-19)_pandemic',\n",
       " 'pandemic_unravels',\n",
       " 'unravels_rapidly,',\n",
       " 'rapidly,_there',\n",
       " 'there_is',\n",
       " 'is_a',\n",
       " 'a_glut',\n",
       " 'glut_of',\n",
       " 'of_confusing',\n",
       " 'confusing_and',\n",
       " 'and_divergent',\n",
       " 'divergent_scientific',\n",
       " 'scientific_information',\n",
       " 'information_emanating',\n",
       " 'emanating_from',\n",
       " 'from_differing',\n",
       " 'differing_sources,',\n",
       " 'sources,_including',\n",
       " 'including_the',\n",
       " 'the_Indian',\n",
       " 'Indian_National',\n",
       " 'National_Task',\n",
       " 'Task_Force',\n",
       " 'Force_for',\n",
       " 'for_COVID-19',\n",
       " 'COVID-19_Thus,',\n",
       " 'Thus,_a',\n",
       " 'a_web-based',\n",
       " 'web-based_survey',\n",
       " 'survey_was',\n",
       " 'was_conducted',\n",
       " 'conducted_to',\n",
       " 'to_decipher',\n",
       " 'decipher_the',\n",
       " 'the_approach',\n",
       " 'approach_of',\n",
       " 'of_Indian',\n",
       " 'Indian_doctors',\n",
       " 'doctors_to',\n",
       " 'to_the',\n",
       " 'the_various',\n",
       " 'various_options',\n",
       " 'options_for',\n",
       " 'for_treatment',\n",
       " 'treatment_of',\n",
       " 'of_COVID-19',\n",
       " 'COVID-19_Methods',\n",
       " 'Methods_A',\n",
       " 'A_web-based',\n",
       " 'web-based_questionnaire',\n",
       " 'questionnaire_among',\n",
       " 'among_one',\n",
       " 'one_lakh',\n",
       " 'lakh_doctors',\n",
       " 'doctors_across',\n",
       " 'across_India',\n",
       " 'India_through',\n",
       " 'through_email',\n",
       " 'email_and',\n",
       " 'and_social',\n",
       " 'social_media',\n",
       " 'media_was',\n",
       " 'was_circulated',\n",
       " 'circulated_After',\n",
       " 'After_data',\n",
       " 'data_quality',\n",
       " 'quality_and',\n",
       " 'and_internal',\n",
       " 'internal_validation,',\n",
       " 'validation,_826',\n",
       " '826_responses',\n",
       " 'responses_were',\n",
       " 'were_included',\n",
       " 'included_for',\n",
       " 'for_analysis',\n",
       " 'analysis_Basic',\n",
       " 'Basic_demographic',\n",
       " 'demographic_and',\n",
       " 'and_comparative',\n",
       " 'comparative_analysis',\n",
       " 'analysis_were',\n",
       " 'were_performed',\n",
       " 'performed_using',\n",
       " 'using_the',\n",
       " 'the_Python3',\n",
       " 'Python3_8',\n",
       " '8_2',\n",
       " '2_software',\n",
       " 'software_(Windows',\n",
       " '(Windows_10',\n",
       " '10_64',\n",
       " '64_bit,',\n",
       " 'bit,_USA)',\n",
       " 'USA)_Results',\n",
       " 'Results_Amongst',\n",
       " 'Amongst_all',\n",
       " 'all_the',\n",
       " 'the_states',\n",
       " 'states_of',\n",
       " 'of_India',\n",
       " 'India_most',\n",
       " 'most_respondents',\n",
       " 'respondents_hailed',\n",
       " 'hailed_from',\n",
       " 'from_the',\n",
       " 'the_top',\n",
       " 'top_ten',\n",
       " 'ten_affected',\n",
       " 'affected_states',\n",
       " 'states_Overall',\n",
       " 'Overall_76',\n",
       " '76_15%',\n",
       " '15%_of',\n",
       " 'of_doctors',\n",
       " 'doctors_would',\n",
       " 'would_either',\n",
       " 'either_prescribe',\n",
       " 'prescribe_or',\n",
       " 'or_consider',\n",
       " 'consider_prescribing',\n",
       " 'prescribing_hydroxychloroquine',\n",
       " 'hydroxychloroquine_(HCQ)',\n",
       " '(HCQ)_as',\n",
       " 'as_prophylaxis',\n",
       " 'prophylaxis_for',\n",
       " 'for_health-care',\n",
       " 'health-care_providers',\n",
       " 'providers_(HCP)',\n",
       " '(HCP)_Doctors',\n",
       " 'Doctors_with',\n",
       " 'with_experience',\n",
       " 'experience_of',\n",
       " 'of_managing',\n",
       " 'managing_COVID-19',\n",
       " 'COVID-19_were',\n",
       " 'were_more',\n",
       " 'more_likely',\n",
       " 'likely_to',\n",
       " 'to_advocate',\n",
       " 'advocate_use',\n",
       " 'use_of',\n",
       " 'of_HCQ',\n",
       " 'HCQ_as',\n",
       " 'as_prophylaxis',\n",
       " 'prophylaxis_for',\n",
       " 'for_HCP',\n",
       " 'HCP_(χ2',\n",
       " '(χ2_=',\n",
       " '=_4',\n",
       " '4_357,',\n",
       " '357,_P',\n",
       " 'P_=',\n",
       " '=_0',\n",
       " '0_037)',\n",
       " '037)_Intensivists',\n",
       " 'Intensivists_were',\n",
       " 'were_more',\n",
       " 'more_likely',\n",
       " 'likely_to',\n",
       " 'to_advocate',\n",
       " 'advocate_HCQ',\n",
       " 'HCQ_as',\n",
       " 'as_prophylaxis',\n",
       " 'prophylaxis_(χ2',\n",
       " '(χ2_=',\n",
       " '=_14',\n",
       " '14_588,',\n",
       " '588,_P',\n",
       " 'P_<',\n",
       " '<_0',\n",
       " '0_001)',\n",
       " '001)_as',\n",
       " 'as_well',\n",
       " 'well_as',\n",
       " 'as_for',\n",
       " 'for_management',\n",
       " 'management_of',\n",
       " 'of_mild',\n",
       " 'mild_to',\n",
       " 'to_moderate',\n",
       " 'moderate_COVID-19',\n",
       " 'COVID-19_(χ2',\n",
       " '(χ2_=',\n",
       " '=_3',\n",
       " '3_91,',\n",
       " '91,_P',\n",
       " 'P_=',\n",
       " '=_0',\n",
       " '0_048)',\n",
       " '048)_In',\n",
       " 'In_COVID-19,',\n",
       " 'COVID-19,_65',\n",
       " '65_8%',\n",
       " '8%_doctors',\n",
       " 'doctors_overwhelmingly',\n",
       " 'overwhelmingly_preferred',\n",
       " 'preferred_using',\n",
       " 'using_anti-viral',\n",
       " 'anti-viral_agents',\n",
       " 'agents_in',\n",
       " 'in_severe',\n",
       " 'severe_cases,',\n",
       " 'cases,_continuing',\n",
       " 'continuing_ACEi/ARB',\n",
       " 'ACEi/ARB_(60',\n",
       " '(60_9%),',\n",
       " '9%),_and',\n",
       " 'and_routinely',\n",
       " 'routinely_screening',\n",
       " 'screening_for',\n",
       " 'for_COVID-19',\n",
       " 'COVID-19_as',\n",
       " 'as_a',\n",
       " 'a_pre-operative',\n",
       " 'pre-operative_strategy',\n",
       " 'strategy_(73',\n",
       " '(73_85%)',\n",
       " '85%)_Conclusions',\n",
       " 'Conclusions_Indian',\n",
       " 'Indian_doctors',\n",
       " 'doctors_are',\n",
       " 'are_largely',\n",
       " 'largely_following',\n",
       " 'following_the',\n",
       " 'the_scientific',\n",
       " 'scientific_guidance',\n",
       " 'guidance_provided',\n",
       " 'provided_by',\n",
       " 'by_Indian',\n",
       " 'Indian_National',\n",
       " 'National_Task',\n",
       " 'Task_Force',\n",
       " 'Force_for',\n",
       " 'for_COVID-19',\n",
       " 'COVID-19_and',\n",
       " 'and_would',\n",
       " 'would_consider',\n",
       " 'consider_prescribing',\n",
       " 'prescribing_HCQ',\n",
       " 'HCQ_as',\n",
       " 'as_prophylaxis',\n",
       " 'prophylaxis_for',\n",
       " 'for_COVID-19',\n",
       " 'COVID-19_They',\n",
       " 'They_would',\n",
       " 'would_also',\n",
       " 'also_consider',\n",
       " 'consider_using',\n",
       " 'using_it',\n",
       " 'it_in',\n",
       " 'in_mild',\n",
       " 'mild_to',\n",
       " 'to_moderate',\n",
       " 'moderate_COVID-19',\n",
       " 'COVID-19_Hydroxychloroquine',\n",
       " 'Hydroxychloroquine_sulfate',\n",
       " 'sulfate_is',\n",
       " 'is_one',\n",
       " 'one_of',\n",
       " 'of_a',\n",
       " 'a_large',\n",
       " 'large_series',\n",
       " 'series_of',\n",
       " 'of_4-aminoquinolines',\n",
       " '4-aminoquinolines_with',\n",
       " 'with_antimalarial',\n",
       " 'antimalarial_activity',\n",
       " 'activity_Moreover,',\n",
       " 'Moreover,_it',\n",
       " 'it_is',\n",
       " 'is_used',\n",
       " 'used_for',\n",
       " 'for_the',\n",
       " 'the_treatment',\n",
       " 'treatment_of',\n",
       " 'of_rheumatoid',\n",
       " 'rheumatoid_arthritis',\n",
       " 'arthritis_Sometimes',\n",
       " 'Sometimes_Hydroxychloroquine',\n",
       " 'Hydroxychloroquine_sulfate',\n",
       " 'sulfate_is',\n",
       " 'is_very',\n",
       " 'very_effective',\n",
       " 'effective_for',\n",
       " 'for_the',\n",
       " 'the_treatment',\n",
       " 'treatment_of',\n",
       " 'of_autoimmune',\n",
       " 'autoimmune_diseases',\n",
       " 'diseases_Based',\n",
       " 'Based_on',\n",
       " 'on_the',\n",
       " 'the_recent',\n",
       " 'recent_clinical',\n",
       " 'clinical_experiments',\n",
       " 'experiments_it',\n",
       " 'it_is',\n",
       " 'is_exploiting',\n",
       " 'exploiting_for',\n",
       " 'for_the',\n",
       " 'the_treatment',\n",
       " 'treatment_of',\n",
       " 'of_COVID-19,',\n",
       " 'COVID-19,_corona',\n",
       " 'corona_virus',\n",
       " 'virus_across',\n",
       " 'across_the',\n",
       " 'the_globe',\n",
       " 'globe_A',\n",
       " 'A_Reverse',\n",
       " 'Reverse_phase',\n",
       " 'phase_RP-HPLC',\n",
       " 'RP-HPLC_method',\n",
       " 'method_have',\n",
       " 'have_been',\n",
       " 'been_developed',\n",
       " 'developed_and',\n",
       " 'and_validated',\n",
       " 'validated_as',\n",
       " 'as_per',\n",
       " 'per_the',\n",
       " 'the_current',\n",
       " 'current_ICH',\n",
       " 'ICH_guidelines',\n",
       " 'guidelines_for',\n",
       " 'for_estimation',\n",
       " 'estimation_of',\n",
       " 'of_Hydroxychloroquine',\n",
       " 'Hydroxychloroquine_sulfate',\n",
       " 'sulfate_tablets',\n",
       " 'tablets_As',\n",
       " 'As_part',\n",
       " 'part_of',\n",
       " 'of_method',\n",
       " 'method_validation',\n",
       " 'validation_specificity,',\n",
       " 'specificity,_linearity,',\n",
       " 'linearity,_precision',\n",
       " 'precision_and',\n",
       " 'and_recovery',\n",
       " 'recovery_parameters',\n",
       " 'parameters_were',\n",
       " 'were_verified',\n",
       " 'verified_The',\n",
       " 'The_concentration',\n",
       " 'concentration_and',\n",
       " 'and_area',\n",
       " 'area_relationships',\n",
       " 'relationships_were',\n",
       " 'were_linear',\n",
       " 'linear_(R',\n",
       " '(R_(2)',\n",
       " '(2)_>',\n",
       " '>_0',\n",
       " '0_999),',\n",
       " '999),_over',\n",
       " 'over_the',\n",
       " 'the_concentration',\n",
       " 'concentration_range',\n",
       " 'range_of',\n",
       " 'of_25',\n",
       " '25_to',\n",
       " 'to_300',\n",
       " '300_µg',\n",
       " 'µg_mL',\n",
       " 'mL_(-1)',\n",
       " '(-1)_for',\n",
       " 'for_HCQ',\n",
       " 'HCQ_The',\n",
       " 'The_relative',\n",
       " 'relative_standard',\n",
       " 'standard_deviations',\n",
       " 'deviations_for',\n",
       " 'for_precision',\n",
       " 'precision_and',\n",
       " 'and_intermediate',\n",
       " 'intermediate_precision',\n",
       " 'precision_were',\n",
       " 'were_less',\n",
       " 'less_than',\n",
       " 'than_1',\n",
       " '1_5%',\n",
       " '5%_The',\n",
       " 'The_proposed',\n",
       " 'proposed_RP-HPLC',\n",
       " 'RP-HPLC_generic',\n",
       " 'generic_method',\n",
       " 'method_was',\n",
       " 'was_applied',\n",
       " 'applied_successfully',\n",
       " 'successfully_for',\n",
       " 'for_evaluation',\n",
       " 'evaluation_of',\n",
       " 'of_invitro',\n",
       " 'invitro_dissolution',\n",
       " 'dissolution_profile',\n",
       " 'profile_with',\n",
       " 'with_different',\n",
       " 'different_pH',\n",
       " 'pH_conditions',\n",
       " 'conditions_like',\n",
       " 'like_0',\n",
       " '0_1N',\n",
       " '1N_HCl,',\n",
       " 'HCl,_pH',\n",
       " 'pH_4',\n",
       " '4_5',\n",
       " '5_Acetate',\n",
       " 'Acetate_buffer',\n",
       " 'buffer_and',\n",
       " 'and_pH',\n",
       " 'pH_6',\n",
       " '6_8',\n",
       " '8_Phosphate',\n",
       " 'Phosphate_buffers',\n",
       " 'buffers_of',\n",
       " 'of_US',\n",
       " 'US_marketed',\n",
       " 'marketed_reference',\n",
       " 'reference_product',\n",
       " 'product_The',\n",
       " 'The_use',\n",
       " 'use_of',\n",
       " 'of_hydroxychloroquine',\n",
       " 'hydroxychloroquine_(HCQ)',\n",
       " '(HCQ)_has',\n",
       " 'has_been',\n",
       " 'been_considered',\n",
       " 'considered_a',\n",
       " 'a_therapeutic',\n",
       " 'therapeutic_option',\n",
       " 'option_by',\n",
       " 'by_international',\n",
       " 'international_guidelines',\n",
       " 'guidelines_and',\n",
       " 'and_expert',\n",
       " 'expert_opinions',\n",
       " 'opinions_during',\n",
       " 'during_the',\n",
       " 'the_first',\n",
       " 'first_phase',\n",
       " 'phase_of',\n",
       " 'of_COVID-19',\n",
       " 'COVID-19_pandemics,',\n",
       " 'pandemics,_1-10',\n",
       " '1-10_although',\n",
       " 'although_scientific',\n",
       " 'scientific_evidence',\n",
       " 'evidence_remained',\n",
       " 'remained_too',\n",
       " 'too_scarce',\n",
       " 'scarce_to',\n",
       " 'to_make',\n",
       " 'make_a',\n",
       " 'a_definitive',\n",
       " 'definitive_recommendation',\n",
       " 'recommendation_11',\n",
       " '11_.',\n",
       " '._While',\n",
       " 'While_HCQ',\n",
       " 'HCQ_use',\n",
       " 'use_has',\n",
       " 'has_now',\n",
       " 'now_been',\n",
       " 'been_questioned',\n",
       " 'questioned_by',\n",
       " 'by_recent',\n",
       " 'recent_data',\n",
       " 'data_7',\n",
       " '7_,',\n",
       " ',_some',\n",
       " 'some_previous',\n",
       " 'previous_works',\n",
       " 'works_draw',\n",
       " 'draw_attention',\n",
       " 'attention_to',\n",
       " 'to_contrasting',\n",
       " 'contrasting_results',\n",
       " 'results_on',\n",
       " 'on_enhanced',\n",
       " 'enhanced_viral',\n",
       " 'viral_clearance',\n",
       " 'clearance_after',\n",
       " 'after_HCQ',\n",
       " 'HCQ_treatment',\n",
       " 'treatment_1-6,10',\n",
       " '1-6,10_.',\n",
       " '._In',\n",
       " 'In_recent',\n",
       " 'recent_months,',\n",
       " 'months,_the',\n",
       " 'the_new',\n",
       " 'new_coronavirus',\n",
       " 'coronavirus_SARS-CoV-2',\n",
       " 'SARS-CoV-2_has',\n",
       " 'has_emerged',\n",
       " 'emerged_as',\n",
       " 'as_a',\n",
       " 'a_worldwide',\n",
       " 'worldwide_threat',\n",
       " 'threat_with',\n",
       " 'with_about',\n",
       " 'about_4.2',\n",
       " '4.2_million',\n",
       " 'million_confirmed',\n",
       " 'confirmed_cases',\n",
       " 'cases_and',\n",
       " 'and_almost',\n",
       " 'almost_300',\n",
       " '300_000',\n",
       " '000_deaths.',\n",
       " 'deaths._Its',\n",
       " 'Its_major',\n",
       " 'major_clinical',\n",
       " 'clinical_presentation',\n",
       " 'presentation_is',\n",
       " 'is_characterized',\n",
       " 'characterized_by',\n",
       " 'by_respiratory',\n",
       " 'respiratory_symptoms',\n",
       " 'symptoms_ranging',\n",
       " 'ranging_from',\n",
       " 'from_mild',\n",
       " 'mild_cough',\n",
       " 'cough_to',\n",
       " 'to_serve',\n",
       " 'serve_pneumonia',\n",
       " 'pneumonia_with',\n",
       " 'with_fever',\n",
       " 'fever_and',\n",
       " 'and_potentially',\n",
       " 'potentially_even',\n",
       " 'even_death.',\n",
       " 'death._Until',\n",
       " 'Until_today,',\n",
       " 'today,_there',\n",
       " 'there_is',\n",
       " 'is_no',\n",
       " 'no_known',\n",
       " 'known_medication',\n",
       " 'medication_to',\n",
       " 'to_improve',\n",
       " 'improve_clinical',\n",
       " 'clinical_symptoms',\n",
       " 'symptoms_or',\n",
       " 'or_even',\n",
       " 'even_prevent',\n",
       " 'prevent_or',\n",
       " 'or_fight',\n",
       " 'fight_the',\n",
       " 'the_infection.',\n",
       " 'infection._The',\n",
       " 'The_search',\n",
       " 'search_for',\n",
       " 'for_a',\n",
       " 'a_useful',\n",
       " 'useful_vaccination',\n",
       " 'vaccination_is',\n",
       " 'is_ongoing',\n",
       " 'ongoing_and',\n",
       " 'and_it',\n",
       " 'it_will',\n",
       " 'will_probably',\n",
       " 'probably_not',\n",
       " 'not_be',\n",
       " 'be_available',\n",
       " 'available_before',\n",
       " 'before_the',\n",
       " 'the_end',\n",
       " 'end_of',\n",
       " 'of_2020.',\n",
       " '2020._In',\n",
       " 'In_this',\n",
       " 'this_review,',\n",
       " 'review,_we',\n",
       " 'we_highlight',\n",
       " 'highlight_hydroxychloroquine',\n",
       " 'hydroxychloroquine_(HCQ)',\n",
       " '(HCQ)_as',\n",
       " 'as_a',\n",
       " 'a_potential',\n",
       " 'potential_agent',\n",
       " 'agent_to',\n",
       " 'to_prevent',\n",
       " 'prevent_coronavirus',\n",
       " 'coronavirus_disease',\n",
       " 'disease_2019',\n",
       " '2019_(COVID-19)',\n",
       " '(COVID-19)_and',\n",
       " 'and_reduce',\n",
       " 'reduce_as',\n",
       " 'as_well',\n",
       " 'well_as',\n",
       " 'as_shorten',\n",
       " 'shorten_clinical',\n",
       " 'clinical_symptoms.',\n",
       " 'symptoms._Moreover,',\n",
       " 'Moreover,_it',\n",
       " 'it_might',\n",
       " 'might_serve',\n",
       " 'serve_as',\n",
       " 'as_a',\n",
       " 'a_potential',\n",
       " 'potential_post-exposition',\n",
       " 'post-exposition_prophylaxis.',\n",
       " 'prophylaxis._Although',\n",
       " 'Although_it',\n",
       " 'it_has',\n",
       " 'has_been',\n",
       " 'been_used',\n",
       " 'used_in',\n",
       " 'in_the',\n",
       " 'the_treatment',\n",
       " 'treatment_of',\n",
       " 'of_rheumatoid',\n",
       " 'rheumatoid_arthritis,',\n",
       " 'arthritis,_discoid',\n",
       " 'discoid_or',\n",
       " 'or_systemic',\n",
       " 'systemic_lupus',\n",
       " 'lupus_erythematosus,',\n",
       " 'erythematosus,_and',\n",
       " 'and_malaria',\n",
       " 'malaria_prophylaxis',\n",
       " 'prophylaxis_and',\n",
       " 'and_therapy',\n",
       " 'therapy_for',\n",
       " 'for_decades,',\n",
       " 'decades,_knowledge',\n",
       " 'knowledge_on',\n",
       " 'on_HCQ',\n",
       " 'HCQ_as',\n",
       " 'as_a',\n",
       " 'a_potential',\n",
       " 'potential_treatment',\n",
       " 'treatment_for',\n",
       " 'for_COVID-19',\n",
       " 'COVID-19_is',\n",
       " 'is_limited',\n",
       " 'limited_and',\n",
       " 'and_multiple',\n",
       " 'multiple_clinical',\n",
       " 'clinical_trials',\n",
       " 'trials_have',\n",
       " 'have_just',\n",
       " 'just_emerged.',\n",
       " 'emerged._Especially,',\n",
       " 'Especially,_rare',\n",
       " 'rare_HCQ',\n",
       " 'HCQ_side',\n",
       " 'side_effects',\n",
       " 'effects_which',\n",
       " 'which_were',\n",
       " 'were_of',\n",
       " 'of_minor',\n",
       " 'minor_importance',\n",
       " 'importance_for',\n",
       " 'for_use',\n",
       " 'use_in',\n",
       " 'in_selected',\n",
       " 'selected_indications',\n",
       " 'indications_might',\n",
       " 'might_gain',\n",
       " 'gain_major',\n",
       " 'major_relevance',\n",
       " 'relevance_with',\n",
       " 'with_population-wide',\n",
       " 'population-wide_application.',\n",
       " 'application._These',\n",
       " 'These_rare',\n",
       " 'rare_side',\n",
       " 'side_effects',\n",
       " 'effects_include',\n",
       " 'include_retinopathy',\n",
       " 'retinopathy_and-even',\n",
       " 'and-even_more',\n",
       " 'more_important-QT',\n",
       " 'important-QT_prolongation',\n",
       " 'prolongation_leading',\n",
       " 'leading_to',\n",
       " 'to_sudden',\n",
       " 'sudden_cardiac',\n",
       " 'cardiac_death',\n",
       " 'death_by',\n",
       " 'by_malignant',\n",
       " 'malignant_arrhythmias.',\n",
       " 'arrhythmias._Severe',\n",
       " 'Severe_acute',\n",
       " 'acute_respiratory',\n",
       " 'respiratory_coronavirus',\n",
       " 'coronavirus_2',\n",
       " '2_(SARS-CoV-2)',\n",
       " '(SARS-CoV-2)_has',\n",
       " 'has_caused',\n",
       " 'caused_a',\n",
       " 'a_devastating',\n",
       " 'devastating_worldwide',\n",
       " 'worldwide_pandemic.',\n",
       " 'pandemic._Hydroxychloroquine',\n",
       " 'Hydroxychloroquine_(HCQ)',\n",
       " '(HCQ)_has',\n",
       " 'has_in',\n",
       " 'in_vitro',\n",
       " 'vitro_activity',\n",
       " 'activity_against',\n",
       " 'against_SARS-CoV-2,',\n",
       " 'SARS-CoV-2,_but',\n",
       " 'but_clinical',\n",
       " 'clinical_data',\n",
       " 'data_supporting',\n",
       " 'supporting_HCQ',\n",
       " 'HCQ_for',\n",
       " 'for_coronavirus',\n",
       " 'coronavirus_disease',\n",
       " 'disease_2019',\n",
       " '2019_(COVID-19)',\n",
       " '(COVID-19)_are',\n",
       " 'are_limited.',\n",
       " 'limited._METHODS:',\n",
       " 'METHODS:_This',\n",
       " 'This_was',\n",
       " 'was_a',\n",
       " 'a_retrospective',\n",
       " 'retrospective_cohort',\n",
       " 'cohort_study',\n",
       " 'study_of',\n",
       " 'of_hospitalized',\n",
       " 'hospitalized_patients',\n",
       " 'patients_with',\n",
       " 'with_COVID-19',\n",
       " 'COVID-19_who',\n",
       " 'who_received',\n",
       " 'received_≥1',\n",
       " '≥1_dose',\n",
       " 'dose_of',\n",
       " 'of_HCQ',\n",
       " 'HCQ_at',\n",
       " 'at_two',\n",
       " 'two_New',\n",
       " 'New_York',\n",
       " 'York_City',\n",
       " 'City_hospitals.',\n",
       " 'hospitals._We',\n",
       " 'We_measured',\n",
       " 'measured_incident',\n",
       " 'incident_Grade',\n",
       " 'Grade_3',\n",
       " '3_or',\n",
       " 'or_4',\n",
       " '4_blood',\n",
       " 'blood_count',\n",
       " 'count_and',\n",
       " 'and_liver',\n",
       " 'liver_test',\n",
       " 'test_abnormalities,',\n",
       " 'abnormalities,_ventricular',\n",
       " 'ventricular_arrhythmias,',\n",
       " 'arrhythmias,_and',\n",
       " 'and_vomiting',\n",
       " 'vomiting_and',\n",
       " 'and_diarrhea',\n",
       " 'diarrhea_within',\n",
       " 'within_10',\n",
       " '10_days',\n",
       " 'days_after',\n",
       " 'after_HCQ',\n",
       " 'HCQ_initiation,',\n",
       " 'initiation,_and',\n",
       " 'and_the',\n",
       " 'the_proportion',\n",
       " 'proportion_of',\n",
       " 'of_patients',\n",
       " 'patients_who',\n",
       " 'who_completed',\n",
       " 'completed_HCQ',\n",
       " 'HCQ_therapy.',\n",
       " 'therapy._We',\n",
       " 'We_also',\n",
       " 'also_describe',\n",
       " 'describe_changes',\n",
       " 'changes_in',\n",
       " ...]"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "new_list"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "\"The_ongoing ongoing_pandemic pandemic_of of_coronavirus coronavirus_disease disease_2019 2019_(COVID-19) (COVID-19)_caused caused_by by_the the_severe severe_acute acute_respiratory respiratory_syndrome syndrome_coronavirus coronavirus_2 2_(SARS-CoV-2) (SARS-CoV-2)_poses poses_a a_serious serious_threat threat_to to_global global_public public_health health_and and_there there_is is_currently currently_no no_effective effective_antiviral antiviral_therapy therapy_It It_has has_been been_suggested suggested_that that_Chloroquine Chloroquine_(CQ) (CQ)_and and_hydroxychloroquine hydroxychloroquine_(HCQ), (HCQ),_which which_were were_primarily primarily_employed employed_as as_prophylaxis prophylaxis_and and_treatment treatment_for for_malaria, malaria,_could could_be be_used used_to to_treat treat_COVID-19 COVID-19_CQ CQ_and and_HCQ HCQ_may may_be be_potential potential_inhibitors inhibitors_of of_SARS-CoV-2 SARS-CoV-2_entry entry_into into_host host_cells, cells,_which which_is is_mediated mediated_via via_the the_angiotensin-converting angiotensin-converting_enzyme enzyme_2 2_(ACE2), (ACE2),_and and_may may_also also_inhibit inhibit_subsequent subsequent_intracellular intracellular_processes processes_which which_lead lead_to to_COVID-19, COVID-19,_including including_damage damage_to to_the the_cardiovascular cardiovascular_system system_However, However,_paradoxically, paradoxically,_CQ CQ_and and_HCQ HCQ_have have_also also_been been_reported reported_to to_cause cause_damage damage_to to_the the_cardiovascular cardiovascular_system system_In In_this this_review, review,_we we_provide provide_a a_critical critical_examination examination_of of_the the_published published_evidence evidence_CQ CQ_and and_HCQ HCQ_could could_potentially potentially_be be_useful useful_drugs drugs_in in_the the_treatment treatment_of of_COVID-19 COVID-19_and and_other other_ACE2 ACE2_involved involved_virus virus_infections, infections,_but but_the the_antiviral antiviral_effects effects_of of_CQ CQ_and and_HCQ HCQ_need need_to to_be be_tested tested_in in_more more_well-designed well-designed_clinical clinical_randomized randomized_studies studies_and and_their their_actions actions_on on_the the_cardiovascular cardiovascular_system system_need need_to to_be be_further further_elucidated elucidated_However, However,_even even_if if_it it_were were_to to_turn turn_out out_that that_CQ CQ_and and_HCQ HCQ_are are_not not_useful useful_drugs drugs_in in_practice, practice,_further further_studies studies_of of_their their_mechanism mechanism_of of_action action_could could_be be_helpful helpful_in in_improving improving_our our_understanding understanding_of of_COVID-19 COVID-19_pathology pathology_Background Background_and and_aims aims_As As_the the_Coronavirus Coronavirus_disease disease_2019 2019_(COVID-19) (COVID-19)_pandemic pandemic_unravels unravels_rapidly, rapidly,_there there_is is_a a_glut glut_of of_confusing confusing_and and_divergent divergent_scientific scientific_information information_emanating emanating_from from_differing differing_sources, sources,_including including_the the_Indian Indian_National National_Task Task_Force Force_for for_COVID-19 COVID-19_Thus, Thus,_a a_web-based web-based_survey survey_was was_conducted conducted_to to_decipher decipher_the the_approach approach_of of_Indian Indian_doctors doctors_to to_the the_various various_options options_for for_treatment treatment_of of_COVID-19 COVID-19_Methods Methods_A A_web-based web-based_questionnaire questionnaire_among among_one one_lakh lakh_doctors doctors_across across_India India_through through_email email_and and_social social_media media_was was_circulated circulated_After After_data data_quality quality_and and_internal internal_validation, validation,_826 826_responses responses_were were_included included_for for_analysis analysis_Basic Basic_demographic demographic_and and_comparative comparative_analysis analysis_were were_performed performed_using using_the the_Python3 Python3_8 8_2 2_software software_(Windows (Windows_10 10_64 64_bit, bit,_USA) USA)_Results Results_Amongst Amongst_all all_the the_states states_of of_India India_most most_respondents respondents_hailed hailed_from from_the the_top top_ten ten_affected affected_states states_Overall Overall_76 76_15% 15%_of of_doctors doctors_would would_either either_prescribe prescribe_or or_consider consider_prescribing prescribing_hydroxychloroquine hydroxychloroquine_(HCQ) (HCQ)_as as_prophylaxis prophylaxis_for for_health-care health-care_providers providers_(HCP) (HCP)_Doctors Doctors_with with_experience experience_of of_managing managing_COVID-19 COVID-19_were were_more more_likely likely_to to_advocate advocate_use use_of of_HCQ HCQ_as as_prophylaxis prophylaxis_for for_HCP HCP_(χ2 (χ2_= =_4 4_357, 357,_P P_= =_0 0_037) 037)_Intensivists Intensivists_were were_more more_likely likely_to to_advocate advocate_HCQ HCQ_as as_prophylaxis prophylaxis_(χ2 (χ2_= =_14 14_588, 588,_P P_< <_0 0_001) 001)_as as_well well_as as_for for_management management_of of_mild mild_to to_moderate moderate_COVID-19 COVID-19_(χ2 (χ2_= =_3 3_91, 91,_P P_= =_0 0_048) 048)_In In_COVID-19, COVID-19,_65 65_8% 8%_doctors doctors_overwhelmingly overwhelmingly_preferred preferred_using using_anti-viral anti-viral_agents agents_in in_severe severe_cases, cases,_continuing continuing_ACEi/ARB ACEi/ARB_(60 (60_9%), 9%),_and and_routinely routinely_screening screening_for for_COVID-19 COVID-19_as as_a a_pre-operative pre-operative_strategy strategy_(73 (73_85%) 85%)_Conclusions Conclusions_Indian Indian_doctors doctors_are are_largely largely_following following_the the_scientific scientific_guidance guidance_provided provided_by by_Indian Indian_National National_Task Task_Force Force_for for_COVID-19 COVID-19_and and_would would_consider consider_prescribing prescribing_HCQ HCQ_as as_prophylaxis prophylaxis_for for_COVID-19 COVID-19_They They_would would_also also_consider consider_using using_it it_in in_mild mild_to to_moderate moderate_COVID-19 COVID-19_Hydroxychloroquine Hydroxychloroquine_sulfate sulfate_is is_one one_of of_a a_large large_series series_of of_4-aminoquinolines 4-aminoquinolines_with with_antimalarial antimalarial_activity activity_Moreover, Moreover,_it it_is is_used used_for for_the the_treatment treatment_of of_rheumatoid rheumatoid_arthritis arthritis_Sometimes Sometimes_Hydroxychloroquine Hydroxychloroquine_sulfate sulfate_is is_very very_effective effective_for for_the the_treatment treatment_of of_autoimmune autoimmune_diseases diseases_Based Based_on on_the the_recent recent_clinical clinical_experiments experiments_it it_is is_exploiting exploiting_for for_the the_treatment treatment_of of_COVID-19, COVID-19,_corona corona_virus virus_across across_the the_globe globe_A A_Reverse Reverse_phase phase_RP-HPLC RP-HPLC_method method_have have_been been_developed developed_and and_validated validated_as as_per per_the the_current current_ICH ICH_guidelines guidelines_for for_estimation estimation_of of_Hydroxychloroquine Hydroxychloroquine_sulfate sulfate_tablets tablets_As As_part part_of of_method method_validation validation_specificity, specificity,_linearity, linearity,_precision precision_and and_recovery recovery_parameters parameters_were were_verified verified_The The_concentration concentration_and and_area area_relationships relationships_were were_linear linear_(R (R_(2) (2)_> >_0 0_999), 999),_over over_the the_concentration concentration_range range_of of_25 25_to to_300 300_µg µg_mL mL_(-1) (-1)_for for_HCQ HCQ_The The_relative relative_standard standard_deviations deviations_for for_precision precision_and and_intermediate intermediate_precision precision_were were_less less_than than_1 1_5% 5%_The The_proposed proposed_RP-HPLC RP-HPLC_generic generic_method method_was was_applied applied_successfully successfully_for for_evaluation evaluation_of of_invitro invitro_dissolution dissolution_profile profile_with with_different different_pH pH_conditions conditions_like like_0 0_1N 1N_HCl, HCl,_pH pH_4 4_5 5_Acetate Acetate_buffer buffer_and and_pH pH_6 6_8 8_Phosphate Phosphate_buffers buffers_of of_US US_marketed marketed_reference reference_product product_The The_use use_of of_hydroxychloroquine hydroxychloroquine_(HCQ) (HCQ)_has has_been been_considered considered_a a_therapeutic therapeutic_option option_by by_international international_guidelines guidelines_and and_expert expert_opinions opinions_during during_the the_first first_phase phase_of of_COVID-19 COVID-19_pandemics, pandemics,_1-10 1-10_although although_scientific scientific_evidence evidence_remained remained_too too_scarce scarce_to to_make make_a a_definitive definitive_recommendation recommendation_11 11_. ._While While_HCQ HCQ_use use_has has_now now_been been_questioned questioned_by by_recent recent_data data_7 7_, ,_some some_previous previous_works works_draw draw_attention attention_to to_contrasting contrasting_results results_on on_enhanced enhanced_viral viral_clearance clearance_after after_HCQ HCQ_treatment treatment_1-6,10 1-6,10_. ._In In_recent recent_months, months,_the the_new new_coronavirus coronavirus_SARS-CoV-2 SARS-CoV-2_has has_emerged emerged_as as_a a_worldwide worldwide_threat threat_with with_about about_4.2 4.2_million million_confirmed confirmed_cases cases_and and_almost almost_300 300_000 000_deaths. deaths._Its Its_major major_clinical clinical_presentation presentation_is is_characterized characterized_by by_respiratory respiratory_symptoms symptoms_ranging ranging_from from_mild mild_cough cough_to to_serve serve_pneumonia pneumonia_with with_fever fever_and and_potentially potentially_even even_death. death._Until Until_today, today,_there there_is is_no no_known known_medication medication_to to_improve improve_clinical clinical_symptoms symptoms_or or_even even_prevent prevent_or or_fight fight_the the_infection. infection._The The_search search_for for_a a_useful useful_vaccination vaccination_is is_ongoing ongoing_and and_it it_will will_probably probably_not not_be be_available available_before before_the the_end end_of of_2020. 2020._In In_this this_review, review,_we we_highlight highlight_hydroxychloroquine hydroxychloroquine_(HCQ) (HCQ)_as as_a a_potential potential_agent agent_to to_prevent prevent_coronavirus coronavirus_disease disease_2019 2019_(COVID-19) (COVID-19)_and and_reduce reduce_as as_well well_as as_shorten shorten_clinical clinical_symptoms. symptoms._Moreover, Moreover,_it it_might might_serve serve_as as_a a_potential potential_post-exposition post-exposition_prophylaxis. prophylaxis._Although Although_it it_has has_been been_used used_in in_the the_treatment treatment_of of_rheumatoid rheumatoid_arthritis, arthritis,_discoid discoid_or or_systemic systemic_lupus lupus_erythematosus, erythematosus,_and and_malaria malaria_prophylaxis prophylaxis_and and_therapy therapy_for for_decades, decades,_knowledge knowledge_on on_HCQ HCQ_as as_a a_potential potential_treatment treatment_for for_COVID-19 COVID-19_is is_limited limited_and and_multiple multiple_clinical clinical_trials trials_have have_just just_emerged. emerged._Especially, Especially,_rare rare_HCQ HCQ_side side_effects effects_which which_were were_of of_minor minor_importance importance_for for_use use_in in_selected selected_indications indications_might might_gain gain_major major_relevance relevance_with with_population-wide population-wide_application. application._These These_rare rare_side side_effects effects_include include_retinopathy retinopathy_and-even and-even_more more_important-QT important-QT_prolongation prolongation_leading leading_to to_sudden sudden_cardiac cardiac_death death_by by_malignant malignant_arrhythmias. arrhythmias._Severe Severe_acute acute_respiratory respiratory_coronavirus coronavirus_2 2_(SARS-CoV-2) (SARS-CoV-2)_has has_caused caused_a a_devastating devastating_worldwide worldwide_pandemic. pandemic._Hydroxychloroquine Hydroxychloroquine_(HCQ) (HCQ)_has has_in in_vitro vitro_activity activity_against against_SARS-CoV-2, SARS-CoV-2,_but but_clinical clinical_data data_supporting supporting_HCQ HCQ_for for_coronavirus coronavirus_disease disease_2019 2019_(COVID-19) (COVID-19)_are are_limited. limited._METHODS: METHODS:_This This_was was_a a_retrospective retrospective_cohort cohort_study study_of of_hospitalized hospitalized_patients patients_with with_COVID-19 COVID-19_who who_received received_≥1 ≥1_dose dose_of of_HCQ HCQ_at at_two two_New New_York York_City City_hospitals. hospitals._We We_measured measured_incident incident_Grade Grade_3 3_or or_4 4_blood blood_count count_and and_liver liver_test test_abnormalities, abnormalities,_ventricular ventricular_arrhythmias, arrhythmias,_and and_vomiting vomiting_and and_diarrhea diarrhea_within within_10 10_days days_after after_HCQ HCQ_initiation, initiation,_and and_the the_proportion proportion_of of_patients patients_who who_completed completed_HCQ HCQ_therapy. therapy._We We_also also_describe describe_changes changes_in in_Sequential Sequential_Organ Organ_Failure Failure_Assessment Assessment_hypoxia hypoxia_scores scores_between between_baseline baseline_and and_day day_10 10_after after_HCQ HCQ_initiation initiation_and and_in-hospital in-hospital_mortality. mortality._RESULTS: RESULTS:_None None_of of_the the_153 153_hospitalized hospitalized_patients patients_with with_COVID-19 COVID-19_who who_received received_HCQ HCQ_developed developed_a a_sustained sustained_ventricular ventricular_tachyarrhythmia. tachyarrhythmia._Incident Incident_blood blood_count count_and and_liver liver_test test_abnormalities abnormalities_occurred occurred_in in_<15% <15%_of of_patients patients_and and_incident incident_vomiting vomiting_or or_diarrhea diarrhea_was was_rare. rare._Eighty-nine Eighty-nine_percent percent_of of_patients patients_completed completed_their their_HCQ HCQ_course course_and and_three three_patients patients_discontinued discontinued_therapy therapy_because because_of of_QT QT_prolongation. prolongation._Fifty-two Fifty-two_percent percent_of of_patients patients_had had_improved improved_hypoxia hypoxia_scores scores_10 10_days days_after after_starting starting_HCQ. HCQ._Thirty-one Thirty-one_percent percent_of of_patients patients_who who_were were_receiving receiving_mechanical mechanical_ventilation ventilation_at at_the the_time time_of of_HCQ HCQ_initiation initiation_died died_during during_their their_hospitalization, hospitalization,_compared compared_to to_18% 18%_of of_patients patients_who who_were were_receiving receiving_supplemental supplemental_oxygen oxygen_but but_not not_requiring requiring_mechanical mechanical_ventilation, ventilation,_and and_8% 8%_of of_patients patients_who who_were were_not not_requiring requiring_supplemental supplemental_oxygen. oxygen._Co-administration Co-administration_of of_azithromycin azithromycin_was was_not not_associated associated_with with_improved improved_outcomes. outcomes._CONCLUSIONS: CONCLUSIONS:_HCQ HCQ_appears appears_to to_be be_reasonably reasonably_safe safe_and and_tolerable tolerable_in in_most most_hospitalized hospitalized_patients patients_with with_COVID-19. COVID-19._However, However,_nearly nearly_one-half one-half_of of_patients patients_did did_not not_improve improve_with with_this this_treatment, treatment,_highlighting highlighting_the the_need need_to to_evaluate evaluate_HCQ HCQ_and and_alternate alternate_therapies therapies_in in_randomized randomized_trials. trials._The The_aim aim_of of_this this_work work_is is_to to_trace trace_how how_rheumatologists rheumatologists_all all_over over_Egypt Egypt_are are_approaching approaching_the the_COVID-19 COVID-19_pandemic pandemic_and and_what what_changes changes_it it_has has_brought brought_about about_in in_the the_patients' patients'_care care_with with_special special_attention attention_to to_its its_effect effect_on on_vulnerable vulnerable_rheumatic rheumatic_disease disease_(RD) (RD)_patients. patients._This This_survey survey_further further_aims aims_to to_help help_inform inform_the the_rheumatology rheumatology_community community_about about_the the_changes changes_in in_practice practice_during during_the the_COVID-19 COVID-19_pandemic. pandemic._The The_survey survey_included included_26 26_questions questions_distributed distributed_to to_University University_staff staff_members members_across across_Egypt Egypt_members members_of of_the the_Egyptian Egyptian_College College_of of_Rheumatology Rheumatology_(ECR). (ECR)._It It_takes takes_5-10 5-10_min min_to to_fill fill_out. out._The The_practice practice_setting setting_of of_participating participating_rheumatologists rheumatologists_included included_University University_Teaching Teaching_Hospitals Hospitals_that that_are are_the the_main main_rheumatology rheumatology_and and_clinical clinical_immunology immunology_service service_providers providers_for for_adults adults_and and_children children_RD RD_patients. patients._There There_was was_an an_overall overall_agreement agreement_across across_the the_country country_in in_the the_responses responses_to to_the the_survey survey_that that_took took_a a_median median_time time_of of_7 7_min min_to to_fill fill_in. in._Potential Potential_changes changes_in in_rheumatology rheumatology_outpatient outpatient_practice practice_by by_staff staff_members members_evolved evolved_since since_the the_COVID-19 COVID-19_pandemic. pandemic._None None_of of_the the_university university_rheumatology rheumatology_staff staff_members members_has has_prescribed prescribed_chloroquine chloroquine_or or_HCQ HCQ_to to_prevent prevent_or or_treat treat_COVID-19 COVID-19_in in_a a_non-hospitalized non-hospitalized_patient patient_who who_was was_not not_previously previously_on on_it. it._Twenty-three Twenty-three_recommended recommended_decrease/avoid decrease/avoid_NSAIDs NSAIDs_if if_the the_RD RD_patient patient_had had_confirmed confirmed_COVID-19 COVID-19_or or_symptoms. symptoms._There There_is is_an an_agreement agreement_to to_the the_key key_emerging emerging_frontline frontline_role role_of of_rheumatologists rheumatologists_in in_treating treating_COVID-19. COVID-19._During During_the the_pandemic, pandemic,_RD RD_cases cases_requiring requiring_admission admission_were were_dealt dealt_with with_by by_several several_modified modified_strategies. strategies._The The_overall overall_agreement agreement_among among_the the_different different_university university_rheumatology rheumatology_departments departments_during during_such such_critical critical_situation situation_has has_provoked provoked_the the_ECR ECR_to to_consider consider_providing providing_provisional provisional_guidelines guidelines_for for_dealing dealing_with with_RD RD_patients patients_during during_this this_global global_catastrophe. catastrophe._COVID-19 COVID-19_has has_rapidly rapidly_become become_a a_pandemic pandemic_for for_which which_no no_antiviral antiviral_drug drug_or or_vaccine vaccine_is is_yet yet_available2-4. available2-4._Several Several_clinical clinical_studies studies_are are_ongoing ongoing_to to_evaluate evaluate_the the_efficacy efficacy_of of_repurposed repurposed_drugs drugs_that that_have have_demonstrated demonstrated_antiviral antiviral_efficacy efficacy_in in_vitro. vitro._Among Among_these these_candidates, candidates,_hydroxychloroquine hydroxychloroquine_(HCQ) (HCQ)_has has_been been_given given_to to_thousands thousands_of of_individuals individuals_worldwide worldwide_but but_definitive definitive_evidence evidence_for for_HCQ HCQ_efficacy efficacy_in in_treatment treatment_of of_COVID-19 COVID-19_is is_still still_missing6,7,17,18. missing6,7,17,18._We We_evaluated evaluated_the the_antiviral antiviral_activity activity_of of_HCQ HCQ_both both_in in_vitro vitro_and and_in in_SARS-CoV-2-infected SARS-CoV-2-infected_macaques. macaques._HCQ HCQ_showed showed_antiviral antiviral_activity activity_in in_African African_green green_monkey monkey_kidney kidney_cells cells_(VeroE6) (VeroE6)_but but_not not_in in_a a_model model_of of_reconstituted reconstituted_human human_airway airway_epithelium. epithelium._In In_macaques, macaques,_we we_tested tested_different different_treatment treatment_strategies strategies_in in_comparison comparison_to to_placebo, placebo,_before before_and and_after after_peak peak_viral viral_load, load,_alone alone_or or_in in_combination combination_with with_azithromycin azithromycin_(AZTH). (AZTH)._Neither Neither_HCQ HCQ_nor nor_HCQ+AZTH HCQ+AZTH_showed showed_a a_significant significant_effect effect_on on_the the_viral viral_load load_levels levels_in in_any any_of of_the the_tested tested_compartments. compartments._When When_the the_drug drug_was was_used used_as as_a a_pre-exposure pre-exposure_prophylaxis prophylaxis_(PrEP), (PrEP),_HCQ HCQ_did did_not not_confer confer_protection protection_against against_acquisition acquisition_of of_infection. infection._Our Our_findings findings_do do_not not_support support_the the_use use_of of_HCQ, HCQ,_either either_alone alone_or or_in in_combination combination_with with_AZTH, AZTH,_as as_an an_antiviral antiviral_treatment treatment_for for_COVID-19 COVID-19_in in_humans. humans._Over Over_the the_last last_few few_months, months,_coronavirus coronavirus_disease disease_2019 2019_(COVID-19) (COVID-19)_pandemic pandemic_caused caused_by by_the the_novel novel_coronavirus coronavirus_SARS-CoV-2 SARS-CoV-2_has has_posed posed_a a_serious serious_threat threat_to to_public public_health health_on on_a a_global global_scale. scale._Given Given_the the_current current_lack lack_of of_an an_effective effective_vaccine, vaccine,_several several_drugs drugs_have have_been been_repurposed repurposed_for for_treatment treatment_and and_prophylaxis prophylaxis_of of_COVID-19 COVID-19_in in_an an_attempt attempt_to to_find find_an an_effective effective_cure. cure._AREAS AREAS_COVERED COVERED_The The_antimalarial antimalarial_drug drug_hydroxychloroquine hydroxychloroquine_(HCQ) (HCQ)_initially initially_garnered garnered_widespread widespread_attention attention_following following_the the_publication publication_of of_preliminary preliminary_results results_showing showing_that that_this this_drug drug_exerts exerts_an an_anti-SARS-CoV-2 anti-SARS-CoV-2_activity activity_in in_vitro. vitro._EXPERT EXPERT_OPINION OPINION_To To_date, date,_clinical clinical_evidence evidence_suggests suggests_lack lack_of of_benefit benefit_from from_HCQ HCQ_use use_for for_the the_treatment treatment_of of_hospitalized hospitalized_patients patients_with with_COVID-19. COVID-19._In In_such such_patients, patients,_HCQ HCQ_also also_appears appears_to to_be be_associated associated_with with_an an_increased increased_risk risk_of of_QT QT_interval interval_prolongation prolongation_and and_potentially potentially_lethal lethal_ventricular ventricular_arrhythmias. arrhythmias._Therefore, Therefore,_FDA FDA_has has_recently recently_revoked revoked_the the_Emergency Emergency_Use Use_Authorization Authorization_(EUA) (EUA)_for for_emergency emergency_use use_of of_HCQ HCQ_and and_chloroquine chloroquine_to to_treat treat_COVID-19. COVID-19._Conversely, Conversely,_whether whether_HCQ HCQ_use use_may may_represent represent_an an_effective effective_prophylactic prophylactic_strategy strategy_against against_COVID-19 COVID-19_is is_a a_separate separate_question question_that that_still still_remains remains_to to_be be_answered. answered._In In_addition, addition,_relevant relevant_aspects aspects_regarding regarding_the the_potential potential_risks risks_and and_benefits benefits_of of_HCQ HCQ_need need_to to_be be_clarified, clarified,_in in_pursuit pursuit_of of_a a_rational rational_use use_of of_this this_drug drug_in in_the the_COVID-19 COVID-19_pandemic pandemic_era. era._Three Three_months months_have have_passed passed_since since_the the_World World_Health Health_Organization Organization_(WHO) (WHO)_declared declared_coronavirus coronavirus_disease disease_19 19_(COVID-19) (COVID-19)_as as_a a_pandemic pandemic_on on_March March_11, 11,_2020. 2020._Due Due_to to_the the_high high_infection infection_rates rates_and and_occurrence occurrence_of of_severe severe_and and_fatal fatal_cases, cases,_the the_search search_for for_effective effective_drugs drugs_to to_treat treat_and and_control control_the the_COVID-19 COVID-19_pandemic pandemic_has has_been been_prioritized prioritized_by by_health health_and and_political political_authorities. authorities._Antimalarials, Antimalarials,_well-known well-known_for for_their their_use use_in in_dermatology dermatology_and and_rheumatology, rheumatology,_are are_one one_of of_the the_medications medications_with with_the the_largest largest_- -_albeit albeit_limited limited_- -_scientific scientific_background background_warranting warranting_their their_use use_in in_the the_COVID-19 COVID-19_treatment treatment_protocols. protocols._Hydroxychloroquine Hydroxychloroquine_(HCQ) (HCQ)_has has_been been_used used_for for_the the_treatment treatment_of of_COVID-19 COVID-19_in in_50 50_patients patients_in in_our our_and and_other other_centres centres_in in_several several_countries countries_with with_encouraging encouraging_results. results._However, However,_recent recent_studies studies_disprove disprove_the the_real real_effectiveness effectiveness_of of_this this_drug, drug,_either either_alone alone_or or_when when_combined combined_with with_macrolides. macrolides._As As_a a_result, result,_the the_World World_Health Health_Organization Organization_has has_discouraged discouraged_the the_use use_of of_HCQ HCQ_in in_the the_treatment treatment_and and_prevention prevention_of of_COVID-19. COVID-19._Herein Herein_we we_report report_our our_experience experience_in in_the the_use use_of of_hydroxychloroquine hydroxychloroquine_for for_COVID-19 COVID-19_treatment. treatment._Novel Novel_coronavirus coronavirus_disease disease_(COVID-19) (COVID-19)_is is_a a_highly highly_contagious contagious_disease disease_caused caused_by by_severe severe_acute acute_respiratory respiratory_distress distress_syndrome syndrome_coronavirus-2 coronavirus-2_that that_has has_resulted resulted_in in_the the_current current_global global_pandemic. pandemic._Currently, Currently,_there there_is is_no no_available available_treatment treatment_proven proven_to to_be be_effective effective_against against_COVID-19, COVID-19,_but but_multiple multiple_medications, medications,_including including_hydroxychloroquine hydroxychloroquine_(HCQ), (HCQ),_are are_used used_off off_label. label._We We_report report_the the_case case_of of_a a_60-year-old 60-year-old_woman woman_without without_any any_cardiac cardiac_history history_who who_developed developed_right right_bundle bundle_brunch brunch_block block_and and_critically critically_prolonged prolonged_corrected corrected_electrocardiographic electrocardiographic_QT QT_interval interval_(QTc (QTc_631 631_ms) ms)_after after_treatment treatment_for for_3 3_days days_with with_HCQ, HCQ,_which which_resolved resolved_on on_discontinuation discontinuation_of of_the the_medication. medication._This This_case case_highlights highlights_a a_significant significant_and and_potentially potentially_life-threatening life-threatening_complication complication_of of_HCQ HCQ_use use_Malaria Malaria_is is_a a_threat threat_to to_human human_mankind mankind_and and_kills kills_about about_half half_a a_million million_people people_every every_year. year._On On_the the_other other_hand, hand,_COVID-19 COVID-19_resulted resulted_in in_several several_hundred hundred_thousand thousand_deaths deaths_since since_December December_2019 2019_and and_remains remains_without without_an an_efficient efficient_and and_safe safe_treatment. treatment._The The_antimalarials antimalarials_chloroquine chloroquine_(CQ) (CQ)_and and_its its_analogue, analogue,_hydroxychloroquine hydroxychloroquine_(HCQ), (HCQ),_have have_been been_tested tested_for for_COVID-19 COVID-19_treatment, treatment,_and and_several several_conflicting conflicting_evidence evidence_has has_been been_obtained. obtained._Therefore, Therefore,_the the_aim aim_of of_this this_review review_was was_to to_summarize summarize_the the_evidence evidence_regarding regarding_action action_mechanisms mechanisms_of of_these these_compounds compounds_against against_Plasmodium Plasmodium_and and_SARS-CoV-2 SARS-CoV-2_infection, infection,_together together_with with_cytometry cytometry_applications. applications._CQ CQ_and and_HCQ HCQ_act act_on on_the the_renin renin_angiotensin angiotensin_system, system,_with with_possible possible_implications implications_on on_the the_cardiorespiratory cardiorespiratory_system. system._In In_this this_context, context,_flow flow_and and_image image_cytometry cytometry_emerge emerge_as as_powerful powerful_technologies technologies_to to_investigate investigate_the the_mechanism mechanism_of of_therapeutic therapeutic_candidates, candidates,_as as_well well_as as_for for_the the_identification identification_of of_the the_immune immune_response response_and and_prognostics prognostics_of of_disease disease_severity. severity._Data Data_from from_the the_large large_randomized randomized_trials trials_support support_the the_conclusion conclusion_that that_CQ CQ_and and_HCQ HCQ_do do_not not_provide provide_any any_clinical clinical_beneficial beneficial_in in_disease disease_severity severity_and and_progression progression_in in_SARS-CoV-2 SARS-CoV-2_patients, patients,_as as_well well_as, as,_do do_not not_present present_any any_solid solid_evidence evidence_of of_increased increased_serious serious_side side_effects. effects._These These_drugs drugs_are are_safe safe_and and_effective effective_antimalarials antimalarials_agents, agents,_but but_in in_SARS-CoV-2 SARS-CoV-2_patients, patients,_they they_need need_further further_studies studies_in in_the the_context context_of of_a a_clinical clinical_trials. trials._Amid Amid_controversial controversial_reports reports_that that_COVID-19 COVID-19_can can_be be_treated treated_with with_a a_combination combination_of of_the the_antimalarial antimalarial_drug drug_hydroxychloroquine hydroxychloroquine_(HCQ) (HCQ)_and and_the the_antibiotic antibiotic_azithromycin azithromycin_(AZI), (AZI),_a a_clinical clinical_trial trial_(ONCOCOVID, (ONCOCOVID,_NCT04341207) NCT04341207)_was was_launched launched_at at_Gustave Gustave_Roussy Roussy_Cancer Cancer_Campus Campus_to to_investigate investigate_the the_utility utility_of of_this this_combination combination_therapy therapy_in in_cancer cancer_patients. patients._In In_this this_preclinical preclinical_study, study,_we we_investigated investigated_whether whether_the the_combination combination_of of_HCQ+AZI HCQ+AZI_would would_be be_compatible compatible_with with_the the_therapeutic therapeutic_induction induction_of of_anticancer anticancer_immune immune_responses. responses._For For_this, this,_we we_used used_doses doses_of of_HCQ HCQ_and and_AZI AZI_that that_affect affect_whole-body whole-body_physiology physiology_(as (as_indicated indicated_by by_a a_partial partial_blockade blockade_in in_cardiac cardiac_and and_hepatic hepatic_autophagic autophagic_flux flux_for for_HCQ HCQ_and and_a a_reduction reduction_in in_body body_weight weight_for for_AZI), AZI),_showing showing_that that_their their_combined combined_administration administration_did did_not not_interfere interfere_with with_tumor tumor_growth growth_control control_induced induced_by by_the the_immunogenic immunogenic_cell cell_death death_inducer inducer_oxaliplatin. oxaliplatin._Moreover, Moreover,_the the_HCQ+AZI HCQ+AZI_combination combination_did did_not not_affect affect_the the_capacity capacity_of of_a a_curative curative_regimen regimen_(cisplatin (cisplatin_+ +_crizotinib crizotinib_+ +_PD-1 PD-1_blockade) blockade)_to to_eradicate eradicate_established established_orthotopic orthotopic_lung lung_cancers cancers_in in_mice. mice._In In_conclusion, conclusion,_it it_appears appears_that that_HCQ+AZI HCQ+AZI_does does_not not_interfere interfere_with with_the the_therapeutic therapeutic_induction induction_of of_therapeutic therapeutic_anticancer anticancer_immune immune_responses. responses._On On_3 3_March March_2020, 2020,_the the_document document_'Drug 'Drug_treatment treatment_options options_for for_patients patients_with with_COVID-19 COVID-19_(infections (infections_with with_SARS-CoV-2)' SARS-CoV-2)'_was was_published published_on on_the the_website website_of of_the the_Dutch Dutch_Working Working_Party Party_on on_Antibiotic Antibiotic_Policy Policy_(Stichting (Stichting_Werkgroep Werkgroep_Antibioticabeleid, Antibioticabeleid,_SWAB) SWAB)_Based Based_on on_a a_7-step 7-step_analysis analysis_of of_the the_literature, literature,_hydroxychloroquine hydroxychloroquine_(HCQ) (HCQ)_and and_chloroquine chloroquine_(CQ) (CQ)_were were_initially initially_included included_in in_the the_SWAB SWAB_document document_as as_possible possible_drug drug_treatments treatments_for for_hospitalized hospitalized_adult adult_COVID-19 COVID-19_patients patients_However, However,_recent recent_weeks weeks_have have_seen seen_the the_publication publication_of of_the the_results results_of of_various various_studies studies_into into_the the_effectiveness effectiveness_of of_treatment treatment_with with_HCQ HCQ_and and_CQ CQ_in in_patients patients_with with_COVID-19 COVID-19_On On_the the_basis basis_of of_these these_results, results,_we we_conclude conclude_that that_there there_is is_insufficient insufficient_evidence evidence_to to_consider consider_HCQ HCQ_and and_CQ CQ_as as_meaningful meaningful_treatment treatment_options options_in in_patients patients_with with_COVID-19 COVID-19_Clinically Clinically_relevant relevant_QTc QTc_prolongation prolongation_occurs occurs_in in_at at_least least_1 1_in in_10 10_COVID-19 COVID-19_patients patients_treated treated_with with_HCQ HCQ_or or_HQ\""
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "NewString=' '.join(new_list)\n",
    "NewString"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "words\n",
       "of_the           12\n",
       "in_the           11\n",
       "of_HCQ            9\n",
       "treatment_of      9\n",
       "for_COVID-19      8\n",
       "of_patients       8\n",
       "the_treatment     8\n",
       "CQ_and            7\n",
       "and_HCQ           7\n",
       "as_a              7\n",
       "dtype: int64"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import pandas as pd\n",
    "\n",
    "WordList1 = NewString.split()\n",
    "WordData1 = pd.DataFrame(data=pd.Series(WordList1), columns=['words'])\n",
    "WordData1.groupby('words').size().nlargest(10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 1080x576 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "import tweepy\n",
    "from wordcloud import WordCloud, STOPWORDS\n",
    "import matplotlib.pyplot as plt\n",
    "customStopwords=list(STOPWORDS)+ ['COVID','covid','of_the','in_the','of_HCQ','for_COVID-19','of_COVID','in_the','HCQ','_and','_The']\n",
    "\n",
    "wordcloudimage = WordCloud(\n",
    "                          max_words=100,\n",
    "                          max_font_size=500,\n",
    "                          font_step=2,\n",
    "                          stopwords=customStopwords,\n",
    "                          background_color='black',\n",
    "                          width=1000,\n",
    "                          height=720\n",
    "                          ).generate(NewString)\n",
    "\n",
    "plt.figure(figsize=(15,8))\n",
    "plt.axis(\"off\")\n",
    "plt.imshow(wordcloudimage)\n",
    "wordcloudimage\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": []
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Tri-gram"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "('The', 'ongoing', 'pandemic')\n",
      "('ongoing', 'pandemic', 'of')\n",
      "('pandemic', 'of', 'coronavirus')\n",
      "('of', 'coronavirus', 'disease')\n",
      "('coronavirus', 'disease', '2019')\n",
      "('disease', '2019', '(')\n",
      "('2019', '(', 'COVID-19')\n",
      "('(', 'COVID-19', ')')\n",
      "('COVID-19', ')', 'caused')\n",
      "(')', 'caused', 'by')\n",
      "('caused', 'by', 'the')\n",
      "('by', 'the', 'severe')\n",
      "('the', 'severe', 'acute')\n",
      "('severe', 'acute', 'respiratory')\n",
      "('acute', 'respiratory', 'syndrome')\n",
      "('respiratory', 'syndrome', 'coronavirus')\n",
      "('syndrome', 'coronavirus', '2')\n",
      "('coronavirus', '2', '(')\n",
      "('2', '(', 'SARS-CoV-2')\n",
      "('(', 'SARS-CoV-2', ')')\n",
      "('SARS-CoV-2', ')', 'poses')\n",
      "(')', 'poses', 'a')\n",
      "('poses', 'a', 'serious')\n",
      "('a', 'serious', 'threat')\n",
      "('serious', 'threat', 'to')\n",
      "('threat', 'to', 'global')\n",
      "('to', 'global', 'public')\n",
      "('global', 'public', 'health')\n",
      "('public', 'health', 'and')\n",
      "('health', 'and', 'there')\n",
      "('and', 'there', 'is')\n",
      "('there', 'is', 'currently')\n",
      "('is', 'currently', 'no')\n",
      "('currently', 'no', 'effective')\n",
      "('no', 'effective', 'antiviral')\n",
      "('effective', 'antiviral', 'therapy')\n",
      "('antiviral', 'therapy', 'It')\n",
      "('therapy', 'It', 'has')\n",
      "('It', 'has', 'been')\n",
      "('has', 'been', 'suggested')\n",
      "('been', 'suggested', 'that')\n",
      "('suggested', 'that', 'Chloroquine')\n",
      "('that', 'Chloroquine', '(')\n",
      "('Chloroquine', '(', 'CQ')\n",
      "('(', 'CQ', ')')\n",
      "('CQ', ')', 'and')\n",
      "(')', 'and', 'hydroxychloroquine')\n",
      "('and', 'hydroxychloroquine', '(')\n",
      "('hydroxychloroquine', '(', 'HCQ')\n",
      "('(', 'HCQ', ')')\n",
      "('HCQ', ')', ',')\n",
      "(')', ',', 'which')\n",
      "(',', 'which', 'were')\n",
      "('which', 'were', 'primarily')\n",
      "('were', 'primarily', 'employed')\n",
      "('primarily', 'employed', 'as')\n",
      "('employed', 'as', 'prophylaxis')\n",
      "('as', 'prophylaxis', 'and')\n",
      "('prophylaxis', 'and', 'treatment')\n",
      "('and', 'treatment', 'for')\n",
      "('treatment', 'for', 'malaria')\n",
      "('for', 'malaria', ',')\n",
      "('malaria', ',', 'could')\n",
      "(',', 'could', 'be')\n",
      "('could', 'be', 'used')\n",
      "('be', 'used', 'to')\n",
      "('used', 'to', 'treat')\n",
      "('to', 'treat', 'COVID-19')\n",
      "('treat', 'COVID-19', 'CQ')\n",
      "('COVID-19', 'CQ', 'and')\n",
      "('CQ', 'and', 'HCQ')\n",
      "('and', 'HCQ', 'may')\n",
      "('HCQ', 'may', 'be')\n",
      "('may', 'be', 'potential')\n",
      "('be', 'potential', 'inhibitors')\n",
      "('potential', 'inhibitors', 'of')\n",
      "('inhibitors', 'of', 'SARS-CoV-2')\n",
      "('of', 'SARS-CoV-2', 'entry')\n",
      "('SARS-CoV-2', 'entry', 'into')\n",
      "('entry', 'into', 'host')\n",
      "('into', 'host', 'cells')\n",
      "('host', 'cells', ',')\n",
      "('cells', ',', 'which')\n",
      "(',', 'which', 'is')\n",
      "('which', 'is', 'mediated')\n",
      "('is', 'mediated', 'via')\n",
      "('mediated', 'via', 'the')\n",
      "('via', 'the', 'angiotensin-converting')\n",
      "('the', 'angiotensin-converting', 'enzyme')\n",
      "('angiotensin-converting', 'enzyme', '2')\n",
      "('enzyme', '2', '(')\n",
      "('2', '(', 'ACE2')\n",
      "('(', 'ACE2', ')')\n",
      "('ACE2', ')', ',')\n",
      "(')', ',', 'and')\n",
      "(',', 'and', 'may')\n",
      "('and', 'may', 'also')\n",
      "('may', 'also', 'inhibit')\n",
      "('also', 'inhibit', 'subsequent')\n",
      "('inhibit', 'subsequent', 'intracellular')\n",
      "('subsequent', 'intracellular', 'processes')\n",
      "('intracellular', 'processes', 'which')\n",
      "('processes', 'which', 'lead')\n",
      "('which', 'lead', 'to')\n",
      "('lead', 'to', 'COVID-19')\n",
      "('to', 'COVID-19', ',')\n",
      "('COVID-19', ',', 'including')\n",
      "(',', 'including', 'damage')\n",
      "('including', 'damage', 'to')\n",
      "('damage', 'to', 'the')\n",
      "('to', 'the', 'cardiovascular')\n",
      "('the', 'cardiovascular', 'system')\n",
      "('cardiovascular', 'system', 'However')\n",
      "('system', 'However', ',')\n",
      "('However', ',', 'paradoxically')\n",
      "(',', 'paradoxically', ',')\n",
      "('paradoxically', ',', 'CQ')\n",
      "(',', 'CQ', 'and')\n",
      "('CQ', 'and', 'HCQ')\n",
      "('and', 'HCQ', 'have')\n",
      "('HCQ', 'have', 'also')\n",
      "('have', 'also', 'been')\n",
      "('also', 'been', 'reported')\n",
      "('been', 'reported', 'to')\n",
      "('reported', 'to', 'cause')\n",
      "('to', 'cause', 'damage')\n",
      "('cause', 'damage', 'to')\n",
      "('damage', 'to', 'the')\n",
      "('to', 'the', 'cardiovascular')\n",
      "('the', 'cardiovascular', 'system')\n",
      "('cardiovascular', 'system', 'In')\n",
      "('system', 'In', 'this')\n",
      "('In', 'this', 'review')\n",
      "('this', 'review', ',')\n",
      "('review', ',', 'we')\n",
      "(',', 'we', 'provide')\n",
      "('we', 'provide', 'a')\n",
      "('provide', 'a', 'critical')\n",
      "('a', 'critical', 'examination')\n",
      "('critical', 'examination', 'of')\n",
      "('examination', 'of', 'the')\n",
      "('of', 'the', 'published')\n",
      "('the', 'published', 'evidence')\n",
      "('published', 'evidence', 'CQ')\n",
      "('evidence', 'CQ', 'and')\n",
      "('CQ', 'and', 'HCQ')\n",
      "('and', 'HCQ', 'could')\n",
      "('HCQ', 'could', 'potentially')\n",
      "('could', 'potentially', 'be')\n",
      "('potentially', 'be', 'useful')\n",
      "('be', 'useful', 'drugs')\n",
      "('useful', 'drugs', 'in')\n",
      "('drugs', 'in', 'the')\n",
      "('in', 'the', 'treatment')\n",
      "('the', 'treatment', 'of')\n",
      "('treatment', 'of', 'COVID-19')\n",
      "('of', 'COVID-19', 'and')\n",
      "('COVID-19', 'and', 'other')\n",
      "('and', 'other', 'ACE2')\n",
      "('other', 'ACE2', 'involved')\n",
      "('ACE2', 'involved', 'virus')\n",
      "('involved', 'virus', 'infections')\n",
      "('virus', 'infections', ',')\n",
      "('infections', ',', 'but')\n",
      "(',', 'but', 'the')\n",
      "('but', 'the', 'antiviral')\n",
      "('the', 'antiviral', 'effects')\n",
      "('antiviral', 'effects', 'of')\n",
      "('effects', 'of', 'CQ')\n",
      "('of', 'CQ', 'and')\n",
      "('CQ', 'and', 'HCQ')\n",
      "('and', 'HCQ', 'need')\n",
      "('HCQ', 'need', 'to')\n",
      "('need', 'to', 'be')\n",
      "('to', 'be', 'tested')\n",
      "('be', 'tested', 'in')\n",
      "('tested', 'in', 'more')\n",
      "('in', 'more', 'well-designed')\n",
      "('more', 'well-designed', 'clinical')\n",
      "('well-designed', 'clinical', 'randomized')\n",
      "('clinical', 'randomized', 'studies')\n",
      "('randomized', 'studies', 'and')\n",
      "('studies', 'and', 'their')\n",
      "('and', 'their', 'actions')\n",
      "('their', 'actions', 'on')\n",
      "('actions', 'on', 'the')\n",
      "('on', 'the', 'cardiovascular')\n",
      "('the', 'cardiovascular', 'system')\n",
      "('cardiovascular', 'system', 'need')\n",
      "('system', 'need', 'to')\n",
      "('need', 'to', 'be')\n",
      "('to', 'be', 'further')\n",
      "('be', 'further', 'elucidated')\n",
      "('further', 'elucidated', 'However')\n",
      "('elucidated', 'However', ',')\n",
      "('However', ',', 'even')\n",
      "(',', 'even', 'if')\n",
      "('even', 'if', 'it')\n",
      "('if', 'it', 'were')\n",
      "('it', 'were', 'to')\n",
      "('were', 'to', 'turn')\n",
      "('to', 'turn', 'out')\n",
      "('turn', 'out', 'that')\n",
      "('out', 'that', 'CQ')\n",
      "('that', 'CQ', 'and')\n",
      "('CQ', 'and', 'HCQ')\n",
      "('and', 'HCQ', 'are')\n",
      "('HCQ', 'are', 'not')\n",
      "('are', 'not', 'useful')\n",
      "('not', 'useful', 'drugs')\n",
      "('useful', 'drugs', 'in')\n",
      "('drugs', 'in', 'practice')\n",
      "('in', 'practice', ',')\n",
      "('practice', ',', 'further')\n",
      "(',', 'further', 'studies')\n",
      "('further', 'studies', 'of')\n",
      "('studies', 'of', 'their')\n",
      "('of', 'their', 'mechanism')\n",
      "('their', 'mechanism', 'of')\n",
      "('mechanism', 'of', 'action')\n",
      "('of', 'action', 'could')\n",
      "('action', 'could', 'be')\n",
      "('could', 'be', 'helpful')\n",
      "('be', 'helpful', 'in')\n",
      "('helpful', 'in', 'improving')\n",
      "('in', 'improving', 'our')\n",
      "('improving', 'our', 'understanding')\n",
      "('our', 'understanding', 'of')\n",
      "('understanding', 'of', 'COVID-19')\n",
      "('of', 'COVID-19', 'pathology')\n",
      "('COVID-19', 'pathology', 'Background')\n",
      "('pathology', 'Background', 'and')\n",
      "('Background', 'and', 'aims')\n",
      "('and', 'aims', 'As')\n",
      "('aims', 'As', 'the')\n",
      "('As', 'the', 'Coronavirus')\n",
      "('the', 'Coronavirus', 'disease')\n",
      "('Coronavirus', 'disease', '2019')\n",
      "('disease', '2019', '(')\n",
      "('2019', '(', 'COVID-19')\n",
      "('(', 'COVID-19', ')')\n",
      "('COVID-19', ')', 'pandemic')\n",
      "(')', 'pandemic', 'unravels')\n",
      "('pandemic', 'unravels', 'rapidly')\n",
      "('unravels', 'rapidly', ',')\n",
      "('rapidly', ',', 'there')\n",
      "(',', 'there', 'is')\n",
      "('there', 'is', 'a')\n",
      "('is', 'a', 'glut')\n",
      "('a', 'glut', 'of')\n",
      "('glut', 'of', 'confusing')\n",
      "('of', 'confusing', 'and')\n",
      "('confusing', 'and', 'divergent')\n",
      "('and', 'divergent', 'scientific')\n",
      "('divergent', 'scientific', 'information')\n",
      "('scientific', 'information', 'emanating')\n",
      "('information', 'emanating', 'from')\n",
      "('emanating', 'from', 'differing')\n",
      "('from', 'differing', 'sources')\n",
      "('differing', 'sources', ',')\n",
      "('sources', ',', 'including')\n",
      "(',', 'including', 'the')\n",
      "('including', 'the', 'Indian')\n",
      "('the', 'Indian', 'National')\n",
      "('Indian', 'National', 'Task')\n",
      "('National', 'Task', 'Force')\n",
      "('Task', 'Force', 'for')\n",
      "('Force', 'for', 'COVID-19')\n",
      "('for', 'COVID-19', 'Thus')\n",
      "('COVID-19', 'Thus', ',')\n",
      "('Thus', ',', 'a')\n",
      "(',', 'a', 'web-based')\n",
      "('a', 'web-based', 'survey')\n",
      "('web-based', 'survey', 'was')\n",
      "('survey', 'was', 'conducted')\n",
      "('was', 'conducted', 'to')\n",
      "('conducted', 'to', 'decipher')\n",
      "('to', 'decipher', 'the')\n",
      "('decipher', 'the', 'approach')\n",
      "('the', 'approach', 'of')\n",
      "('approach', 'of', 'Indian')\n",
      "('of', 'Indian', 'doctors')\n",
      "('Indian', 'doctors', 'to')\n",
      "('doctors', 'to', 'the')\n",
      "('to', 'the', 'various')\n",
      "('the', 'various', 'options')\n",
      "('various', 'options', 'for')\n",
      "('options', 'for', 'treatment')\n",
      "('for', 'treatment', 'of')\n",
      "('treatment', 'of', 'COVID-19')\n",
      "('of', 'COVID-19', 'Methods')\n",
      "('COVID-19', 'Methods', 'A')\n",
      "('Methods', 'A', 'web-based')\n",
      "('A', 'web-based', 'questionnaire')\n",
      "('web-based', 'questionnaire', 'among')\n",
      "('questionnaire', 'among', 'one')\n",
      "('among', 'one', 'lakh')\n",
      "('one', 'lakh', 'doctors')\n",
      "('lakh', 'doctors', 'across')\n",
      "('doctors', 'across', 'India')\n",
      "('across', 'India', 'through')\n",
      "('India', 'through', 'email')\n",
      "('through', 'email', 'and')\n",
      "('email', 'and', 'social')\n",
      "('and', 'social', 'media')\n",
      "('social', 'media', 'was')\n",
      "('media', 'was', 'circulated')\n",
      "('was', 'circulated', 'After')\n",
      "('circulated', 'After', 'data')\n",
      "('After', 'data', 'quality')\n",
      "('data', 'quality', 'and')\n",
      "('quality', 'and', 'internal')\n",
      "('and', 'internal', 'validation')\n",
      "('internal', 'validation', ',')\n",
      "('validation', ',', '826')\n",
      "(',', '826', 'responses')\n",
      "('826', 'responses', 'were')\n",
      "('responses', 'were', 'included')\n",
      "('were', 'included', 'for')\n",
      "('included', 'for', 'analysis')\n",
      "('for', 'analysis', 'Basic')\n",
      "('analysis', 'Basic', 'demographic')\n",
      "('Basic', 'demographic', 'and')\n",
      "('demographic', 'and', 'comparative')\n",
      "('and', 'comparative', 'analysis')\n",
      "('comparative', 'analysis', 'were')\n",
      "('analysis', 'were', 'performed')\n",
      "('were', 'performed', 'using')\n",
      "('performed', 'using', 'the')\n",
      "('using', 'the', 'Python3')\n",
      "('the', 'Python3', '8')\n",
      "('Python3', '8', '2')\n",
      "('8', '2', 'software')\n",
      "('2', 'software', '(')\n",
      "('software', '(', 'Windows')\n",
      "('(', 'Windows', '10')\n",
      "('Windows', '10', '64')\n",
      "('10', '64', 'bit')\n",
      "('64', 'bit', ',')\n",
      "('bit', ',', 'USA')\n",
      "(',', 'USA', ')')\n",
      "('USA', ')', 'Results')\n",
      "(')', 'Results', 'Amongst')\n",
      "('Results', 'Amongst', 'all')\n",
      "('Amongst', 'all', 'the')\n",
      "('all', 'the', 'states')\n",
      "('the', 'states', 'of')\n",
      "('states', 'of', 'India')\n",
      "('of', 'India', 'most')\n",
      "('India', 'most', 'respondents')\n",
      "('most', 'respondents', 'hailed')\n",
      "('respondents', 'hailed', 'from')\n",
      "('hailed', 'from', 'the')\n",
      "('from', 'the', 'top')\n",
      "('the', 'top', 'ten')\n",
      "('top', 'ten', 'affected')\n",
      "('ten', 'affected', 'states')\n",
      "('affected', 'states', 'Overall')\n",
      "('states', 'Overall', '76')\n",
      "('Overall', '76', '15')\n",
      "('76', '15', '%')\n",
      "('15', '%', 'of')\n",
      "('%', 'of', 'doctors')\n",
      "('of', 'doctors', 'would')\n",
      "('doctors', 'would', 'either')\n",
      "('would', 'either', 'prescribe')\n",
      "('either', 'prescribe', 'or')\n",
      "('prescribe', 'or', 'consider')\n",
      "('or', 'consider', 'prescribing')\n",
      "('consider', 'prescribing', 'hydroxychloroquine')\n",
      "('prescribing', 'hydroxychloroquine', '(')\n",
      "('hydroxychloroquine', '(', 'HCQ')\n",
      "('(', 'HCQ', ')')\n",
      "('HCQ', ')', 'as')\n",
      "(')', 'as', 'prophylaxis')\n",
      "('as', 'prophylaxis', 'for')\n",
      "('prophylaxis', 'for', 'health-care')\n",
      "('for', 'health-care', 'providers')\n",
      "('health-care', 'providers', '(')\n",
      "('providers', '(', 'HCP')\n",
      "('(', 'HCP', ')')\n",
      "('HCP', ')', 'Doctors')\n",
      "(')', 'Doctors', 'with')\n",
      "('Doctors', 'with', 'experience')\n",
      "('with', 'experience', 'of')\n",
      "('experience', 'of', 'managing')\n",
      "('of', 'managing', 'COVID-19')\n",
      "('managing', 'COVID-19', 'were')\n",
      "('COVID-19', 'were', 'more')\n",
      "('were', 'more', 'likely')\n",
      "('more', 'likely', 'to')\n",
      "('likely', 'to', 'advocate')\n",
      "('to', 'advocate', 'use')\n",
      "('advocate', 'use', 'of')\n",
      "('use', 'of', 'HCQ')\n",
      "('of', 'HCQ', 'as')\n",
      "('HCQ', 'as', 'prophylaxis')\n",
      "('as', 'prophylaxis', 'for')\n",
      "('prophylaxis', 'for', 'HCP')\n",
      "('for', 'HCP', '(')\n",
      "('HCP', '(', 'χ2')\n",
      "('(', 'χ2', '=')\n",
      "('χ2', '=', '4')\n",
      "('=', '4', '357')\n",
      "('4', '357', ',')\n",
      "('357', ',', 'P')\n",
      "(',', 'P', '=')\n",
      "('P', '=', '0')\n",
      "('=', '0', '037')\n",
      "('0', '037', ')')\n",
      "('037', ')', 'Intensivists')\n",
      "(')', 'Intensivists', 'were')\n",
      "('Intensivists', 'were', 'more')\n",
      "('were', 'more', 'likely')\n",
      "('more', 'likely', 'to')\n",
      "('likely', 'to', 'advocate')\n",
      "('to', 'advocate', 'HCQ')\n",
      "('advocate', 'HCQ', 'as')\n",
      "('HCQ', 'as', 'prophylaxis')\n",
      "('as', 'prophylaxis', '(')\n",
      "('prophylaxis', '(', 'χ2')\n",
      "('(', 'χ2', '=')\n",
      "('χ2', '=', '14')\n",
      "('=', '14', '588')\n",
      "('14', '588', ',')\n",
      "('588', ',', 'P')\n",
      "(',', 'P', '<')\n",
      "('P', '<', '0')\n",
      "('<', '0', '001')\n",
      "('0', '001', ')')\n",
      "('001', ')', 'as')\n",
      "(')', 'as', 'well')\n",
      "('as', 'well', 'as')\n",
      "('well', 'as', 'for')\n",
      "('as', 'for', 'management')\n",
      "('for', 'management', 'of')\n",
      "('management', 'of', 'mild')\n",
      "('of', 'mild', 'to')\n",
      "('mild', 'to', 'moderate')\n",
      "('to', 'moderate', 'COVID-19')\n",
      "('moderate', 'COVID-19', '(')\n",
      "('COVID-19', '(', 'χ2')\n",
      "('(', 'χ2', '=')\n",
      "('χ2', '=', '3')\n",
      "('=', '3', '91')\n",
      "('3', '91', ',')\n",
      "('91', ',', 'P')\n",
      "(',', 'P', '=')\n",
      "('P', '=', '0')\n",
      "('=', '0', '048')\n",
      "('0', '048', ')')\n",
      "('048', ')', 'In')\n",
      "(')', 'In', 'COVID-19')\n",
      "('In', 'COVID-19', ',')\n",
      "('COVID-19', ',', '65')\n",
      "(',', '65', '8')\n",
      "('65', '8', '%')\n",
      "('8', '%', 'doctors')\n",
      "('%', 'doctors', 'overwhelmingly')\n",
      "('doctors', 'overwhelmingly', 'preferred')\n",
      "('overwhelmingly', 'preferred', 'using')\n",
      "('preferred', 'using', 'anti-viral')\n",
      "('using', 'anti-viral', 'agents')\n",
      "('anti-viral', 'agents', 'in')\n",
      "('agents', 'in', 'severe')\n",
      "('in', 'severe', 'cases')\n",
      "('severe', 'cases', ',')\n",
      "('cases', ',', 'continuing')\n",
      "(',', 'continuing', 'ACEi/ARB')\n",
      "('continuing', 'ACEi/ARB', '(')\n",
      "('ACEi/ARB', '(', '60')\n",
      "('(', '60', '9')\n",
      "('60', '9', '%')\n",
      "('9', '%', ')')\n",
      "('%', ')', ',')\n",
      "(')', ',', 'and')\n",
      "(',', 'and', 'routinely')\n",
      "('and', 'routinely', 'screening')\n",
      "('routinely', 'screening', 'for')\n",
      "('screening', 'for', 'COVID-19')\n",
      "('for', 'COVID-19', 'as')\n",
      "('COVID-19', 'as', 'a')\n",
      "('as', 'a', 'pre-operative')\n",
      "('a', 'pre-operative', 'strategy')\n",
      "('pre-operative', 'strategy', '(')\n",
      "('strategy', '(', '73')\n",
      "('(', '73', '85')\n",
      "('73', '85', '%')\n",
      "('85', '%', ')')\n",
      "('%', ')', 'Conclusions')\n",
      "(')', 'Conclusions', 'Indian')\n",
      "('Conclusions', 'Indian', 'doctors')\n",
      "('Indian', 'doctors', 'are')\n",
      "('doctors', 'are', 'largely')\n",
      "('are', 'largely', 'following')\n",
      "('largely', 'following', 'the')\n",
      "('following', 'the', 'scientific')\n",
      "('the', 'scientific', 'guidance')\n",
      "('scientific', 'guidance', 'provided')\n",
      "('guidance', 'provided', 'by')\n",
      "('provided', 'by', 'Indian')\n",
      "('by', 'Indian', 'National')\n",
      "('Indian', 'National', 'Task')\n",
      "('National', 'Task', 'Force')\n",
      "('Task', 'Force', 'for')\n",
      "('Force', 'for', 'COVID-19')\n",
      "('for', 'COVID-19', 'and')\n",
      "('COVID-19', 'and', 'would')\n",
      "('and', 'would', 'consider')\n",
      "('would', 'consider', 'prescribing')\n",
      "('consider', 'prescribing', 'HCQ')\n",
      "('prescribing', 'HCQ', 'as')\n",
      "('HCQ', 'as', 'prophylaxis')\n",
      "('as', 'prophylaxis', 'for')\n",
      "('prophylaxis', 'for', 'COVID-19')\n",
      "('for', 'COVID-19', 'They')\n",
      "('COVID-19', 'They', 'would')\n",
      "('They', 'would', 'also')\n",
      "('would', 'also', 'consider')\n",
      "('also', 'consider', 'using')\n",
      "('consider', 'using', 'it')\n",
      "('using', 'it', 'in')\n",
      "('it', 'in', 'mild')\n",
      "('in', 'mild', 'to')\n",
      "('mild', 'to', 'moderate')\n",
      "('to', 'moderate', 'COVID-19')\n",
      "('moderate', 'COVID-19', 'Hydroxychloroquine')\n",
      "('COVID-19', 'Hydroxychloroquine', 'sulfate')\n",
      "('Hydroxychloroquine', 'sulfate', 'is')\n",
      "('sulfate', 'is', 'one')\n",
      "('is', 'one', 'of')\n",
      "('one', 'of', 'a')\n",
      "('of', 'a', 'large')\n",
      "('a', 'large', 'series')\n",
      "('large', 'series', 'of')\n",
      "('series', 'of', '4-aminoquinolines')\n",
      "('of', '4-aminoquinolines', 'with')\n",
      "('4-aminoquinolines', 'with', 'antimalarial')\n",
      "('with', 'antimalarial', 'activity')\n",
      "('antimalarial', 'activity', 'Moreover')\n",
      "('activity', 'Moreover', ',')\n",
      "('Moreover', ',', 'it')\n",
      "(',', 'it', 'is')\n",
      "('it', 'is', 'used')\n",
      "('is', 'used', 'for')\n",
      "('used', 'for', 'the')\n",
      "('for', 'the', 'treatment')\n",
      "('the', 'treatment', 'of')\n",
      "('treatment', 'of', 'rheumatoid')\n",
      "('of', 'rheumatoid', 'arthritis')\n",
      "('rheumatoid', 'arthritis', 'Sometimes')\n",
      "('arthritis', 'Sometimes', 'Hydroxychloroquine')\n",
      "('Sometimes', 'Hydroxychloroquine', 'sulfate')\n",
      "('Hydroxychloroquine', 'sulfate', 'is')\n",
      "('sulfate', 'is', 'very')\n",
      "('is', 'very', 'effective')\n",
      "('very', 'effective', 'for')\n",
      "('effective', 'for', 'the')\n",
      "('for', 'the', 'treatment')\n",
      "('the', 'treatment', 'of')\n",
      "('treatment', 'of', 'autoimmune')\n",
      "('of', 'autoimmune', 'diseases')\n",
      "('autoimmune', 'diseases', 'Based')\n",
      "('diseases', 'Based', 'on')\n",
      "('Based', 'on', 'the')\n",
      "('on', 'the', 'recent')\n",
      "('the', 'recent', 'clinical')\n",
      "('recent', 'clinical', 'experiments')\n",
      "('clinical', 'experiments', 'it')\n",
      "('experiments', 'it', 'is')\n",
      "('it', 'is', 'exploiting')\n",
      "('is', 'exploiting', 'for')\n",
      "('exploiting', 'for', 'the')\n",
      "('for', 'the', 'treatment')\n",
      "('the', 'treatment', 'of')\n",
      "('treatment', 'of', 'COVID-19')\n",
      "('of', 'COVID-19', ',')\n",
      "('COVID-19', ',', 'corona')\n",
      "(',', 'corona', 'virus')\n",
      "('corona', 'virus', 'across')\n",
      "('virus', 'across', 'the')\n",
      "('across', 'the', 'globe')\n",
      "('the', 'globe', 'A')\n",
      "('globe', 'A', 'Reverse')\n",
      "('A', 'Reverse', 'phase')\n",
      "('Reverse', 'phase', 'RP-HPLC')\n",
      "('phase', 'RP-HPLC', 'method')\n",
      "('RP-HPLC', 'method', 'have')\n",
      "('method', 'have', 'been')\n",
      "('have', 'been', 'developed')\n",
      "('been', 'developed', 'and')\n",
      "('developed', 'and', 'validated')\n",
      "('and', 'validated', 'as')\n",
      "('validated', 'as', 'per')\n",
      "('as', 'per', 'the')\n",
      "('per', 'the', 'current')\n",
      "('the', 'current', 'ICH')\n",
      "('current', 'ICH', 'guidelines')\n",
      "('ICH', 'guidelines', 'for')\n",
      "('guidelines', 'for', 'estimation')\n",
      "('for', 'estimation', 'of')\n",
      "('estimation', 'of', 'Hydroxychloroquine')\n",
      "('of', 'Hydroxychloroquine', 'sulfate')\n",
      "('Hydroxychloroquine', 'sulfate', 'tablets')\n",
      "('sulfate', 'tablets', 'As')\n",
      "('tablets', 'As', 'part')\n",
      "('As', 'part', 'of')\n",
      "('part', 'of', 'method')\n",
      "('of', 'method', 'validation')\n",
      "('method', 'validation', 'specificity')\n",
      "('validation', 'specificity', ',')\n",
      "('specificity', ',', 'linearity')\n",
      "(',', 'linearity', ',')\n",
      "('linearity', ',', 'precision')\n",
      "(',', 'precision', 'and')\n",
      "('precision', 'and', 'recovery')\n",
      "('and', 'recovery', 'parameters')\n",
      "('recovery', 'parameters', 'were')\n",
      "('parameters', 'were', 'verified')\n",
      "('were', 'verified', 'The')\n",
      "('verified', 'The', 'concentration')\n",
      "('The', 'concentration', 'and')\n",
      "('concentration', 'and', 'area')\n",
      "('and', 'area', 'relationships')\n",
      "('area', 'relationships', 'were')\n",
      "('relationships', 'were', 'linear')\n",
      "('were', 'linear', '(')\n",
      "('linear', '(', 'R')\n",
      "('(', 'R', '(')\n",
      "('R', '(', '2')\n",
      "('(', '2', ')')\n",
      "('2', ')', '>')\n",
      "(')', '>', '0')\n",
      "('>', '0', '999')\n",
      "('0', '999', ')')\n",
      "('999', ')', ',')\n",
      "(')', ',', 'over')\n",
      "(',', 'over', 'the')\n",
      "('over', 'the', 'concentration')\n",
      "('the', 'concentration', 'range')\n",
      "('concentration', 'range', 'of')\n",
      "('range', 'of', '25')\n",
      "('of', '25', 'to')\n",
      "('25', 'to', '300')\n",
      "('to', '300', 'µg')\n",
      "('300', 'µg', 'mL')\n",
      "('µg', 'mL', '(')\n",
      "('mL', '(', '-1')\n",
      "('(', '-1', ')')\n",
      "('-1', ')', 'for')\n",
      "(')', 'for', 'HCQ')\n",
      "('for', 'HCQ', 'The')\n",
      "('HCQ', 'The', 'relative')\n",
      "('The', 'relative', 'standard')\n",
      "('relative', 'standard', 'deviations')\n",
      "('standard', 'deviations', 'for')\n",
      "('deviations', 'for', 'precision')\n",
      "('for', 'precision', 'and')\n",
      "('precision', 'and', 'intermediate')\n",
      "('and', 'intermediate', 'precision')\n",
      "('intermediate', 'precision', 'were')\n",
      "('precision', 'were', 'less')\n",
      "('were', 'less', 'than')\n",
      "('less', 'than', '1')\n",
      "('than', '1', '5')\n",
      "('1', '5', '%')\n",
      "('5', '%', 'The')\n",
      "('%', 'The', 'proposed')\n",
      "('The', 'proposed', 'RP-HPLC')\n",
      "('proposed', 'RP-HPLC', 'generic')\n",
      "('RP-HPLC', 'generic', 'method')\n",
      "('generic', 'method', 'was')\n",
      "('method', 'was', 'applied')\n",
      "('was', 'applied', 'successfully')\n",
      "('applied', 'successfully', 'for')\n",
      "('successfully', 'for', 'evaluation')\n",
      "('for', 'evaluation', 'of')\n",
      "('evaluation', 'of', 'invitro')\n",
      "('of', 'invitro', 'dissolution')\n",
      "('invitro', 'dissolution', 'profile')\n",
      "('dissolution', 'profile', 'with')\n",
      "('profile', 'with', 'different')\n",
      "('with', 'different', 'pH')\n",
      "('different', 'pH', 'conditions')\n",
      "('pH', 'conditions', 'like')\n",
      "('conditions', 'like', '0')\n",
      "('like', '0', '1N')\n",
      "('0', '1N', 'HCl')\n",
      "('1N', 'HCl', ',')\n",
      "('HCl', ',', 'pH')\n",
      "(',', 'pH', '4')\n",
      "('pH', '4', '5')\n",
      "('4', '5', 'Acetate')\n",
      "('5', 'Acetate', 'buffer')\n",
      "('Acetate', 'buffer', 'and')\n",
      "('buffer', 'and', 'pH')\n",
      "('and', 'pH', '6')\n",
      "('pH', '6', '8')\n",
      "('6', '8', 'Phosphate')\n",
      "('8', 'Phosphate', 'buffers')\n",
      "('Phosphate', 'buffers', 'of')\n",
      "('buffers', 'of', 'US')\n",
      "('of', 'US', 'marketed')\n",
      "('US', 'marketed', 'reference')\n",
      "('marketed', 'reference', 'product')\n",
      "('reference', 'product', 'The')\n",
      "('product', 'The', 'use')\n",
      "('The', 'use', 'of')\n",
      "('use', 'of', 'hydroxychloroquine')\n",
      "('of', 'hydroxychloroquine', '(')\n",
      "('hydroxychloroquine', '(', 'HCQ')\n",
      "('(', 'HCQ', ')')\n",
      "('HCQ', ')', 'has')\n",
      "(')', 'has', 'been')\n",
      "('has', 'been', 'considered')\n",
      "('been', 'considered', 'a')\n",
      "('considered', 'a', 'therapeutic')\n",
      "('a', 'therapeutic', 'option')\n",
      "('therapeutic', 'option', 'by')\n",
      "('option', 'by', 'international')\n",
      "('by', 'international', 'guidelines')\n",
      "('international', 'guidelines', 'and')\n",
      "('guidelines', 'and', 'expert')\n",
      "('and', 'expert', 'opinions')\n",
      "('expert', 'opinions', 'during')\n",
      "('opinions', 'during', 'the')\n",
      "('during', 'the', 'first')\n",
      "('the', 'first', 'phase')\n",
      "('first', 'phase', 'of')\n",
      "('phase', 'of', 'COVID-19')\n",
      "('of', 'COVID-19', 'pandemics')\n",
      "('COVID-19', 'pandemics', ',')\n",
      "('pandemics', ',', '1-10')\n",
      "(',', '1-10', 'although')\n",
      "('1-10', 'although', 'scientific')\n",
      "('although', 'scientific', 'evidence')\n",
      "('scientific', 'evidence', 'remained')\n",
      "('evidence', 'remained', 'too')\n",
      "('remained', 'too', 'scarce')\n",
      "('too', 'scarce', 'to')\n",
      "('scarce', 'to', 'make')\n",
      "('to', 'make', 'a')\n",
      "('make', 'a', 'definitive')\n",
      "('a', 'definitive', 'recommendation')\n",
      "('definitive', 'recommendation', '11')\n",
      "('recommendation', '11', '.')\n",
      "('11', '.', 'While')\n",
      "('.', 'While', 'HCQ')\n",
      "('While', 'HCQ', 'use')\n",
      "('HCQ', 'use', 'has')\n",
      "('use', 'has', 'now')\n",
      "('has', 'now', 'been')\n",
      "('now', 'been', 'questioned')\n",
      "('been', 'questioned', 'by')\n",
      "('questioned', 'by', 'recent')\n",
      "('by', 'recent', 'data')\n",
      "('recent', 'data', '7')\n",
      "('data', '7', ',')\n",
      "('7', ',', 'some')\n",
      "(',', 'some', 'previous')\n",
      "('some', 'previous', 'works')\n",
      "('previous', 'works', 'draw')\n",
      "('works', 'draw', 'attention')\n",
      "('draw', 'attention', 'to')\n",
      "('attention', 'to', 'contrasting')\n",
      "('to', 'contrasting', 'results')\n",
      "('contrasting', 'results', 'on')\n",
      "('results', 'on', 'enhanced')\n",
      "('on', 'enhanced', 'viral')\n",
      "('enhanced', 'viral', 'clearance')\n",
      "('viral', 'clearance', 'after')\n",
      "('clearance', 'after', 'HCQ')\n",
      "('after', 'HCQ', 'treatment')\n",
      "('HCQ', 'treatment', '1-6,10')\n",
      "('treatment', '1-6,10', '.')\n",
      "('1-6,10', '.', 'In')\n",
      "('.', 'In', 'recent')\n",
      "('In', 'recent', 'months')\n",
      "('recent', 'months', ',')\n",
      "('months', ',', 'the')\n",
      "(',', 'the', 'new')\n",
      "('the', 'new', 'coronavirus')\n",
      "('new', 'coronavirus', 'SARS-CoV-2')\n",
      "('coronavirus', 'SARS-CoV-2', 'has')\n",
      "('SARS-CoV-2', 'has', 'emerged')\n",
      "('has', 'emerged', 'as')\n",
      "('emerged', 'as', 'a')\n",
      "('as', 'a', 'worldwide')\n",
      "('a', 'worldwide', 'threat')\n",
      "('worldwide', 'threat', 'with')\n",
      "('threat', 'with', 'about')\n",
      "('with', 'about', '4.2')\n",
      "('about', '4.2', 'million')\n",
      "('4.2', 'million', 'confirmed')\n",
      "('million', 'confirmed', 'cases')\n",
      "('confirmed', 'cases', 'and')\n",
      "('cases', 'and', 'almost')\n",
      "('and', 'almost', '300')\n",
      "('almost', '300', '000')\n",
      "('300', '000', 'deaths')\n",
      "('000', 'deaths', '.')\n",
      "('deaths', '.', 'Its')\n",
      "('.', 'Its', 'major')\n",
      "('Its', 'major', 'clinical')\n",
      "('major', 'clinical', 'presentation')\n",
      "('clinical', 'presentation', 'is')\n",
      "('presentation', 'is', 'characterized')\n",
      "('is', 'characterized', 'by')\n",
      "('characterized', 'by', 'respiratory')\n",
      "('by', 'respiratory', 'symptoms')\n",
      "('respiratory', 'symptoms', 'ranging')\n",
      "('symptoms', 'ranging', 'from')\n",
      "('ranging', 'from', 'mild')\n",
      "('from', 'mild', 'cough')\n",
      "('mild', 'cough', 'to')\n",
      "('cough', 'to', 'serve')\n",
      "('to', 'serve', 'pneumonia')\n",
      "('serve', 'pneumonia', 'with')\n",
      "('pneumonia', 'with', 'fever')\n",
      "('with', 'fever', 'and')\n",
      "('fever', 'and', 'potentially')\n",
      "('and', 'potentially', 'even')\n",
      "('potentially', 'even', 'death')\n",
      "('even', 'death', '.')\n",
      "('death', '.', 'Until')\n",
      "('.', 'Until', 'today')\n",
      "('Until', 'today', ',')\n",
      "('today', ',', 'there')\n",
      "(',', 'there', 'is')\n",
      "('there', 'is', 'no')\n",
      "('is', 'no', 'known')\n",
      "('no', 'known', 'medication')\n",
      "('known', 'medication', 'to')\n",
      "('medication', 'to', 'improve')\n",
      "('to', 'improve', 'clinical')\n",
      "('improve', 'clinical', 'symptoms')\n",
      "('clinical', 'symptoms', 'or')\n",
      "('symptoms', 'or', 'even')\n",
      "('or', 'even', 'prevent')\n",
      "('even', 'prevent', 'or')\n",
      "('prevent', 'or', 'fight')\n",
      "('or', 'fight', 'the')\n",
      "('fight', 'the', 'infection')\n",
      "('the', 'infection', '.')\n",
      "('infection', '.', 'The')\n",
      "('.', 'The', 'search')\n",
      "('The', 'search', 'for')\n",
      "('search', 'for', 'a')\n",
      "('for', 'a', 'useful')\n",
      "('a', 'useful', 'vaccination')\n",
      "('useful', 'vaccination', 'is')\n",
      "('vaccination', 'is', 'ongoing')\n",
      "('is', 'ongoing', 'and')\n",
      "('ongoing', 'and', 'it')\n",
      "('and', 'it', 'will')\n",
      "('it', 'will', 'probably')\n",
      "('will', 'probably', 'not')\n",
      "('probably', 'not', 'be')\n",
      "('not', 'be', 'available')\n",
      "('be', 'available', 'before')\n",
      "('available', 'before', 'the')\n",
      "('before', 'the', 'end')\n",
      "('the', 'end', 'of')\n",
      "('end', 'of', '2020')\n",
      "('of', '2020', '.')\n",
      "('2020', '.', 'In')\n",
      "('.', 'In', 'this')\n",
      "('In', 'this', 'review')\n",
      "('this', 'review', ',')\n",
      "('review', ',', 'we')\n",
      "(',', 'we', 'highlight')\n",
      "('we', 'highlight', 'hydroxychloroquine')\n",
      "('highlight', 'hydroxychloroquine', '(')\n",
      "('hydroxychloroquine', '(', 'HCQ')\n",
      "('(', 'HCQ', ')')\n",
      "('HCQ', ')', 'as')\n",
      "(')', 'as', 'a')\n",
      "('as', 'a', 'potential')\n",
      "('a', 'potential', 'agent')\n",
      "('potential', 'agent', 'to')\n",
      "('agent', 'to', 'prevent')\n",
      "('to', 'prevent', 'coronavirus')\n",
      "('prevent', 'coronavirus', 'disease')\n",
      "('coronavirus', 'disease', '2019')\n",
      "('disease', '2019', '(')\n",
      "('2019', '(', 'COVID-19')\n",
      "('(', 'COVID-19', ')')\n",
      "('COVID-19', ')', 'and')\n",
      "(')', 'and', 'reduce')\n",
      "('and', 'reduce', 'as')\n",
      "('reduce', 'as', 'well')\n",
      "('as', 'well', 'as')\n",
      "('well', 'as', 'shorten')\n",
      "('as', 'shorten', 'clinical')\n",
      "('shorten', 'clinical', 'symptoms')\n",
      "('clinical', 'symptoms', '.')\n",
      "('symptoms', '.', 'Moreover')\n",
      "('.', 'Moreover', ',')\n",
      "('Moreover', ',', 'it')\n",
      "(',', 'it', 'might')\n",
      "('it', 'might', 'serve')\n",
      "('might', 'serve', 'as')\n",
      "('serve', 'as', 'a')\n",
      "('as', 'a', 'potential')\n",
      "('a', 'potential', 'post-exposition')\n",
      "('potential', 'post-exposition', 'prophylaxis')\n",
      "('post-exposition', 'prophylaxis', '.')\n",
      "('prophylaxis', '.', 'Although')\n",
      "('.', 'Although', 'it')\n",
      "('Although', 'it', 'has')\n",
      "('it', 'has', 'been')\n",
      "('has', 'been', 'used')\n",
      "('been', 'used', 'in')\n",
      "('used', 'in', 'the')\n",
      "('in', 'the', 'treatment')\n",
      "('the', 'treatment', 'of')\n",
      "('treatment', 'of', 'rheumatoid')\n",
      "('of', 'rheumatoid', 'arthritis')\n",
      "('rheumatoid', 'arthritis', ',')\n",
      "('arthritis', ',', 'discoid')\n",
      "(',', 'discoid', 'or')\n",
      "('discoid', 'or', 'systemic')\n",
      "('or', 'systemic', 'lupus')\n",
      "('systemic', 'lupus', 'erythematosus')\n",
      "('lupus', 'erythematosus', ',')\n",
      "('erythematosus', ',', 'and')\n",
      "(',', 'and', 'malaria')\n",
      "('and', 'malaria', 'prophylaxis')\n",
      "('malaria', 'prophylaxis', 'and')\n",
      "('prophylaxis', 'and', 'therapy')\n",
      "('and', 'therapy', 'for')\n",
      "('therapy', 'for', 'decades')\n",
      "('for', 'decades', ',')\n",
      "('decades', ',', 'knowledge')\n",
      "(',', 'knowledge', 'on')\n",
      "('knowledge', 'on', 'HCQ')\n",
      "('on', 'HCQ', 'as')\n",
      "('HCQ', 'as', 'a')\n",
      "('as', 'a', 'potential')\n",
      "('a', 'potential', 'treatment')\n",
      "('potential', 'treatment', 'for')\n",
      "('treatment', 'for', 'COVID-19')\n",
      "('for', 'COVID-19', 'is')\n",
      "('COVID-19', 'is', 'limited')\n",
      "('is', 'limited', 'and')\n",
      "('limited', 'and', 'multiple')\n",
      "('and', 'multiple', 'clinical')\n",
      "('multiple', 'clinical', 'trials')\n",
      "('clinical', 'trials', 'have')\n",
      "('trials', 'have', 'just')\n",
      "('have', 'just', 'emerged')\n",
      "('just', 'emerged', '.')\n",
      "('emerged', '.', 'Especially')\n",
      "('.', 'Especially', ',')\n",
      "('Especially', ',', 'rare')\n",
      "(',', 'rare', 'HCQ')\n",
      "('rare', 'HCQ', 'side')\n",
      "('HCQ', 'side', 'effects')\n",
      "('side', 'effects', 'which')\n",
      "('effects', 'which', 'were')\n",
      "('which', 'were', 'of')\n",
      "('were', 'of', 'minor')\n",
      "('of', 'minor', 'importance')\n",
      "('minor', 'importance', 'for')\n",
      "('importance', 'for', 'use')\n",
      "('for', 'use', 'in')\n",
      "('use', 'in', 'selected')\n",
      "('in', 'selected', 'indications')\n",
      "('selected', 'indications', 'might')\n",
      "('indications', 'might', 'gain')\n",
      "('might', 'gain', 'major')\n",
      "('gain', 'major', 'relevance')\n",
      "('major', 'relevance', 'with')\n",
      "('relevance', 'with', 'population-wide')\n",
      "('with', 'population-wide', 'application')\n",
      "('population-wide', 'application', '.')\n",
      "('application', '.', 'These')\n",
      "('.', 'These', 'rare')\n",
      "('These', 'rare', 'side')\n",
      "('rare', 'side', 'effects')\n",
      "('side', 'effects', 'include')\n",
      "('effects', 'include', 'retinopathy')\n",
      "('include', 'retinopathy', 'and-even')\n",
      "('retinopathy', 'and-even', 'more')\n",
      "('and-even', 'more', 'important-QT')\n",
      "('more', 'important-QT', 'prolongation')\n",
      "('important-QT', 'prolongation', 'leading')\n",
      "('prolongation', 'leading', 'to')\n",
      "('leading', 'to', 'sudden')\n",
      "('to', 'sudden', 'cardiac')\n",
      "('sudden', 'cardiac', 'death')\n",
      "('cardiac', 'death', 'by')\n",
      "('death', 'by', 'malignant')\n",
      "('by', 'malignant', 'arrhythmias')\n",
      "('malignant', 'arrhythmias', '.')\n",
      "('arrhythmias', '.', 'Severe')\n",
      "('.', 'Severe', 'acute')\n",
      "('Severe', 'acute', 'respiratory')\n",
      "('acute', 'respiratory', 'coronavirus')\n",
      "('respiratory', 'coronavirus', '2')\n",
      "('coronavirus', '2', '(')\n",
      "('2', '(', 'SARS-CoV-2')\n",
      "('(', 'SARS-CoV-2', ')')\n",
      "('SARS-CoV-2', ')', 'has')\n",
      "(')', 'has', 'caused')\n",
      "('has', 'caused', 'a')\n",
      "('caused', 'a', 'devastating')\n",
      "('a', 'devastating', 'worldwide')\n",
      "('devastating', 'worldwide', 'pandemic')\n",
      "('worldwide', 'pandemic', '.')\n",
      "('pandemic', '.', 'Hydroxychloroquine')\n",
      "('.', 'Hydroxychloroquine', '(')\n",
      "('Hydroxychloroquine', '(', 'HCQ')\n",
      "('(', 'HCQ', ')')\n",
      "('HCQ', ')', 'has')\n",
      "(')', 'has', 'in')\n",
      "('has', 'in', 'vitro')\n",
      "('in', 'vitro', 'activity')\n",
      "('vitro', 'activity', 'against')\n",
      "('activity', 'against', 'SARS-CoV-2')\n",
      "('against', 'SARS-CoV-2', ',')\n",
      "('SARS-CoV-2', ',', 'but')\n",
      "(',', 'but', 'clinical')\n",
      "('but', 'clinical', 'data')\n",
      "('clinical', 'data', 'supporting')\n",
      "('data', 'supporting', 'HCQ')\n",
      "('supporting', 'HCQ', 'for')\n",
      "('HCQ', 'for', 'coronavirus')\n",
      "('for', 'coronavirus', 'disease')\n",
      "('coronavirus', 'disease', '2019')\n",
      "('disease', '2019', '(')\n",
      "('2019', '(', 'COVID-19')\n",
      "('(', 'COVID-19', ')')\n",
      "('COVID-19', ')', 'are')\n",
      "(')', 'are', 'limited')\n",
      "('are', 'limited', '.')\n",
      "('limited', '.', 'METHODS')\n",
      "('.', 'METHODS', ':')\n",
      "('METHODS', ':', 'This')\n",
      "(':', 'This', 'was')\n",
      "('This', 'was', 'a')\n",
      "('was', 'a', 'retrospective')\n",
      "('a', 'retrospective', 'cohort')\n",
      "('retrospective', 'cohort', 'study')\n",
      "('cohort', 'study', 'of')\n",
      "('study', 'of', 'hospitalized')\n",
      "('of', 'hospitalized', 'patients')\n",
      "('hospitalized', 'patients', 'with')\n",
      "('patients', 'with', 'COVID-19')\n",
      "('with', 'COVID-19', 'who')\n",
      "('COVID-19', 'who', 'received')\n",
      "('who', 'received', '≥1')\n",
      "('received', '≥1', 'dose')\n",
      "('≥1', 'dose', 'of')\n",
      "('dose', 'of', 'HCQ')\n",
      "('of', 'HCQ', 'at')\n",
      "('HCQ', 'at', 'two')\n",
      "('at', 'two', 'New')\n",
      "('two', 'New', 'York')\n",
      "('New', 'York', 'City')\n",
      "('York', 'City', 'hospitals')\n",
      "('City', 'hospitals', '.')\n",
      "('hospitals', '.', 'We')\n",
      "('.', 'We', 'measured')\n",
      "('We', 'measured', 'incident')\n",
      "('measured', 'incident', 'Grade')\n",
      "('incident', 'Grade', '3')\n",
      "('Grade', '3', 'or')\n",
      "('3', 'or', '4')\n",
      "('or', '4', 'blood')\n",
      "('4', 'blood', 'count')\n",
      "('blood', 'count', 'and')\n",
      "('count', 'and', 'liver')\n",
      "('and', 'liver', 'test')\n",
      "('liver', 'test', 'abnormalities')\n",
      "('test', 'abnormalities', ',')\n",
      "('abnormalities', ',', 'ventricular')\n",
      "(',', 'ventricular', 'arrhythmias')\n",
      "('ventricular', 'arrhythmias', ',')\n",
      "('arrhythmias', ',', 'and')\n",
      "(',', 'and', 'vomiting')\n",
      "('and', 'vomiting', 'and')\n",
      "('vomiting', 'and', 'diarrhea')\n",
      "('and', 'diarrhea', 'within')\n",
      "('diarrhea', 'within', '10')\n",
      "('within', '10', 'days')\n",
      "('10', 'days', 'after')\n",
      "('days', 'after', 'HCQ')\n",
      "('after', 'HCQ', 'initiation')\n",
      "('HCQ', 'initiation', ',')\n",
      "('initiation', ',', 'and')\n",
      "(',', 'and', 'the')\n",
      "('and', 'the', 'proportion')\n",
      "('the', 'proportion', 'of')\n",
      "('proportion', 'of', 'patients')\n",
      "('of', 'patients', 'who')\n",
      "('patients', 'who', 'completed')\n",
      "('who', 'completed', 'HCQ')\n",
      "('completed', 'HCQ', 'therapy')\n",
      "('HCQ', 'therapy', '.')\n",
      "('therapy', '.', 'We')\n",
      "('.', 'We', 'also')\n",
      "('We', 'also', 'describe')\n",
      "('also', 'describe', 'changes')\n",
      "('describe', 'changes', 'in')\n",
      "('changes', 'in', 'Sequential')\n",
      "('in', 'Sequential', 'Organ')\n",
      "('Sequential', 'Organ', 'Failure')\n",
      "('Organ', 'Failure', 'Assessment')\n",
      "('Failure', 'Assessment', 'hypoxia')\n",
      "('Assessment', 'hypoxia', 'scores')\n",
      "('hypoxia', 'scores', 'between')\n",
      "('scores', 'between', 'baseline')\n",
      "('between', 'baseline', 'and')\n",
      "('baseline', 'and', 'day')\n",
      "('and', 'day', '10')\n",
      "('day', '10', 'after')\n",
      "('10', 'after', 'HCQ')\n",
      "('after', 'HCQ', 'initiation')\n",
      "('HCQ', 'initiation', 'and')\n",
      "('initiation', 'and', 'in-hospital')\n",
      "('and', 'in-hospital', 'mortality')\n",
      "('in-hospital', 'mortality', '.')\n",
      "('mortality', '.', 'RESULTS')\n",
      "('.', 'RESULTS', ':')\n",
      "('RESULTS', ':', 'None')\n",
      "(':', 'None', 'of')\n",
      "('None', 'of', 'the')\n",
      "('of', 'the', '153')\n",
      "('the', '153', 'hospitalized')\n",
      "('153', 'hospitalized', 'patients')\n",
      "('hospitalized', 'patients', 'with')\n",
      "('patients', 'with', 'COVID-19')\n",
      "('with', 'COVID-19', 'who')\n",
      "('COVID-19', 'who', 'received')\n",
      "('who', 'received', 'HCQ')\n",
      "('received', 'HCQ', 'developed')\n",
      "('HCQ', 'developed', 'a')\n",
      "('developed', 'a', 'sustained')\n",
      "('a', 'sustained', 'ventricular')\n",
      "('sustained', 'ventricular', 'tachyarrhythmia')\n",
      "('ventricular', 'tachyarrhythmia', '.')\n",
      "('tachyarrhythmia', '.', 'Incident')\n",
      "('.', 'Incident', 'blood')\n",
      "('Incident', 'blood', 'count')\n",
      "('blood', 'count', 'and')\n",
      "('count', 'and', 'liver')\n",
      "('and', 'liver', 'test')\n",
      "('liver', 'test', 'abnormalities')\n",
      "('test', 'abnormalities', 'occurred')\n",
      "('abnormalities', 'occurred', 'in')\n",
      "('occurred', 'in', '<')\n",
      "('in', '<', '15')\n",
      "('<', '15', '%')\n",
      "('15', '%', 'of')\n",
      "('%', 'of', 'patients')\n",
      "('of', 'patients', 'and')\n",
      "('patients', 'and', 'incident')\n",
      "('and', 'incident', 'vomiting')\n",
      "('incident', 'vomiting', 'or')\n",
      "('vomiting', 'or', 'diarrhea')\n",
      "('or', 'diarrhea', 'was')\n",
      "('diarrhea', 'was', 'rare')\n",
      "('was', 'rare', '.')\n",
      "('rare', '.', 'Eighty-nine')\n",
      "('.', 'Eighty-nine', 'percent')\n",
      "('Eighty-nine', 'percent', 'of')\n",
      "('percent', 'of', 'patients')\n",
      "('of', 'patients', 'completed')\n",
      "('patients', 'completed', 'their')\n",
      "('completed', 'their', 'HCQ')\n",
      "('their', 'HCQ', 'course')\n",
      "('HCQ', 'course', 'and')\n",
      "('course', 'and', 'three')\n",
      "('and', 'three', 'patients')\n",
      "('three', 'patients', 'discontinued')\n",
      "('patients', 'discontinued', 'therapy')\n",
      "('discontinued', 'therapy', 'because')\n",
      "('therapy', 'because', 'of')\n",
      "('because', 'of', 'QT')\n",
      "('of', 'QT', 'prolongation')\n",
      "('QT', 'prolongation', '.')\n",
      "('prolongation', '.', 'Fifty-two')\n",
      "('.', 'Fifty-two', 'percent')\n",
      "('Fifty-two', 'percent', 'of')\n",
      "('percent', 'of', 'patients')\n",
      "('of', 'patients', 'had')\n",
      "('patients', 'had', 'improved')\n",
      "('had', 'improved', 'hypoxia')\n",
      "('improved', 'hypoxia', 'scores')\n",
      "('hypoxia', 'scores', '10')\n",
      "('scores', '10', 'days')\n",
      "('10', 'days', 'after')\n",
      "('days', 'after', 'starting')\n",
      "('after', 'starting', 'HCQ')\n",
      "('starting', 'HCQ', '.')\n",
      "('HCQ', '.', 'Thirty-one')\n",
      "('.', 'Thirty-one', 'percent')\n",
      "('Thirty-one', 'percent', 'of')\n",
      "('percent', 'of', 'patients')\n",
      "('of', 'patients', 'who')\n",
      "('patients', 'who', 'were')\n",
      "('who', 'were', 'receiving')\n",
      "('were', 'receiving', 'mechanical')\n",
      "('receiving', 'mechanical', 'ventilation')\n",
      "('mechanical', 'ventilation', 'at')\n",
      "('ventilation', 'at', 'the')\n",
      "('at', 'the', 'time')\n",
      "('the', 'time', 'of')\n",
      "('time', 'of', 'HCQ')\n",
      "('of', 'HCQ', 'initiation')\n",
      "('HCQ', 'initiation', 'died')\n",
      "('initiation', 'died', 'during')\n",
      "('died', 'during', 'their')\n",
      "('during', 'their', 'hospitalization')\n",
      "('their', 'hospitalization', ',')\n",
      "('hospitalization', ',', 'compared')\n",
      "(',', 'compared', 'to')\n",
      "('compared', 'to', '18')\n",
      "('to', '18', '%')\n",
      "('18', '%', 'of')\n",
      "('%', 'of', 'patients')\n",
      "('of', 'patients', 'who')\n",
      "('patients', 'who', 'were')\n",
      "('who', 'were', 'receiving')\n",
      "('were', 'receiving', 'supplemental')\n",
      "('receiving', 'supplemental', 'oxygen')\n",
      "('supplemental', 'oxygen', 'but')\n",
      "('oxygen', 'but', 'not')\n",
      "('but', 'not', 'requiring')\n",
      "('not', 'requiring', 'mechanical')\n",
      "('requiring', 'mechanical', 'ventilation')\n",
      "('mechanical', 'ventilation', ',')\n",
      "('ventilation', ',', 'and')\n",
      "(',', 'and', '8')\n",
      "('and', '8', '%')\n",
      "('8', '%', 'of')\n",
      "('%', 'of', 'patients')\n",
      "('of', 'patients', 'who')\n",
      "('patients', 'who', 'were')\n",
      "('who', 'were', 'not')\n",
      "('were', 'not', 'requiring')\n",
      "('not', 'requiring', 'supplemental')\n",
      "('requiring', 'supplemental', 'oxygen')\n",
      "('supplemental', 'oxygen', '.')\n",
      "('oxygen', '.', 'Co-administration')\n",
      "('.', 'Co-administration', 'of')\n",
      "('Co-administration', 'of', 'azithromycin')\n",
      "('of', 'azithromycin', 'was')\n",
      "('azithromycin', 'was', 'not')\n",
      "('was', 'not', 'associated')\n",
      "('not', 'associated', 'with')\n",
      "('associated', 'with', 'improved')\n",
      "('with', 'improved', 'outcomes')\n",
      "('improved', 'outcomes', '.')\n",
      "('outcomes', '.', 'CONCLUSIONS')\n",
      "('.', 'CONCLUSIONS', ':')\n",
      "('CONCLUSIONS', ':', 'HCQ')\n",
      "(':', 'HCQ', 'appears')\n",
      "('HCQ', 'appears', 'to')\n",
      "('appears', 'to', 'be')\n",
      "('to', 'be', 'reasonably')\n",
      "('be', 'reasonably', 'safe')\n",
      "('reasonably', 'safe', 'and')\n",
      "('safe', 'and', 'tolerable')\n",
      "('and', 'tolerable', 'in')\n",
      "('tolerable', 'in', 'most')\n",
      "('in', 'most', 'hospitalized')\n",
      "('most', 'hospitalized', 'patients')\n",
      "('hospitalized', 'patients', 'with')\n",
      "('patients', 'with', 'COVID-19')\n",
      "('with', 'COVID-19', '.')\n",
      "('COVID-19', '.', 'However')\n",
      "('.', 'However', ',')\n",
      "('However', ',', 'nearly')\n",
      "(',', 'nearly', 'one-half')\n",
      "('nearly', 'one-half', 'of')\n",
      "('one-half', 'of', 'patients')\n",
      "('of', 'patients', 'did')\n",
      "('patients', 'did', 'not')\n",
      "('did', 'not', 'improve')\n",
      "('not', 'improve', 'with')\n",
      "('improve', 'with', 'this')\n",
      "('with', 'this', 'treatment')\n",
      "('this', 'treatment', ',')\n",
      "('treatment', ',', 'highlighting')\n",
      "(',', 'highlighting', 'the')\n",
      "('highlighting', 'the', 'need')\n",
      "('the', 'need', 'to')\n",
      "('need', 'to', 'evaluate')\n",
      "('to', 'evaluate', 'HCQ')\n",
      "('evaluate', 'HCQ', 'and')\n",
      "('HCQ', 'and', 'alternate')\n",
      "('and', 'alternate', 'therapies')\n",
      "('alternate', 'therapies', 'in')\n",
      "('therapies', 'in', 'randomized')\n",
      "('in', 'randomized', 'trials')\n",
      "('randomized', 'trials', '.')\n",
      "('trials', '.', 'The')\n",
      "('.', 'The', 'aim')\n",
      "('The', 'aim', 'of')\n",
      "('aim', 'of', 'this')\n",
      "('of', 'this', 'work')\n",
      "('this', 'work', 'is')\n",
      "('work', 'is', 'to')\n",
      "('is', 'to', 'trace')\n",
      "('to', 'trace', 'how')\n",
      "('trace', 'how', 'rheumatologists')\n",
      "('how', 'rheumatologists', 'all')\n",
      "('rheumatologists', 'all', 'over')\n",
      "('all', 'over', 'Egypt')\n",
      "('over', 'Egypt', 'are')\n",
      "('Egypt', 'are', 'approaching')\n",
      "('are', 'approaching', 'the')\n",
      "('approaching', 'the', 'COVID-19')\n",
      "('the', 'COVID-19', 'pandemic')\n",
      "('COVID-19', 'pandemic', 'and')\n",
      "('pandemic', 'and', 'what')\n",
      "('and', 'what', 'changes')\n",
      "('what', 'changes', 'it')\n",
      "('changes', 'it', 'has')\n",
      "('it', 'has', 'brought')\n",
      "('has', 'brought', 'about')\n",
      "('brought', 'about', 'in')\n",
      "('about', 'in', 'the')\n",
      "('in', 'the', 'patients')\n",
      "('the', 'patients', \"'\")\n",
      "('patients', \"'\", 'care')\n",
      "(\"'\", 'care', 'with')\n",
      "('care', 'with', 'special')\n",
      "('with', 'special', 'attention')\n",
      "('special', 'attention', 'to')\n",
      "('attention', 'to', 'its')\n",
      "('to', 'its', 'effect')\n",
      "('its', 'effect', 'on')\n",
      "('effect', 'on', 'vulnerable')\n",
      "('on', 'vulnerable', 'rheumatic')\n",
      "('vulnerable', 'rheumatic', 'disease')\n",
      "('rheumatic', 'disease', '(')\n",
      "('disease', '(', 'RD')\n",
      "('(', 'RD', ')')\n",
      "('RD', ')', 'patients')\n",
      "(')', 'patients', '.')\n",
      "('patients', '.', 'This')\n",
      "('.', 'This', 'survey')\n",
      "('This', 'survey', 'further')\n",
      "('survey', 'further', 'aims')\n",
      "('further', 'aims', 'to')\n",
      "('aims', 'to', 'help')\n",
      "('to', 'help', 'inform')\n",
      "('help', 'inform', 'the')\n",
      "('inform', 'the', 'rheumatology')\n",
      "('the', 'rheumatology', 'community')\n",
      "('rheumatology', 'community', 'about')\n",
      "('community', 'about', 'the')\n",
      "('about', 'the', 'changes')\n",
      "('the', 'changes', 'in')\n",
      "('changes', 'in', 'practice')\n",
      "('in', 'practice', 'during')\n",
      "('practice', 'during', 'the')\n",
      "('during', 'the', 'COVID-19')\n",
      "('the', 'COVID-19', 'pandemic')\n",
      "('COVID-19', 'pandemic', '.')\n",
      "('pandemic', '.', 'The')\n",
      "('.', 'The', 'survey')\n",
      "('The', 'survey', 'included')\n",
      "('survey', 'included', '26')\n",
      "('included', '26', 'questions')\n",
      "('26', 'questions', 'distributed')\n",
      "('questions', 'distributed', 'to')\n",
      "('distributed', 'to', 'University')\n",
      "('to', 'University', 'staff')\n",
      "('University', 'staff', 'members')\n",
      "('staff', 'members', 'across')\n",
      "('members', 'across', 'Egypt')\n",
      "('across', 'Egypt', 'members')\n",
      "('Egypt', 'members', 'of')\n",
      "('members', 'of', 'the')\n",
      "('of', 'the', 'Egyptian')\n",
      "('the', 'Egyptian', 'College')\n",
      "('Egyptian', 'College', 'of')\n",
      "('College', 'of', 'Rheumatology')\n",
      "('of', 'Rheumatology', '(')\n",
      "('Rheumatology', '(', 'ECR')\n",
      "('(', 'ECR', ')')\n",
      "('ECR', ')', '.')\n",
      "(')', '.', 'It')\n",
      "('.', 'It', 'takes')\n",
      "('It', 'takes', '5-10')\n",
      "('takes', '5-10', 'min')\n",
      "('5-10', 'min', 'to')\n",
      "('min', 'to', 'fill')\n",
      "('to', 'fill', 'out')\n",
      "('fill', 'out', '.')\n",
      "('out', '.', 'The')\n",
      "('.', 'The', 'practice')\n",
      "('The', 'practice', 'setting')\n",
      "('practice', 'setting', 'of')\n",
      "('setting', 'of', 'participating')\n",
      "('of', 'participating', 'rheumatologists')\n",
      "('participating', 'rheumatologists', 'included')\n",
      "('rheumatologists', 'included', 'University')\n",
      "('included', 'University', 'Teaching')\n",
      "('University', 'Teaching', 'Hospitals')\n",
      "('Teaching', 'Hospitals', 'that')\n",
      "('Hospitals', 'that', 'are')\n",
      "('that', 'are', 'the')\n",
      "('are', 'the', 'main')\n",
      "('the', 'main', 'rheumatology')\n",
      "('main', 'rheumatology', 'and')\n",
      "('rheumatology', 'and', 'clinical')\n",
      "('and', 'clinical', 'immunology')\n",
      "('clinical', 'immunology', 'service')\n",
      "('immunology', 'service', 'providers')\n",
      "('service', 'providers', 'for')\n",
      "('providers', 'for', 'adults')\n",
      "('for', 'adults', 'and')\n",
      "('adults', 'and', 'children')\n",
      "('and', 'children', 'RD')\n",
      "('children', 'RD', 'patients')\n",
      "('RD', 'patients', '.')\n",
      "('patients', '.', 'There')\n",
      "('.', 'There', 'was')\n",
      "('There', 'was', 'an')\n",
      "('was', 'an', 'overall')\n",
      "('an', 'overall', 'agreement')\n",
      "('overall', 'agreement', 'across')\n",
      "('agreement', 'across', 'the')\n",
      "('across', 'the', 'country')\n",
      "('the', 'country', 'in')\n",
      "('country', 'in', 'the')\n",
      "('in', 'the', 'responses')\n",
      "('the', 'responses', 'to')\n",
      "('responses', 'to', 'the')\n",
      "('to', 'the', 'survey')\n",
      "('the', 'survey', 'that')\n",
      "('survey', 'that', 'took')\n",
      "('that', 'took', 'a')\n",
      "('took', 'a', 'median')\n",
      "('a', 'median', 'time')\n",
      "('median', 'time', 'of')\n",
      "('time', 'of', '7')\n",
      "('of', '7', 'min')\n",
      "('7', 'min', 'to')\n",
      "('min', 'to', 'fill')\n",
      "('to', 'fill', 'in')\n",
      "('fill', 'in', '.')\n",
      "('in', '.', 'Potential')\n",
      "('.', 'Potential', 'changes')\n",
      "('Potential', 'changes', 'in')\n",
      "('changes', 'in', 'rheumatology')\n",
      "('in', 'rheumatology', 'outpatient')\n",
      "('rheumatology', 'outpatient', 'practice')\n",
      "('outpatient', 'practice', 'by')\n",
      "('practice', 'by', 'staff')\n",
      "('by', 'staff', 'members')\n",
      "('staff', 'members', 'evolved')\n",
      "('members', 'evolved', 'since')\n",
      "('evolved', 'since', 'the')\n",
      "('since', 'the', 'COVID-19')\n",
      "('the', 'COVID-19', 'pandemic')\n",
      "('COVID-19', 'pandemic', '.')\n",
      "('pandemic', '.', 'None')\n",
      "('.', 'None', 'of')\n",
      "('None', 'of', 'the')\n",
      "('of', 'the', 'university')\n",
      "('the', 'university', 'rheumatology')\n",
      "('university', 'rheumatology', 'staff')\n",
      "('rheumatology', 'staff', 'members')\n",
      "('staff', 'members', 'has')\n",
      "('members', 'has', 'prescribed')\n",
      "('has', 'prescribed', 'chloroquine')\n",
      "('prescribed', 'chloroquine', 'or')\n",
      "('chloroquine', 'or', 'HCQ')\n",
      "('or', 'HCQ', 'to')\n",
      "('HCQ', 'to', 'prevent')\n",
      "('to', 'prevent', 'or')\n",
      "('prevent', 'or', 'treat')\n",
      "('or', 'treat', 'COVID-19')\n",
      "('treat', 'COVID-19', 'in')\n",
      "('COVID-19', 'in', 'a')\n",
      "('in', 'a', 'non-hospitalized')\n",
      "('a', 'non-hospitalized', 'patient')\n",
      "('non-hospitalized', 'patient', 'who')\n",
      "('patient', 'who', 'was')\n",
      "('who', 'was', 'not')\n",
      "('was', 'not', 'previously')\n",
      "('not', 'previously', 'on')\n",
      "('previously', 'on', 'it')\n",
      "('on', 'it', '.')\n",
      "('it', '.', 'Twenty-three')\n",
      "('.', 'Twenty-three', 'recommended')\n",
      "('Twenty-three', 'recommended', 'decrease/avoid')\n",
      "('recommended', 'decrease/avoid', 'NSAIDs')\n",
      "('decrease/avoid', 'NSAIDs', 'if')\n",
      "('NSAIDs', 'if', 'the')\n",
      "('if', 'the', 'RD')\n",
      "('the', 'RD', 'patient')\n",
      "('RD', 'patient', 'had')\n",
      "('patient', 'had', 'confirmed')\n",
      "('had', 'confirmed', 'COVID-19')\n",
      "('confirmed', 'COVID-19', 'or')\n",
      "('COVID-19', 'or', 'symptoms')\n",
      "('or', 'symptoms', '.')\n",
      "('symptoms', '.', 'There')\n",
      "('.', 'There', 'is')\n",
      "('There', 'is', 'an')\n",
      "('is', 'an', 'agreement')\n",
      "('an', 'agreement', 'to')\n",
      "('agreement', 'to', 'the')\n",
      "('to', 'the', 'key')\n",
      "('the', 'key', 'emerging')\n",
      "('key', 'emerging', 'frontline')\n",
      "('emerging', 'frontline', 'role')\n",
      "('frontline', 'role', 'of')\n",
      "('role', 'of', 'rheumatologists')\n",
      "('of', 'rheumatologists', 'in')\n",
      "('rheumatologists', 'in', 'treating')\n",
      "('in', 'treating', 'COVID-19')\n",
      "('treating', 'COVID-19', '.')\n",
      "('COVID-19', '.', 'During')\n",
      "('.', 'During', 'the')\n",
      "('During', 'the', 'pandemic')\n",
      "('the', 'pandemic', ',')\n",
      "('pandemic', ',', 'RD')\n",
      "(',', 'RD', 'cases')\n",
      "('RD', 'cases', 'requiring')\n",
      "('cases', 'requiring', 'admission')\n",
      "('requiring', 'admission', 'were')\n",
      "('admission', 'were', 'dealt')\n",
      "('were', 'dealt', 'with')\n",
      "('dealt', 'with', 'by')\n",
      "('with', 'by', 'several')\n",
      "('by', 'several', 'modified')\n",
      "('several', 'modified', 'strategies')\n",
      "('modified', 'strategies', '.')\n",
      "('strategies', '.', 'The')\n",
      "('.', 'The', 'overall')\n",
      "('The', 'overall', 'agreement')\n",
      "('overall', 'agreement', 'among')\n",
      "('agreement', 'among', 'the')\n",
      "('among', 'the', 'different')\n",
      "('the', 'different', 'university')\n",
      "('different', 'university', 'rheumatology')\n",
      "('university', 'rheumatology', 'departments')\n",
      "('rheumatology', 'departments', 'during')\n",
      "('departments', 'during', 'such')\n",
      "('during', 'such', 'critical')\n",
      "('such', 'critical', 'situation')\n",
      "('critical', 'situation', 'has')\n",
      "('situation', 'has', 'provoked')\n",
      "('has', 'provoked', 'the')\n",
      "('provoked', 'the', 'ECR')\n",
      "('the', 'ECR', 'to')\n",
      "('ECR', 'to', 'consider')\n",
      "('to', 'consider', 'providing')\n",
      "('consider', 'providing', 'provisional')\n",
      "('providing', 'provisional', 'guidelines')\n",
      "('provisional', 'guidelines', 'for')\n",
      "('guidelines', 'for', 'dealing')\n",
      "('for', 'dealing', 'with')\n",
      "('dealing', 'with', 'RD')\n",
      "('with', 'RD', 'patients')\n",
      "('RD', 'patients', 'during')\n",
      "('patients', 'during', 'this')\n",
      "('during', 'this', 'global')\n",
      "('this', 'global', 'catastrophe')\n",
      "('global', 'catastrophe', '.')\n",
      "('catastrophe', '.', 'COVID-19')\n",
      "('.', 'COVID-19', 'has')\n",
      "('COVID-19', 'has', 'rapidly')\n",
      "('has', 'rapidly', 'become')\n",
      "('rapidly', 'become', 'a')\n",
      "('become', 'a', 'pandemic')\n",
      "('a', 'pandemic', 'for')\n",
      "('pandemic', 'for', 'which')\n",
      "('for', 'which', 'no')\n",
      "('which', 'no', 'antiviral')\n",
      "('no', 'antiviral', 'drug')\n",
      "('antiviral', 'drug', 'or')\n",
      "('drug', 'or', 'vaccine')\n",
      "('or', 'vaccine', 'is')\n",
      "('vaccine', 'is', 'yet')\n",
      "('is', 'yet', 'available2-4')\n",
      "('yet', 'available2-4', '.')\n",
      "('available2-4', '.', 'Several')\n",
      "('.', 'Several', 'clinical')\n",
      "('Several', 'clinical', 'studies')\n",
      "('clinical', 'studies', 'are')\n",
      "('studies', 'are', 'ongoing')\n",
      "('are', 'ongoing', 'to')\n",
      "('ongoing', 'to', 'evaluate')\n",
      "('to', 'evaluate', 'the')\n",
      "('evaluate', 'the', 'efficacy')\n",
      "('the', 'efficacy', 'of')\n",
      "('efficacy', 'of', 'repurposed')\n",
      "('of', 'repurposed', 'drugs')\n",
      "('repurposed', 'drugs', 'that')\n",
      "('drugs', 'that', 'have')\n",
      "('that', 'have', 'demonstrated')\n",
      "('have', 'demonstrated', 'antiviral')\n",
      "('demonstrated', 'antiviral', 'efficacy')\n",
      "('antiviral', 'efficacy', 'in')\n",
      "('efficacy', 'in', 'vitro')\n",
      "('in', 'vitro', '.')\n",
      "('vitro', '.', 'Among')\n",
      "('.', 'Among', 'these')\n",
      "('Among', 'these', 'candidates')\n",
      "('these', 'candidates', ',')\n",
      "('candidates', ',', 'hydroxychloroquine')\n",
      "(',', 'hydroxychloroquine', '(')\n",
      "('hydroxychloroquine', '(', 'HCQ')\n",
      "('(', 'HCQ', ')')\n",
      "('HCQ', ')', 'has')\n",
      "(')', 'has', 'been')\n",
      "('has', 'been', 'given')\n",
      "('been', 'given', 'to')\n",
      "('given', 'to', 'thousands')\n",
      "('to', 'thousands', 'of')\n",
      "('thousands', 'of', 'individuals')\n",
      "('of', 'individuals', 'worldwide')\n",
      "('individuals', 'worldwide', 'but')\n",
      "('worldwide', 'but', 'definitive')\n",
      "('but', 'definitive', 'evidence')\n",
      "('definitive', 'evidence', 'for')\n",
      "('evidence', 'for', 'HCQ')\n",
      "('for', 'HCQ', 'efficacy')\n",
      "('HCQ', 'efficacy', 'in')\n",
      "('efficacy', 'in', 'treatment')\n",
      "('in', 'treatment', 'of')\n",
      "('treatment', 'of', 'COVID-19')\n",
      "('of', 'COVID-19', 'is')\n",
      "('COVID-19', 'is', 'still')\n",
      "('is', 'still', 'missing6,7,17,18')\n",
      "('still', 'missing6,7,17,18', '.')\n",
      "('missing6,7,17,18', '.', 'We')\n",
      "('.', 'We', 'evaluated')\n",
      "('We', 'evaluated', 'the')\n",
      "('evaluated', 'the', 'antiviral')\n",
      "('the', 'antiviral', 'activity')\n",
      "('antiviral', 'activity', 'of')\n",
      "('activity', 'of', 'HCQ')\n",
      "('of', 'HCQ', 'both')\n",
      "('HCQ', 'both', 'in')\n",
      "('both', 'in', 'vitro')\n",
      "('in', 'vitro', 'and')\n",
      "('vitro', 'and', 'in')\n",
      "('and', 'in', 'SARS-CoV-2-infected')\n",
      "('in', 'SARS-CoV-2-infected', 'macaques')\n",
      "('SARS-CoV-2-infected', 'macaques', '.')\n",
      "('macaques', '.', 'HCQ')\n",
      "('.', 'HCQ', 'showed')\n",
      "('HCQ', 'showed', 'antiviral')\n",
      "('showed', 'antiviral', 'activity')\n",
      "('antiviral', 'activity', 'in')\n",
      "('activity', 'in', 'African')\n",
      "('in', 'African', 'green')\n",
      "('African', 'green', 'monkey')\n",
      "('green', 'monkey', 'kidney')\n",
      "('monkey', 'kidney', 'cells')\n",
      "('kidney', 'cells', '(')\n",
      "('cells', '(', 'VeroE6')\n",
      "('(', 'VeroE6', ')')\n",
      "('VeroE6', ')', 'but')\n",
      "(')', 'but', 'not')\n",
      "('but', 'not', 'in')\n",
      "('not', 'in', 'a')\n",
      "('in', 'a', 'model')\n",
      "('a', 'model', 'of')\n",
      "('model', 'of', 'reconstituted')\n",
      "('of', 'reconstituted', 'human')\n",
      "('reconstituted', 'human', 'airway')\n",
      "('human', 'airway', 'epithelium')\n",
      "('airway', 'epithelium', '.')\n",
      "('epithelium', '.', 'In')\n",
      "('.', 'In', 'macaques')\n",
      "('In', 'macaques', ',')\n",
      "('macaques', ',', 'we')\n",
      "(',', 'we', 'tested')\n",
      "('we', 'tested', 'different')\n",
      "('tested', 'different', 'treatment')\n",
      "('different', 'treatment', 'strategies')\n",
      "('treatment', 'strategies', 'in')\n",
      "('strategies', 'in', 'comparison')\n",
      "('in', 'comparison', 'to')\n",
      "('comparison', 'to', 'placebo')\n",
      "('to', 'placebo', ',')\n",
      "('placebo', ',', 'before')\n",
      "(',', 'before', 'and')\n",
      "('before', 'and', 'after')\n",
      "('and', 'after', 'peak')\n",
      "('after', 'peak', 'viral')\n",
      "('peak', 'viral', 'load')\n",
      "('viral', 'load', ',')\n",
      "('load', ',', 'alone')\n",
      "(',', 'alone', 'or')\n",
      "('alone', 'or', 'in')\n",
      "('or', 'in', 'combination')\n",
      "('in', 'combination', 'with')\n",
      "('combination', 'with', 'azithromycin')\n",
      "('with', 'azithromycin', '(')\n",
      "('azithromycin', '(', 'AZTH')\n",
      "('(', 'AZTH', ')')\n",
      "('AZTH', ')', '.')\n",
      "(')', '.', 'Neither')\n",
      "('.', 'Neither', 'HCQ')\n",
      "('Neither', 'HCQ', 'nor')\n",
      "('HCQ', 'nor', 'HCQ+AZTH')\n",
      "('nor', 'HCQ+AZTH', 'showed')\n",
      "('HCQ+AZTH', 'showed', 'a')\n",
      "('showed', 'a', 'significant')\n",
      "('a', 'significant', 'effect')\n",
      "('significant', 'effect', 'on')\n",
      "('effect', 'on', 'the')\n",
      "('on', 'the', 'viral')\n",
      "('the', 'viral', 'load')\n",
      "('viral', 'load', 'levels')\n",
      "('load', 'levels', 'in')\n",
      "('levels', 'in', 'any')\n",
      "('in', 'any', 'of')\n",
      "('any', 'of', 'the')\n",
      "('of', 'the', 'tested')\n",
      "('the', 'tested', 'compartments')\n",
      "('tested', 'compartments', '.')\n",
      "('compartments', '.', 'When')\n",
      "('.', 'When', 'the')\n",
      "('When', 'the', 'drug')\n",
      "('the', 'drug', 'was')\n",
      "('drug', 'was', 'used')\n",
      "('was', 'used', 'as')\n",
      "('used', 'as', 'a')\n",
      "('as', 'a', 'pre-exposure')\n",
      "('a', 'pre-exposure', 'prophylaxis')\n",
      "('pre-exposure', 'prophylaxis', '(')\n",
      "('prophylaxis', '(', 'PrEP')\n",
      "('(', 'PrEP', ')')\n",
      "('PrEP', ')', ',')\n",
      "(')', ',', 'HCQ')\n",
      "(',', 'HCQ', 'did')\n",
      "('HCQ', 'did', 'not')\n",
      "('did', 'not', 'confer')\n",
      "('not', 'confer', 'protection')\n",
      "('confer', 'protection', 'against')\n",
      "('protection', 'against', 'acquisition')\n",
      "('against', 'acquisition', 'of')\n",
      "('acquisition', 'of', 'infection')\n",
      "('of', 'infection', '.')\n",
      "('infection', '.', 'Our')\n",
      "('.', 'Our', 'findings')\n",
      "('Our', 'findings', 'do')\n",
      "('findings', 'do', 'not')\n",
      "('do', 'not', 'support')\n",
      "('not', 'support', 'the')\n",
      "('support', 'the', 'use')\n",
      "('the', 'use', 'of')\n",
      "('use', 'of', 'HCQ')\n",
      "('of', 'HCQ', ',')\n",
      "('HCQ', ',', 'either')\n",
      "(',', 'either', 'alone')\n",
      "('either', 'alone', 'or')\n",
      "('alone', 'or', 'in')\n",
      "('or', 'in', 'combination')\n",
      "('in', 'combination', 'with')\n",
      "('combination', 'with', 'AZTH')\n",
      "('with', 'AZTH', ',')\n",
      "('AZTH', ',', 'as')\n",
      "(',', 'as', 'an')\n",
      "('as', 'an', 'antiviral')\n",
      "('an', 'antiviral', 'treatment')\n",
      "('antiviral', 'treatment', 'for')\n",
      "('treatment', 'for', 'COVID-19')\n",
      "('for', 'COVID-19', 'in')\n",
      "('COVID-19', 'in', 'humans')\n",
      "('in', 'humans', '.')\n",
      "('humans', '.', 'Over')\n",
      "('.', 'Over', 'the')\n",
      "('Over', 'the', 'last')\n",
      "('the', 'last', 'few')\n",
      "('last', 'few', 'months')\n",
      "('few', 'months', ',')\n",
      "('months', ',', 'coronavirus')\n",
      "(',', 'coronavirus', 'disease')\n",
      "('coronavirus', 'disease', '2019')\n",
      "('disease', '2019', '(')\n",
      "('2019', '(', 'COVID-19')\n",
      "('(', 'COVID-19', ')')\n",
      "('COVID-19', ')', 'pandemic')\n",
      "(')', 'pandemic', 'caused')\n",
      "('pandemic', 'caused', 'by')\n",
      "('caused', 'by', 'the')\n",
      "('by', 'the', 'novel')\n",
      "('the', 'novel', 'coronavirus')\n",
      "('novel', 'coronavirus', 'SARS-CoV-2')\n",
      "('coronavirus', 'SARS-CoV-2', 'has')\n",
      "('SARS-CoV-2', 'has', 'posed')\n",
      "('has', 'posed', 'a')\n",
      "('posed', 'a', 'serious')\n",
      "('a', 'serious', 'threat')\n",
      "('serious', 'threat', 'to')\n",
      "('threat', 'to', 'public')\n",
      "('to', 'public', 'health')\n",
      "('public', 'health', 'on')\n",
      "('health', 'on', 'a')\n",
      "('on', 'a', 'global')\n",
      "('a', 'global', 'scale')\n",
      "('global', 'scale', '.')\n",
      "('scale', '.', 'Given')\n",
      "('.', 'Given', 'the')\n",
      "('Given', 'the', 'current')\n",
      "('the', 'current', 'lack')\n",
      "('current', 'lack', 'of')\n",
      "('lack', 'of', 'an')\n",
      "('of', 'an', 'effective')\n",
      "('an', 'effective', 'vaccine')\n",
      "('effective', 'vaccine', ',')\n",
      "('vaccine', ',', 'several')\n",
      "(',', 'several', 'drugs')\n",
      "('several', 'drugs', 'have')\n",
      "('drugs', 'have', 'been')\n",
      "('have', 'been', 'repurposed')\n",
      "('been', 'repurposed', 'for')\n",
      "('repurposed', 'for', 'treatment')\n",
      "('for', 'treatment', 'and')\n",
      "('treatment', 'and', 'prophylaxis')\n",
      "('and', 'prophylaxis', 'of')\n",
      "('prophylaxis', 'of', 'COVID-19')\n",
      "('of', 'COVID-19', 'in')\n",
      "('COVID-19', 'in', 'an')\n",
      "('in', 'an', 'attempt')\n",
      "('an', 'attempt', 'to')\n",
      "('attempt', 'to', 'find')\n",
      "('to', 'find', 'an')\n",
      "('find', 'an', 'effective')\n",
      "('an', 'effective', 'cure')\n",
      "('effective', 'cure', '.')\n",
      "('cure', '.', 'AREAS')\n",
      "('.', 'AREAS', 'COVERED')\n",
      "('AREAS', 'COVERED', 'The')\n",
      "('COVERED', 'The', 'antimalarial')\n",
      "('The', 'antimalarial', 'drug')\n",
      "('antimalarial', 'drug', 'hydroxychloroquine')\n",
      "('drug', 'hydroxychloroquine', '(')\n",
      "('hydroxychloroquine', '(', 'HCQ')\n",
      "('(', 'HCQ', ')')\n",
      "('HCQ', ')', 'initially')\n",
      "(')', 'initially', 'garnered')\n",
      "('initially', 'garnered', 'widespread')\n",
      "('garnered', 'widespread', 'attention')\n",
      "('widespread', 'attention', 'following')\n",
      "('attention', 'following', 'the')\n",
      "('following', 'the', 'publication')\n",
      "('the', 'publication', 'of')\n",
      "('publication', 'of', 'preliminary')\n",
      "('of', 'preliminary', 'results')\n",
      "('preliminary', 'results', 'showing')\n",
      "('results', 'showing', 'that')\n",
      "('showing', 'that', 'this')\n",
      "('that', 'this', 'drug')\n",
      "('this', 'drug', 'exerts')\n",
      "('drug', 'exerts', 'an')\n",
      "('exerts', 'an', 'anti-SARS-CoV-2')\n",
      "('an', 'anti-SARS-CoV-2', 'activity')\n",
      "('anti-SARS-CoV-2', 'activity', 'in')\n",
      "('activity', 'in', 'vitro')\n",
      "('in', 'vitro', '.')\n",
      "('vitro', '.', 'EXPERT')\n",
      "('.', 'EXPERT', 'OPINION')\n",
      "('EXPERT', 'OPINION', 'To')\n",
      "('OPINION', 'To', 'date')\n",
      "('To', 'date', ',')\n",
      "('date', ',', 'clinical')\n",
      "(',', 'clinical', 'evidence')\n",
      "('clinical', 'evidence', 'suggests')\n",
      "('evidence', 'suggests', 'lack')\n",
      "('suggests', 'lack', 'of')\n",
      "('lack', 'of', 'benefit')\n",
      "('of', 'benefit', 'from')\n",
      "('benefit', 'from', 'HCQ')\n",
      "('from', 'HCQ', 'use')\n",
      "('HCQ', 'use', 'for')\n",
      "('use', 'for', 'the')\n",
      "('for', 'the', 'treatment')\n",
      "('the', 'treatment', 'of')\n",
      "('treatment', 'of', 'hospitalized')\n",
      "('of', 'hospitalized', 'patients')\n",
      "('hospitalized', 'patients', 'with')\n",
      "('patients', 'with', 'COVID-19')\n",
      "('with', 'COVID-19', '.')\n",
      "('COVID-19', '.', 'In')\n",
      "('.', 'In', 'such')\n",
      "('In', 'such', 'patients')\n",
      "('such', 'patients', ',')\n",
      "('patients', ',', 'HCQ')\n",
      "(',', 'HCQ', 'also')\n",
      "('HCQ', 'also', 'appears')\n",
      "('also', 'appears', 'to')\n",
      "('appears', 'to', 'be')\n",
      "('to', 'be', 'associated')\n",
      "('be', 'associated', 'with')\n",
      "('associated', 'with', 'an')\n",
      "('with', 'an', 'increased')\n",
      "('an', 'increased', 'risk')\n",
      "('increased', 'risk', 'of')\n",
      "('risk', 'of', 'QT')\n",
      "('of', 'QT', 'interval')\n",
      "('QT', 'interval', 'prolongation')\n",
      "('interval', 'prolongation', 'and')\n",
      "('prolongation', 'and', 'potentially')\n",
      "('and', 'potentially', 'lethal')\n",
      "('potentially', 'lethal', 'ventricular')\n",
      "('lethal', 'ventricular', 'arrhythmias')\n",
      "('ventricular', 'arrhythmias', '.')\n",
      "('arrhythmias', '.', 'Therefore')\n",
      "('.', 'Therefore', ',')\n",
      "('Therefore', ',', 'FDA')\n",
      "(',', 'FDA', 'has')\n",
      "('FDA', 'has', 'recently')\n",
      "('has', 'recently', 'revoked')\n",
      "('recently', 'revoked', 'the')\n",
      "('revoked', 'the', 'Emergency')\n",
      "('the', 'Emergency', 'Use')\n",
      "('Emergency', 'Use', 'Authorization')\n",
      "('Use', 'Authorization', '(')\n",
      "('Authorization', '(', 'EUA')\n",
      "('(', 'EUA', ')')\n",
      "('EUA', ')', 'for')\n",
      "(')', 'for', 'emergency')\n",
      "('for', 'emergency', 'use')\n",
      "('emergency', 'use', 'of')\n",
      "('use', 'of', 'HCQ')\n",
      "('of', 'HCQ', 'and')\n",
      "('HCQ', 'and', 'chloroquine')\n",
      "('and', 'chloroquine', 'to')\n",
      "('chloroquine', 'to', 'treat')\n",
      "('to', 'treat', 'COVID-19')\n",
      "('treat', 'COVID-19', '.')\n",
      "('COVID-19', '.', 'Conversely')\n",
      "('.', 'Conversely', ',')\n",
      "('Conversely', ',', 'whether')\n",
      "(',', 'whether', 'HCQ')\n",
      "('whether', 'HCQ', 'use')\n",
      "('HCQ', 'use', 'may')\n",
      "('use', 'may', 'represent')\n",
      "('may', 'represent', 'an')\n",
      "('represent', 'an', 'effective')\n",
      "('an', 'effective', 'prophylactic')\n",
      "('effective', 'prophylactic', 'strategy')\n",
      "('prophylactic', 'strategy', 'against')\n",
      "('strategy', 'against', 'COVID-19')\n",
      "('against', 'COVID-19', 'is')\n",
      "('COVID-19', 'is', 'a')\n",
      "('is', 'a', 'separate')\n",
      "('a', 'separate', 'question')\n",
      "('separate', 'question', 'that')\n",
      "('question', 'that', 'still')\n",
      "('that', 'still', 'remains')\n",
      "('still', 'remains', 'to')\n",
      "('remains', 'to', 'be')\n",
      "('to', 'be', 'answered')\n",
      "('be', 'answered', '.')\n",
      "('answered', '.', 'In')\n",
      "('.', 'In', 'addition')\n",
      "('In', 'addition', ',')\n",
      "('addition', ',', 'relevant')\n",
      "(',', 'relevant', 'aspects')\n",
      "('relevant', 'aspects', 'regarding')\n",
      "('aspects', 'regarding', 'the')\n",
      "('regarding', 'the', 'potential')\n",
      "('the', 'potential', 'risks')\n",
      "('potential', 'risks', 'and')\n",
      "('risks', 'and', 'benefits')\n",
      "('and', 'benefits', 'of')\n",
      "('benefits', 'of', 'HCQ')\n",
      "('of', 'HCQ', 'need')\n",
      "('HCQ', 'need', 'to')\n",
      "('need', 'to', 'be')\n",
      "('to', 'be', 'clarified')\n",
      "('be', 'clarified', ',')\n",
      "('clarified', ',', 'in')\n",
      "(',', 'in', 'pursuit')\n",
      "('in', 'pursuit', 'of')\n",
      "('pursuit', 'of', 'a')\n",
      "('of', 'a', 'rational')\n",
      "('a', 'rational', 'use')\n",
      "('rational', 'use', 'of')\n",
      "('use', 'of', 'this')\n",
      "('of', 'this', 'drug')\n",
      "('this', 'drug', 'in')\n",
      "('drug', 'in', 'the')\n",
      "('in', 'the', 'COVID-19')\n",
      "('the', 'COVID-19', 'pandemic')\n",
      "('COVID-19', 'pandemic', 'era')\n",
      "('pandemic', 'era', '.')\n",
      "('era', '.', 'Three')\n",
      "('.', 'Three', 'months')\n",
      "('Three', 'months', 'have')\n",
      "('months', 'have', 'passed')\n",
      "('have', 'passed', 'since')\n",
      "('passed', 'since', 'the')\n",
      "('since', 'the', 'World')\n",
      "('the', 'World', 'Health')\n",
      "('World', 'Health', 'Organization')\n",
      "('Health', 'Organization', '(')\n",
      "('Organization', '(', 'WHO')\n",
      "('(', 'WHO', ')')\n",
      "('WHO', ')', 'declared')\n",
      "(')', 'declared', 'coronavirus')\n",
      "('declared', 'coronavirus', 'disease')\n",
      "('coronavirus', 'disease', '19')\n",
      "('disease', '19', '(')\n",
      "('19', '(', 'COVID-19')\n",
      "('(', 'COVID-19', ')')\n",
      "('COVID-19', ')', 'as')\n",
      "(')', 'as', 'a')\n",
      "('as', 'a', 'pandemic')\n",
      "('a', 'pandemic', 'on')\n",
      "('pandemic', 'on', 'March')\n",
      "('on', 'March', '11')\n",
      "('March', '11', ',')\n",
      "('11', ',', '2020')\n",
      "(',', '2020', '.')\n",
      "('2020', '.', 'Due')\n",
      "('.', 'Due', 'to')\n",
      "('Due', 'to', 'the')\n",
      "('to', 'the', 'high')\n",
      "('the', 'high', 'infection')\n",
      "('high', 'infection', 'rates')\n",
      "('infection', 'rates', 'and')\n",
      "('rates', 'and', 'occurrence')\n",
      "('and', 'occurrence', 'of')\n",
      "('occurrence', 'of', 'severe')\n",
      "('of', 'severe', 'and')\n",
      "('severe', 'and', 'fatal')\n",
      "('and', 'fatal', 'cases')\n",
      "('fatal', 'cases', ',')\n",
      "('cases', ',', 'the')\n",
      "(',', 'the', 'search')\n",
      "('the', 'search', 'for')\n",
      "('search', 'for', 'effective')\n",
      "('for', 'effective', 'drugs')\n",
      "('effective', 'drugs', 'to')\n",
      "('drugs', 'to', 'treat')\n",
      "('to', 'treat', 'and')\n",
      "('treat', 'and', 'control')\n",
      "('and', 'control', 'the')\n",
      "('control', 'the', 'COVID-19')\n",
      "('the', 'COVID-19', 'pandemic')\n",
      "('COVID-19', 'pandemic', 'has')\n",
      "('pandemic', 'has', 'been')\n",
      "('has', 'been', 'prioritized')\n",
      "('been', 'prioritized', 'by')\n",
      "('prioritized', 'by', 'health')\n",
      "('by', 'health', 'and')\n",
      "('health', 'and', 'political')\n",
      "('and', 'political', 'authorities')\n",
      "('political', 'authorities', '.')\n",
      "('authorities', '.', 'Antimalarials')\n",
      "('.', 'Antimalarials', ',')\n",
      "('Antimalarials', ',', 'well-known')\n",
      "(',', 'well-known', 'for')\n",
      "('well-known', 'for', 'their')\n",
      "('for', 'their', 'use')\n",
      "('their', 'use', 'in')\n",
      "('use', 'in', 'dermatology')\n",
      "('in', 'dermatology', 'and')\n",
      "('dermatology', 'and', 'rheumatology')\n",
      "('and', 'rheumatology', ',')\n",
      "('rheumatology', ',', 'are')\n",
      "(',', 'are', 'one')\n",
      "('are', 'one', 'of')\n",
      "('one', 'of', 'the')\n",
      "('of', 'the', 'medications')\n",
      "('the', 'medications', 'with')\n",
      "('medications', 'with', 'the')\n",
      "('with', 'the', 'largest')\n",
      "('the', 'largest', '-')\n",
      "('largest', '-', 'albeit')\n",
      "('-', 'albeit', 'limited')\n",
      "('albeit', 'limited', '-')\n",
      "('limited', '-', 'scientific')\n",
      "('-', 'scientific', 'background')\n",
      "('scientific', 'background', 'warranting')\n",
      "('background', 'warranting', 'their')\n",
      "('warranting', 'their', 'use')\n",
      "('their', 'use', 'in')\n",
      "('use', 'in', 'the')\n",
      "('in', 'the', 'COVID-19')\n",
      "('the', 'COVID-19', 'treatment')\n",
      "('COVID-19', 'treatment', 'protocols')\n",
      "('treatment', 'protocols', '.')\n",
      "('protocols', '.', 'Hydroxychloroquine')\n",
      "('.', 'Hydroxychloroquine', '(')\n",
      "('Hydroxychloroquine', '(', 'HCQ')\n",
      "('(', 'HCQ', ')')\n",
      "('HCQ', ')', 'has')\n",
      "(')', 'has', 'been')\n",
      "('has', 'been', 'used')\n",
      "('been', 'used', 'for')\n",
      "('used', 'for', 'the')\n",
      "('for', 'the', 'treatment')\n",
      "('the', 'treatment', 'of')\n",
      "('treatment', 'of', 'COVID-19')\n",
      "('of', 'COVID-19', 'in')\n",
      "('COVID-19', 'in', '50')\n",
      "('in', '50', 'patients')\n",
      "('50', 'patients', 'in')\n",
      "('patients', 'in', 'our')\n",
      "('in', 'our', 'and')\n",
      "('our', 'and', 'other')\n",
      "('and', 'other', 'centres')\n",
      "('other', 'centres', 'in')\n",
      "('centres', 'in', 'several')\n",
      "('in', 'several', 'countries')\n",
      "('several', 'countries', 'with')\n",
      "('countries', 'with', 'encouraging')\n",
      "('with', 'encouraging', 'results')\n",
      "('encouraging', 'results', '.')\n",
      "('results', '.', 'However')\n",
      "('.', 'However', ',')\n",
      "('However', ',', 'recent')\n",
      "(',', 'recent', 'studies')\n",
      "('recent', 'studies', 'disprove')\n",
      "('studies', 'disprove', 'the')\n",
      "('disprove', 'the', 'real')\n",
      "('the', 'real', 'effectiveness')\n",
      "('real', 'effectiveness', 'of')\n",
      "('effectiveness', 'of', 'this')\n",
      "('of', 'this', 'drug')\n",
      "('this', 'drug', ',')\n",
      "('drug', ',', 'either')\n",
      "(',', 'either', 'alone')\n",
      "('either', 'alone', 'or')\n",
      "('alone', 'or', 'when')\n",
      "('or', 'when', 'combined')\n",
      "('when', 'combined', 'with')\n",
      "('combined', 'with', 'macrolides')\n",
      "('with', 'macrolides', '.')\n",
      "('macrolides', '.', 'As')\n",
      "('.', 'As', 'a')\n",
      "('As', 'a', 'result')\n",
      "('a', 'result', ',')\n",
      "('result', ',', 'the')\n",
      "(',', 'the', 'World')\n",
      "('the', 'World', 'Health')\n",
      "('World', 'Health', 'Organization')\n",
      "('Health', 'Organization', 'has')\n",
      "('Organization', 'has', 'discouraged')\n",
      "('has', 'discouraged', 'the')\n",
      "('discouraged', 'the', 'use')\n",
      "('the', 'use', 'of')\n",
      "('use', 'of', 'HCQ')\n",
      "('of', 'HCQ', 'in')\n",
      "('HCQ', 'in', 'the')\n",
      "('in', 'the', 'treatment')\n",
      "('the', 'treatment', 'and')\n",
      "('treatment', 'and', 'prevention')\n",
      "('and', 'prevention', 'of')\n",
      "('prevention', 'of', 'COVID-19')\n",
      "('of', 'COVID-19', '.')\n",
      "('COVID-19', '.', 'Herein')\n",
      "('.', 'Herein', 'we')\n",
      "('Herein', 'we', 'report')\n",
      "('we', 'report', 'our')\n",
      "('report', 'our', 'experience')\n",
      "('our', 'experience', 'in')\n",
      "('experience', 'in', 'the')\n",
      "('in', 'the', 'use')\n",
      "('the', 'use', 'of')\n",
      "('use', 'of', 'hydroxychloroquine')\n",
      "('of', 'hydroxychloroquine', 'for')\n",
      "('hydroxychloroquine', 'for', 'COVID-19')\n",
      "('for', 'COVID-19', 'treatment')\n",
      "('COVID-19', 'treatment', '.')\n",
      "('treatment', '.', 'Novel')\n",
      "('.', 'Novel', 'coronavirus')\n",
      "('Novel', 'coronavirus', 'disease')\n",
      "('coronavirus', 'disease', '(')\n",
      "('disease', '(', 'COVID-19')\n",
      "('(', 'COVID-19', ')')\n",
      "('COVID-19', ')', 'is')\n",
      "(')', 'is', 'a')\n",
      "('is', 'a', 'highly')\n",
      "('a', 'highly', 'contagious')\n",
      "('highly', 'contagious', 'disease')\n",
      "('contagious', 'disease', 'caused')\n",
      "('disease', 'caused', 'by')\n",
      "('caused', 'by', 'severe')\n",
      "('by', 'severe', 'acute')\n",
      "('severe', 'acute', 'respiratory')\n",
      "('acute', 'respiratory', 'distress')\n",
      "('respiratory', 'distress', 'syndrome')\n",
      "('distress', 'syndrome', 'coronavirus-2')\n",
      "('syndrome', 'coronavirus-2', 'that')\n",
      "('coronavirus-2', 'that', 'has')\n",
      "('that', 'has', 'resulted')\n",
      "('has', 'resulted', 'in')\n",
      "('resulted', 'in', 'the')\n",
      "('in', 'the', 'current')\n",
      "('the', 'current', 'global')\n",
      "('current', 'global', 'pandemic')\n",
      "('global', 'pandemic', '.')\n",
      "('pandemic', '.', 'Currently')\n",
      "('.', 'Currently', ',')\n",
      "('Currently', ',', 'there')\n",
      "(',', 'there', 'is')\n",
      "('there', 'is', 'no')\n",
      "('is', 'no', 'available')\n",
      "('no', 'available', 'treatment')\n",
      "('available', 'treatment', 'proven')\n",
      "('treatment', 'proven', 'to')\n",
      "('proven', 'to', 'be')\n",
      "('to', 'be', 'effective')\n",
      "('be', 'effective', 'against')\n",
      "('effective', 'against', 'COVID-19')\n",
      "('against', 'COVID-19', ',')\n",
      "('COVID-19', ',', 'but')\n",
      "(',', 'but', 'multiple')\n",
      "('but', 'multiple', 'medications')\n",
      "('multiple', 'medications', ',')\n",
      "('medications', ',', 'including')\n",
      "(',', 'including', 'hydroxychloroquine')\n",
      "('including', 'hydroxychloroquine', '(')\n",
      "('hydroxychloroquine', '(', 'HCQ')\n",
      "('(', 'HCQ', ')')\n",
      "('HCQ', ')', ',')\n",
      "(')', ',', 'are')\n",
      "(',', 'are', 'used')\n",
      "('are', 'used', 'off')\n",
      "('used', 'off', 'label')\n",
      "('off', 'label', '.')\n",
      "('label', '.', 'We')\n",
      "('.', 'We', 'report')\n",
      "('We', 'report', 'the')\n",
      "('report', 'the', 'case')\n",
      "('the', 'case', 'of')\n",
      "('case', 'of', 'a')\n",
      "('of', 'a', '60-year-old')\n",
      "('a', '60-year-old', 'woman')\n",
      "('60-year-old', 'woman', 'without')\n",
      "('woman', 'without', 'any')\n",
      "('without', 'any', 'cardiac')\n",
      "('any', 'cardiac', 'history')\n",
      "('cardiac', 'history', 'who')\n",
      "('history', 'who', 'developed')\n",
      "('who', 'developed', 'right')\n",
      "('developed', 'right', 'bundle')\n",
      "('right', 'bundle', 'brunch')\n",
      "('bundle', 'brunch', 'block')\n",
      "('brunch', 'block', 'and')\n",
      "('block', 'and', 'critically')\n",
      "('and', 'critically', 'prolonged')\n",
      "('critically', 'prolonged', 'corrected')\n",
      "('prolonged', 'corrected', 'electrocardiographic')\n",
      "('corrected', 'electrocardiographic', 'QT')\n",
      "('electrocardiographic', 'QT', 'interval')\n",
      "('QT', 'interval', '(')\n",
      "('interval', '(', 'QTc')\n",
      "('(', 'QTc', '631')\n",
      "('QTc', '631', 'ms')\n",
      "('631', 'ms', ')')\n",
      "('ms', ')', 'after')\n",
      "(')', 'after', 'treatment')\n",
      "('after', 'treatment', 'for')\n",
      "('treatment', 'for', '3')\n",
      "('for', '3', 'days')\n",
      "('3', 'days', 'with')\n",
      "('days', 'with', 'HCQ')\n",
      "('with', 'HCQ', ',')\n",
      "('HCQ', ',', 'which')\n",
      "(',', 'which', 'resolved')\n",
      "('which', 'resolved', 'on')\n",
      "('resolved', 'on', 'discontinuation')\n",
      "('on', 'discontinuation', 'of')\n",
      "('discontinuation', 'of', 'the')\n",
      "('of', 'the', 'medication')\n",
      "('the', 'medication', '.')\n",
      "('medication', '.', 'This')\n",
      "('.', 'This', 'case')\n",
      "('This', 'case', 'highlights')\n",
      "('case', 'highlights', 'a')\n",
      "('highlights', 'a', 'significant')\n",
      "('a', 'significant', 'and')\n",
      "('significant', 'and', 'potentially')\n",
      "('and', 'potentially', 'life-threatening')\n",
      "('potentially', 'life-threatening', 'complication')\n",
      "('life-threatening', 'complication', 'of')\n",
      "('complication', 'of', 'HCQ')\n",
      "('of', 'HCQ', 'use')\n",
      "('HCQ', 'use', 'Malaria')\n",
      "('use', 'Malaria', 'is')\n",
      "('Malaria', 'is', 'a')\n",
      "('is', 'a', 'threat')\n",
      "('a', 'threat', 'to')\n",
      "('threat', 'to', 'human')\n",
      "('to', 'human', 'mankind')\n",
      "('human', 'mankind', 'and')\n",
      "('mankind', 'and', 'kills')\n",
      "('and', 'kills', 'about')\n",
      "('kills', 'about', 'half')\n",
      "('about', 'half', 'a')\n",
      "('half', 'a', 'million')\n",
      "('a', 'million', 'people')\n",
      "('million', 'people', 'every')\n",
      "('people', 'every', 'year')\n",
      "('every', 'year', '.')\n",
      "('year', '.', 'On')\n",
      "('.', 'On', 'the')\n",
      "('On', 'the', 'other')\n",
      "('the', 'other', 'hand')\n",
      "('other', 'hand', ',')\n",
      "('hand', ',', 'COVID-19')\n",
      "(',', 'COVID-19', 'resulted')\n",
      "('COVID-19', 'resulted', 'in')\n",
      "('resulted', 'in', 'several')\n",
      "('in', 'several', 'hundred')\n",
      "('several', 'hundred', 'thousand')\n",
      "('hundred', 'thousand', 'deaths')\n",
      "('thousand', 'deaths', 'since')\n",
      "('deaths', 'since', 'December')\n",
      "('since', 'December', '2019')\n",
      "('December', '2019', 'and')\n",
      "('2019', 'and', 'remains')\n",
      "('and', 'remains', 'without')\n",
      "('remains', 'without', 'an')\n",
      "('without', 'an', 'efficient')\n",
      "('an', 'efficient', 'and')\n",
      "('efficient', 'and', 'safe')\n",
      "('and', 'safe', 'treatment')\n",
      "('safe', 'treatment', '.')\n",
      "('treatment', '.', 'The')\n",
      "('.', 'The', 'antimalarials')\n",
      "('The', 'antimalarials', 'chloroquine')\n",
      "('antimalarials', 'chloroquine', '(')\n",
      "('chloroquine', '(', 'CQ')\n",
      "('(', 'CQ', ')')\n",
      "('CQ', ')', 'and')\n",
      "(')', 'and', 'its')\n",
      "('and', 'its', 'analogue')\n",
      "('its', 'analogue', ',')\n",
      "('analogue', ',', 'hydroxychloroquine')\n",
      "(',', 'hydroxychloroquine', '(')\n",
      "('hydroxychloroquine', '(', 'HCQ')\n",
      "('(', 'HCQ', ')')\n",
      "('HCQ', ')', ',')\n",
      "(')', ',', 'have')\n",
      "(',', 'have', 'been')\n",
      "('have', 'been', 'tested')\n",
      "('been', 'tested', 'for')\n",
      "('tested', 'for', 'COVID-19')\n",
      "('for', 'COVID-19', 'treatment')\n",
      "('COVID-19', 'treatment', ',')\n",
      "('treatment', ',', 'and')\n",
      "(',', 'and', 'several')\n",
      "('and', 'several', 'conflicting')\n",
      "('several', 'conflicting', 'evidence')\n",
      "('conflicting', 'evidence', 'has')\n",
      "('evidence', 'has', 'been')\n",
      "('has', 'been', 'obtained')\n",
      "('been', 'obtained', '.')\n",
      "('obtained', '.', 'Therefore')\n",
      "('.', 'Therefore', ',')\n",
      "('Therefore', ',', 'the')\n",
      "(',', 'the', 'aim')\n",
      "('the', 'aim', 'of')\n",
      "('aim', 'of', 'this')\n",
      "('of', 'this', 'review')\n",
      "('this', 'review', 'was')\n",
      "('review', 'was', 'to')\n",
      "('was', 'to', 'summarize')\n",
      "('to', 'summarize', 'the')\n",
      "('summarize', 'the', 'evidence')\n",
      "('the', 'evidence', 'regarding')\n",
      "('evidence', 'regarding', 'action')\n",
      "('regarding', 'action', 'mechanisms')\n",
      "('action', 'mechanisms', 'of')\n",
      "('mechanisms', 'of', 'these')\n",
      "('of', 'these', 'compounds')\n",
      "('these', 'compounds', 'against')\n",
      "('compounds', 'against', 'Plasmodium')\n",
      "('against', 'Plasmodium', 'and')\n",
      "('Plasmodium', 'and', 'SARS-CoV-2')\n",
      "('and', 'SARS-CoV-2', 'infection')\n",
      "('SARS-CoV-2', 'infection', ',')\n",
      "('infection', ',', 'together')\n",
      "(',', 'together', 'with')\n",
      "('together', 'with', 'cytometry')\n",
      "('with', 'cytometry', 'applications')\n",
      "('cytometry', 'applications', '.')\n",
      "('applications', '.', 'CQ')\n",
      "('.', 'CQ', 'and')\n",
      "('CQ', 'and', 'HCQ')\n",
      "('and', 'HCQ', 'act')\n",
      "('HCQ', 'act', 'on')\n",
      "('act', 'on', 'the')\n",
      "('on', 'the', 'renin')\n",
      "('the', 'renin', 'angiotensin')\n",
      "('renin', 'angiotensin', 'system')\n",
      "('angiotensin', 'system', ',')\n",
      "('system', ',', 'with')\n",
      "(',', 'with', 'possible')\n",
      "('with', 'possible', 'implications')\n",
      "('possible', 'implications', 'on')\n",
      "('implications', 'on', 'the')\n",
      "('on', 'the', 'cardiorespiratory')\n",
      "('the', 'cardiorespiratory', 'system')\n",
      "('cardiorespiratory', 'system', '.')\n",
      "('system', '.', 'In')\n",
      "('.', 'In', 'this')\n",
      "('In', 'this', 'context')\n",
      "('this', 'context', ',')\n",
      "('context', ',', 'flow')\n",
      "(',', 'flow', 'and')\n",
      "('flow', 'and', 'image')\n",
      "('and', 'image', 'cytometry')\n",
      "('image', 'cytometry', 'emerge')\n",
      "('cytometry', 'emerge', 'as')\n",
      "('emerge', 'as', 'powerful')\n",
      "('as', 'powerful', 'technologies')\n",
      "('powerful', 'technologies', 'to')\n",
      "('technologies', 'to', 'investigate')\n",
      "('to', 'investigate', 'the')\n",
      "('investigate', 'the', 'mechanism')\n",
      "('the', 'mechanism', 'of')\n",
      "('mechanism', 'of', 'therapeutic')\n",
      "('of', 'therapeutic', 'candidates')\n",
      "('therapeutic', 'candidates', ',')\n",
      "('candidates', ',', 'as')\n",
      "(',', 'as', 'well')\n",
      "('as', 'well', 'as')\n",
      "('well', 'as', 'for')\n",
      "('as', 'for', 'the')\n",
      "('for', 'the', 'identification')\n",
      "('the', 'identification', 'of')\n",
      "('identification', 'of', 'the')\n",
      "('of', 'the', 'immune')\n",
      "('the', 'immune', 'response')\n",
      "('immune', 'response', 'and')\n",
      "('response', 'and', 'prognostics')\n",
      "('and', 'prognostics', 'of')\n",
      "('prognostics', 'of', 'disease')\n",
      "('of', 'disease', 'severity')\n",
      "('disease', 'severity', '.')\n",
      "('severity', '.', 'Data')\n",
      "('.', 'Data', 'from')\n",
      "('Data', 'from', 'the')\n",
      "('from', 'the', 'large')\n",
      "('the', 'large', 'randomized')\n",
      "('large', 'randomized', 'trials')\n",
      "('randomized', 'trials', 'support')\n",
      "('trials', 'support', 'the')\n",
      "('support', 'the', 'conclusion')\n",
      "('the', 'conclusion', 'that')\n",
      "('conclusion', 'that', 'CQ')\n",
      "('that', 'CQ', 'and')\n",
      "('CQ', 'and', 'HCQ')\n",
      "('and', 'HCQ', 'do')\n",
      "('HCQ', 'do', 'not')\n",
      "('do', 'not', 'provide')\n",
      "('not', 'provide', 'any')\n",
      "('provide', 'any', 'clinical')\n",
      "('any', 'clinical', 'beneficial')\n",
      "('clinical', 'beneficial', 'in')\n",
      "('beneficial', 'in', 'disease')\n",
      "('in', 'disease', 'severity')\n",
      "('disease', 'severity', 'and')\n",
      "('severity', 'and', 'progression')\n",
      "('and', 'progression', 'in')\n",
      "('progression', 'in', 'SARS-CoV-2')\n",
      "('in', 'SARS-CoV-2', 'patients')\n",
      "('SARS-CoV-2', 'patients', ',')\n",
      "('patients', ',', 'as')\n",
      "(',', 'as', 'well')\n",
      "('as', 'well', 'as')\n",
      "('well', 'as', ',')\n",
      "('as', ',', 'do')\n",
      "(',', 'do', 'not')\n",
      "('do', 'not', 'present')\n",
      "('not', 'present', 'any')\n",
      "('present', 'any', 'solid')\n",
      "('any', 'solid', 'evidence')\n",
      "('solid', 'evidence', 'of')\n",
      "('evidence', 'of', 'increased')\n",
      "('of', 'increased', 'serious')\n",
      "('increased', 'serious', 'side')\n",
      "('serious', 'side', 'effects')\n",
      "('side', 'effects', '.')\n",
      "('effects', '.', 'These')\n",
      "('.', 'These', 'drugs')\n",
      "('These', 'drugs', 'are')\n",
      "('drugs', 'are', 'safe')\n",
      "('are', 'safe', 'and')\n",
      "('safe', 'and', 'effective')\n",
      "('and', 'effective', 'antimalarials')\n",
      "('effective', 'antimalarials', 'agents')\n",
      "('antimalarials', 'agents', ',')\n",
      "('agents', ',', 'but')\n",
      "(',', 'but', 'in')\n",
      "('but', 'in', 'SARS-CoV-2')\n",
      "('in', 'SARS-CoV-2', 'patients')\n",
      "('SARS-CoV-2', 'patients', ',')\n",
      "('patients', ',', 'they')\n",
      "(',', 'they', 'need')\n",
      "('they', 'need', 'further')\n",
      "('need', 'further', 'studies')\n",
      "('further', 'studies', 'in')\n",
      "('studies', 'in', 'the')\n",
      "('in', 'the', 'context')\n",
      "('the', 'context', 'of')\n",
      "('context', 'of', 'a')\n",
      "('of', 'a', 'clinical')\n",
      "('a', 'clinical', 'trials')\n",
      "('clinical', 'trials', '.')\n",
      "('trials', '.', 'Amid')\n",
      "('.', 'Amid', 'controversial')\n",
      "('Amid', 'controversial', 'reports')\n",
      "('controversial', 'reports', 'that')\n",
      "('reports', 'that', 'COVID-19')\n",
      "('that', 'COVID-19', 'can')\n",
      "('COVID-19', 'can', 'be')\n",
      "('can', 'be', 'treated')\n",
      "('be', 'treated', 'with')\n",
      "('treated', 'with', 'a')\n",
      "('with', 'a', 'combination')\n",
      "('a', 'combination', 'of')\n",
      "('combination', 'of', 'the')\n",
      "('of', 'the', 'antimalarial')\n",
      "('the', 'antimalarial', 'drug')\n",
      "('antimalarial', 'drug', 'hydroxychloroquine')\n",
      "('drug', 'hydroxychloroquine', '(')\n",
      "('hydroxychloroquine', '(', 'HCQ')\n",
      "('(', 'HCQ', ')')\n",
      "('HCQ', ')', 'and')\n",
      "(')', 'and', 'the')\n",
      "('and', 'the', 'antibiotic')\n",
      "('the', 'antibiotic', 'azithromycin')\n",
      "('antibiotic', 'azithromycin', '(')\n",
      "('azithromycin', '(', 'AZI')\n",
      "('(', 'AZI', ')')\n",
      "('AZI', ')', ',')\n",
      "(')', ',', 'a')\n",
      "(',', 'a', 'clinical')\n",
      "('a', 'clinical', 'trial')\n",
      "('clinical', 'trial', '(')\n",
      "('trial', '(', 'ONCOCOVID')\n",
      "('(', 'ONCOCOVID', ',')\n",
      "('ONCOCOVID', ',', 'NCT04341207')\n",
      "(',', 'NCT04341207', ')')\n",
      "('NCT04341207', ')', 'was')\n",
      "(')', 'was', 'launched')\n",
      "('was', 'launched', 'at')\n",
      "('launched', 'at', 'Gustave')\n",
      "('at', 'Gustave', 'Roussy')\n",
      "('Gustave', 'Roussy', 'Cancer')\n",
      "('Roussy', 'Cancer', 'Campus')\n",
      "('Cancer', 'Campus', 'to')\n",
      "('Campus', 'to', 'investigate')\n",
      "('to', 'investigate', 'the')\n",
      "('investigate', 'the', 'utility')\n",
      "('the', 'utility', 'of')\n",
      "('utility', 'of', 'this')\n",
      "('of', 'this', 'combination')\n",
      "('this', 'combination', 'therapy')\n",
      "('combination', 'therapy', 'in')\n",
      "('therapy', 'in', 'cancer')\n",
      "('in', 'cancer', 'patients')\n",
      "('cancer', 'patients', '.')\n",
      "('patients', '.', 'In')\n",
      "('.', 'In', 'this')\n",
      "('In', 'this', 'preclinical')\n",
      "('this', 'preclinical', 'study')\n",
      "('preclinical', 'study', ',')\n",
      "('study', ',', 'we')\n",
      "(',', 'we', 'investigated')\n",
      "('we', 'investigated', 'whether')\n",
      "('investigated', 'whether', 'the')\n",
      "('whether', 'the', 'combination')\n",
      "('the', 'combination', 'of')\n",
      "('combination', 'of', 'HCQ+AZI')\n",
      "('of', 'HCQ+AZI', 'would')\n",
      "('HCQ+AZI', 'would', 'be')\n",
      "('would', 'be', 'compatible')\n",
      "('be', 'compatible', 'with')\n",
      "('compatible', 'with', 'the')\n",
      "('with', 'the', 'therapeutic')\n",
      "('the', 'therapeutic', 'induction')\n",
      "('therapeutic', 'induction', 'of')\n",
      "('induction', 'of', 'anticancer')\n",
      "('of', 'anticancer', 'immune')\n",
      "('anticancer', 'immune', 'responses')\n",
      "('immune', 'responses', '.')\n",
      "('responses', '.', 'For')\n",
      "('.', 'For', 'this')\n",
      "('For', 'this', ',')\n",
      "('this', ',', 'we')\n",
      "(',', 'we', 'used')\n",
      "('we', 'used', 'doses')\n",
      "('used', 'doses', 'of')\n",
      "('doses', 'of', 'HCQ')\n",
      "('of', 'HCQ', 'and')\n",
      "('HCQ', 'and', 'AZI')\n",
      "('and', 'AZI', 'that')\n",
      "('AZI', 'that', 'affect')\n",
      "('that', 'affect', 'whole-body')\n",
      "('affect', 'whole-body', 'physiology')\n",
      "('whole-body', 'physiology', '(')\n",
      "('physiology', '(', 'as')\n",
      "('(', 'as', 'indicated')\n",
      "('as', 'indicated', 'by')\n",
      "('indicated', 'by', 'a')\n",
      "('by', 'a', 'partial')\n",
      "('a', 'partial', 'blockade')\n",
      "('partial', 'blockade', 'in')\n",
      "('blockade', 'in', 'cardiac')\n",
      "('in', 'cardiac', 'and')\n",
      "('cardiac', 'and', 'hepatic')\n",
      "('and', 'hepatic', 'autophagic')\n",
      "('hepatic', 'autophagic', 'flux')\n",
      "('autophagic', 'flux', 'for')\n",
      "('flux', 'for', 'HCQ')\n",
      "('for', 'HCQ', 'and')\n",
      "('HCQ', 'and', 'a')\n",
      "('and', 'a', 'reduction')\n",
      "('a', 'reduction', 'in')\n",
      "('reduction', 'in', 'body')\n",
      "('in', 'body', 'weight')\n",
      "('body', 'weight', 'for')\n",
      "('weight', 'for', 'AZI')\n",
      "('for', 'AZI', ')')\n",
      "('AZI', ')', ',')\n",
      "(')', ',', 'showing')\n",
      "(',', 'showing', 'that')\n",
      "('showing', 'that', 'their')\n",
      "('that', 'their', 'combined')\n",
      "('their', 'combined', 'administration')\n",
      "('combined', 'administration', 'did')\n",
      "('administration', 'did', 'not')\n",
      "('did', 'not', 'interfere')\n",
      "('not', 'interfere', 'with')\n",
      "('interfere', 'with', 'tumor')\n",
      "('with', 'tumor', 'growth')\n",
      "('tumor', 'growth', 'control')\n",
      "('growth', 'control', 'induced')\n",
      "('control', 'induced', 'by')\n",
      "('induced', 'by', 'the')\n",
      "('by', 'the', 'immunogenic')\n",
      "('the', 'immunogenic', 'cell')\n",
      "('immunogenic', 'cell', 'death')\n",
      "('cell', 'death', 'inducer')\n",
      "('death', 'inducer', 'oxaliplatin')\n",
      "('inducer', 'oxaliplatin', '.')\n",
      "('oxaliplatin', '.', 'Moreover')\n",
      "('.', 'Moreover', ',')\n",
      "('Moreover', ',', 'the')\n",
      "(',', 'the', 'HCQ+AZI')\n",
      "('the', 'HCQ+AZI', 'combination')\n",
      "('HCQ+AZI', 'combination', 'did')\n",
      "('combination', 'did', 'not')\n",
      "('did', 'not', 'affect')\n",
      "('not', 'affect', 'the')\n",
      "('affect', 'the', 'capacity')\n",
      "('the', 'capacity', 'of')\n",
      "('capacity', 'of', 'a')\n",
      "('of', 'a', 'curative')\n",
      "('a', 'curative', 'regimen')\n",
      "('curative', 'regimen', '(')\n",
      "('regimen', '(', 'cisplatin')\n",
      "('(', 'cisplatin', '+')\n",
      "('cisplatin', '+', 'crizotinib')\n",
      "('+', 'crizotinib', '+')\n",
      "('crizotinib', '+', 'PD-1')\n",
      "('+', 'PD-1', 'blockade')\n",
      "('PD-1', 'blockade', ')')\n",
      "('blockade', ')', 'to')\n",
      "(')', 'to', 'eradicate')\n",
      "('to', 'eradicate', 'established')\n",
      "('eradicate', 'established', 'orthotopic')\n",
      "('established', 'orthotopic', 'lung')\n",
      "('orthotopic', 'lung', 'cancers')\n",
      "('lung', 'cancers', 'in')\n",
      "('cancers', 'in', 'mice')\n",
      "('in', 'mice', '.')\n",
      "('mice', '.', 'In')\n",
      "('.', 'In', 'conclusion')\n",
      "('In', 'conclusion', ',')\n",
      "('conclusion', ',', 'it')\n",
      "(',', 'it', 'appears')\n",
      "('it', 'appears', 'that')\n",
      "('appears', 'that', 'HCQ+AZI')\n",
      "('that', 'HCQ+AZI', 'does')\n",
      "('HCQ+AZI', 'does', 'not')\n",
      "('does', 'not', 'interfere')\n",
      "('not', 'interfere', 'with')\n",
      "('interfere', 'with', 'the')\n",
      "('with', 'the', 'therapeutic')\n",
      "('the', 'therapeutic', 'induction')\n",
      "('therapeutic', 'induction', 'of')\n",
      "('induction', 'of', 'therapeutic')\n",
      "('of', 'therapeutic', 'anticancer')\n",
      "('therapeutic', 'anticancer', 'immune')\n",
      "('anticancer', 'immune', 'responses')\n",
      "('immune', 'responses', '.')\n",
      "('responses', '.', 'On')\n",
      "('.', 'On', '3')\n",
      "('On', '3', 'March')\n",
      "('3', 'March', '2020')\n",
      "('March', '2020', ',')\n",
      "('2020', ',', 'the')\n",
      "(',', 'the', 'document')\n",
      "('the', 'document', \"'Drug\")\n",
      "('document', \"'Drug\", 'treatment')\n",
      "(\"'Drug\", 'treatment', 'options')\n",
      "('treatment', 'options', 'for')\n",
      "('options', 'for', 'patients')\n",
      "('for', 'patients', 'with')\n",
      "('patients', 'with', 'COVID-19')\n",
      "('with', 'COVID-19', '(')\n",
      "('COVID-19', '(', 'infections')\n",
      "('(', 'infections', 'with')\n",
      "('infections', 'with', 'SARS-CoV-2')\n",
      "('with', 'SARS-CoV-2', ')')\n",
      "('SARS-CoV-2', ')', \"'\")\n",
      "(')', \"'\", 'was')\n",
      "(\"'\", 'was', 'published')\n",
      "('was', 'published', 'on')\n",
      "('published', 'on', 'the')\n",
      "('on', 'the', 'website')\n",
      "('the', 'website', 'of')\n",
      "('website', 'of', 'the')\n",
      "('of', 'the', 'Dutch')\n",
      "('the', 'Dutch', 'Working')\n",
      "('Dutch', 'Working', 'Party')\n",
      "('Working', 'Party', 'on')\n",
      "('Party', 'on', 'Antibiotic')\n",
      "('on', 'Antibiotic', 'Policy')\n",
      "('Antibiotic', 'Policy', '(')\n",
      "('Policy', '(', 'Stichting')\n",
      "('(', 'Stichting', 'Werkgroep')\n",
      "('Stichting', 'Werkgroep', 'Antibioticabeleid')\n",
      "('Werkgroep', 'Antibioticabeleid', ',')\n",
      "('Antibioticabeleid', ',', 'SWAB')\n",
      "(',', 'SWAB', ')')\n",
      "('SWAB', ')', 'Based')\n",
      "(')', 'Based', 'on')\n",
      "('Based', 'on', 'a')\n",
      "('on', 'a', '7-step')\n",
      "('a', '7-step', 'analysis')\n",
      "('7-step', 'analysis', 'of')\n",
      "('analysis', 'of', 'the')\n",
      "('of', 'the', 'literature')\n",
      "('the', 'literature', ',')\n",
      "('literature', ',', 'hydroxychloroquine')\n",
      "(',', 'hydroxychloroquine', '(')\n",
      "('hydroxychloroquine', '(', 'HCQ')\n",
      "('(', 'HCQ', ')')\n",
      "('HCQ', ')', 'and')\n",
      "(')', 'and', 'chloroquine')\n",
      "('and', 'chloroquine', '(')\n",
      "('chloroquine', '(', 'CQ')\n",
      "('(', 'CQ', ')')\n",
      "('CQ', ')', 'were')\n",
      "(')', 'were', 'initially')\n",
      "('were', 'initially', 'included')\n",
      "('initially', 'included', 'in')\n",
      "('included', 'in', 'the')\n",
      "('in', 'the', 'SWAB')\n",
      "('the', 'SWAB', 'document')\n",
      "('SWAB', 'document', 'as')\n",
      "('document', 'as', 'possible')\n",
      "('as', 'possible', 'drug')\n",
      "('possible', 'drug', 'treatments')\n",
      "('drug', 'treatments', 'for')\n",
      "('treatments', 'for', 'hospitalized')\n",
      "('for', 'hospitalized', 'adult')\n",
      "('hospitalized', 'adult', 'COVID-19')\n",
      "('adult', 'COVID-19', 'patients')\n",
      "('COVID-19', 'patients', 'However')\n",
      "('patients', 'However', ',')\n",
      "('However', ',', 'recent')\n",
      "(',', 'recent', 'weeks')\n",
      "('recent', 'weeks', 'have')\n",
      "('weeks', 'have', 'seen')\n",
      "('have', 'seen', 'the')\n",
      "('seen', 'the', 'publication')\n",
      "('the', 'publication', 'of')\n",
      "('publication', 'of', 'the')\n",
      "('of', 'the', 'results')\n",
      "('the', 'results', 'of')\n",
      "('results', 'of', 'various')\n",
      "('of', 'various', 'studies')\n",
      "('various', 'studies', 'into')\n",
      "('studies', 'into', 'the')\n",
      "('into', 'the', 'effectiveness')\n",
      "('the', 'effectiveness', 'of')\n",
      "('effectiveness', 'of', 'treatment')\n",
      "('of', 'treatment', 'with')\n",
      "('treatment', 'with', 'HCQ')\n",
      "('with', 'HCQ', 'and')\n",
      "('HCQ', 'and', 'CQ')\n",
      "('and', 'CQ', 'in')\n",
      "('CQ', 'in', 'patients')\n",
      "('in', 'patients', 'with')\n",
      "('patients', 'with', 'COVID-19')\n",
      "('with', 'COVID-19', 'On')\n",
      "('COVID-19', 'On', 'the')\n",
      "('On', 'the', 'basis')\n",
      "('the', 'basis', 'of')\n",
      "('basis', 'of', 'these')\n",
      "('of', 'these', 'results')\n",
      "('these', 'results', ',')\n",
      "('results', ',', 'we')\n",
      "(',', 'we', 'conclude')\n",
      "('we', 'conclude', 'that')\n",
      "('conclude', 'that', 'there')\n",
      "('that', 'there', 'is')\n",
      "('there', 'is', 'insufficient')\n",
      "('is', 'insufficient', 'evidence')\n",
      "('insufficient', 'evidence', 'to')\n",
      "('evidence', 'to', 'consider')\n",
      "('to', 'consider', 'HCQ')\n",
      "('consider', 'HCQ', 'and')\n",
      "('HCQ', 'and', 'CQ')\n",
      "('and', 'CQ', 'as')\n",
      "('CQ', 'as', 'meaningful')\n",
      "('as', 'meaningful', 'treatment')\n",
      "('meaningful', 'treatment', 'options')\n",
      "('treatment', 'options', 'in')\n",
      "('options', 'in', 'patients')\n",
      "('in', 'patients', 'with')\n",
      "('patients', 'with', 'COVID-19')\n",
      "('with', 'COVID-19', 'Clinically')\n",
      "('COVID-19', 'Clinically', 'relevant')\n",
      "('Clinically', 'relevant', 'QTc')\n",
      "('relevant', 'QTc', 'prolongation')\n",
      "('QTc', 'prolongation', 'occurs')\n",
      "('prolongation', 'occurs', 'in')\n",
      "('occurs', 'in', 'at')\n",
      "('in', 'at', 'least')\n",
      "('at', 'least', '1')\n",
      "('least', '1', 'in')\n",
      "('1', 'in', '10')\n",
      "('in', '10', 'COVID-19')\n",
      "('10', 'COVID-19', 'patients')\n",
      "('COVID-19', 'patients', 'treated')\n",
      "('patients', 'treated', 'with')\n",
      "('treated', 'with', 'HCQ')\n",
      "('with', 'HCQ', 'or')\n",
      "('HCQ', 'or', 'HQ')\n"
     ]
    }
   ],
   "source": [
    "import nltk\n",
    "from nltk.util import ngrams\n",
    "sampleText=cleantext\n",
    "NGRAMS3=ngrams(sequence=nltk.word_tokenize(cleantext), n=3)\n",
    "for grams in NGRAMS3:\n",
    "    print(grams)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [],
   "source": [
    "l3=generate_ngrams(cleantext,3)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[['The', 'ongoing', 'pandemic'],\n",
       " ['ongoing', 'pandemic', 'of'],\n",
       " ['pandemic', 'of', 'coronavirus'],\n",
       " ['of', 'coronavirus', 'disease'],\n",
       " ['coronavirus', 'disease', '2019'],\n",
       " ['disease', '2019', '(COVID-19)'],\n",
       " ['2019', '(COVID-19)', 'caused'],\n",
       " ['(COVID-19)', 'caused', 'by'],\n",
       " ['caused', 'by', 'the'],\n",
       " ['by', 'the', 'severe'],\n",
       " ['the', 'severe', 'acute'],\n",
       " ['severe', 'acute', 'respiratory'],\n",
       " ['acute', 'respiratory', 'syndrome'],\n",
       " ['respiratory', 'syndrome', 'coronavirus'],\n",
       " ['syndrome', 'coronavirus', '2'],\n",
       " ['coronavirus', '2', '(SARS-CoV-2)'],\n",
       " ['2', '(SARS-CoV-2)', 'poses'],\n",
       " ['(SARS-CoV-2)', 'poses', 'a'],\n",
       " ['poses', 'a', 'serious'],\n",
       " ['a', 'serious', 'threat'],\n",
       " ['serious', 'threat', 'to'],\n",
       " ['threat', 'to', 'global'],\n",
       " ['to', 'global', 'public'],\n",
       " ['global', 'public', 'health'],\n",
       " ['public', 'health', 'and'],\n",
       " ['health', 'and', 'there'],\n",
       " ['and', 'there', 'is'],\n",
       " ['there', 'is', 'currently'],\n",
       " ['is', 'currently', 'no'],\n",
       " ['currently', 'no', 'effective'],\n",
       " ['no', 'effective', 'antiviral'],\n",
       " ['effective', 'antiviral', 'therapy'],\n",
       " ['antiviral', 'therapy', 'It'],\n",
       " ['therapy', 'It', 'has'],\n",
       " ['It', 'has', 'been'],\n",
       " ['has', 'been', 'suggested'],\n",
       " ['been', 'suggested', 'that'],\n",
       " ['suggested', 'that', 'Chloroquine'],\n",
       " ['that', 'Chloroquine', '(CQ)'],\n",
       " ['Chloroquine', '(CQ)', 'and'],\n",
       " ['(CQ)', 'and', 'hydroxychloroquine'],\n",
       " ['and', 'hydroxychloroquine', '(HCQ),'],\n",
       " ['hydroxychloroquine', '(HCQ),', 'which'],\n",
       " ['(HCQ),', 'which', 'were'],\n",
       " ['which', 'were', 'primarily'],\n",
       " ['were', 'primarily', 'employed'],\n",
       " ['primarily', 'employed', 'as'],\n",
       " ['employed', 'as', 'prophylaxis'],\n",
       " ['as', 'prophylaxis', 'and'],\n",
       " ['prophylaxis', 'and', 'treatment'],\n",
       " ['and', 'treatment', 'for'],\n",
       " ['treatment', 'for', 'malaria,'],\n",
       " ['for', 'malaria,', 'could'],\n",
       " ['malaria,', 'could', 'be'],\n",
       " ['could', 'be', 'used'],\n",
       " ['be', 'used', 'to'],\n",
       " ['used', 'to', 'treat'],\n",
       " ['to', 'treat', 'COVID-19'],\n",
       " ['treat', 'COVID-19', 'CQ'],\n",
       " ['COVID-19', 'CQ', 'and'],\n",
       " ['CQ', 'and', 'HCQ'],\n",
       " ['and', 'HCQ', 'may'],\n",
       " ['HCQ', 'may', 'be'],\n",
       " ['may', 'be', 'potential'],\n",
       " ['be', 'potential', 'inhibitors'],\n",
       " ['potential', 'inhibitors', 'of'],\n",
       " ['inhibitors', 'of', 'SARS-CoV-2'],\n",
       " ['of', 'SARS-CoV-2', 'entry'],\n",
       " ['SARS-CoV-2', 'entry', 'into'],\n",
       " ['entry', 'into', 'host'],\n",
       " ['into', 'host', 'cells,'],\n",
       " ['host', 'cells,', 'which'],\n",
       " ['cells,', 'which', 'is'],\n",
       " ['which', 'is', 'mediated'],\n",
       " ['is', 'mediated', 'via'],\n",
       " ['mediated', 'via', 'the'],\n",
       " ['via', 'the', 'angiotensin-converting'],\n",
       " ['the', 'angiotensin-converting', 'enzyme'],\n",
       " ['angiotensin-converting', 'enzyme', '2'],\n",
       " ['enzyme', '2', '(ACE2),'],\n",
       " ['2', '(ACE2),', 'and'],\n",
       " ['(ACE2),', 'and', 'may'],\n",
       " ['and', 'may', 'also'],\n",
       " ['may', 'also', 'inhibit'],\n",
       " ['also', 'inhibit', 'subsequent'],\n",
       " ['inhibit', 'subsequent', 'intracellular'],\n",
       " ['subsequent', 'intracellular', 'processes'],\n",
       " ['intracellular', 'processes', 'which'],\n",
       " ['processes', 'which', 'lead'],\n",
       " ['which', 'lead', 'to'],\n",
       " ['lead', 'to', 'COVID-19,'],\n",
       " ['to', 'COVID-19,', 'including'],\n",
       " ['COVID-19,', 'including', 'damage'],\n",
       " ['including', 'damage', 'to'],\n",
       " ['damage', 'to', 'the'],\n",
       " ['to', 'the', 'cardiovascular'],\n",
       " ['the', 'cardiovascular', 'system'],\n",
       " ['cardiovascular', 'system', 'However,'],\n",
       " ['system', 'However,', 'paradoxically,'],\n",
       " ['However,', 'paradoxically,', 'CQ'],\n",
       " ['paradoxically,', 'CQ', 'and'],\n",
       " ['CQ', 'and', 'HCQ'],\n",
       " ['and', 'HCQ', 'have'],\n",
       " ['HCQ', 'have', 'also'],\n",
       " ['have', 'also', 'been'],\n",
       " ['also', 'been', 'reported'],\n",
       " ['been', 'reported', 'to'],\n",
       " ['reported', 'to', 'cause'],\n",
       " ['to', 'cause', 'damage'],\n",
       " ['cause', 'damage', 'to'],\n",
       " ['damage', 'to', 'the'],\n",
       " ['to', 'the', 'cardiovascular'],\n",
       " ['the', 'cardiovascular', 'system'],\n",
       " ['cardiovascular', 'system', 'In'],\n",
       " ['system', 'In', 'this'],\n",
       " ['In', 'this', 'review,'],\n",
       " ['this', 'review,', 'we'],\n",
       " ['review,', 'we', 'provide'],\n",
       " ['we', 'provide', 'a'],\n",
       " ['provide', 'a', 'critical'],\n",
       " ['a', 'critical', 'examination'],\n",
       " ['critical', 'examination', 'of'],\n",
       " ['examination', 'of', 'the'],\n",
       " ['of', 'the', 'published'],\n",
       " ['the', 'published', 'evidence'],\n",
       " ['published', 'evidence', 'CQ'],\n",
       " ['evidence', 'CQ', 'and'],\n",
       " ['CQ', 'and', 'HCQ'],\n",
       " ['and', 'HCQ', 'could'],\n",
       " ['HCQ', 'could', 'potentially'],\n",
       " ['could', 'potentially', 'be'],\n",
       " ['potentially', 'be', 'useful'],\n",
       " ['be', 'useful', 'drugs'],\n",
       " ['useful', 'drugs', 'in'],\n",
       " ['drugs', 'in', 'the'],\n",
       " ['in', 'the', 'treatment'],\n",
       " ['the', 'treatment', 'of'],\n",
       " ['treatment', 'of', 'COVID-19'],\n",
       " ['of', 'COVID-19', 'and'],\n",
       " ['COVID-19', 'and', 'other'],\n",
       " ['and', 'other', 'ACE2'],\n",
       " ['other', 'ACE2', 'involved'],\n",
       " ['ACE2', 'involved', 'virus'],\n",
       " ['involved', 'virus', 'infections,'],\n",
       " ['virus', 'infections,', 'but'],\n",
       " ['infections,', 'but', 'the'],\n",
       " ['but', 'the', 'antiviral'],\n",
       " ['the', 'antiviral', 'effects'],\n",
       " ['antiviral', 'effects', 'of'],\n",
       " ['effects', 'of', 'CQ'],\n",
       " ['of', 'CQ', 'and'],\n",
       " ['CQ', 'and', 'HCQ'],\n",
       " ['and', 'HCQ', 'need'],\n",
       " ['HCQ', 'need', 'to'],\n",
       " ['need', 'to', 'be'],\n",
       " ['to', 'be', 'tested'],\n",
       " ['be', 'tested', 'in'],\n",
       " ['tested', 'in', 'more'],\n",
       " ['in', 'more', 'well-designed'],\n",
       " ['more', 'well-designed', 'clinical'],\n",
       " ['well-designed', 'clinical', 'randomized'],\n",
       " ['clinical', 'randomized', 'studies'],\n",
       " ['randomized', 'studies', 'and'],\n",
       " ['studies', 'and', 'their'],\n",
       " ['and', 'their', 'actions'],\n",
       " ['their', 'actions', 'on'],\n",
       " ['actions', 'on', 'the'],\n",
       " ['on', 'the', 'cardiovascular'],\n",
       " ['the', 'cardiovascular', 'system'],\n",
       " ['cardiovascular', 'system', 'need'],\n",
       " ['system', 'need', 'to'],\n",
       " ['need', 'to', 'be'],\n",
       " ['to', 'be', 'further'],\n",
       " ['be', 'further', 'elucidated'],\n",
       " ['further', 'elucidated', 'However,'],\n",
       " ['elucidated', 'However,', 'even'],\n",
       " ['However,', 'even', 'if'],\n",
       " ['even', 'if', 'it'],\n",
       " ['if', 'it', 'were'],\n",
       " ['it', 'were', 'to'],\n",
       " ['were', 'to', 'turn'],\n",
       " ['to', 'turn', 'out'],\n",
       " ['turn', 'out', 'that'],\n",
       " ['out', 'that', 'CQ'],\n",
       " ['that', 'CQ', 'and'],\n",
       " ['CQ', 'and', 'HCQ'],\n",
       " ['and', 'HCQ', 'are'],\n",
       " ['HCQ', 'are', 'not'],\n",
       " ['are', 'not', 'useful'],\n",
       " ['not', 'useful', 'drugs'],\n",
       " ['useful', 'drugs', 'in'],\n",
       " ['drugs', 'in', 'practice,'],\n",
       " ['in', 'practice,', 'further'],\n",
       " ['practice,', 'further', 'studies'],\n",
       " ['further', 'studies', 'of'],\n",
       " ['studies', 'of', 'their'],\n",
       " ['of', 'their', 'mechanism'],\n",
       " ['their', 'mechanism', 'of'],\n",
       " ['mechanism', 'of', 'action'],\n",
       " ['of', 'action', 'could'],\n",
       " ['action', 'could', 'be'],\n",
       " ['could', 'be', 'helpful'],\n",
       " ['be', 'helpful', 'in'],\n",
       " ['helpful', 'in', 'improving'],\n",
       " ['in', 'improving', 'our'],\n",
       " ['improving', 'our', 'understanding'],\n",
       " ['our', 'understanding', 'of'],\n",
       " ['understanding', 'of', 'COVID-19'],\n",
       " ['of', 'COVID-19', 'pathology'],\n",
       " ['COVID-19', 'pathology', 'Background'],\n",
       " ['pathology', 'Background', 'and'],\n",
       " ['Background', 'and', 'aims'],\n",
       " ['and', 'aims', 'As'],\n",
       " ['aims', 'As', 'the'],\n",
       " ['As', 'the', 'Coronavirus'],\n",
       " ['the', 'Coronavirus', 'disease'],\n",
       " ['Coronavirus', 'disease', '2019'],\n",
       " ['disease', '2019', '(COVID-19)'],\n",
       " ['2019', '(COVID-19)', 'pandemic'],\n",
       " ['(COVID-19)', 'pandemic', 'unravels'],\n",
       " ['pandemic', 'unravels', 'rapidly,'],\n",
       " ['unravels', 'rapidly,', 'there'],\n",
       " ['rapidly,', 'there', 'is'],\n",
       " ['there', 'is', 'a'],\n",
       " ['is', 'a', 'glut'],\n",
       " ['a', 'glut', 'of'],\n",
       " ['glut', 'of', 'confusing'],\n",
       " ['of', 'confusing', 'and'],\n",
       " ['confusing', 'and', 'divergent'],\n",
       " ['and', 'divergent', 'scientific'],\n",
       " ['divergent', 'scientific', 'information'],\n",
       " ['scientific', 'information', 'emanating'],\n",
       " ['information', 'emanating', 'from'],\n",
       " ['emanating', 'from', 'differing'],\n",
       " ['from', 'differing', 'sources,'],\n",
       " ['differing', 'sources,', 'including'],\n",
       " ['sources,', 'including', 'the'],\n",
       " ['including', 'the', 'Indian'],\n",
       " ['the', 'Indian', 'National'],\n",
       " ['Indian', 'National', 'Task'],\n",
       " ['National', 'Task', 'Force'],\n",
       " ['Task', 'Force', 'for'],\n",
       " ['Force', 'for', 'COVID-19'],\n",
       " ['for', 'COVID-19', 'Thus,'],\n",
       " ['COVID-19', 'Thus,', 'a'],\n",
       " ['Thus,', 'a', 'web-based'],\n",
       " ['a', 'web-based', 'survey'],\n",
       " ['web-based', 'survey', 'was'],\n",
       " ['survey', 'was', 'conducted'],\n",
       " ['was', 'conducted', 'to'],\n",
       " ['conducted', 'to', 'decipher'],\n",
       " ['to', 'decipher', 'the'],\n",
       " ['decipher', 'the', 'approach'],\n",
       " ['the', 'approach', 'of'],\n",
       " ['approach', 'of', 'Indian'],\n",
       " ['of', 'Indian', 'doctors'],\n",
       " ['Indian', 'doctors', 'to'],\n",
       " ['doctors', 'to', 'the'],\n",
       " ['to', 'the', 'various'],\n",
       " ['the', 'various', 'options'],\n",
       " ['various', 'options', 'for'],\n",
       " ['options', 'for', 'treatment'],\n",
       " ['for', 'treatment', 'of'],\n",
       " ['treatment', 'of', 'COVID-19'],\n",
       " ['of', 'COVID-19', 'Methods'],\n",
       " ['COVID-19', 'Methods', 'A'],\n",
       " ['Methods', 'A', 'web-based'],\n",
       " ['A', 'web-based', 'questionnaire'],\n",
       " ['web-based', 'questionnaire', 'among'],\n",
       " ['questionnaire', 'among', 'one'],\n",
       " ['among', 'one', 'lakh'],\n",
       " ['one', 'lakh', 'doctors'],\n",
       " ['lakh', 'doctors', 'across'],\n",
       " ['doctors', 'across', 'India'],\n",
       " ['across', 'India', 'through'],\n",
       " ['India', 'through', 'email'],\n",
       " ['through', 'email', 'and'],\n",
       " ['email', 'and', 'social'],\n",
       " ['and', 'social', 'media'],\n",
       " ['social', 'media', 'was'],\n",
       " ['media', 'was', 'circulated'],\n",
       " ['was', 'circulated', 'After'],\n",
       " ['circulated', 'After', 'data'],\n",
       " ['After', 'data', 'quality'],\n",
       " ['data', 'quality', 'and'],\n",
       " ['quality', 'and', 'internal'],\n",
       " ['and', 'internal', 'validation,'],\n",
       " ['internal', 'validation,', '826'],\n",
       " ['validation,', '826', 'responses'],\n",
       " ['826', 'responses', 'were'],\n",
       " ['responses', 'were', 'included'],\n",
       " ['were', 'included', 'for'],\n",
       " ['included', 'for', 'analysis'],\n",
       " ['for', 'analysis', 'Basic'],\n",
       " ['analysis', 'Basic', 'demographic'],\n",
       " ['Basic', 'demographic', 'and'],\n",
       " ['demographic', 'and', 'comparative'],\n",
       " ['and', 'comparative', 'analysis'],\n",
       " ['comparative', 'analysis', 'were'],\n",
       " ['analysis', 'were', 'performed'],\n",
       " ['were', 'performed', 'using'],\n",
       " ['performed', 'using', 'the'],\n",
       " ['using', 'the', 'Python3'],\n",
       " ['the', 'Python3', '8'],\n",
       " ['Python3', '8', '2'],\n",
       " ['8', '2', 'software'],\n",
       " ['2', 'software', '(Windows'],\n",
       " ['software', '(Windows', '10'],\n",
       " ['(Windows', '10', '64'],\n",
       " ['10', '64', 'bit,'],\n",
       " ['64', 'bit,', 'USA)'],\n",
       " ['bit,', 'USA)', 'Results'],\n",
       " ['USA)', 'Results', 'Amongst'],\n",
       " ['Results', 'Amongst', 'all'],\n",
       " ['Amongst', 'all', 'the'],\n",
       " ['all', 'the', 'states'],\n",
       " ['the', 'states', 'of'],\n",
       " ['states', 'of', 'India'],\n",
       " ['of', 'India', 'most'],\n",
       " ['India', 'most', 'respondents'],\n",
       " ['most', 'respondents', 'hailed'],\n",
       " ['respondents', 'hailed', 'from'],\n",
       " ['hailed', 'from', 'the'],\n",
       " ['from', 'the', 'top'],\n",
       " ['the', 'top', 'ten'],\n",
       " ['top', 'ten', 'affected'],\n",
       " ['ten', 'affected', 'states'],\n",
       " ['affected', 'states', 'Overall'],\n",
       " ['states', 'Overall', '76'],\n",
       " ['Overall', '76', '15%'],\n",
       " ['76', '15%', 'of'],\n",
       " ['15%', 'of', 'doctors'],\n",
       " ['of', 'doctors', 'would'],\n",
       " ['doctors', 'would', 'either'],\n",
       " ['would', 'either', 'prescribe'],\n",
       " ['either', 'prescribe', 'or'],\n",
       " ['prescribe', 'or', 'consider'],\n",
       " ['or', 'consider', 'prescribing'],\n",
       " ['consider', 'prescribing', 'hydroxychloroquine'],\n",
       " ['prescribing', 'hydroxychloroquine', '(HCQ)'],\n",
       " ['hydroxychloroquine', '(HCQ)', 'as'],\n",
       " ['(HCQ)', 'as', 'prophylaxis'],\n",
       " ['as', 'prophylaxis', 'for'],\n",
       " ['prophylaxis', 'for', 'health-care'],\n",
       " ['for', 'health-care', 'providers'],\n",
       " ['health-care', 'providers', '(HCP)'],\n",
       " ['providers', '(HCP)', 'Doctors'],\n",
       " ['(HCP)', 'Doctors', 'with'],\n",
       " ['Doctors', 'with', 'experience'],\n",
       " ['with', 'experience', 'of'],\n",
       " ['experience', 'of', 'managing'],\n",
       " ['of', 'managing', 'COVID-19'],\n",
       " ['managing', 'COVID-19', 'were'],\n",
       " ['COVID-19', 'were', 'more'],\n",
       " ['were', 'more', 'likely'],\n",
       " ['more', 'likely', 'to'],\n",
       " ['likely', 'to', 'advocate'],\n",
       " ['to', 'advocate', 'use'],\n",
       " ['advocate', 'use', 'of'],\n",
       " ['use', 'of', 'HCQ'],\n",
       " ['of', 'HCQ', 'as'],\n",
       " ['HCQ', 'as', 'prophylaxis'],\n",
       " ['as', 'prophylaxis', 'for'],\n",
       " ['prophylaxis', 'for', 'HCP'],\n",
       " ['for', 'HCP', '(χ2'],\n",
       " ['HCP', '(χ2', '='],\n",
       " ['(χ2', '=', '4'],\n",
       " ['=', '4', '357,'],\n",
       " ['4', '357,', 'P'],\n",
       " ['357,', 'P', '='],\n",
       " ['P', '=', '0'],\n",
       " ['=', '0', '037)'],\n",
       " ['0', '037)', 'Intensivists'],\n",
       " ['037)', 'Intensivists', 'were'],\n",
       " ['Intensivists', 'were', 'more'],\n",
       " ['were', 'more', 'likely'],\n",
       " ['more', 'likely', 'to'],\n",
       " ['likely', 'to', 'advocate'],\n",
       " ['to', 'advocate', 'HCQ'],\n",
       " ['advocate', 'HCQ', 'as'],\n",
       " ['HCQ', 'as', 'prophylaxis'],\n",
       " ['as', 'prophylaxis', '(χ2'],\n",
       " ['prophylaxis', '(χ2', '='],\n",
       " ['(χ2', '=', '14'],\n",
       " ['=', '14', '588,'],\n",
       " ['14', '588,', 'P'],\n",
       " ['588,', 'P', '<'],\n",
       " ['P', '<', '0'],\n",
       " ['<', '0', '001)'],\n",
       " ['0', '001)', 'as'],\n",
       " ['001)', 'as', 'well'],\n",
       " ['as', 'well', 'as'],\n",
       " ['well', 'as', 'for'],\n",
       " ['as', 'for', 'management'],\n",
       " ['for', 'management', 'of'],\n",
       " ['management', 'of', 'mild'],\n",
       " ['of', 'mild', 'to'],\n",
       " ['mild', 'to', 'moderate'],\n",
       " ['to', 'moderate', 'COVID-19'],\n",
       " ['moderate', 'COVID-19', '(χ2'],\n",
       " ['COVID-19', '(χ2', '='],\n",
       " ['(χ2', '=', '3'],\n",
       " ['=', '3', '91,'],\n",
       " ['3', '91,', 'P'],\n",
       " ['91,', 'P', '='],\n",
       " ['P', '=', '0'],\n",
       " ['=', '0', '048)'],\n",
       " ['0', '048)', 'In'],\n",
       " ['048)', 'In', 'COVID-19,'],\n",
       " ['In', 'COVID-19,', '65'],\n",
       " ['COVID-19,', '65', '8%'],\n",
       " ['65', '8%', 'doctors'],\n",
       " ['8%', 'doctors', 'overwhelmingly'],\n",
       " ['doctors', 'overwhelmingly', 'preferred'],\n",
       " ['overwhelmingly', 'preferred', 'using'],\n",
       " ['preferred', 'using', 'anti-viral'],\n",
       " ['using', 'anti-viral', 'agents'],\n",
       " ['anti-viral', 'agents', 'in'],\n",
       " ['agents', 'in', 'severe'],\n",
       " ['in', 'severe', 'cases,'],\n",
       " ['severe', 'cases,', 'continuing'],\n",
       " ['cases,', 'continuing', 'ACEi/ARB'],\n",
       " ['continuing', 'ACEi/ARB', '(60'],\n",
       " ['ACEi/ARB', '(60', '9%),'],\n",
       " ['(60', '9%),', 'and'],\n",
       " ['9%),', 'and', 'routinely'],\n",
       " ['and', 'routinely', 'screening'],\n",
       " ['routinely', 'screening', 'for'],\n",
       " ['screening', 'for', 'COVID-19'],\n",
       " ['for', 'COVID-19', 'as'],\n",
       " ['COVID-19', 'as', 'a'],\n",
       " ['as', 'a', 'pre-operative'],\n",
       " ['a', 'pre-operative', 'strategy'],\n",
       " ['pre-operative', 'strategy', '(73'],\n",
       " ['strategy', '(73', '85%)'],\n",
       " ['(73', '85%)', 'Conclusions'],\n",
       " ['85%)', 'Conclusions', 'Indian'],\n",
       " ['Conclusions', 'Indian', 'doctors'],\n",
       " ['Indian', 'doctors', 'are'],\n",
       " ['doctors', 'are', 'largely'],\n",
       " ['are', 'largely', 'following'],\n",
       " ['largely', 'following', 'the'],\n",
       " ['following', 'the', 'scientific'],\n",
       " ['the', 'scientific', 'guidance'],\n",
       " ['scientific', 'guidance', 'provided'],\n",
       " ['guidance', 'provided', 'by'],\n",
       " ['provided', 'by', 'Indian'],\n",
       " ['by', 'Indian', 'National'],\n",
       " ['Indian', 'National', 'Task'],\n",
       " ['National', 'Task', 'Force'],\n",
       " ['Task', 'Force', 'for'],\n",
       " ['Force', 'for', 'COVID-19'],\n",
       " ['for', 'COVID-19', 'and'],\n",
       " ['COVID-19', 'and', 'would'],\n",
       " ['and', 'would', 'consider'],\n",
       " ['would', 'consider', 'prescribing'],\n",
       " ['consider', 'prescribing', 'HCQ'],\n",
       " ['prescribing', 'HCQ', 'as'],\n",
       " ['HCQ', 'as', 'prophylaxis'],\n",
       " ['as', 'prophylaxis', 'for'],\n",
       " ['prophylaxis', 'for', 'COVID-19'],\n",
       " ['for', 'COVID-19', 'They'],\n",
       " ['COVID-19', 'They', 'would'],\n",
       " ['They', 'would', 'also'],\n",
       " ['would', 'also', 'consider'],\n",
       " ['also', 'consider', 'using'],\n",
       " ['consider', 'using', 'it'],\n",
       " ['using', 'it', 'in'],\n",
       " ['it', 'in', 'mild'],\n",
       " ['in', 'mild', 'to'],\n",
       " ['mild', 'to', 'moderate'],\n",
       " ['to', 'moderate', 'COVID-19'],\n",
       " ['moderate', 'COVID-19', 'Hydroxychloroquine'],\n",
       " ['COVID-19', 'Hydroxychloroquine', 'sulfate'],\n",
       " ['Hydroxychloroquine', 'sulfate', 'is'],\n",
       " ['sulfate', 'is', 'one'],\n",
       " ['is', 'one', 'of'],\n",
       " ['one', 'of', 'a'],\n",
       " ['of', 'a', 'large'],\n",
       " ['a', 'large', 'series'],\n",
       " ['large', 'series', 'of'],\n",
       " ['series', 'of', '4-aminoquinolines'],\n",
       " ['of', '4-aminoquinolines', 'with'],\n",
       " ['4-aminoquinolines', 'with', 'antimalarial'],\n",
       " ['with', 'antimalarial', 'activity'],\n",
       " ['antimalarial', 'activity', 'Moreover,'],\n",
       " ['activity', 'Moreover,', 'it'],\n",
       " ['Moreover,', 'it', 'is'],\n",
       " ['it', 'is', 'used'],\n",
       " ['is', 'used', 'for'],\n",
       " ['used', 'for', 'the'],\n",
       " ['for', 'the', 'treatment'],\n",
       " ['the', 'treatment', 'of'],\n",
       " ['treatment', 'of', 'rheumatoid'],\n",
       " ['of', 'rheumatoid', 'arthritis'],\n",
       " ['rheumatoid', 'arthritis', 'Sometimes'],\n",
       " ['arthritis', 'Sometimes', 'Hydroxychloroquine'],\n",
       " ['Sometimes', 'Hydroxychloroquine', 'sulfate'],\n",
       " ['Hydroxychloroquine', 'sulfate', 'is'],\n",
       " ['sulfate', 'is', 'very'],\n",
       " ['is', 'very', 'effective'],\n",
       " ['very', 'effective', 'for'],\n",
       " ['effective', 'for', 'the'],\n",
       " ['for', 'the', 'treatment'],\n",
       " ['the', 'treatment', 'of'],\n",
       " ['treatment', 'of', 'autoimmune'],\n",
       " ['of', 'autoimmune', 'diseases'],\n",
       " ['autoimmune', 'diseases', 'Based'],\n",
       " ['diseases', 'Based', 'on'],\n",
       " ['Based', 'on', 'the'],\n",
       " ['on', 'the', 'recent'],\n",
       " ['the', 'recent', 'clinical'],\n",
       " ['recent', 'clinical', 'experiments'],\n",
       " ['clinical', 'experiments', 'it'],\n",
       " ['experiments', 'it', 'is'],\n",
       " ['it', 'is', 'exploiting'],\n",
       " ['is', 'exploiting', 'for'],\n",
       " ['exploiting', 'for', 'the'],\n",
       " ['for', 'the', 'treatment'],\n",
       " ['the', 'treatment', 'of'],\n",
       " ['treatment', 'of', 'COVID-19,'],\n",
       " ['of', 'COVID-19,', 'corona'],\n",
       " ['COVID-19,', 'corona', 'virus'],\n",
       " ['corona', 'virus', 'across'],\n",
       " ['virus', 'across', 'the'],\n",
       " ['across', 'the', 'globe'],\n",
       " ['the', 'globe', 'A'],\n",
       " ['globe', 'A', 'Reverse'],\n",
       " ['A', 'Reverse', 'phase'],\n",
       " ['Reverse', 'phase', 'RP-HPLC'],\n",
       " ['phase', 'RP-HPLC', 'method'],\n",
       " ['RP-HPLC', 'method', 'have'],\n",
       " ['method', 'have', 'been'],\n",
       " ['have', 'been', 'developed'],\n",
       " ['been', 'developed', 'and'],\n",
       " ['developed', 'and', 'validated'],\n",
       " ['and', 'validated', 'as'],\n",
       " ['validated', 'as', 'per'],\n",
       " ['as', 'per', 'the'],\n",
       " ['per', 'the', 'current'],\n",
       " ['the', 'current', 'ICH'],\n",
       " ['current', 'ICH', 'guidelines'],\n",
       " ['ICH', 'guidelines', 'for'],\n",
       " ['guidelines', 'for', 'estimation'],\n",
       " ['for', 'estimation', 'of'],\n",
       " ['estimation', 'of', 'Hydroxychloroquine'],\n",
       " ['of', 'Hydroxychloroquine', 'sulfate'],\n",
       " ['Hydroxychloroquine', 'sulfate', 'tablets'],\n",
       " ['sulfate', 'tablets', 'As'],\n",
       " ['tablets', 'As', 'part'],\n",
       " ['As', 'part', 'of'],\n",
       " ['part', 'of', 'method'],\n",
       " ['of', 'method', 'validation'],\n",
       " ['method', 'validation', 'specificity,'],\n",
       " ['validation', 'specificity,', 'linearity,'],\n",
       " ['specificity,', 'linearity,', 'precision'],\n",
       " ['linearity,', 'precision', 'and'],\n",
       " ['precision', 'and', 'recovery'],\n",
       " ['and', 'recovery', 'parameters'],\n",
       " ['recovery', 'parameters', 'were'],\n",
       " ['parameters', 'were', 'verified'],\n",
       " ['were', 'verified', 'The'],\n",
       " ['verified', 'The', 'concentration'],\n",
       " ['The', 'concentration', 'and'],\n",
       " ['concentration', 'and', 'area'],\n",
       " ['and', 'area', 'relationships'],\n",
       " ['area', 'relationships', 'were'],\n",
       " ['relationships', 'were', 'linear'],\n",
       " ['were', 'linear', '(R'],\n",
       " ['linear', '(R', '(2)'],\n",
       " ['(R', '(2)', '>'],\n",
       " ['(2)', '>', '0'],\n",
       " ['>', '0', '999),'],\n",
       " ['0', '999),', 'over'],\n",
       " ['999),', 'over', 'the'],\n",
       " ['over', 'the', 'concentration'],\n",
       " ['the', 'concentration', 'range'],\n",
       " ['concentration', 'range', 'of'],\n",
       " ['range', 'of', '25'],\n",
       " ['of', '25', 'to'],\n",
       " ['25', 'to', '300'],\n",
       " ['to', '300', 'µg'],\n",
       " ['300', 'µg', 'mL'],\n",
       " ['µg', 'mL', '(-1)'],\n",
       " ['mL', '(-1)', 'for'],\n",
       " ['(-1)', 'for', 'HCQ'],\n",
       " ['for', 'HCQ', 'The'],\n",
       " ['HCQ', 'The', 'relative'],\n",
       " ['The', 'relative', 'standard'],\n",
       " ['relative', 'standard', 'deviations'],\n",
       " ['standard', 'deviations', 'for'],\n",
       " ['deviations', 'for', 'precision'],\n",
       " ['for', 'precision', 'and'],\n",
       " ['precision', 'and', 'intermediate'],\n",
       " ['and', 'intermediate', 'precision'],\n",
       " ['intermediate', 'precision', 'were'],\n",
       " ['precision', 'were', 'less'],\n",
       " ['were', 'less', 'than'],\n",
       " ['less', 'than', '1'],\n",
       " ['than', '1', '5%'],\n",
       " ['1', '5%', 'The'],\n",
       " ['5%', 'The', 'proposed'],\n",
       " ['The', 'proposed', 'RP-HPLC'],\n",
       " ['proposed', 'RP-HPLC', 'generic'],\n",
       " ['RP-HPLC', 'generic', 'method'],\n",
       " ['generic', 'method', 'was'],\n",
       " ['method', 'was', 'applied'],\n",
       " ['was', 'applied', 'successfully'],\n",
       " ['applied', 'successfully', 'for'],\n",
       " ['successfully', 'for', 'evaluation'],\n",
       " ['for', 'evaluation', 'of'],\n",
       " ['evaluation', 'of', 'invitro'],\n",
       " ['of', 'invitro', 'dissolution'],\n",
       " ['invitro', 'dissolution', 'profile'],\n",
       " ['dissolution', 'profile', 'with'],\n",
       " ['profile', 'with', 'different'],\n",
       " ['with', 'different', 'pH'],\n",
       " ['different', 'pH', 'conditions'],\n",
       " ['pH', 'conditions', 'like'],\n",
       " ['conditions', 'like', '0'],\n",
       " ['like', '0', '1N'],\n",
       " ['0', '1N', 'HCl,'],\n",
       " ['1N', 'HCl,', 'pH'],\n",
       " ['HCl,', 'pH', '4'],\n",
       " ['pH', '4', '5'],\n",
       " ['4', '5', 'Acetate'],\n",
       " ['5', 'Acetate', 'buffer'],\n",
       " ['Acetate', 'buffer', 'and'],\n",
       " ['buffer', 'and', 'pH'],\n",
       " ['and', 'pH', '6'],\n",
       " ['pH', '6', '8'],\n",
       " ['6', '8', 'Phosphate'],\n",
       " ['8', 'Phosphate', 'buffers'],\n",
       " ['Phosphate', 'buffers', 'of'],\n",
       " ['buffers', 'of', 'US'],\n",
       " ['of', 'US', 'marketed'],\n",
       " ['US', 'marketed', 'reference'],\n",
       " ['marketed', 'reference', 'product'],\n",
       " ['reference', 'product', 'The'],\n",
       " ['product', 'The', 'use'],\n",
       " ['The', 'use', 'of'],\n",
       " ['use', 'of', 'hydroxychloroquine'],\n",
       " ['of', 'hydroxychloroquine', '(HCQ)'],\n",
       " ['hydroxychloroquine', '(HCQ)', 'has'],\n",
       " ['(HCQ)', 'has', 'been'],\n",
       " ['has', 'been', 'considered'],\n",
       " ['been', 'considered', 'a'],\n",
       " ['considered', 'a', 'therapeutic'],\n",
       " ['a', 'therapeutic', 'option'],\n",
       " ['therapeutic', 'option', 'by'],\n",
       " ['option', 'by', 'international'],\n",
       " ['by', 'international', 'guidelines'],\n",
       " ['international', 'guidelines', 'and'],\n",
       " ['guidelines', 'and', 'expert'],\n",
       " ['and', 'expert', 'opinions'],\n",
       " ['expert', 'opinions', 'during'],\n",
       " ['opinions', 'during', 'the'],\n",
       " ['during', 'the', 'first'],\n",
       " ['the', 'first', 'phase'],\n",
       " ['first', 'phase', 'of'],\n",
       " ['phase', 'of', 'COVID-19'],\n",
       " ['of', 'COVID-19', 'pandemics,'],\n",
       " ['COVID-19', 'pandemics,', '1-10'],\n",
       " ['pandemics,', '1-10', 'although'],\n",
       " ['1-10', 'although', 'scientific'],\n",
       " ['although', 'scientific', 'evidence'],\n",
       " ['scientific', 'evidence', 'remained'],\n",
       " ['evidence', 'remained', 'too'],\n",
       " ['remained', 'too', 'scarce'],\n",
       " ['too', 'scarce', 'to'],\n",
       " ['scarce', 'to', 'make'],\n",
       " ['to', 'make', 'a'],\n",
       " ['make', 'a', 'definitive'],\n",
       " ['a', 'definitive', 'recommendation'],\n",
       " ['definitive', 'recommendation', '11'],\n",
       " ['recommendation', '11', '.'],\n",
       " ['11', '.', 'While'],\n",
       " ['.', 'While', 'HCQ'],\n",
       " ['While', 'HCQ', 'use'],\n",
       " ['HCQ', 'use', 'has'],\n",
       " ['use', 'has', 'now'],\n",
       " ['has', 'now', 'been'],\n",
       " ['now', 'been', 'questioned'],\n",
       " ['been', 'questioned', 'by'],\n",
       " ['questioned', 'by', 'recent'],\n",
       " ['by', 'recent', 'data'],\n",
       " ['recent', 'data', '7'],\n",
       " ['data', '7', ','],\n",
       " ['7', ',', 'some'],\n",
       " [',', 'some', 'previous'],\n",
       " ['some', 'previous', 'works'],\n",
       " ['previous', 'works', 'draw'],\n",
       " ['works', 'draw', 'attention'],\n",
       " ['draw', 'attention', 'to'],\n",
       " ['attention', 'to', 'contrasting'],\n",
       " ['to', 'contrasting', 'results'],\n",
       " ['contrasting', 'results', 'on'],\n",
       " ['results', 'on', 'enhanced'],\n",
       " ['on', 'enhanced', 'viral'],\n",
       " ['enhanced', 'viral', 'clearance'],\n",
       " ['viral', 'clearance', 'after'],\n",
       " ['clearance', 'after', 'HCQ'],\n",
       " ['after', 'HCQ', 'treatment'],\n",
       " ['HCQ', 'treatment', '1-6,10'],\n",
       " ['treatment', '1-6,10', '.'],\n",
       " ['1-6,10', '.', 'In'],\n",
       " ['.', 'In', 'recent'],\n",
       " ['In', 'recent', 'months,'],\n",
       " ['recent', 'months,', 'the'],\n",
       " ['months,', 'the', 'new'],\n",
       " ['the', 'new', 'coronavirus'],\n",
       " ['new', 'coronavirus', 'SARS-CoV-2'],\n",
       " ['coronavirus', 'SARS-CoV-2', 'has'],\n",
       " ['SARS-CoV-2', 'has', 'emerged'],\n",
       " ['has', 'emerged', 'as'],\n",
       " ['emerged', 'as', 'a'],\n",
       " ['as', 'a', 'worldwide'],\n",
       " ['a', 'worldwide', 'threat'],\n",
       " ['worldwide', 'threat', 'with'],\n",
       " ['threat', 'with', 'about'],\n",
       " ['with', 'about', '4.2'],\n",
       " ['about', '4.2', 'million'],\n",
       " ['4.2', 'million', 'confirmed'],\n",
       " ['million', 'confirmed', 'cases'],\n",
       " ['confirmed', 'cases', 'and'],\n",
       " ['cases', 'and', 'almost'],\n",
       " ['and', 'almost', '300'],\n",
       " ['almost', '300', '000'],\n",
       " ['300', '000', 'deaths.'],\n",
       " ['000', 'deaths.', 'Its'],\n",
       " ['deaths.', 'Its', 'major'],\n",
       " ['Its', 'major', 'clinical'],\n",
       " ['major', 'clinical', 'presentation'],\n",
       " ['clinical', 'presentation', 'is'],\n",
       " ['presentation', 'is', 'characterized'],\n",
       " ['is', 'characterized', 'by'],\n",
       " ['characterized', 'by', 'respiratory'],\n",
       " ['by', 'respiratory', 'symptoms'],\n",
       " ['respiratory', 'symptoms', 'ranging'],\n",
       " ['symptoms', 'ranging', 'from'],\n",
       " ['ranging', 'from', 'mild'],\n",
       " ['from', 'mild', 'cough'],\n",
       " ['mild', 'cough', 'to'],\n",
       " ['cough', 'to', 'serve'],\n",
       " ['to', 'serve', 'pneumonia'],\n",
       " ['serve', 'pneumonia', 'with'],\n",
       " ['pneumonia', 'with', 'fever'],\n",
       " ['with', 'fever', 'and'],\n",
       " ['fever', 'and', 'potentially'],\n",
       " ['and', 'potentially', 'even'],\n",
       " ['potentially', 'even', 'death.'],\n",
       " ['even', 'death.', 'Until'],\n",
       " ['death.', 'Until', 'today,'],\n",
       " ['Until', 'today,', 'there'],\n",
       " ['today,', 'there', 'is'],\n",
       " ['there', 'is', 'no'],\n",
       " ['is', 'no', 'known'],\n",
       " ['no', 'known', 'medication'],\n",
       " ['known', 'medication', 'to'],\n",
       " ['medication', 'to', 'improve'],\n",
       " ['to', 'improve', 'clinical'],\n",
       " ['improve', 'clinical', 'symptoms'],\n",
       " ['clinical', 'symptoms', 'or'],\n",
       " ['symptoms', 'or', 'even'],\n",
       " ['or', 'even', 'prevent'],\n",
       " ['even', 'prevent', 'or'],\n",
       " ['prevent', 'or', 'fight'],\n",
       " ['or', 'fight', 'the'],\n",
       " ['fight', 'the', 'infection.'],\n",
       " ['the', 'infection.', 'The'],\n",
       " ['infection.', 'The', 'search'],\n",
       " ['The', 'search', 'for'],\n",
       " ['search', 'for', 'a'],\n",
       " ['for', 'a', 'useful'],\n",
       " ['a', 'useful', 'vaccination'],\n",
       " ['useful', 'vaccination', 'is'],\n",
       " ['vaccination', 'is', 'ongoing'],\n",
       " ['is', 'ongoing', 'and'],\n",
       " ['ongoing', 'and', 'it'],\n",
       " ['and', 'it', 'will'],\n",
       " ['it', 'will', 'probably'],\n",
       " ['will', 'probably', 'not'],\n",
       " ['probably', 'not', 'be'],\n",
       " ['not', 'be', 'available'],\n",
       " ['be', 'available', 'before'],\n",
       " ['available', 'before', 'the'],\n",
       " ['before', 'the', 'end'],\n",
       " ['the', 'end', 'of'],\n",
       " ['end', 'of', '2020.'],\n",
       " ['of', '2020.', 'In'],\n",
       " ['2020.', 'In', 'this'],\n",
       " ['In', 'this', 'review,'],\n",
       " ['this', 'review,', 'we'],\n",
       " ['review,', 'we', 'highlight'],\n",
       " ['we', 'highlight', 'hydroxychloroquine'],\n",
       " ['highlight', 'hydroxychloroquine', '(HCQ)'],\n",
       " ['hydroxychloroquine', '(HCQ)', 'as'],\n",
       " ['(HCQ)', 'as', 'a'],\n",
       " ['as', 'a', 'potential'],\n",
       " ['a', 'potential', 'agent'],\n",
       " ['potential', 'agent', 'to'],\n",
       " ['agent', 'to', 'prevent'],\n",
       " ['to', 'prevent', 'coronavirus'],\n",
       " ['prevent', 'coronavirus', 'disease'],\n",
       " ['coronavirus', 'disease', '2019'],\n",
       " ['disease', '2019', '(COVID-19)'],\n",
       " ['2019', '(COVID-19)', 'and'],\n",
       " ['(COVID-19)', 'and', 'reduce'],\n",
       " ['and', 'reduce', 'as'],\n",
       " ['reduce', 'as', 'well'],\n",
       " ['as', 'well', 'as'],\n",
       " ['well', 'as', 'shorten'],\n",
       " ['as', 'shorten', 'clinical'],\n",
       " ['shorten', 'clinical', 'symptoms.'],\n",
       " ['clinical', 'symptoms.', 'Moreover,'],\n",
       " ['symptoms.', 'Moreover,', 'it'],\n",
       " ['Moreover,', 'it', 'might'],\n",
       " ['it', 'might', 'serve'],\n",
       " ['might', 'serve', 'as'],\n",
       " ['serve', 'as', 'a'],\n",
       " ['as', 'a', 'potential'],\n",
       " ['a', 'potential', 'post-exposition'],\n",
       " ['potential', 'post-exposition', 'prophylaxis.'],\n",
       " ['post-exposition', 'prophylaxis.', 'Although'],\n",
       " ['prophylaxis.', 'Although', 'it'],\n",
       " ['Although', 'it', 'has'],\n",
       " ['it', 'has', 'been'],\n",
       " ['has', 'been', 'used'],\n",
       " ['been', 'used', 'in'],\n",
       " ['used', 'in', 'the'],\n",
       " ['in', 'the', 'treatment'],\n",
       " ['the', 'treatment', 'of'],\n",
       " ['treatment', 'of', 'rheumatoid'],\n",
       " ['of', 'rheumatoid', 'arthritis,'],\n",
       " ['rheumatoid', 'arthritis,', 'discoid'],\n",
       " ['arthritis,', 'discoid', 'or'],\n",
       " ['discoid', 'or', 'systemic'],\n",
       " ['or', 'systemic', 'lupus'],\n",
       " ['systemic', 'lupus', 'erythematosus,'],\n",
       " ['lupus', 'erythematosus,', 'and'],\n",
       " ['erythematosus,', 'and', 'malaria'],\n",
       " ['and', 'malaria', 'prophylaxis'],\n",
       " ['malaria', 'prophylaxis', 'and'],\n",
       " ['prophylaxis', 'and', 'therapy'],\n",
       " ['and', 'therapy', 'for'],\n",
       " ['therapy', 'for', 'decades,'],\n",
       " ['for', 'decades,', 'knowledge'],\n",
       " ['decades,', 'knowledge', 'on'],\n",
       " ['knowledge', 'on', 'HCQ'],\n",
       " ['on', 'HCQ', 'as'],\n",
       " ['HCQ', 'as', 'a'],\n",
       " ['as', 'a', 'potential'],\n",
       " ['a', 'potential', 'treatment'],\n",
       " ['potential', 'treatment', 'for'],\n",
       " ['treatment', 'for', 'COVID-19'],\n",
       " ['for', 'COVID-19', 'is'],\n",
       " ['COVID-19', 'is', 'limited'],\n",
       " ['is', 'limited', 'and'],\n",
       " ['limited', 'and', 'multiple'],\n",
       " ['and', 'multiple', 'clinical'],\n",
       " ['multiple', 'clinical', 'trials'],\n",
       " ['clinical', 'trials', 'have'],\n",
       " ['trials', 'have', 'just'],\n",
       " ['have', 'just', 'emerged.'],\n",
       " ['just', 'emerged.', 'Especially,'],\n",
       " ['emerged.', 'Especially,', 'rare'],\n",
       " ['Especially,', 'rare', 'HCQ'],\n",
       " ['rare', 'HCQ', 'side'],\n",
       " ['HCQ', 'side', 'effects'],\n",
       " ['side', 'effects', 'which'],\n",
       " ['effects', 'which', 'were'],\n",
       " ['which', 'were', 'of'],\n",
       " ['were', 'of', 'minor'],\n",
       " ['of', 'minor', 'importance'],\n",
       " ['minor', 'importance', 'for'],\n",
       " ['importance', 'for', 'use'],\n",
       " ['for', 'use', 'in'],\n",
       " ['use', 'in', 'selected'],\n",
       " ['in', 'selected', 'indications'],\n",
       " ['selected', 'indications', 'might'],\n",
       " ['indications', 'might', 'gain'],\n",
       " ['might', 'gain', 'major'],\n",
       " ['gain', 'major', 'relevance'],\n",
       " ['major', 'relevance', 'with'],\n",
       " ['relevance', 'with', 'population-wide'],\n",
       " ['with', 'population-wide', 'application.'],\n",
       " ['population-wide', 'application.', 'These'],\n",
       " ['application.', 'These', 'rare'],\n",
       " ['These', 'rare', 'side'],\n",
       " ['rare', 'side', 'effects'],\n",
       " ['side', 'effects', 'include'],\n",
       " ['effects', 'include', 'retinopathy'],\n",
       " ['include', 'retinopathy', 'and-even'],\n",
       " ['retinopathy', 'and-even', 'more'],\n",
       " ['and-even', 'more', 'important-QT'],\n",
       " ['more', 'important-QT', 'prolongation'],\n",
       " ['important-QT', 'prolongation', 'leading'],\n",
       " ['prolongation', 'leading', 'to'],\n",
       " ['leading', 'to', 'sudden'],\n",
       " ['to', 'sudden', 'cardiac'],\n",
       " ['sudden', 'cardiac', 'death'],\n",
       " ['cardiac', 'death', 'by'],\n",
       " ['death', 'by', 'malignant'],\n",
       " ['by', 'malignant', 'arrhythmias.'],\n",
       " ['malignant', 'arrhythmias.', 'Severe'],\n",
       " ['arrhythmias.', 'Severe', 'acute'],\n",
       " ['Severe', 'acute', 'respiratory'],\n",
       " ['acute', 'respiratory', 'coronavirus'],\n",
       " ['respiratory', 'coronavirus', '2'],\n",
       " ['coronavirus', '2', '(SARS-CoV-2)'],\n",
       " ['2', '(SARS-CoV-2)', 'has'],\n",
       " ['(SARS-CoV-2)', 'has', 'caused'],\n",
       " ['has', 'caused', 'a'],\n",
       " ['caused', 'a', 'devastating'],\n",
       " ['a', 'devastating', 'worldwide'],\n",
       " ['devastating', 'worldwide', 'pandemic.'],\n",
       " ['worldwide', 'pandemic.', 'Hydroxychloroquine'],\n",
       " ['pandemic.', 'Hydroxychloroquine', '(HCQ)'],\n",
       " ['Hydroxychloroquine', '(HCQ)', 'has'],\n",
       " ['(HCQ)', 'has', 'in'],\n",
       " ['has', 'in', 'vitro'],\n",
       " ['in', 'vitro', 'activity'],\n",
       " ['vitro', 'activity', 'against'],\n",
       " ['activity', 'against', 'SARS-CoV-2,'],\n",
       " ['against', 'SARS-CoV-2,', 'but'],\n",
       " ['SARS-CoV-2,', 'but', 'clinical'],\n",
       " ['but', 'clinical', 'data'],\n",
       " ['clinical', 'data', 'supporting'],\n",
       " ['data', 'supporting', 'HCQ'],\n",
       " ['supporting', 'HCQ', 'for'],\n",
       " ['HCQ', 'for', 'coronavirus'],\n",
       " ['for', 'coronavirus', 'disease'],\n",
       " ['coronavirus', 'disease', '2019'],\n",
       " ['disease', '2019', '(COVID-19)'],\n",
       " ['2019', '(COVID-19)', 'are'],\n",
       " ['(COVID-19)', 'are', 'limited.'],\n",
       " ['are', 'limited.', 'METHODS:'],\n",
       " ['limited.', 'METHODS:', 'This'],\n",
       " ['METHODS:', 'This', 'was'],\n",
       " ['This', 'was', 'a'],\n",
       " ['was', 'a', 'retrospective'],\n",
       " ['a', 'retrospective', 'cohort'],\n",
       " ['retrospective', 'cohort', 'study'],\n",
       " ['cohort', 'study', 'of'],\n",
       " ['study', 'of', 'hospitalized'],\n",
       " ['of', 'hospitalized', 'patients'],\n",
       " ['hospitalized', 'patients', 'with'],\n",
       " ['patients', 'with', 'COVID-19'],\n",
       " ['with', 'COVID-19', 'who'],\n",
       " ['COVID-19', 'who', 'received'],\n",
       " ['who', 'received', '≥1'],\n",
       " ['received', '≥1', 'dose'],\n",
       " ['≥1', 'dose', 'of'],\n",
       " ['dose', 'of', 'HCQ'],\n",
       " ['of', 'HCQ', 'at'],\n",
       " ['HCQ', 'at', 'two'],\n",
       " ['at', 'two', 'New'],\n",
       " ['two', 'New', 'York'],\n",
       " ['New', 'York', 'City'],\n",
       " ['York', 'City', 'hospitals.'],\n",
       " ['City', 'hospitals.', 'We'],\n",
       " ['hospitals.', 'We', 'measured'],\n",
       " ['We', 'measured', 'incident'],\n",
       " ['measured', 'incident', 'Grade'],\n",
       " ['incident', 'Grade', '3'],\n",
       " ['Grade', '3', 'or'],\n",
       " ['3', 'or', '4'],\n",
       " ['or', '4', 'blood'],\n",
       " ['4', 'blood', 'count'],\n",
       " ['blood', 'count', 'and'],\n",
       " ['count', 'and', 'liver'],\n",
       " ['and', 'liver', 'test'],\n",
       " ['liver', 'test', 'abnormalities,'],\n",
       " ['test', 'abnormalities,', 'ventricular'],\n",
       " ['abnormalities,', 'ventricular', 'arrhythmias,'],\n",
       " ['ventricular', 'arrhythmias,', 'and'],\n",
       " ['arrhythmias,', 'and', 'vomiting'],\n",
       " ['and', 'vomiting', 'and'],\n",
       " ['vomiting', 'and', 'diarrhea'],\n",
       " ['and', 'diarrhea', 'within'],\n",
       " ['diarrhea', 'within', '10'],\n",
       " ['within', '10', 'days'],\n",
       " ['10', 'days', 'after'],\n",
       " ['days', 'after', 'HCQ'],\n",
       " ['after', 'HCQ', 'initiation,'],\n",
       " ['HCQ', 'initiation,', 'and'],\n",
       " ['initiation,', 'and', 'the'],\n",
       " ['and', 'the', 'proportion'],\n",
       " ['the', 'proportion', 'of'],\n",
       " ['proportion', 'of', 'patients'],\n",
       " ['of', 'patients', 'who'],\n",
       " ['patients', 'who', 'completed'],\n",
       " ['who', 'completed', 'HCQ'],\n",
       " ['completed', 'HCQ', 'therapy.'],\n",
       " ['HCQ', 'therapy.', 'We'],\n",
       " ['therapy.', 'We', 'also'],\n",
       " ['We', 'also', 'describe'],\n",
       " ['also', 'describe', 'changes'],\n",
       " ['describe', 'changes', 'in'],\n",
       " ['changes', 'in', 'Sequential'],\n",
       " ...]"
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "l3"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [],
   "source": [
    "new1_list=[]\n",
    "for x in l3:\n",
    "    new1_list.append('_'.join(x))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['The_ongoing_pandemic',\n",
       " 'ongoing_pandemic_of',\n",
       " 'pandemic_of_coronavirus',\n",
       " 'of_coronavirus_disease',\n",
       " 'coronavirus_disease_2019',\n",
       " 'disease_2019_(COVID-19)',\n",
       " '2019_(COVID-19)_caused',\n",
       " '(COVID-19)_caused_by',\n",
       " 'caused_by_the',\n",
       " 'by_the_severe',\n",
       " 'the_severe_acute',\n",
       " 'severe_acute_respiratory',\n",
       " 'acute_respiratory_syndrome',\n",
       " 'respiratory_syndrome_coronavirus',\n",
       " 'syndrome_coronavirus_2',\n",
       " 'coronavirus_2_(SARS-CoV-2)',\n",
       " '2_(SARS-CoV-2)_poses',\n",
       " '(SARS-CoV-2)_poses_a',\n",
       " 'poses_a_serious',\n",
       " 'a_serious_threat',\n",
       " 'serious_threat_to',\n",
       " 'threat_to_global',\n",
       " 'to_global_public',\n",
       " 'global_public_health',\n",
       " 'public_health_and',\n",
       " 'health_and_there',\n",
       " 'and_there_is',\n",
       " 'there_is_currently',\n",
       " 'is_currently_no',\n",
       " 'currently_no_effective',\n",
       " 'no_effective_antiviral',\n",
       " 'effective_antiviral_therapy',\n",
       " 'antiviral_therapy_It',\n",
       " 'therapy_It_has',\n",
       " 'It_has_been',\n",
       " 'has_been_suggested',\n",
       " 'been_suggested_that',\n",
       " 'suggested_that_Chloroquine',\n",
       " 'that_Chloroquine_(CQ)',\n",
       " 'Chloroquine_(CQ)_and',\n",
       " '(CQ)_and_hydroxychloroquine',\n",
       " 'and_hydroxychloroquine_(HCQ),',\n",
       " 'hydroxychloroquine_(HCQ),_which',\n",
       " '(HCQ),_which_were',\n",
       " 'which_were_primarily',\n",
       " 'were_primarily_employed',\n",
       " 'primarily_employed_as',\n",
       " 'employed_as_prophylaxis',\n",
       " 'as_prophylaxis_and',\n",
       " 'prophylaxis_and_treatment',\n",
       " 'and_treatment_for',\n",
       " 'treatment_for_malaria,',\n",
       " 'for_malaria,_could',\n",
       " 'malaria,_could_be',\n",
       " 'could_be_used',\n",
       " 'be_used_to',\n",
       " 'used_to_treat',\n",
       " 'to_treat_COVID-19',\n",
       " 'treat_COVID-19_CQ',\n",
       " 'COVID-19_CQ_and',\n",
       " 'CQ_and_HCQ',\n",
       " 'and_HCQ_may',\n",
       " 'HCQ_may_be',\n",
       " 'may_be_potential',\n",
       " 'be_potential_inhibitors',\n",
       " 'potential_inhibitors_of',\n",
       " 'inhibitors_of_SARS-CoV-2',\n",
       " 'of_SARS-CoV-2_entry',\n",
       " 'SARS-CoV-2_entry_into',\n",
       " 'entry_into_host',\n",
       " 'into_host_cells,',\n",
       " 'host_cells,_which',\n",
       " 'cells,_which_is',\n",
       " 'which_is_mediated',\n",
       " 'is_mediated_via',\n",
       " 'mediated_via_the',\n",
       " 'via_the_angiotensin-converting',\n",
       " 'the_angiotensin-converting_enzyme',\n",
       " 'angiotensin-converting_enzyme_2',\n",
       " 'enzyme_2_(ACE2),',\n",
       " '2_(ACE2),_and',\n",
       " '(ACE2),_and_may',\n",
       " 'and_may_also',\n",
       " 'may_also_inhibit',\n",
       " 'also_inhibit_subsequent',\n",
       " 'inhibit_subsequent_intracellular',\n",
       " 'subsequent_intracellular_processes',\n",
       " 'intracellular_processes_which',\n",
       " 'processes_which_lead',\n",
       " 'which_lead_to',\n",
       " 'lead_to_COVID-19,',\n",
       " 'to_COVID-19,_including',\n",
       " 'COVID-19,_including_damage',\n",
       " 'including_damage_to',\n",
       " 'damage_to_the',\n",
       " 'to_the_cardiovascular',\n",
       " 'the_cardiovascular_system',\n",
       " 'cardiovascular_system_However,',\n",
       " 'system_However,_paradoxically,',\n",
       " 'However,_paradoxically,_CQ',\n",
       " 'paradoxically,_CQ_and',\n",
       " 'CQ_and_HCQ',\n",
       " 'and_HCQ_have',\n",
       " 'HCQ_have_also',\n",
       " 'have_also_been',\n",
       " 'also_been_reported',\n",
       " 'been_reported_to',\n",
       " 'reported_to_cause',\n",
       " 'to_cause_damage',\n",
       " 'cause_damage_to',\n",
       " 'damage_to_the',\n",
       " 'to_the_cardiovascular',\n",
       " 'the_cardiovascular_system',\n",
       " 'cardiovascular_system_In',\n",
       " 'system_In_this',\n",
       " 'In_this_review,',\n",
       " 'this_review,_we',\n",
       " 'review,_we_provide',\n",
       " 'we_provide_a',\n",
       " 'provide_a_critical',\n",
       " 'a_critical_examination',\n",
       " 'critical_examination_of',\n",
       " 'examination_of_the',\n",
       " 'of_the_published',\n",
       " 'the_published_evidence',\n",
       " 'published_evidence_CQ',\n",
       " 'evidence_CQ_and',\n",
       " 'CQ_and_HCQ',\n",
       " 'and_HCQ_could',\n",
       " 'HCQ_could_potentially',\n",
       " 'could_potentially_be',\n",
       " 'potentially_be_useful',\n",
       " 'be_useful_drugs',\n",
       " 'useful_drugs_in',\n",
       " 'drugs_in_the',\n",
       " 'in_the_treatment',\n",
       " 'the_treatment_of',\n",
       " 'treatment_of_COVID-19',\n",
       " 'of_COVID-19_and',\n",
       " 'COVID-19_and_other',\n",
       " 'and_other_ACE2',\n",
       " 'other_ACE2_involved',\n",
       " 'ACE2_involved_virus',\n",
       " 'involved_virus_infections,',\n",
       " 'virus_infections,_but',\n",
       " 'infections,_but_the',\n",
       " 'but_the_antiviral',\n",
       " 'the_antiviral_effects',\n",
       " 'antiviral_effects_of',\n",
       " 'effects_of_CQ',\n",
       " 'of_CQ_and',\n",
       " 'CQ_and_HCQ',\n",
       " 'and_HCQ_need',\n",
       " 'HCQ_need_to',\n",
       " 'need_to_be',\n",
       " 'to_be_tested',\n",
       " 'be_tested_in',\n",
       " 'tested_in_more',\n",
       " 'in_more_well-designed',\n",
       " 'more_well-designed_clinical',\n",
       " 'well-designed_clinical_randomized',\n",
       " 'clinical_randomized_studies',\n",
       " 'randomized_studies_and',\n",
       " 'studies_and_their',\n",
       " 'and_their_actions',\n",
       " 'their_actions_on',\n",
       " 'actions_on_the',\n",
       " 'on_the_cardiovascular',\n",
       " 'the_cardiovascular_system',\n",
       " 'cardiovascular_system_need',\n",
       " 'system_need_to',\n",
       " 'need_to_be',\n",
       " 'to_be_further',\n",
       " 'be_further_elucidated',\n",
       " 'further_elucidated_However,',\n",
       " 'elucidated_However,_even',\n",
       " 'However,_even_if',\n",
       " 'even_if_it',\n",
       " 'if_it_were',\n",
       " 'it_were_to',\n",
       " 'were_to_turn',\n",
       " 'to_turn_out',\n",
       " 'turn_out_that',\n",
       " 'out_that_CQ',\n",
       " 'that_CQ_and',\n",
       " 'CQ_and_HCQ',\n",
       " 'and_HCQ_are',\n",
       " 'HCQ_are_not',\n",
       " 'are_not_useful',\n",
       " 'not_useful_drugs',\n",
       " 'useful_drugs_in',\n",
       " 'drugs_in_practice,',\n",
       " 'in_practice,_further',\n",
       " 'practice,_further_studies',\n",
       " 'further_studies_of',\n",
       " 'studies_of_their',\n",
       " 'of_their_mechanism',\n",
       " 'their_mechanism_of',\n",
       " 'mechanism_of_action',\n",
       " 'of_action_could',\n",
       " 'action_could_be',\n",
       " 'could_be_helpful',\n",
       " 'be_helpful_in',\n",
       " 'helpful_in_improving',\n",
       " 'in_improving_our',\n",
       " 'improving_our_understanding',\n",
       " 'our_understanding_of',\n",
       " 'understanding_of_COVID-19',\n",
       " 'of_COVID-19_pathology',\n",
       " 'COVID-19_pathology_Background',\n",
       " 'pathology_Background_and',\n",
       " 'Background_and_aims',\n",
       " 'and_aims_As',\n",
       " 'aims_As_the',\n",
       " 'As_the_Coronavirus',\n",
       " 'the_Coronavirus_disease',\n",
       " 'Coronavirus_disease_2019',\n",
       " 'disease_2019_(COVID-19)',\n",
       " '2019_(COVID-19)_pandemic',\n",
       " '(COVID-19)_pandemic_unravels',\n",
       " 'pandemic_unravels_rapidly,',\n",
       " 'unravels_rapidly,_there',\n",
       " 'rapidly,_there_is',\n",
       " 'there_is_a',\n",
       " 'is_a_glut',\n",
       " 'a_glut_of',\n",
       " 'glut_of_confusing',\n",
       " 'of_confusing_and',\n",
       " 'confusing_and_divergent',\n",
       " 'and_divergent_scientific',\n",
       " 'divergent_scientific_information',\n",
       " 'scientific_information_emanating',\n",
       " 'information_emanating_from',\n",
       " 'emanating_from_differing',\n",
       " 'from_differing_sources,',\n",
       " 'differing_sources,_including',\n",
       " 'sources,_including_the',\n",
       " 'including_the_Indian',\n",
       " 'the_Indian_National',\n",
       " 'Indian_National_Task',\n",
       " 'National_Task_Force',\n",
       " 'Task_Force_for',\n",
       " 'Force_for_COVID-19',\n",
       " 'for_COVID-19_Thus,',\n",
       " 'COVID-19_Thus,_a',\n",
       " 'Thus,_a_web-based',\n",
       " 'a_web-based_survey',\n",
       " 'web-based_survey_was',\n",
       " 'survey_was_conducted',\n",
       " 'was_conducted_to',\n",
       " 'conducted_to_decipher',\n",
       " 'to_decipher_the',\n",
       " 'decipher_the_approach',\n",
       " 'the_approach_of',\n",
       " 'approach_of_Indian',\n",
       " 'of_Indian_doctors',\n",
       " 'Indian_doctors_to',\n",
       " 'doctors_to_the',\n",
       " 'to_the_various',\n",
       " 'the_various_options',\n",
       " 'various_options_for',\n",
       " 'options_for_treatment',\n",
       " 'for_treatment_of',\n",
       " 'treatment_of_COVID-19',\n",
       " 'of_COVID-19_Methods',\n",
       " 'COVID-19_Methods_A',\n",
       " 'Methods_A_web-based',\n",
       " 'A_web-based_questionnaire',\n",
       " 'web-based_questionnaire_among',\n",
       " 'questionnaire_among_one',\n",
       " 'among_one_lakh',\n",
       " 'one_lakh_doctors',\n",
       " 'lakh_doctors_across',\n",
       " 'doctors_across_India',\n",
       " 'across_India_through',\n",
       " 'India_through_email',\n",
       " 'through_email_and',\n",
       " 'email_and_social',\n",
       " 'and_social_media',\n",
       " 'social_media_was',\n",
       " 'media_was_circulated',\n",
       " 'was_circulated_After',\n",
       " 'circulated_After_data',\n",
       " 'After_data_quality',\n",
       " 'data_quality_and',\n",
       " 'quality_and_internal',\n",
       " 'and_internal_validation,',\n",
       " 'internal_validation,_826',\n",
       " 'validation,_826_responses',\n",
       " '826_responses_were',\n",
       " 'responses_were_included',\n",
       " 'were_included_for',\n",
       " 'included_for_analysis',\n",
       " 'for_analysis_Basic',\n",
       " 'analysis_Basic_demographic',\n",
       " 'Basic_demographic_and',\n",
       " 'demographic_and_comparative',\n",
       " 'and_comparative_analysis',\n",
       " 'comparative_analysis_were',\n",
       " 'analysis_were_performed',\n",
       " 'were_performed_using',\n",
       " 'performed_using_the',\n",
       " 'using_the_Python3',\n",
       " 'the_Python3_8',\n",
       " 'Python3_8_2',\n",
       " '8_2_software',\n",
       " '2_software_(Windows',\n",
       " 'software_(Windows_10',\n",
       " '(Windows_10_64',\n",
       " '10_64_bit,',\n",
       " '64_bit,_USA)',\n",
       " 'bit,_USA)_Results',\n",
       " 'USA)_Results_Amongst',\n",
       " 'Results_Amongst_all',\n",
       " 'Amongst_all_the',\n",
       " 'all_the_states',\n",
       " 'the_states_of',\n",
       " 'states_of_India',\n",
       " 'of_India_most',\n",
       " 'India_most_respondents',\n",
       " 'most_respondents_hailed',\n",
       " 'respondents_hailed_from',\n",
       " 'hailed_from_the',\n",
       " 'from_the_top',\n",
       " 'the_top_ten',\n",
       " 'top_ten_affected',\n",
       " 'ten_affected_states',\n",
       " 'affected_states_Overall',\n",
       " 'states_Overall_76',\n",
       " 'Overall_76_15%',\n",
       " '76_15%_of',\n",
       " '15%_of_doctors',\n",
       " 'of_doctors_would',\n",
       " 'doctors_would_either',\n",
       " 'would_either_prescribe',\n",
       " 'either_prescribe_or',\n",
       " 'prescribe_or_consider',\n",
       " 'or_consider_prescribing',\n",
       " 'consider_prescribing_hydroxychloroquine',\n",
       " 'prescribing_hydroxychloroquine_(HCQ)',\n",
       " 'hydroxychloroquine_(HCQ)_as',\n",
       " '(HCQ)_as_prophylaxis',\n",
       " 'as_prophylaxis_for',\n",
       " 'prophylaxis_for_health-care',\n",
       " 'for_health-care_providers',\n",
       " 'health-care_providers_(HCP)',\n",
       " 'providers_(HCP)_Doctors',\n",
       " '(HCP)_Doctors_with',\n",
       " 'Doctors_with_experience',\n",
       " 'with_experience_of',\n",
       " 'experience_of_managing',\n",
       " 'of_managing_COVID-19',\n",
       " 'managing_COVID-19_were',\n",
       " 'COVID-19_were_more',\n",
       " 'were_more_likely',\n",
       " 'more_likely_to',\n",
       " 'likely_to_advocate',\n",
       " 'to_advocate_use',\n",
       " 'advocate_use_of',\n",
       " 'use_of_HCQ',\n",
       " 'of_HCQ_as',\n",
       " 'HCQ_as_prophylaxis',\n",
       " 'as_prophylaxis_for',\n",
       " 'prophylaxis_for_HCP',\n",
       " 'for_HCP_(χ2',\n",
       " 'HCP_(χ2_=',\n",
       " '(χ2_=_4',\n",
       " '=_4_357,',\n",
       " '4_357,_P',\n",
       " '357,_P_=',\n",
       " 'P_=_0',\n",
       " '=_0_037)',\n",
       " '0_037)_Intensivists',\n",
       " '037)_Intensivists_were',\n",
       " 'Intensivists_were_more',\n",
       " 'were_more_likely',\n",
       " 'more_likely_to',\n",
       " 'likely_to_advocate',\n",
       " 'to_advocate_HCQ',\n",
       " 'advocate_HCQ_as',\n",
       " 'HCQ_as_prophylaxis',\n",
       " 'as_prophylaxis_(χ2',\n",
       " 'prophylaxis_(χ2_=',\n",
       " '(χ2_=_14',\n",
       " '=_14_588,',\n",
       " '14_588,_P',\n",
       " '588,_P_<',\n",
       " 'P_<_0',\n",
       " '<_0_001)',\n",
       " '0_001)_as',\n",
       " '001)_as_well',\n",
       " 'as_well_as',\n",
       " 'well_as_for',\n",
       " 'as_for_management',\n",
       " 'for_management_of',\n",
       " 'management_of_mild',\n",
       " 'of_mild_to',\n",
       " 'mild_to_moderate',\n",
       " 'to_moderate_COVID-19',\n",
       " 'moderate_COVID-19_(χ2',\n",
       " 'COVID-19_(χ2_=',\n",
       " '(χ2_=_3',\n",
       " '=_3_91,',\n",
       " '3_91,_P',\n",
       " '91,_P_=',\n",
       " 'P_=_0',\n",
       " '=_0_048)',\n",
       " '0_048)_In',\n",
       " '048)_In_COVID-19,',\n",
       " 'In_COVID-19,_65',\n",
       " 'COVID-19,_65_8%',\n",
       " '65_8%_doctors',\n",
       " '8%_doctors_overwhelmingly',\n",
       " 'doctors_overwhelmingly_preferred',\n",
       " 'overwhelmingly_preferred_using',\n",
       " 'preferred_using_anti-viral',\n",
       " 'using_anti-viral_agents',\n",
       " 'anti-viral_agents_in',\n",
       " 'agents_in_severe',\n",
       " 'in_severe_cases,',\n",
       " 'severe_cases,_continuing',\n",
       " 'cases,_continuing_ACEi/ARB',\n",
       " 'continuing_ACEi/ARB_(60',\n",
       " 'ACEi/ARB_(60_9%),',\n",
       " '(60_9%),_and',\n",
       " '9%),_and_routinely',\n",
       " 'and_routinely_screening',\n",
       " 'routinely_screening_for',\n",
       " 'screening_for_COVID-19',\n",
       " 'for_COVID-19_as',\n",
       " 'COVID-19_as_a',\n",
       " 'as_a_pre-operative',\n",
       " 'a_pre-operative_strategy',\n",
       " 'pre-operative_strategy_(73',\n",
       " 'strategy_(73_85%)',\n",
       " '(73_85%)_Conclusions',\n",
       " '85%)_Conclusions_Indian',\n",
       " 'Conclusions_Indian_doctors',\n",
       " 'Indian_doctors_are',\n",
       " 'doctors_are_largely',\n",
       " 'are_largely_following',\n",
       " 'largely_following_the',\n",
       " 'following_the_scientific',\n",
       " 'the_scientific_guidance',\n",
       " 'scientific_guidance_provided',\n",
       " 'guidance_provided_by',\n",
       " 'provided_by_Indian',\n",
       " 'by_Indian_National',\n",
       " 'Indian_National_Task',\n",
       " 'National_Task_Force',\n",
       " 'Task_Force_for',\n",
       " 'Force_for_COVID-19',\n",
       " 'for_COVID-19_and',\n",
       " 'COVID-19_and_would',\n",
       " 'and_would_consider',\n",
       " 'would_consider_prescribing',\n",
       " 'consider_prescribing_HCQ',\n",
       " 'prescribing_HCQ_as',\n",
       " 'HCQ_as_prophylaxis',\n",
       " 'as_prophylaxis_for',\n",
       " 'prophylaxis_for_COVID-19',\n",
       " 'for_COVID-19_They',\n",
       " 'COVID-19_They_would',\n",
       " 'They_would_also',\n",
       " 'would_also_consider',\n",
       " 'also_consider_using',\n",
       " 'consider_using_it',\n",
       " 'using_it_in',\n",
       " 'it_in_mild',\n",
       " 'in_mild_to',\n",
       " 'mild_to_moderate',\n",
       " 'to_moderate_COVID-19',\n",
       " 'moderate_COVID-19_Hydroxychloroquine',\n",
       " 'COVID-19_Hydroxychloroquine_sulfate',\n",
       " 'Hydroxychloroquine_sulfate_is',\n",
       " 'sulfate_is_one',\n",
       " 'is_one_of',\n",
       " 'one_of_a',\n",
       " 'of_a_large',\n",
       " 'a_large_series',\n",
       " 'large_series_of',\n",
       " 'series_of_4-aminoquinolines',\n",
       " 'of_4-aminoquinolines_with',\n",
       " '4-aminoquinolines_with_antimalarial',\n",
       " 'with_antimalarial_activity',\n",
       " 'antimalarial_activity_Moreover,',\n",
       " 'activity_Moreover,_it',\n",
       " 'Moreover,_it_is',\n",
       " 'it_is_used',\n",
       " 'is_used_for',\n",
       " 'used_for_the',\n",
       " 'for_the_treatment',\n",
       " 'the_treatment_of',\n",
       " 'treatment_of_rheumatoid',\n",
       " 'of_rheumatoid_arthritis',\n",
       " 'rheumatoid_arthritis_Sometimes',\n",
       " 'arthritis_Sometimes_Hydroxychloroquine',\n",
       " 'Sometimes_Hydroxychloroquine_sulfate',\n",
       " 'Hydroxychloroquine_sulfate_is',\n",
       " 'sulfate_is_very',\n",
       " 'is_very_effective',\n",
       " 'very_effective_for',\n",
       " 'effective_for_the',\n",
       " 'for_the_treatment',\n",
       " 'the_treatment_of',\n",
       " 'treatment_of_autoimmune',\n",
       " 'of_autoimmune_diseases',\n",
       " 'autoimmune_diseases_Based',\n",
       " 'diseases_Based_on',\n",
       " 'Based_on_the',\n",
       " 'on_the_recent',\n",
       " 'the_recent_clinical',\n",
       " 'recent_clinical_experiments',\n",
       " 'clinical_experiments_it',\n",
       " 'experiments_it_is',\n",
       " 'it_is_exploiting',\n",
       " 'is_exploiting_for',\n",
       " 'exploiting_for_the',\n",
       " 'for_the_treatment',\n",
       " 'the_treatment_of',\n",
       " 'treatment_of_COVID-19,',\n",
       " 'of_COVID-19,_corona',\n",
       " 'COVID-19,_corona_virus',\n",
       " 'corona_virus_across',\n",
       " 'virus_across_the',\n",
       " 'across_the_globe',\n",
       " 'the_globe_A',\n",
       " 'globe_A_Reverse',\n",
       " 'A_Reverse_phase',\n",
       " 'Reverse_phase_RP-HPLC',\n",
       " 'phase_RP-HPLC_method',\n",
       " 'RP-HPLC_method_have',\n",
       " 'method_have_been',\n",
       " 'have_been_developed',\n",
       " 'been_developed_and',\n",
       " 'developed_and_validated',\n",
       " 'and_validated_as',\n",
       " 'validated_as_per',\n",
       " 'as_per_the',\n",
       " 'per_the_current',\n",
       " 'the_current_ICH',\n",
       " 'current_ICH_guidelines',\n",
       " 'ICH_guidelines_for',\n",
       " 'guidelines_for_estimation',\n",
       " 'for_estimation_of',\n",
       " 'estimation_of_Hydroxychloroquine',\n",
       " 'of_Hydroxychloroquine_sulfate',\n",
       " 'Hydroxychloroquine_sulfate_tablets',\n",
       " 'sulfate_tablets_As',\n",
       " 'tablets_As_part',\n",
       " 'As_part_of',\n",
       " 'part_of_method',\n",
       " 'of_method_validation',\n",
       " 'method_validation_specificity,',\n",
       " 'validation_specificity,_linearity,',\n",
       " 'specificity,_linearity,_precision',\n",
       " 'linearity,_precision_and',\n",
       " 'precision_and_recovery',\n",
       " 'and_recovery_parameters',\n",
       " 'recovery_parameters_were',\n",
       " 'parameters_were_verified',\n",
       " 'were_verified_The',\n",
       " 'verified_The_concentration',\n",
       " 'The_concentration_and',\n",
       " 'concentration_and_area',\n",
       " 'and_area_relationships',\n",
       " 'area_relationships_were',\n",
       " 'relationships_were_linear',\n",
       " 'were_linear_(R',\n",
       " 'linear_(R_(2)',\n",
       " '(R_(2)_>',\n",
       " '(2)_>_0',\n",
       " '>_0_999),',\n",
       " '0_999),_over',\n",
       " '999),_over_the',\n",
       " 'over_the_concentration',\n",
       " 'the_concentration_range',\n",
       " 'concentration_range_of',\n",
       " 'range_of_25',\n",
       " 'of_25_to',\n",
       " '25_to_300',\n",
       " 'to_300_µg',\n",
       " '300_µg_mL',\n",
       " 'µg_mL_(-1)',\n",
       " 'mL_(-1)_for',\n",
       " '(-1)_for_HCQ',\n",
       " 'for_HCQ_The',\n",
       " 'HCQ_The_relative',\n",
       " 'The_relative_standard',\n",
       " 'relative_standard_deviations',\n",
       " 'standard_deviations_for',\n",
       " 'deviations_for_precision',\n",
       " 'for_precision_and',\n",
       " 'precision_and_intermediate',\n",
       " 'and_intermediate_precision',\n",
       " 'intermediate_precision_were',\n",
       " 'precision_were_less',\n",
       " 'were_less_than',\n",
       " 'less_than_1',\n",
       " 'than_1_5%',\n",
       " '1_5%_The',\n",
       " '5%_The_proposed',\n",
       " 'The_proposed_RP-HPLC',\n",
       " 'proposed_RP-HPLC_generic',\n",
       " 'RP-HPLC_generic_method',\n",
       " 'generic_method_was',\n",
       " 'method_was_applied',\n",
       " 'was_applied_successfully',\n",
       " 'applied_successfully_for',\n",
       " 'successfully_for_evaluation',\n",
       " 'for_evaluation_of',\n",
       " 'evaluation_of_invitro',\n",
       " 'of_invitro_dissolution',\n",
       " 'invitro_dissolution_profile',\n",
       " 'dissolution_profile_with',\n",
       " 'profile_with_different',\n",
       " 'with_different_pH',\n",
       " 'different_pH_conditions',\n",
       " 'pH_conditions_like',\n",
       " 'conditions_like_0',\n",
       " 'like_0_1N',\n",
       " '0_1N_HCl,',\n",
       " '1N_HCl,_pH',\n",
       " 'HCl,_pH_4',\n",
       " 'pH_4_5',\n",
       " '4_5_Acetate',\n",
       " '5_Acetate_buffer',\n",
       " 'Acetate_buffer_and',\n",
       " 'buffer_and_pH',\n",
       " 'and_pH_6',\n",
       " 'pH_6_8',\n",
       " '6_8_Phosphate',\n",
       " '8_Phosphate_buffers',\n",
       " 'Phosphate_buffers_of',\n",
       " 'buffers_of_US',\n",
       " 'of_US_marketed',\n",
       " 'US_marketed_reference',\n",
       " 'marketed_reference_product',\n",
       " 'reference_product_The',\n",
       " 'product_The_use',\n",
       " 'The_use_of',\n",
       " 'use_of_hydroxychloroquine',\n",
       " 'of_hydroxychloroquine_(HCQ)',\n",
       " 'hydroxychloroquine_(HCQ)_has',\n",
       " '(HCQ)_has_been',\n",
       " 'has_been_considered',\n",
       " 'been_considered_a',\n",
       " 'considered_a_therapeutic',\n",
       " 'a_therapeutic_option',\n",
       " 'therapeutic_option_by',\n",
       " 'option_by_international',\n",
       " 'by_international_guidelines',\n",
       " 'international_guidelines_and',\n",
       " 'guidelines_and_expert',\n",
       " 'and_expert_opinions',\n",
       " 'expert_opinions_during',\n",
       " 'opinions_during_the',\n",
       " 'during_the_first',\n",
       " 'the_first_phase',\n",
       " 'first_phase_of',\n",
       " 'phase_of_COVID-19',\n",
       " 'of_COVID-19_pandemics,',\n",
       " 'COVID-19_pandemics,_1-10',\n",
       " 'pandemics,_1-10_although',\n",
       " '1-10_although_scientific',\n",
       " 'although_scientific_evidence',\n",
       " 'scientific_evidence_remained',\n",
       " 'evidence_remained_too',\n",
       " 'remained_too_scarce',\n",
       " 'too_scarce_to',\n",
       " 'scarce_to_make',\n",
       " 'to_make_a',\n",
       " 'make_a_definitive',\n",
       " 'a_definitive_recommendation',\n",
       " 'definitive_recommendation_11',\n",
       " 'recommendation_11_.',\n",
       " '11_._While',\n",
       " '._While_HCQ',\n",
       " 'While_HCQ_use',\n",
       " 'HCQ_use_has',\n",
       " 'use_has_now',\n",
       " 'has_now_been',\n",
       " 'now_been_questioned',\n",
       " 'been_questioned_by',\n",
       " 'questioned_by_recent',\n",
       " 'by_recent_data',\n",
       " 'recent_data_7',\n",
       " 'data_7_,',\n",
       " '7_,_some',\n",
       " ',_some_previous',\n",
       " 'some_previous_works',\n",
       " 'previous_works_draw',\n",
       " 'works_draw_attention',\n",
       " 'draw_attention_to',\n",
       " 'attention_to_contrasting',\n",
       " 'to_contrasting_results',\n",
       " 'contrasting_results_on',\n",
       " 'results_on_enhanced',\n",
       " 'on_enhanced_viral',\n",
       " 'enhanced_viral_clearance',\n",
       " 'viral_clearance_after',\n",
       " 'clearance_after_HCQ',\n",
       " 'after_HCQ_treatment',\n",
       " 'HCQ_treatment_1-6,10',\n",
       " 'treatment_1-6,10_.',\n",
       " '1-6,10_._In',\n",
       " '._In_recent',\n",
       " 'In_recent_months,',\n",
       " 'recent_months,_the',\n",
       " 'months,_the_new',\n",
       " 'the_new_coronavirus',\n",
       " 'new_coronavirus_SARS-CoV-2',\n",
       " 'coronavirus_SARS-CoV-2_has',\n",
       " 'SARS-CoV-2_has_emerged',\n",
       " 'has_emerged_as',\n",
       " 'emerged_as_a',\n",
       " 'as_a_worldwide',\n",
       " 'a_worldwide_threat',\n",
       " 'worldwide_threat_with',\n",
       " 'threat_with_about',\n",
       " 'with_about_4.2',\n",
       " 'about_4.2_million',\n",
       " '4.2_million_confirmed',\n",
       " 'million_confirmed_cases',\n",
       " 'confirmed_cases_and',\n",
       " 'cases_and_almost',\n",
       " 'and_almost_300',\n",
       " 'almost_300_000',\n",
       " '300_000_deaths.',\n",
       " '000_deaths._Its',\n",
       " 'deaths._Its_major',\n",
       " 'Its_major_clinical',\n",
       " 'major_clinical_presentation',\n",
       " 'clinical_presentation_is',\n",
       " 'presentation_is_characterized',\n",
       " 'is_characterized_by',\n",
       " 'characterized_by_respiratory',\n",
       " 'by_respiratory_symptoms',\n",
       " 'respiratory_symptoms_ranging',\n",
       " 'symptoms_ranging_from',\n",
       " 'ranging_from_mild',\n",
       " 'from_mild_cough',\n",
       " 'mild_cough_to',\n",
       " 'cough_to_serve',\n",
       " 'to_serve_pneumonia',\n",
       " 'serve_pneumonia_with',\n",
       " 'pneumonia_with_fever',\n",
       " 'with_fever_and',\n",
       " 'fever_and_potentially',\n",
       " 'and_potentially_even',\n",
       " 'potentially_even_death.',\n",
       " 'even_death._Until',\n",
       " 'death._Until_today,',\n",
       " 'Until_today,_there',\n",
       " 'today,_there_is',\n",
       " 'there_is_no',\n",
       " 'is_no_known',\n",
       " 'no_known_medication',\n",
       " 'known_medication_to',\n",
       " 'medication_to_improve',\n",
       " 'to_improve_clinical',\n",
       " 'improve_clinical_symptoms',\n",
       " 'clinical_symptoms_or',\n",
       " 'symptoms_or_even',\n",
       " 'or_even_prevent',\n",
       " 'even_prevent_or',\n",
       " 'prevent_or_fight',\n",
       " 'or_fight_the',\n",
       " 'fight_the_infection.',\n",
       " 'the_infection._The',\n",
       " 'infection._The_search',\n",
       " 'The_search_for',\n",
       " 'search_for_a',\n",
       " 'for_a_useful',\n",
       " 'a_useful_vaccination',\n",
       " 'useful_vaccination_is',\n",
       " 'vaccination_is_ongoing',\n",
       " 'is_ongoing_and',\n",
       " 'ongoing_and_it',\n",
       " 'and_it_will',\n",
       " 'it_will_probably',\n",
       " 'will_probably_not',\n",
       " 'probably_not_be',\n",
       " 'not_be_available',\n",
       " 'be_available_before',\n",
       " 'available_before_the',\n",
       " 'before_the_end',\n",
       " 'the_end_of',\n",
       " 'end_of_2020.',\n",
       " 'of_2020._In',\n",
       " '2020._In_this',\n",
       " 'In_this_review,',\n",
       " 'this_review,_we',\n",
       " 'review,_we_highlight',\n",
       " 'we_highlight_hydroxychloroquine',\n",
       " 'highlight_hydroxychloroquine_(HCQ)',\n",
       " 'hydroxychloroquine_(HCQ)_as',\n",
       " '(HCQ)_as_a',\n",
       " 'as_a_potential',\n",
       " 'a_potential_agent',\n",
       " 'potential_agent_to',\n",
       " 'agent_to_prevent',\n",
       " 'to_prevent_coronavirus',\n",
       " 'prevent_coronavirus_disease',\n",
       " 'coronavirus_disease_2019',\n",
       " 'disease_2019_(COVID-19)',\n",
       " '2019_(COVID-19)_and',\n",
       " '(COVID-19)_and_reduce',\n",
       " 'and_reduce_as',\n",
       " 'reduce_as_well',\n",
       " 'as_well_as',\n",
       " 'well_as_shorten',\n",
       " 'as_shorten_clinical',\n",
       " 'shorten_clinical_symptoms.',\n",
       " 'clinical_symptoms._Moreover,',\n",
       " 'symptoms._Moreover,_it',\n",
       " 'Moreover,_it_might',\n",
       " 'it_might_serve',\n",
       " 'might_serve_as',\n",
       " 'serve_as_a',\n",
       " 'as_a_potential',\n",
       " 'a_potential_post-exposition',\n",
       " 'potential_post-exposition_prophylaxis.',\n",
       " 'post-exposition_prophylaxis._Although',\n",
       " 'prophylaxis._Although_it',\n",
       " 'Although_it_has',\n",
       " 'it_has_been',\n",
       " 'has_been_used',\n",
       " 'been_used_in',\n",
       " 'used_in_the',\n",
       " 'in_the_treatment',\n",
       " 'the_treatment_of',\n",
       " 'treatment_of_rheumatoid',\n",
       " 'of_rheumatoid_arthritis,',\n",
       " 'rheumatoid_arthritis,_discoid',\n",
       " 'arthritis,_discoid_or',\n",
       " 'discoid_or_systemic',\n",
       " 'or_systemic_lupus',\n",
       " 'systemic_lupus_erythematosus,',\n",
       " 'lupus_erythematosus,_and',\n",
       " 'erythematosus,_and_malaria',\n",
       " 'and_malaria_prophylaxis',\n",
       " 'malaria_prophylaxis_and',\n",
       " 'prophylaxis_and_therapy',\n",
       " 'and_therapy_for',\n",
       " 'therapy_for_decades,',\n",
       " 'for_decades,_knowledge',\n",
       " 'decades,_knowledge_on',\n",
       " 'knowledge_on_HCQ',\n",
       " 'on_HCQ_as',\n",
       " 'HCQ_as_a',\n",
       " 'as_a_potential',\n",
       " 'a_potential_treatment',\n",
       " 'potential_treatment_for',\n",
       " 'treatment_for_COVID-19',\n",
       " 'for_COVID-19_is',\n",
       " 'COVID-19_is_limited',\n",
       " 'is_limited_and',\n",
       " 'limited_and_multiple',\n",
       " 'and_multiple_clinical',\n",
       " 'multiple_clinical_trials',\n",
       " 'clinical_trials_have',\n",
       " 'trials_have_just',\n",
       " 'have_just_emerged.',\n",
       " 'just_emerged._Especially,',\n",
       " 'emerged._Especially,_rare',\n",
       " 'Especially,_rare_HCQ',\n",
       " 'rare_HCQ_side',\n",
       " 'HCQ_side_effects',\n",
       " 'side_effects_which',\n",
       " 'effects_which_were',\n",
       " 'which_were_of',\n",
       " 'were_of_minor',\n",
       " 'of_minor_importance',\n",
       " 'minor_importance_for',\n",
       " 'importance_for_use',\n",
       " 'for_use_in',\n",
       " 'use_in_selected',\n",
       " 'in_selected_indications',\n",
       " 'selected_indications_might',\n",
       " 'indications_might_gain',\n",
       " 'might_gain_major',\n",
       " 'gain_major_relevance',\n",
       " 'major_relevance_with',\n",
       " 'relevance_with_population-wide',\n",
       " 'with_population-wide_application.',\n",
       " 'population-wide_application._These',\n",
       " 'application._These_rare',\n",
       " 'These_rare_side',\n",
       " 'rare_side_effects',\n",
       " 'side_effects_include',\n",
       " 'effects_include_retinopathy',\n",
       " 'include_retinopathy_and-even',\n",
       " 'retinopathy_and-even_more',\n",
       " 'and-even_more_important-QT',\n",
       " 'more_important-QT_prolongation',\n",
       " 'important-QT_prolongation_leading',\n",
       " 'prolongation_leading_to',\n",
       " 'leading_to_sudden',\n",
       " 'to_sudden_cardiac',\n",
       " 'sudden_cardiac_death',\n",
       " 'cardiac_death_by',\n",
       " 'death_by_malignant',\n",
       " 'by_malignant_arrhythmias.',\n",
       " 'malignant_arrhythmias._Severe',\n",
       " 'arrhythmias._Severe_acute',\n",
       " 'Severe_acute_respiratory',\n",
       " 'acute_respiratory_coronavirus',\n",
       " 'respiratory_coronavirus_2',\n",
       " 'coronavirus_2_(SARS-CoV-2)',\n",
       " '2_(SARS-CoV-2)_has',\n",
       " '(SARS-CoV-2)_has_caused',\n",
       " 'has_caused_a',\n",
       " 'caused_a_devastating',\n",
       " 'a_devastating_worldwide',\n",
       " 'devastating_worldwide_pandemic.',\n",
       " 'worldwide_pandemic._Hydroxychloroquine',\n",
       " 'pandemic._Hydroxychloroquine_(HCQ)',\n",
       " 'Hydroxychloroquine_(HCQ)_has',\n",
       " '(HCQ)_has_in',\n",
       " 'has_in_vitro',\n",
       " 'in_vitro_activity',\n",
       " 'vitro_activity_against',\n",
       " 'activity_against_SARS-CoV-2,',\n",
       " 'against_SARS-CoV-2,_but',\n",
       " 'SARS-CoV-2,_but_clinical',\n",
       " 'but_clinical_data',\n",
       " 'clinical_data_supporting',\n",
       " 'data_supporting_HCQ',\n",
       " 'supporting_HCQ_for',\n",
       " 'HCQ_for_coronavirus',\n",
       " 'for_coronavirus_disease',\n",
       " 'coronavirus_disease_2019',\n",
       " 'disease_2019_(COVID-19)',\n",
       " '2019_(COVID-19)_are',\n",
       " '(COVID-19)_are_limited.',\n",
       " 'are_limited._METHODS:',\n",
       " 'limited._METHODS:_This',\n",
       " 'METHODS:_This_was',\n",
       " 'This_was_a',\n",
       " 'was_a_retrospective',\n",
       " 'a_retrospective_cohort',\n",
       " 'retrospective_cohort_study',\n",
       " 'cohort_study_of',\n",
       " 'study_of_hospitalized',\n",
       " 'of_hospitalized_patients',\n",
       " 'hospitalized_patients_with',\n",
       " 'patients_with_COVID-19',\n",
       " 'with_COVID-19_who',\n",
       " 'COVID-19_who_received',\n",
       " 'who_received_≥1',\n",
       " 'received_≥1_dose',\n",
       " '≥1_dose_of',\n",
       " 'dose_of_HCQ',\n",
       " 'of_HCQ_at',\n",
       " 'HCQ_at_two',\n",
       " 'at_two_New',\n",
       " 'two_New_York',\n",
       " 'New_York_City',\n",
       " 'York_City_hospitals.',\n",
       " 'City_hospitals._We',\n",
       " 'hospitals._We_measured',\n",
       " 'We_measured_incident',\n",
       " 'measured_incident_Grade',\n",
       " 'incident_Grade_3',\n",
       " 'Grade_3_or',\n",
       " '3_or_4',\n",
       " 'or_4_blood',\n",
       " '4_blood_count',\n",
       " 'blood_count_and',\n",
       " 'count_and_liver',\n",
       " 'and_liver_test',\n",
       " 'liver_test_abnormalities,',\n",
       " 'test_abnormalities,_ventricular',\n",
       " 'abnormalities,_ventricular_arrhythmias,',\n",
       " 'ventricular_arrhythmias,_and',\n",
       " 'arrhythmias,_and_vomiting',\n",
       " 'and_vomiting_and',\n",
       " 'vomiting_and_diarrhea',\n",
       " 'and_diarrhea_within',\n",
       " 'diarrhea_within_10',\n",
       " 'within_10_days',\n",
       " '10_days_after',\n",
       " 'days_after_HCQ',\n",
       " 'after_HCQ_initiation,',\n",
       " 'HCQ_initiation,_and',\n",
       " 'initiation,_and_the',\n",
       " 'and_the_proportion',\n",
       " 'the_proportion_of',\n",
       " 'proportion_of_patients',\n",
       " 'of_patients_who',\n",
       " 'patients_who_completed',\n",
       " 'who_completed_HCQ',\n",
       " 'completed_HCQ_therapy.',\n",
       " 'HCQ_therapy._We',\n",
       " 'therapy._We_also',\n",
       " 'We_also_describe',\n",
       " 'also_describe_changes',\n",
       " 'describe_changes_in',\n",
       " 'changes_in_Sequential',\n",
       " ...]"
      ]
     },
     "execution_count": 25,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "new1_list"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "\"The_ongoing_pandemic ongoing_pandemic_of pandemic_of_coronavirus of_coronavirus_disease coronavirus_disease_2019 disease_2019_(COVID-19) 2019_(COVID-19)_caused (COVID-19)_caused_by caused_by_the by_the_severe the_severe_acute severe_acute_respiratory acute_respiratory_syndrome respiratory_syndrome_coronavirus syndrome_coronavirus_2 coronavirus_2_(SARS-CoV-2) 2_(SARS-CoV-2)_poses (SARS-CoV-2)_poses_a poses_a_serious a_serious_threat serious_threat_to threat_to_global to_global_public global_public_health public_health_and health_and_there and_there_is there_is_currently is_currently_no currently_no_effective no_effective_antiviral effective_antiviral_therapy antiviral_therapy_It therapy_It_has It_has_been has_been_suggested been_suggested_that suggested_that_Chloroquine that_Chloroquine_(CQ) Chloroquine_(CQ)_and (CQ)_and_hydroxychloroquine and_hydroxychloroquine_(HCQ), hydroxychloroquine_(HCQ),_which (HCQ),_which_were which_were_primarily were_primarily_employed primarily_employed_as employed_as_prophylaxis as_prophylaxis_and prophylaxis_and_treatment and_treatment_for treatment_for_malaria, for_malaria,_could malaria,_could_be could_be_used be_used_to used_to_treat to_treat_COVID-19 treat_COVID-19_CQ COVID-19_CQ_and CQ_and_HCQ and_HCQ_may HCQ_may_be may_be_potential be_potential_inhibitors potential_inhibitors_of inhibitors_of_SARS-CoV-2 of_SARS-CoV-2_entry SARS-CoV-2_entry_into entry_into_host into_host_cells, host_cells,_which cells,_which_is which_is_mediated is_mediated_via mediated_via_the via_the_angiotensin-converting the_angiotensin-converting_enzyme angiotensin-converting_enzyme_2 enzyme_2_(ACE2), 2_(ACE2),_and (ACE2),_and_may and_may_also may_also_inhibit also_inhibit_subsequent inhibit_subsequent_intracellular subsequent_intracellular_processes intracellular_processes_which processes_which_lead which_lead_to lead_to_COVID-19, to_COVID-19,_including COVID-19,_including_damage including_damage_to damage_to_the to_the_cardiovascular the_cardiovascular_system cardiovascular_system_However, system_However,_paradoxically, However,_paradoxically,_CQ paradoxically,_CQ_and CQ_and_HCQ and_HCQ_have HCQ_have_also have_also_been also_been_reported been_reported_to reported_to_cause to_cause_damage cause_damage_to damage_to_the to_the_cardiovascular the_cardiovascular_system cardiovascular_system_In system_In_this In_this_review, this_review,_we review,_we_provide we_provide_a provide_a_critical a_critical_examination critical_examination_of examination_of_the of_the_published the_published_evidence published_evidence_CQ evidence_CQ_and CQ_and_HCQ and_HCQ_could HCQ_could_potentially could_potentially_be potentially_be_useful be_useful_drugs useful_drugs_in drugs_in_the in_the_treatment the_treatment_of treatment_of_COVID-19 of_COVID-19_and COVID-19_and_other and_other_ACE2 other_ACE2_involved ACE2_involved_virus involved_virus_infections, virus_infections,_but infections,_but_the but_the_antiviral the_antiviral_effects antiviral_effects_of effects_of_CQ of_CQ_and CQ_and_HCQ and_HCQ_need HCQ_need_to need_to_be to_be_tested be_tested_in tested_in_more in_more_well-designed more_well-designed_clinical well-designed_clinical_randomized clinical_randomized_studies randomized_studies_and studies_and_their and_their_actions their_actions_on actions_on_the on_the_cardiovascular the_cardiovascular_system cardiovascular_system_need system_need_to need_to_be to_be_further be_further_elucidated further_elucidated_However, elucidated_However,_even However,_even_if even_if_it if_it_were it_were_to were_to_turn to_turn_out turn_out_that out_that_CQ that_CQ_and CQ_and_HCQ and_HCQ_are HCQ_are_not are_not_useful not_useful_drugs useful_drugs_in drugs_in_practice, in_practice,_further practice,_further_studies further_studies_of studies_of_their of_their_mechanism their_mechanism_of mechanism_of_action of_action_could action_could_be could_be_helpful be_helpful_in helpful_in_improving in_improving_our improving_our_understanding our_understanding_of understanding_of_COVID-19 of_COVID-19_pathology COVID-19_pathology_Background pathology_Background_and Background_and_aims and_aims_As aims_As_the As_the_Coronavirus the_Coronavirus_disease Coronavirus_disease_2019 disease_2019_(COVID-19) 2019_(COVID-19)_pandemic (COVID-19)_pandemic_unravels pandemic_unravels_rapidly, unravels_rapidly,_there rapidly,_there_is there_is_a is_a_glut a_glut_of glut_of_confusing of_confusing_and confusing_and_divergent and_divergent_scientific divergent_scientific_information scientific_information_emanating information_emanating_from emanating_from_differing from_differing_sources, differing_sources,_including sources,_including_the including_the_Indian the_Indian_National Indian_National_Task National_Task_Force Task_Force_for Force_for_COVID-19 for_COVID-19_Thus, COVID-19_Thus,_a Thus,_a_web-based a_web-based_survey web-based_survey_was survey_was_conducted was_conducted_to conducted_to_decipher to_decipher_the decipher_the_approach the_approach_of approach_of_Indian of_Indian_doctors Indian_doctors_to doctors_to_the to_the_various the_various_options various_options_for options_for_treatment for_treatment_of treatment_of_COVID-19 of_COVID-19_Methods COVID-19_Methods_A Methods_A_web-based A_web-based_questionnaire web-based_questionnaire_among questionnaire_among_one among_one_lakh one_lakh_doctors lakh_doctors_across doctors_across_India across_India_through India_through_email through_email_and email_and_social and_social_media social_media_was media_was_circulated was_circulated_After circulated_After_data After_data_quality data_quality_and quality_and_internal and_internal_validation, internal_validation,_826 validation,_826_responses 826_responses_were responses_were_included were_included_for included_for_analysis for_analysis_Basic analysis_Basic_demographic Basic_demographic_and demographic_and_comparative and_comparative_analysis comparative_analysis_were analysis_were_performed were_performed_using performed_using_the using_the_Python3 the_Python3_8 Python3_8_2 8_2_software 2_software_(Windows software_(Windows_10 (Windows_10_64 10_64_bit, 64_bit,_USA) bit,_USA)_Results USA)_Results_Amongst Results_Amongst_all Amongst_all_the all_the_states the_states_of states_of_India of_India_most India_most_respondents most_respondents_hailed respondents_hailed_from hailed_from_the from_the_top the_top_ten top_ten_affected ten_affected_states affected_states_Overall states_Overall_76 Overall_76_15% 76_15%_of 15%_of_doctors of_doctors_would doctors_would_either would_either_prescribe either_prescribe_or prescribe_or_consider or_consider_prescribing consider_prescribing_hydroxychloroquine prescribing_hydroxychloroquine_(HCQ) hydroxychloroquine_(HCQ)_as (HCQ)_as_prophylaxis as_prophylaxis_for prophylaxis_for_health-care for_health-care_providers health-care_providers_(HCP) providers_(HCP)_Doctors (HCP)_Doctors_with Doctors_with_experience with_experience_of experience_of_managing of_managing_COVID-19 managing_COVID-19_were COVID-19_were_more were_more_likely more_likely_to likely_to_advocate to_advocate_use advocate_use_of use_of_HCQ of_HCQ_as HCQ_as_prophylaxis as_prophylaxis_for prophylaxis_for_HCP for_HCP_(χ2 HCP_(χ2_= (χ2_=_4 =_4_357, 4_357,_P 357,_P_= P_=_0 =_0_037) 0_037)_Intensivists 037)_Intensivists_were Intensivists_were_more were_more_likely more_likely_to likely_to_advocate to_advocate_HCQ advocate_HCQ_as HCQ_as_prophylaxis as_prophylaxis_(χ2 prophylaxis_(χ2_= (χ2_=_14 =_14_588, 14_588,_P 588,_P_< P_<_0 <_0_001) 0_001)_as 001)_as_well as_well_as well_as_for as_for_management for_management_of management_of_mild of_mild_to mild_to_moderate to_moderate_COVID-19 moderate_COVID-19_(χ2 COVID-19_(χ2_= (χ2_=_3 =_3_91, 3_91,_P 91,_P_= P_=_0 =_0_048) 0_048)_In 048)_In_COVID-19, In_COVID-19,_65 COVID-19,_65_8% 65_8%_doctors 8%_doctors_overwhelmingly doctors_overwhelmingly_preferred overwhelmingly_preferred_using preferred_using_anti-viral using_anti-viral_agents anti-viral_agents_in agents_in_severe in_severe_cases, severe_cases,_continuing cases,_continuing_ACEi/ARB continuing_ACEi/ARB_(60 ACEi/ARB_(60_9%), (60_9%),_and 9%),_and_routinely and_routinely_screening routinely_screening_for screening_for_COVID-19 for_COVID-19_as COVID-19_as_a as_a_pre-operative a_pre-operative_strategy pre-operative_strategy_(73 strategy_(73_85%) (73_85%)_Conclusions 85%)_Conclusions_Indian Conclusions_Indian_doctors Indian_doctors_are doctors_are_largely are_largely_following largely_following_the following_the_scientific the_scientific_guidance scientific_guidance_provided guidance_provided_by provided_by_Indian by_Indian_National Indian_National_Task National_Task_Force Task_Force_for Force_for_COVID-19 for_COVID-19_and COVID-19_and_would and_would_consider would_consider_prescribing consider_prescribing_HCQ prescribing_HCQ_as HCQ_as_prophylaxis as_prophylaxis_for prophylaxis_for_COVID-19 for_COVID-19_They COVID-19_They_would They_would_also would_also_consider also_consider_using consider_using_it using_it_in it_in_mild in_mild_to mild_to_moderate to_moderate_COVID-19 moderate_COVID-19_Hydroxychloroquine COVID-19_Hydroxychloroquine_sulfate Hydroxychloroquine_sulfate_is sulfate_is_one is_one_of one_of_a of_a_large a_large_series large_series_of series_of_4-aminoquinolines of_4-aminoquinolines_with 4-aminoquinolines_with_antimalarial with_antimalarial_activity antimalarial_activity_Moreover, activity_Moreover,_it Moreover,_it_is it_is_used is_used_for used_for_the for_the_treatment the_treatment_of treatment_of_rheumatoid of_rheumatoid_arthritis rheumatoid_arthritis_Sometimes arthritis_Sometimes_Hydroxychloroquine Sometimes_Hydroxychloroquine_sulfate Hydroxychloroquine_sulfate_is sulfate_is_very is_very_effective very_effective_for effective_for_the for_the_treatment the_treatment_of treatment_of_autoimmune of_autoimmune_diseases autoimmune_diseases_Based diseases_Based_on Based_on_the on_the_recent the_recent_clinical recent_clinical_experiments clinical_experiments_it experiments_it_is it_is_exploiting is_exploiting_for exploiting_for_the for_the_treatment the_treatment_of treatment_of_COVID-19, of_COVID-19,_corona COVID-19,_corona_virus corona_virus_across virus_across_the across_the_globe the_globe_A globe_A_Reverse A_Reverse_phase Reverse_phase_RP-HPLC phase_RP-HPLC_method RP-HPLC_method_have method_have_been have_been_developed been_developed_and developed_and_validated and_validated_as validated_as_per as_per_the per_the_current the_current_ICH current_ICH_guidelines ICH_guidelines_for guidelines_for_estimation for_estimation_of estimation_of_Hydroxychloroquine of_Hydroxychloroquine_sulfate Hydroxychloroquine_sulfate_tablets sulfate_tablets_As tablets_As_part As_part_of part_of_method of_method_validation method_validation_specificity, validation_specificity,_linearity, specificity,_linearity,_precision linearity,_precision_and precision_and_recovery and_recovery_parameters recovery_parameters_were parameters_were_verified were_verified_The verified_The_concentration The_concentration_and concentration_and_area and_area_relationships area_relationships_were relationships_were_linear were_linear_(R linear_(R_(2) (R_(2)_> (2)_>_0 >_0_999), 0_999),_over 999),_over_the over_the_concentration the_concentration_range concentration_range_of range_of_25 of_25_to 25_to_300 to_300_µg 300_µg_mL µg_mL_(-1) mL_(-1)_for (-1)_for_HCQ for_HCQ_The HCQ_The_relative The_relative_standard relative_standard_deviations standard_deviations_for deviations_for_precision for_precision_and precision_and_intermediate and_intermediate_precision intermediate_precision_were precision_were_less were_less_than less_than_1 than_1_5% 1_5%_The 5%_The_proposed The_proposed_RP-HPLC proposed_RP-HPLC_generic RP-HPLC_generic_method generic_method_was method_was_applied was_applied_successfully applied_successfully_for successfully_for_evaluation for_evaluation_of evaluation_of_invitro of_invitro_dissolution invitro_dissolution_profile dissolution_profile_with profile_with_different with_different_pH different_pH_conditions pH_conditions_like conditions_like_0 like_0_1N 0_1N_HCl, 1N_HCl,_pH HCl,_pH_4 pH_4_5 4_5_Acetate 5_Acetate_buffer Acetate_buffer_and buffer_and_pH and_pH_6 pH_6_8 6_8_Phosphate 8_Phosphate_buffers Phosphate_buffers_of buffers_of_US of_US_marketed US_marketed_reference marketed_reference_product reference_product_The product_The_use The_use_of use_of_hydroxychloroquine of_hydroxychloroquine_(HCQ) hydroxychloroquine_(HCQ)_has (HCQ)_has_been has_been_considered been_considered_a considered_a_therapeutic a_therapeutic_option therapeutic_option_by option_by_international by_international_guidelines international_guidelines_and guidelines_and_expert and_expert_opinions expert_opinions_during opinions_during_the during_the_first the_first_phase first_phase_of phase_of_COVID-19 of_COVID-19_pandemics, COVID-19_pandemics,_1-10 pandemics,_1-10_although 1-10_although_scientific although_scientific_evidence scientific_evidence_remained evidence_remained_too remained_too_scarce too_scarce_to scarce_to_make to_make_a make_a_definitive a_definitive_recommendation definitive_recommendation_11 recommendation_11_. 11_._While ._While_HCQ While_HCQ_use HCQ_use_has use_has_now has_now_been now_been_questioned been_questioned_by questioned_by_recent by_recent_data recent_data_7 data_7_, 7_,_some ,_some_previous some_previous_works previous_works_draw works_draw_attention draw_attention_to attention_to_contrasting to_contrasting_results contrasting_results_on results_on_enhanced on_enhanced_viral enhanced_viral_clearance viral_clearance_after clearance_after_HCQ after_HCQ_treatment HCQ_treatment_1-6,10 treatment_1-6,10_. 1-6,10_._In ._In_recent In_recent_months, recent_months,_the months,_the_new the_new_coronavirus new_coronavirus_SARS-CoV-2 coronavirus_SARS-CoV-2_has SARS-CoV-2_has_emerged has_emerged_as emerged_as_a as_a_worldwide a_worldwide_threat worldwide_threat_with threat_with_about with_about_4.2 about_4.2_million 4.2_million_confirmed million_confirmed_cases confirmed_cases_and cases_and_almost and_almost_300 almost_300_000 300_000_deaths. 000_deaths._Its deaths._Its_major Its_major_clinical major_clinical_presentation clinical_presentation_is presentation_is_characterized is_characterized_by characterized_by_respiratory by_respiratory_symptoms respiratory_symptoms_ranging symptoms_ranging_from ranging_from_mild from_mild_cough mild_cough_to cough_to_serve to_serve_pneumonia serve_pneumonia_with pneumonia_with_fever with_fever_and fever_and_potentially and_potentially_even potentially_even_death. even_death._Until death._Until_today, Until_today,_there today,_there_is there_is_no is_no_known no_known_medication known_medication_to medication_to_improve to_improve_clinical improve_clinical_symptoms clinical_symptoms_or symptoms_or_even or_even_prevent even_prevent_or prevent_or_fight or_fight_the fight_the_infection. the_infection._The infection._The_search The_search_for search_for_a for_a_useful a_useful_vaccination useful_vaccination_is vaccination_is_ongoing is_ongoing_and ongoing_and_it and_it_will it_will_probably will_probably_not probably_not_be not_be_available be_available_before available_before_the before_the_end the_end_of end_of_2020. of_2020._In 2020._In_this In_this_review, this_review,_we review,_we_highlight we_highlight_hydroxychloroquine highlight_hydroxychloroquine_(HCQ) hydroxychloroquine_(HCQ)_as (HCQ)_as_a as_a_potential a_potential_agent potential_agent_to agent_to_prevent to_prevent_coronavirus prevent_coronavirus_disease coronavirus_disease_2019 disease_2019_(COVID-19) 2019_(COVID-19)_and (COVID-19)_and_reduce and_reduce_as reduce_as_well as_well_as well_as_shorten as_shorten_clinical shorten_clinical_symptoms. clinical_symptoms._Moreover, symptoms._Moreover,_it Moreover,_it_might it_might_serve might_serve_as serve_as_a as_a_potential a_potential_post-exposition potential_post-exposition_prophylaxis. post-exposition_prophylaxis._Although prophylaxis._Although_it Although_it_has it_has_been has_been_used been_used_in used_in_the in_the_treatment the_treatment_of treatment_of_rheumatoid of_rheumatoid_arthritis, rheumatoid_arthritis,_discoid arthritis,_discoid_or discoid_or_systemic or_systemic_lupus systemic_lupus_erythematosus, lupus_erythematosus,_and erythematosus,_and_malaria and_malaria_prophylaxis malaria_prophylaxis_and prophylaxis_and_therapy and_therapy_for therapy_for_decades, for_decades,_knowledge decades,_knowledge_on knowledge_on_HCQ on_HCQ_as HCQ_as_a as_a_potential a_potential_treatment potential_treatment_for treatment_for_COVID-19 for_COVID-19_is COVID-19_is_limited is_limited_and limited_and_multiple and_multiple_clinical multiple_clinical_trials clinical_trials_have trials_have_just have_just_emerged. just_emerged._Especially, emerged._Especially,_rare Especially,_rare_HCQ rare_HCQ_side HCQ_side_effects side_effects_which effects_which_were which_were_of were_of_minor of_minor_importance minor_importance_for importance_for_use for_use_in use_in_selected in_selected_indications selected_indications_might indications_might_gain might_gain_major gain_major_relevance major_relevance_with relevance_with_population-wide with_population-wide_application. population-wide_application._These application._These_rare These_rare_side rare_side_effects side_effects_include effects_include_retinopathy include_retinopathy_and-even retinopathy_and-even_more and-even_more_important-QT more_important-QT_prolongation important-QT_prolongation_leading prolongation_leading_to leading_to_sudden to_sudden_cardiac sudden_cardiac_death cardiac_death_by death_by_malignant by_malignant_arrhythmias. malignant_arrhythmias._Severe arrhythmias._Severe_acute Severe_acute_respiratory acute_respiratory_coronavirus respiratory_coronavirus_2 coronavirus_2_(SARS-CoV-2) 2_(SARS-CoV-2)_has (SARS-CoV-2)_has_caused has_caused_a caused_a_devastating a_devastating_worldwide devastating_worldwide_pandemic. worldwide_pandemic._Hydroxychloroquine pandemic._Hydroxychloroquine_(HCQ) Hydroxychloroquine_(HCQ)_has (HCQ)_has_in has_in_vitro in_vitro_activity vitro_activity_against activity_against_SARS-CoV-2, against_SARS-CoV-2,_but SARS-CoV-2,_but_clinical but_clinical_data clinical_data_supporting data_supporting_HCQ supporting_HCQ_for HCQ_for_coronavirus for_coronavirus_disease coronavirus_disease_2019 disease_2019_(COVID-19) 2019_(COVID-19)_are (COVID-19)_are_limited. are_limited._METHODS: limited._METHODS:_This METHODS:_This_was This_was_a was_a_retrospective a_retrospective_cohort retrospective_cohort_study cohort_study_of study_of_hospitalized of_hospitalized_patients hospitalized_patients_with patients_with_COVID-19 with_COVID-19_who COVID-19_who_received who_received_≥1 received_≥1_dose ≥1_dose_of dose_of_HCQ of_HCQ_at HCQ_at_two at_two_New two_New_York New_York_City York_City_hospitals. City_hospitals._We hospitals._We_measured We_measured_incident measured_incident_Grade incident_Grade_3 Grade_3_or 3_or_4 or_4_blood 4_blood_count blood_count_and count_and_liver and_liver_test liver_test_abnormalities, test_abnormalities,_ventricular abnormalities,_ventricular_arrhythmias, ventricular_arrhythmias,_and arrhythmias,_and_vomiting and_vomiting_and vomiting_and_diarrhea and_diarrhea_within diarrhea_within_10 within_10_days 10_days_after days_after_HCQ after_HCQ_initiation, HCQ_initiation,_and initiation,_and_the and_the_proportion the_proportion_of proportion_of_patients of_patients_who patients_who_completed who_completed_HCQ completed_HCQ_therapy. HCQ_therapy._We therapy._We_also We_also_describe also_describe_changes describe_changes_in changes_in_Sequential in_Sequential_Organ Sequential_Organ_Failure Organ_Failure_Assessment Failure_Assessment_hypoxia Assessment_hypoxia_scores hypoxia_scores_between scores_between_baseline between_baseline_and baseline_and_day and_day_10 day_10_after 10_after_HCQ after_HCQ_initiation HCQ_initiation_and initiation_and_in-hospital and_in-hospital_mortality. in-hospital_mortality._RESULTS: mortality._RESULTS:_None RESULTS:_None_of None_of_the of_the_153 the_153_hospitalized 153_hospitalized_patients hospitalized_patients_with patients_with_COVID-19 with_COVID-19_who COVID-19_who_received who_received_HCQ received_HCQ_developed HCQ_developed_a developed_a_sustained a_sustained_ventricular sustained_ventricular_tachyarrhythmia. ventricular_tachyarrhythmia._Incident tachyarrhythmia._Incident_blood Incident_blood_count blood_count_and count_and_liver and_liver_test liver_test_abnormalities test_abnormalities_occurred abnormalities_occurred_in occurred_in_<15% in_<15%_of <15%_of_patients of_patients_and patients_and_incident and_incident_vomiting incident_vomiting_or vomiting_or_diarrhea or_diarrhea_was diarrhea_was_rare. was_rare._Eighty-nine rare._Eighty-nine_percent Eighty-nine_percent_of percent_of_patients of_patients_completed patients_completed_their completed_their_HCQ their_HCQ_course HCQ_course_and course_and_three and_three_patients three_patients_discontinued patients_discontinued_therapy discontinued_therapy_because therapy_because_of because_of_QT of_QT_prolongation. QT_prolongation._Fifty-two prolongation._Fifty-two_percent Fifty-two_percent_of percent_of_patients of_patients_had patients_had_improved had_improved_hypoxia improved_hypoxia_scores hypoxia_scores_10 scores_10_days 10_days_after days_after_starting after_starting_HCQ. starting_HCQ._Thirty-one HCQ._Thirty-one_percent Thirty-one_percent_of percent_of_patients of_patients_who patients_who_were who_were_receiving were_receiving_mechanical receiving_mechanical_ventilation mechanical_ventilation_at ventilation_at_the at_the_time the_time_of time_of_HCQ of_HCQ_initiation HCQ_initiation_died initiation_died_during died_during_their during_their_hospitalization, their_hospitalization,_compared hospitalization,_compared_to compared_to_18% to_18%_of 18%_of_patients of_patients_who patients_who_were who_were_receiving were_receiving_supplemental receiving_supplemental_oxygen supplemental_oxygen_but oxygen_but_not but_not_requiring not_requiring_mechanical requiring_mechanical_ventilation, mechanical_ventilation,_and ventilation,_and_8% and_8%_of 8%_of_patients of_patients_who patients_who_were who_were_not were_not_requiring not_requiring_supplemental requiring_supplemental_oxygen. supplemental_oxygen._Co-administration oxygen._Co-administration_of Co-administration_of_azithromycin of_azithromycin_was azithromycin_was_not was_not_associated not_associated_with associated_with_improved with_improved_outcomes. improved_outcomes._CONCLUSIONS: outcomes._CONCLUSIONS:_HCQ CONCLUSIONS:_HCQ_appears HCQ_appears_to appears_to_be to_be_reasonably be_reasonably_safe reasonably_safe_and safe_and_tolerable and_tolerable_in tolerable_in_most in_most_hospitalized most_hospitalized_patients hospitalized_patients_with patients_with_COVID-19. with_COVID-19._However, COVID-19._However,_nearly However,_nearly_one-half nearly_one-half_of one-half_of_patients of_patients_did patients_did_not did_not_improve not_improve_with improve_with_this with_this_treatment, this_treatment,_highlighting treatment,_highlighting_the highlighting_the_need the_need_to need_to_evaluate to_evaluate_HCQ evaluate_HCQ_and HCQ_and_alternate and_alternate_therapies alternate_therapies_in therapies_in_randomized in_randomized_trials. randomized_trials._The trials._The_aim The_aim_of aim_of_this of_this_work this_work_is work_is_to is_to_trace to_trace_how trace_how_rheumatologists how_rheumatologists_all rheumatologists_all_over all_over_Egypt over_Egypt_are Egypt_are_approaching are_approaching_the approaching_the_COVID-19 the_COVID-19_pandemic COVID-19_pandemic_and pandemic_and_what and_what_changes what_changes_it changes_it_has it_has_brought has_brought_about brought_about_in about_in_the in_the_patients' the_patients'_care patients'_care_with care_with_special with_special_attention special_attention_to attention_to_its to_its_effect its_effect_on effect_on_vulnerable on_vulnerable_rheumatic vulnerable_rheumatic_disease rheumatic_disease_(RD) disease_(RD)_patients. (RD)_patients._This patients._This_survey This_survey_further survey_further_aims further_aims_to aims_to_help to_help_inform help_inform_the inform_the_rheumatology the_rheumatology_community rheumatology_community_about community_about_the about_the_changes the_changes_in changes_in_practice in_practice_during practice_during_the during_the_COVID-19 the_COVID-19_pandemic. COVID-19_pandemic._The pandemic._The_survey The_survey_included survey_included_26 included_26_questions 26_questions_distributed questions_distributed_to distributed_to_University to_University_staff University_staff_members staff_members_across members_across_Egypt across_Egypt_members Egypt_members_of members_of_the of_the_Egyptian the_Egyptian_College Egyptian_College_of College_of_Rheumatology of_Rheumatology_(ECR). Rheumatology_(ECR)._It (ECR)._It_takes It_takes_5-10 takes_5-10_min 5-10_min_to min_to_fill to_fill_out. fill_out._The out._The_practice The_practice_setting practice_setting_of setting_of_participating of_participating_rheumatologists participating_rheumatologists_included rheumatologists_included_University included_University_Teaching University_Teaching_Hospitals Teaching_Hospitals_that Hospitals_that_are that_are_the are_the_main the_main_rheumatology main_rheumatology_and rheumatology_and_clinical and_clinical_immunology clinical_immunology_service immunology_service_providers service_providers_for providers_for_adults for_adults_and adults_and_children and_children_RD children_RD_patients. RD_patients._There patients._There_was There_was_an was_an_overall an_overall_agreement overall_agreement_across agreement_across_the across_the_country the_country_in country_in_the in_the_responses the_responses_to responses_to_the to_the_survey the_survey_that survey_that_took that_took_a took_a_median a_median_time median_time_of time_of_7 of_7_min 7_min_to min_to_fill to_fill_in. fill_in._Potential in._Potential_changes Potential_changes_in changes_in_rheumatology in_rheumatology_outpatient rheumatology_outpatient_practice outpatient_practice_by practice_by_staff by_staff_members staff_members_evolved members_evolved_since evolved_since_the since_the_COVID-19 the_COVID-19_pandemic. COVID-19_pandemic._None pandemic._None_of None_of_the of_the_university the_university_rheumatology university_rheumatology_staff rheumatology_staff_members staff_members_has members_has_prescribed has_prescribed_chloroquine prescribed_chloroquine_or chloroquine_or_HCQ or_HCQ_to HCQ_to_prevent to_prevent_or prevent_or_treat or_treat_COVID-19 treat_COVID-19_in COVID-19_in_a in_a_non-hospitalized a_non-hospitalized_patient non-hospitalized_patient_who patient_who_was who_was_not was_not_previously not_previously_on previously_on_it. on_it._Twenty-three it._Twenty-three_recommended Twenty-three_recommended_decrease/avoid recommended_decrease/avoid_NSAIDs decrease/avoid_NSAIDs_if NSAIDs_if_the if_the_RD the_RD_patient RD_patient_had patient_had_confirmed had_confirmed_COVID-19 confirmed_COVID-19_or COVID-19_or_symptoms. or_symptoms._There symptoms._There_is There_is_an is_an_agreement an_agreement_to agreement_to_the to_the_key the_key_emerging key_emerging_frontline emerging_frontline_role frontline_role_of role_of_rheumatologists of_rheumatologists_in rheumatologists_in_treating in_treating_COVID-19. treating_COVID-19._During COVID-19._During_the During_the_pandemic, the_pandemic,_RD pandemic,_RD_cases RD_cases_requiring cases_requiring_admission requiring_admission_were admission_were_dealt were_dealt_with dealt_with_by with_by_several by_several_modified several_modified_strategies. modified_strategies._The strategies._The_overall The_overall_agreement overall_agreement_among agreement_among_the among_the_different the_different_university different_university_rheumatology university_rheumatology_departments rheumatology_departments_during departments_during_such during_such_critical such_critical_situation critical_situation_has situation_has_provoked has_provoked_the provoked_the_ECR the_ECR_to ECR_to_consider to_consider_providing consider_providing_provisional providing_provisional_guidelines provisional_guidelines_for guidelines_for_dealing for_dealing_with dealing_with_RD with_RD_patients RD_patients_during patients_during_this during_this_global this_global_catastrophe. global_catastrophe._COVID-19 catastrophe._COVID-19_has COVID-19_has_rapidly has_rapidly_become rapidly_become_a become_a_pandemic a_pandemic_for pandemic_for_which for_which_no which_no_antiviral no_antiviral_drug antiviral_drug_or drug_or_vaccine or_vaccine_is vaccine_is_yet is_yet_available2-4. yet_available2-4._Several available2-4._Several_clinical Several_clinical_studies clinical_studies_are studies_are_ongoing are_ongoing_to ongoing_to_evaluate to_evaluate_the evaluate_the_efficacy the_efficacy_of efficacy_of_repurposed of_repurposed_drugs repurposed_drugs_that drugs_that_have that_have_demonstrated have_demonstrated_antiviral demonstrated_antiviral_efficacy antiviral_efficacy_in efficacy_in_vitro. in_vitro._Among vitro._Among_these Among_these_candidates, these_candidates,_hydroxychloroquine candidates,_hydroxychloroquine_(HCQ) hydroxychloroquine_(HCQ)_has (HCQ)_has_been has_been_given been_given_to given_to_thousands to_thousands_of thousands_of_individuals of_individuals_worldwide individuals_worldwide_but worldwide_but_definitive but_definitive_evidence definitive_evidence_for evidence_for_HCQ for_HCQ_efficacy HCQ_efficacy_in efficacy_in_treatment in_treatment_of treatment_of_COVID-19 of_COVID-19_is COVID-19_is_still is_still_missing6,7,17,18. still_missing6,7,17,18._We missing6,7,17,18._We_evaluated We_evaluated_the evaluated_the_antiviral the_antiviral_activity antiviral_activity_of activity_of_HCQ of_HCQ_both HCQ_both_in both_in_vitro in_vitro_and vitro_and_in and_in_SARS-CoV-2-infected in_SARS-CoV-2-infected_macaques. SARS-CoV-2-infected_macaques._HCQ macaques._HCQ_showed HCQ_showed_antiviral showed_antiviral_activity antiviral_activity_in activity_in_African in_African_green African_green_monkey green_monkey_kidney monkey_kidney_cells kidney_cells_(VeroE6) cells_(VeroE6)_but (VeroE6)_but_not but_not_in not_in_a in_a_model a_model_of model_of_reconstituted of_reconstituted_human reconstituted_human_airway human_airway_epithelium. airway_epithelium._In epithelium._In_macaques, In_macaques,_we macaques,_we_tested we_tested_different tested_different_treatment different_treatment_strategies treatment_strategies_in strategies_in_comparison in_comparison_to comparison_to_placebo, to_placebo,_before placebo,_before_and before_and_after and_after_peak after_peak_viral peak_viral_load, viral_load,_alone load,_alone_or alone_or_in or_in_combination in_combination_with combination_with_azithromycin with_azithromycin_(AZTH). azithromycin_(AZTH)._Neither (AZTH)._Neither_HCQ Neither_HCQ_nor HCQ_nor_HCQ+AZTH nor_HCQ+AZTH_showed HCQ+AZTH_showed_a showed_a_significant a_significant_effect significant_effect_on effect_on_the on_the_viral the_viral_load viral_load_levels load_levels_in levels_in_any in_any_of any_of_the of_the_tested the_tested_compartments. tested_compartments._When compartments._When_the When_the_drug the_drug_was drug_was_used was_used_as used_as_a as_a_pre-exposure a_pre-exposure_prophylaxis pre-exposure_prophylaxis_(PrEP), prophylaxis_(PrEP),_HCQ (PrEP),_HCQ_did HCQ_did_not did_not_confer not_confer_protection confer_protection_against protection_against_acquisition against_acquisition_of acquisition_of_infection. of_infection._Our infection._Our_findings Our_findings_do findings_do_not do_not_support not_support_the support_the_use the_use_of use_of_HCQ, of_HCQ,_either HCQ,_either_alone either_alone_or alone_or_in or_in_combination in_combination_with combination_with_AZTH, with_AZTH,_as AZTH,_as_an as_an_antiviral an_antiviral_treatment antiviral_treatment_for treatment_for_COVID-19 for_COVID-19_in COVID-19_in_humans. in_humans._Over humans._Over_the Over_the_last the_last_few last_few_months, few_months,_coronavirus months,_coronavirus_disease coronavirus_disease_2019 disease_2019_(COVID-19) 2019_(COVID-19)_pandemic (COVID-19)_pandemic_caused pandemic_caused_by caused_by_the by_the_novel the_novel_coronavirus novel_coronavirus_SARS-CoV-2 coronavirus_SARS-CoV-2_has SARS-CoV-2_has_posed has_posed_a posed_a_serious a_serious_threat serious_threat_to threat_to_public to_public_health public_health_on health_on_a on_a_global a_global_scale. global_scale._Given scale._Given_the Given_the_current the_current_lack current_lack_of lack_of_an of_an_effective an_effective_vaccine, effective_vaccine,_several vaccine,_several_drugs several_drugs_have drugs_have_been have_been_repurposed been_repurposed_for repurposed_for_treatment for_treatment_and treatment_and_prophylaxis and_prophylaxis_of prophylaxis_of_COVID-19 of_COVID-19_in COVID-19_in_an in_an_attempt an_attempt_to attempt_to_find to_find_an find_an_effective an_effective_cure. effective_cure._AREAS cure._AREAS_COVERED AREAS_COVERED_The COVERED_The_antimalarial The_antimalarial_drug antimalarial_drug_hydroxychloroquine drug_hydroxychloroquine_(HCQ) hydroxychloroquine_(HCQ)_initially (HCQ)_initially_garnered initially_garnered_widespread garnered_widespread_attention widespread_attention_following attention_following_the following_the_publication the_publication_of publication_of_preliminary of_preliminary_results preliminary_results_showing results_showing_that showing_that_this that_this_drug this_drug_exerts drug_exerts_an exerts_an_anti-SARS-CoV-2 an_anti-SARS-CoV-2_activity anti-SARS-CoV-2_activity_in activity_in_vitro. in_vitro._EXPERT vitro._EXPERT_OPINION EXPERT_OPINION_To OPINION_To_date, To_date,_clinical date,_clinical_evidence clinical_evidence_suggests evidence_suggests_lack suggests_lack_of lack_of_benefit of_benefit_from benefit_from_HCQ from_HCQ_use HCQ_use_for use_for_the for_the_treatment the_treatment_of treatment_of_hospitalized of_hospitalized_patients hospitalized_patients_with patients_with_COVID-19. with_COVID-19._In COVID-19._In_such In_such_patients, such_patients,_HCQ patients,_HCQ_also HCQ_also_appears also_appears_to appears_to_be to_be_associated be_associated_with associated_with_an with_an_increased an_increased_risk increased_risk_of risk_of_QT of_QT_interval QT_interval_prolongation interval_prolongation_and prolongation_and_potentially and_potentially_lethal potentially_lethal_ventricular lethal_ventricular_arrhythmias. ventricular_arrhythmias._Therefore, arrhythmias._Therefore,_FDA Therefore,_FDA_has FDA_has_recently has_recently_revoked recently_revoked_the revoked_the_Emergency the_Emergency_Use Emergency_Use_Authorization Use_Authorization_(EUA) Authorization_(EUA)_for (EUA)_for_emergency for_emergency_use emergency_use_of use_of_HCQ of_HCQ_and HCQ_and_chloroquine and_chloroquine_to chloroquine_to_treat to_treat_COVID-19. treat_COVID-19._Conversely, COVID-19._Conversely,_whether Conversely,_whether_HCQ whether_HCQ_use HCQ_use_may use_may_represent may_represent_an represent_an_effective an_effective_prophylactic effective_prophylactic_strategy prophylactic_strategy_against strategy_against_COVID-19 against_COVID-19_is COVID-19_is_a is_a_separate a_separate_question separate_question_that question_that_still that_still_remains still_remains_to remains_to_be to_be_answered. be_answered._In answered._In_addition, In_addition,_relevant addition,_relevant_aspects relevant_aspects_regarding aspects_regarding_the regarding_the_potential the_potential_risks potential_risks_and risks_and_benefits and_benefits_of benefits_of_HCQ of_HCQ_need HCQ_need_to need_to_be to_be_clarified, be_clarified,_in clarified,_in_pursuit in_pursuit_of pursuit_of_a of_a_rational a_rational_use rational_use_of use_of_this of_this_drug this_drug_in drug_in_the in_the_COVID-19 the_COVID-19_pandemic COVID-19_pandemic_era. pandemic_era._Three era._Three_months Three_months_have months_have_passed have_passed_since passed_since_the since_the_World the_World_Health World_Health_Organization Health_Organization_(WHO) Organization_(WHO)_declared (WHO)_declared_coronavirus declared_coronavirus_disease coronavirus_disease_19 disease_19_(COVID-19) 19_(COVID-19)_as (COVID-19)_as_a as_a_pandemic a_pandemic_on pandemic_on_March on_March_11, March_11,_2020. 11,_2020._Due 2020._Due_to Due_to_the to_the_high the_high_infection high_infection_rates infection_rates_and rates_and_occurrence and_occurrence_of occurrence_of_severe of_severe_and severe_and_fatal and_fatal_cases, fatal_cases,_the cases,_the_search the_search_for search_for_effective for_effective_drugs effective_drugs_to drugs_to_treat to_treat_and treat_and_control and_control_the control_the_COVID-19 the_COVID-19_pandemic COVID-19_pandemic_has pandemic_has_been has_been_prioritized been_prioritized_by prioritized_by_health by_health_and health_and_political and_political_authorities. political_authorities._Antimalarials, authorities._Antimalarials,_well-known Antimalarials,_well-known_for well-known_for_their for_their_use their_use_in use_in_dermatology in_dermatology_and dermatology_and_rheumatology, and_rheumatology,_are rheumatology,_are_one are_one_of one_of_the of_the_medications the_medications_with medications_with_the with_the_largest the_largest_- largest_-_albeit -_albeit_limited albeit_limited_- limited_-_scientific -_scientific_background scientific_background_warranting background_warranting_their warranting_their_use their_use_in use_in_the in_the_COVID-19 the_COVID-19_treatment COVID-19_treatment_protocols. treatment_protocols._Hydroxychloroquine protocols._Hydroxychloroquine_(HCQ) Hydroxychloroquine_(HCQ)_has (HCQ)_has_been has_been_used been_used_for used_for_the for_the_treatment the_treatment_of treatment_of_COVID-19 of_COVID-19_in COVID-19_in_50 in_50_patients 50_patients_in patients_in_our in_our_and our_and_other and_other_centres other_centres_in centres_in_several in_several_countries several_countries_with countries_with_encouraging with_encouraging_results. encouraging_results._However, results._However,_recent However,_recent_studies recent_studies_disprove studies_disprove_the disprove_the_real the_real_effectiveness real_effectiveness_of effectiveness_of_this of_this_drug, this_drug,_either drug,_either_alone either_alone_or alone_or_when or_when_combined when_combined_with combined_with_macrolides. with_macrolides._As macrolides._As_a As_a_result, a_result,_the result,_the_World the_World_Health World_Health_Organization Health_Organization_has Organization_has_discouraged has_discouraged_the discouraged_the_use the_use_of use_of_HCQ of_HCQ_in HCQ_in_the in_the_treatment the_treatment_and treatment_and_prevention and_prevention_of prevention_of_COVID-19. of_COVID-19._Herein COVID-19._Herein_we Herein_we_report we_report_our report_our_experience our_experience_in experience_in_the in_the_use the_use_of use_of_hydroxychloroquine of_hydroxychloroquine_for hydroxychloroquine_for_COVID-19 for_COVID-19_treatment. COVID-19_treatment._Novel treatment._Novel_coronavirus Novel_coronavirus_disease coronavirus_disease_(COVID-19) disease_(COVID-19)_is (COVID-19)_is_a is_a_highly a_highly_contagious highly_contagious_disease contagious_disease_caused disease_caused_by caused_by_severe by_severe_acute severe_acute_respiratory acute_respiratory_distress respiratory_distress_syndrome distress_syndrome_coronavirus-2 syndrome_coronavirus-2_that coronavirus-2_that_has that_has_resulted has_resulted_in resulted_in_the in_the_current the_current_global current_global_pandemic. global_pandemic._Currently, pandemic._Currently,_there Currently,_there_is there_is_no is_no_available no_available_treatment available_treatment_proven treatment_proven_to proven_to_be to_be_effective be_effective_against effective_against_COVID-19, against_COVID-19,_but COVID-19,_but_multiple but_multiple_medications, multiple_medications,_including medications,_including_hydroxychloroquine including_hydroxychloroquine_(HCQ), hydroxychloroquine_(HCQ),_are (HCQ),_are_used are_used_off used_off_label. off_label._We label._We_report We_report_the report_the_case the_case_of case_of_a of_a_60-year-old a_60-year-old_woman 60-year-old_woman_without woman_without_any without_any_cardiac any_cardiac_history cardiac_history_who history_who_developed who_developed_right developed_right_bundle right_bundle_brunch bundle_brunch_block brunch_block_and block_and_critically and_critically_prolonged critically_prolonged_corrected prolonged_corrected_electrocardiographic corrected_electrocardiographic_QT electrocardiographic_QT_interval QT_interval_(QTc interval_(QTc_631 (QTc_631_ms) 631_ms)_after ms)_after_treatment after_treatment_for treatment_for_3 for_3_days 3_days_with days_with_HCQ, with_HCQ,_which HCQ,_which_resolved which_resolved_on resolved_on_discontinuation on_discontinuation_of discontinuation_of_the of_the_medication. the_medication._This medication._This_case This_case_highlights case_highlights_a highlights_a_significant a_significant_and significant_and_potentially and_potentially_life-threatening potentially_life-threatening_complication life-threatening_complication_of complication_of_HCQ of_HCQ_use HCQ_use_Malaria use_Malaria_is Malaria_is_a is_a_threat a_threat_to threat_to_human to_human_mankind human_mankind_and mankind_and_kills and_kills_about kills_about_half about_half_a half_a_million a_million_people million_people_every people_every_year. every_year._On year._On_the On_the_other the_other_hand, other_hand,_COVID-19 hand,_COVID-19_resulted COVID-19_resulted_in resulted_in_several in_several_hundred several_hundred_thousand hundred_thousand_deaths thousand_deaths_since deaths_since_December since_December_2019 December_2019_and 2019_and_remains and_remains_without remains_without_an without_an_efficient an_efficient_and efficient_and_safe and_safe_treatment. safe_treatment._The treatment._The_antimalarials The_antimalarials_chloroquine antimalarials_chloroquine_(CQ) chloroquine_(CQ)_and (CQ)_and_its and_its_analogue, its_analogue,_hydroxychloroquine analogue,_hydroxychloroquine_(HCQ), hydroxychloroquine_(HCQ),_have (HCQ),_have_been have_been_tested been_tested_for tested_for_COVID-19 for_COVID-19_treatment, COVID-19_treatment,_and treatment,_and_several and_several_conflicting several_conflicting_evidence conflicting_evidence_has evidence_has_been has_been_obtained. been_obtained._Therefore, obtained._Therefore,_the Therefore,_the_aim the_aim_of aim_of_this of_this_review this_review_was review_was_to was_to_summarize to_summarize_the summarize_the_evidence the_evidence_regarding evidence_regarding_action regarding_action_mechanisms action_mechanisms_of mechanisms_of_these of_these_compounds these_compounds_against compounds_against_Plasmodium against_Plasmodium_and Plasmodium_and_SARS-CoV-2 and_SARS-CoV-2_infection, SARS-CoV-2_infection,_together infection,_together_with together_with_cytometry with_cytometry_applications. cytometry_applications._CQ applications._CQ_and CQ_and_HCQ and_HCQ_act HCQ_act_on act_on_the on_the_renin the_renin_angiotensin renin_angiotensin_system, angiotensin_system,_with system,_with_possible with_possible_implications possible_implications_on implications_on_the on_the_cardiorespiratory the_cardiorespiratory_system. cardiorespiratory_system._In system._In_this In_this_context, this_context,_flow context,_flow_and flow_and_image and_image_cytometry image_cytometry_emerge cytometry_emerge_as emerge_as_powerful as_powerful_technologies powerful_technologies_to technologies_to_investigate to_investigate_the investigate_the_mechanism the_mechanism_of mechanism_of_therapeutic of_therapeutic_candidates, therapeutic_candidates,_as candidates,_as_well as_well_as well_as_for as_for_the for_the_identification the_identification_of identification_of_the of_the_immune the_immune_response immune_response_and response_and_prognostics and_prognostics_of prognostics_of_disease of_disease_severity. disease_severity._Data severity._Data_from Data_from_the from_the_large the_large_randomized large_randomized_trials randomized_trials_support trials_support_the support_the_conclusion the_conclusion_that conclusion_that_CQ that_CQ_and CQ_and_HCQ and_HCQ_do HCQ_do_not do_not_provide not_provide_any provide_any_clinical any_clinical_beneficial clinical_beneficial_in beneficial_in_disease in_disease_severity disease_severity_and severity_and_progression and_progression_in progression_in_SARS-CoV-2 in_SARS-CoV-2_patients, SARS-CoV-2_patients,_as patients,_as_well as_well_as, well_as,_do as,_do_not do_not_present not_present_any present_any_solid any_solid_evidence solid_evidence_of evidence_of_increased of_increased_serious increased_serious_side serious_side_effects. side_effects._These effects._These_drugs These_drugs_are drugs_are_safe are_safe_and safe_and_effective and_effective_antimalarials effective_antimalarials_agents, antimalarials_agents,_but agents,_but_in but_in_SARS-CoV-2 in_SARS-CoV-2_patients, SARS-CoV-2_patients,_they patients,_they_need they_need_further need_further_studies further_studies_in studies_in_the in_the_context the_context_of context_of_a of_a_clinical a_clinical_trials. clinical_trials._Amid trials._Amid_controversial Amid_controversial_reports controversial_reports_that reports_that_COVID-19 that_COVID-19_can COVID-19_can_be can_be_treated be_treated_with treated_with_a with_a_combination a_combination_of combination_of_the of_the_antimalarial the_antimalarial_drug antimalarial_drug_hydroxychloroquine drug_hydroxychloroquine_(HCQ) hydroxychloroquine_(HCQ)_and (HCQ)_and_the and_the_antibiotic the_antibiotic_azithromycin antibiotic_azithromycin_(AZI), azithromycin_(AZI),_a (AZI),_a_clinical a_clinical_trial clinical_trial_(ONCOCOVID, trial_(ONCOCOVID,_NCT04341207) (ONCOCOVID,_NCT04341207)_was NCT04341207)_was_launched was_launched_at launched_at_Gustave at_Gustave_Roussy Gustave_Roussy_Cancer Roussy_Cancer_Campus Cancer_Campus_to Campus_to_investigate to_investigate_the investigate_the_utility the_utility_of utility_of_this of_this_combination this_combination_therapy combination_therapy_in therapy_in_cancer in_cancer_patients. cancer_patients._In patients._In_this In_this_preclinical this_preclinical_study, preclinical_study,_we study,_we_investigated we_investigated_whether investigated_whether_the whether_the_combination the_combination_of combination_of_HCQ+AZI of_HCQ+AZI_would HCQ+AZI_would_be would_be_compatible be_compatible_with compatible_with_the with_the_therapeutic the_therapeutic_induction therapeutic_induction_of induction_of_anticancer of_anticancer_immune anticancer_immune_responses. immune_responses._For responses._For_this, For_this,_we this,_we_used we_used_doses used_doses_of doses_of_HCQ of_HCQ_and HCQ_and_AZI and_AZI_that AZI_that_affect that_affect_whole-body affect_whole-body_physiology whole-body_physiology_(as physiology_(as_indicated (as_indicated_by indicated_by_a by_a_partial a_partial_blockade partial_blockade_in blockade_in_cardiac in_cardiac_and cardiac_and_hepatic and_hepatic_autophagic hepatic_autophagic_flux autophagic_flux_for flux_for_HCQ for_HCQ_and HCQ_and_a and_a_reduction a_reduction_in reduction_in_body in_body_weight body_weight_for weight_for_AZI), for_AZI),_showing AZI),_showing_that showing_that_their that_their_combined their_combined_administration combined_administration_did administration_did_not did_not_interfere not_interfere_with interfere_with_tumor with_tumor_growth tumor_growth_control growth_control_induced control_induced_by induced_by_the by_the_immunogenic the_immunogenic_cell immunogenic_cell_death cell_death_inducer death_inducer_oxaliplatin. inducer_oxaliplatin._Moreover, oxaliplatin._Moreover,_the Moreover,_the_HCQ+AZI the_HCQ+AZI_combination HCQ+AZI_combination_did combination_did_not did_not_affect not_affect_the affect_the_capacity the_capacity_of capacity_of_a of_a_curative a_curative_regimen curative_regimen_(cisplatin regimen_(cisplatin_+ (cisplatin_+_crizotinib +_crizotinib_+ crizotinib_+_PD-1 +_PD-1_blockade) PD-1_blockade)_to blockade)_to_eradicate to_eradicate_established eradicate_established_orthotopic established_orthotopic_lung orthotopic_lung_cancers lung_cancers_in cancers_in_mice. in_mice._In mice._In_conclusion, In_conclusion,_it conclusion,_it_appears it_appears_that appears_that_HCQ+AZI that_HCQ+AZI_does HCQ+AZI_does_not does_not_interfere not_interfere_with interfere_with_the with_the_therapeutic the_therapeutic_induction therapeutic_induction_of induction_of_therapeutic of_therapeutic_anticancer therapeutic_anticancer_immune anticancer_immune_responses. immune_responses._On responses._On_3 On_3_March 3_March_2020, March_2020,_the 2020,_the_document the_document_'Drug document_'Drug_treatment 'Drug_treatment_options treatment_options_for options_for_patients for_patients_with patients_with_COVID-19 with_COVID-19_(infections COVID-19_(infections_with (infections_with_SARS-CoV-2)' with_SARS-CoV-2)'_was SARS-CoV-2)'_was_published was_published_on published_on_the on_the_website the_website_of website_of_the of_the_Dutch the_Dutch_Working Dutch_Working_Party Working_Party_on Party_on_Antibiotic on_Antibiotic_Policy Antibiotic_Policy_(Stichting Policy_(Stichting_Werkgroep (Stichting_Werkgroep_Antibioticabeleid, Werkgroep_Antibioticabeleid,_SWAB) Antibioticabeleid,_SWAB)_Based SWAB)_Based_on Based_on_a on_a_7-step a_7-step_analysis 7-step_analysis_of analysis_of_the of_the_literature, the_literature,_hydroxychloroquine literature,_hydroxychloroquine_(HCQ) hydroxychloroquine_(HCQ)_and (HCQ)_and_chloroquine and_chloroquine_(CQ) chloroquine_(CQ)_were (CQ)_were_initially were_initially_included initially_included_in included_in_the in_the_SWAB the_SWAB_document SWAB_document_as document_as_possible as_possible_drug possible_drug_treatments drug_treatments_for treatments_for_hospitalized for_hospitalized_adult hospitalized_adult_COVID-19 adult_COVID-19_patients COVID-19_patients_However, patients_However,_recent However,_recent_weeks recent_weeks_have weeks_have_seen have_seen_the seen_the_publication the_publication_of publication_of_the of_the_results the_results_of results_of_various of_various_studies various_studies_into studies_into_the into_the_effectiveness the_effectiveness_of effectiveness_of_treatment of_treatment_with treatment_with_HCQ with_HCQ_and HCQ_and_CQ and_CQ_in CQ_in_patients in_patients_with patients_with_COVID-19 with_COVID-19_On COVID-19_On_the On_the_basis the_basis_of basis_of_these of_these_results, these_results,_we results,_we_conclude we_conclude_that conclude_that_there that_there_is there_is_insufficient is_insufficient_evidence insufficient_evidence_to evidence_to_consider to_consider_HCQ consider_HCQ_and HCQ_and_CQ and_CQ_as CQ_as_meaningful as_meaningful_treatment meaningful_treatment_options treatment_options_in options_in_patients in_patients_with patients_with_COVID-19 with_COVID-19_Clinically COVID-19_Clinically_relevant Clinically_relevant_QTc relevant_QTc_prolongation QTc_prolongation_occurs prolongation_occurs_in occurs_in_at in_at_least at_least_1 least_1_in 1_in_10 in_10_COVID-19 10_COVID-19_patients COVID-19_patients_treated patients_treated_with treated_with_HCQ with_HCQ_or HCQ_or_HQ\""
      ]
     },
     "execution_count": 26,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "NewString1=' '.join(new1_list)\n",
    "NewString1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 1080x576 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "import tweepy\n",
    "from wordcloud import WordCloud, STOPWORDS\n",
    "import matplotlib.pyplot as plt\n",
    "customStopwords=list(STOPWORDS)+ ['COVID','of_covid','the_covid','to_the','for_covid','of_COVID','in_the','_and','_The']\n",
    "\n",
    "wordcloudimage = WordCloud(\n",
    "                          max_words=100,\n",
    "                          max_font_size=500,\n",
    "                          font_step=2,\n",
    "                          stopwords=customStopwords,\n",
    "                          background_color='black',\n",
    "                          width=1000,\n",
    "                          height=720\n",
    "                          ).generate(NewString)\n",
    "\n",
    "plt.figure(figsize=(15,8))\n",
    "plt.axis(\"off\")\n",
    "plt.imshow(wordcloudimage)\n",
    "wordcloudimage\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.6"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
